data_1eww_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1eww _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.075 0.464 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.503 ' CG2' ' HB2' ' A' ' 17' ' ' CYS . 5.8 t -145.46 13.59 1.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 0.0 110.453 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.478 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 2.3 m120 -97.05 96.41 8.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -113.77 20.18 16.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.33 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.403 ' HB3' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -108.73 -151.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.967 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -143.36 110.19 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.439 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' SER . 25.6 tp -94.15 36.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 68.92 2.19 3.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.737 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 46.56 23.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.941 -1.1 . . . . 0.0 109.639 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -159.91 12.12 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.945 . . . . 0.0 111.465 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . 4.3 m -98.65 -144.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.788 -1.195 . . . . 0.0 109.537 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 18' ' ' GLU . 1.4 tptt -107.41 89.97 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 29.7 p -65.55 64.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 0.0 110.746 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 16' ' ' LYS . 33.2 mm-40 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.031 -1.043 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 38' ' ' THR . 36.4 m-80 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.049 0.452 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -155.79 128.02 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -136.23 91.95 2.73 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.562 ' CG1' ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -94.4 164.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 110.776 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.558 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.8 t0 -137.42 117.04 12.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ASP . 6.7 tttt 40.29 71.3 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.064 -1.023 . . . . 0.0 110.189 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.534 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.6 m -131.51 -175.01 3.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -144.13 100.8 3.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.612 -0.68 . . . . 0.0 109.996 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 10.4 m -110.22 151.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.637 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.547 ' O ' ' CA ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -125.85 94.45 4.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.099 -1.0 . . . . 0.0 110.348 -179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 18' ' ' GLU . . . 60.97 46.11 95.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 50' ' ' SER . 6.2 m -102.45 146.43 28.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -1.092 . . . . 0.0 110.369 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 53' ' ' THR . 2.7 t -90.32 159.7 16.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.431 -0.793 . . . . 0.0 110.39 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 38' ' ' THR . 1.2 m -113.87 -79.79 0.59 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.488 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.1 m 68.25 -68.39 0.17 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.124 -0.985 . . . . 0.0 110.405 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 53' ' ' THR . . . -155.61 104.34 0.25 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.547 ' HB2' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -178.34 179.56 0.78 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -1.132 . . . . 0.0 109.924 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' CG ' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.46 127.56 13.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 110.104 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.562 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 4.6 m-85 -109.17 172.85 6.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.398 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 58' ' ' SER . 0.9 OUTLIER 177.21 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.821 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 66.07 66.48 2.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' A' ' 57' ' ' ILE . 2.4 t -146.28 148.83 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 110.564 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.504 ' N ' HG13 ' A' ' 45' ' ' VAL . 13.3 m -122.25 89.7 3.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.447 -0.783 . . . . 0.0 109.312 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.524 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.65 168.92 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 5.4 t -115.89 -164.88 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.547 ' CA ' ' O ' ' A' ' 33' ' ' TYR . 2.0 m -49.63 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.918 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 6.2 p -132.21 137.46 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.052 -1.03 . . . . 0.0 111.253 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.435 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 26.3 m -87.86 40.13 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.587 -0.696 . . . . 0.0 109.268 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -102.17 103.01 13.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.149 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 6.0 p -146.28 95.56 2.63 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.547 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -156.0 -53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' N ' ' A' ' 89' ' ' ALA . 2.6 p -105.73 -162.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 11.4 mtp180 -95.84 137.62 34.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.519 -0.738 . . . . 0.0 109.917 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' HG12 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -118.3 128.57 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.993 . . . . 0.0 110.186 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -145.68 157.4 43.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.48 125.6 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.2 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.635 1.334 . . . . 0.0 109.4 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.07 33.63 0.2 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.3 t -72.89 146.25 46.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.353 -1.087 . . . . 0.0 110.646 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 111.28 9.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.446 -0.784 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 5.4 tt -104.39 171.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 110.611 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.506 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.3 OUTLIER -142.97 96.35 2.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.32 -0.863 . . . . 0.0 110.046 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 16.7 p 54.64 -93.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.691 -0.631 . . . . 0.0 110.597 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.514 ' N ' ' OG1' ' A' ' 66' ' ' THR . 3.9 m 70.3 -167.5 0.16 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.044 -1.035 . . . . 0.0 109.994 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' SER . 0.5 OUTLIER -130.59 -169.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' ILE . 5.4 mt -42.47 167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.333 -0.854 . . . . 0.0 110.703 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 -139.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 110.867 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 108.87 44.41 1.12 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.528 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.485 1.922 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.193 0.52 . . . . 0.0 109.944 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.545 HD11 ' CE2' ' A' ' 87' ' ' PHE . 1.1 tt -120.66 124.18 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.73 123.53 23.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 71.9 60.8 4.05 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 82' ' ' ILE . 56.3 m -138.79 146.12 40.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 111.25 13.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 109.607 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -142.69 160.13 40.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.948 . . . . 0.0 110.58 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -176.02 94.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' N ' ' CB ' ' A' ' 55' ' ' SER . . . 50.89 172.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.523 ' HA ' ' CD ' ' A' ' 56' ' ' ARG . 28.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.217 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.023 0.439 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 5' ' ' THR . 5.5 t -127.96 53.34 1.79 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.009 -1.057 . . . . 0.0 109.577 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.65 70.45 1.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 111.001 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 4.4 t -98.97 21.82 11.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.086 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 7' ' ' THR . 2.7 m-20 168.49 -17.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.652 -0.655 . . . . 0.0 110.808 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -108.02 -160.44 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 0.0 110.068 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.14 117.34 11.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 1.8 tp -111.24 19.93 17.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 17.1 t 53.34 104.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.901 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.71 -24.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 110.429 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.2 m-20 -87.46 2.54 50.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 111.361 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -101.12 -162.98 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.619 -1.301 . . . . 0.0 110.547 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -111.55 162.75 14.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 28.6 p -128.92 71.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.69 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.527 ' OE2' ' CZ ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 110.516 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.477 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.118 0.485 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -153.84 113.9 3.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.802 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.504 ' HB2' ' HD3' ' A' ' 41' ' ' ARG . 37.7 m-85 -108.98 110.62 21.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 3.4 t -114.64 164.33 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.816 -1.177 . . . . 0.0 111.041 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.3 t70 -149.29 110.3 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.462 -0.774 . . . . 0.0 109.865 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.8 OUTLIER 54.95 63.45 2.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 110.061 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.9 m -133.88 -167.81 2.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 111.324 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.3 tt0 -143.28 104.03 4.21 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.1 t -103.94 142.19 18.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.97 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.54 ' HB3' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -114.25 -152.6 0.51 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.364 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 18' ' ' GLU . . . -66.69 67.55 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 33' ' ' TYR . 2.9 m -110.2 159.56 17.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -1.144 . . . . 0.0 110.801 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 51' ' ' THR . 1.3 p -89.2 -168.81 2.28 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.484 -0.76 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 30.6 t -174.33 102.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.1 m -118.42 1.33 11.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 151.16 77.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.489 ' HB2' ' CA ' ' A' ' 53' ' ' THR . 11.7 t -149.93 170.63 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -1.197 . . . . 0.0 110.515 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HD3' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -132.99 133.07 42.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.625 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.55 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 2.8 m-85 -111.4 160.79 16.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 110.455 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.466 ' O ' HG21 ' A' ' 45' ' ' VAL . 8.5 t0 -171.74 116.13 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.68 67.34 1.58 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.538 HG23 ' CG2' ' A' ' 57' ' ' ILE . 2.7 t -144.86 126.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.442 -1.034 . . . . 0.0 110.537 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 25.3 m -106.86 96.28 6.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.288 -0.883 . . . . 0.0 109.194 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.528 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pt -113.72 160.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.493 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -106.01 -162.31 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.54 ' N ' ' HB3' ' A' ' 33' ' ' TYR . 55.1 m -64.16 91.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' THR . 13.7 p -139.24 164.5 29.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.684 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 36' ' ' THR . 13.1 p -108.68 72.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 109.83 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.454 ' O ' HG21 ' A' ' 53' ' ' THR . 5.5 t -124.16 105.8 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.14 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.544 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -151.07 117.84 5.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.215 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 168.51 -30.74 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.447 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -122.8 167.6 13.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.556 -0.967 . . . . 0.0 109.555 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.471 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 9.9 ttm180 -91.56 136.4 33.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.767 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 3.3 mt -114.66 163.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.4 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -148.3 145.84 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.764 -0.585 . . . . 0.0 110.052 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 165.74 109.67 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.42 -1.371 . . . . 0.0 110.494 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.01 -4.77 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.758 1.399 . . . . 0.0 108.748 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.98 30.08 0.6 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.3 t -72.07 157.85 37.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -1.063 . . . . 0.0 110.608 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' HG2' ' C ' ' A' ' 62' ' ' CYS . 2.7 mmtp -144.5 110.98 5.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.659 -0.65 . . . . 0.0 109.653 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.492 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 6.9 tt -101.1 170.52 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.905 -1.122 . . . . 0.0 109.812 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.74 91.1 1.52 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.124 . . . . 0.0 111.387 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 65' ' ' SER . 13.3 p 46.08 109.81 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.654 0.74 . . . . 0.0 111.576 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.4 ' O ' ' OG1' ' A' ' 51' ' ' THR . 66.8 m -140.24 145.4 37.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.396 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 pt -55.36 -179.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 0.0 109.9 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 70' ' ' THR . 14.0 mt -54.79 153.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.522 ' N ' HG22 ' A' ' 69' ' ' ILE . 5.7 m -98.33 -122.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.916 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.519 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 95.29 35.59 5.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.252 0.549 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.45 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -125.83 158.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 110.161 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.41 96.58 2.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 0.0 110.883 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.1 55.14 4.92 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.545 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -132.02 158.2 42.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.167 . . . . 0.0 110.881 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.582 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -111.06 161.04 16.3 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 57' ' ' ILE . 7.5 m-85 -146.43 162.22 38.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 111.276 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 1.2 t 169.19 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -37.62 138.01 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.447 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.853 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.386 0.612 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 17' ' ' CYS . 7.3 t -134.08 50.78 2.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.791 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 9' ' ' SER . 6.6 m120 -140.64 106.68 5.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.97 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -98.62 28.55 4.16 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.953 0.882 . . . . 0.0 108.64 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.71 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.297 0.57 . . . . 0.0 109.596 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 19.3 m -107.74 -165.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 109.277 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.73 115.94 7.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.786 -1.196 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 1.7 tp -91.63 140.71 29.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -0.945 . . . . 0.0 109.096 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.504 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -54.07 139.09 35.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -12.48 9.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.342 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -115.61 17.4 16.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.977 . . . . 0.0 110.702 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.2 p -94.28 -147.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.52 ' CB ' ' HG3' ' A' ' 31' ' ' GLU . 4.0 tttt -121.41 120.4 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.18 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.476 ' HA ' HG23 ' A' ' 5' ' ' THR . 1.6 t -56.21 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 110.329 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' CB ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.484 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 68.7 m-80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.289 0.566 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 12.9 m -141.97 109.26 5.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 110.31 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.482 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 6.6 t80 -100.8 103.86 15.09 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 8.0 t -101.69 164.62 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -142.47 119.29 11.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.421 -0.799 . . . . 0.0 109.452 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 26.2 tttt 42.78 67.75 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 109.835 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.535 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 2.1 m -132.96 -168.04 2.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.52 ' HG3' ' CB ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -144.8 96.91 2.94 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.13 -0.982 . . . . 0.0 109.784 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 18' ' ' GLU . 61.3 t -102.33 138.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 110.086 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 49' ' ' THR . 4.6 t80 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.085 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 42.26 48.58 5.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.457 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 22.5 m -104.9 163.92 12.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -1.134 . . . . 0.0 109.771 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 53' ' ' THR . 28.3 p -99.79 174.63 6.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.848 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 0.1 OUTLIER -157.5 143.35 17.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.722 . . . . 0.0 109.872 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -166.62 37.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.13 62.03 0.38 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 9.2 t -142.91 176.17 9.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -145.75 124.16 12.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.536 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.3 m-85 -99.65 172.69 7.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.235 -0.916 . . . . 0.0 110.139 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.453 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 7.8 t70 179.0 95.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 68.7 67.66 1.89 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 57' ' ' ILE . 1.1 t -145.88 159.42 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 110.603 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.51 ' N ' HG11 ' A' ' 45' ' ' VAL . 27.4 m -130.33 88.26 2.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.543 -0.723 . . . . 0.0 109.617 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.522 ' CB ' HG22 ' A' ' 64' ' ' ILE . 1.1 pp -111.08 165.59 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -129.88 -157.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.085 . . . . 0.0 110.788 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.503 ' N ' ' CG2' ' A' ' 48' ' ' THR . 5.6 m -46.45 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 110.858 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.3 m -140.5 -167.05 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.068 -1.02 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -150.03 72.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.376 -0.828 . . . . 0.0 109.84 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 8.4 t -131.79 112.47 12.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.567 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -151.65 121.75 7.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 168.48 -25.98 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.438 ' HA ' ' C ' ' A' ' 89' ' ' ALA . 26.0 p -122.7 -170.15 2.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -1.11 . . . . 0.0 109.918 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 28.1 mtp180 -94.87 115.94 28.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.843 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.589 ' CG2' ' CG2' ' A' ' 45' ' ' VAL . 1.2 mm -98.98 122.52 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.076 . . . . 0.0 109.965 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 44.9 m -145.78 168.3 21.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 110.46 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 151.02 123.05 1.08 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.5 -5.68 17.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.691 1.363 . . . . 0.0 109.416 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 23.72 0.87 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 5.1 t -73.17 143.44 47.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.499 -1.001 . . . . 0.0 110.648 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 113.22 7.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.0 109.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.522 HG22 ' CB ' ' A' ' 47' ' ' ILE . 3.0 tt -104.04 168.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 15.2 t -152.26 89.88 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 65' ' ' SER . 2.2 p 56.71 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.459 ' O ' HG22 ' A' ' 51' ' ' THR . 83.5 m -146.5 -159.09 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.0 155.72 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.929 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.481 ' O ' ' CG1' ' A' ' 69' ' ' ILE . 1.8 pp -92.51 121.85 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.438 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.7 m -148.41 150.77 34.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.39 51.32 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 65' ' ' SER . 3.6 mptp? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.369 0.604 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.97 154.76 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.48 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -148.05 89.77 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.781 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 97.19 61.67 0.93 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.598 ' HB3' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -138.39 171.95 13.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -1.224 . . . . 0.0 110.563 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.11 119.06 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.767 . . . . 0.0 109.554 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -147.4 149.6 33.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.174 . . . . 0.0 111.614 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 p -163.72 73.08 0.29 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.735 -0.603 . . . . 0.0 109.688 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.438 ' C ' ' HA ' ' A' ' 55' ' ' SER . . . 59.75 162.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 0.0 109.937 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.351 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.117 0.484 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 5' ' ' THR . 9.9 t -145.81 49.02 1.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.425 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 2.8 m120 -138.85 117.83 12.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.113 -0.992 . . . . 0.0 110.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 40.6 p -102.17 106.16 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.366 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER 74.01 -1.47 3.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.378 -0.826 . . . . 0.0 110.023 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.62 177.43 4.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.673 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -131.06 112.32 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.169 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.503 ' HG ' ' OG ' ' A' ' 15' ' ' SER . 7.3 tp -88.63 54.57 3.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 110.053 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.53 ' HB2' ' CA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 63.06 8.17 3.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 0.0 110.961 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 54.05 16.98 1.26 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER 174.75 30.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.98 -1.075 . . . . 0.0 110.918 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -92.44 -146.24 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.05 . . . . 0.0 109.564 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.571 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -104.69 103.83 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.967 -1.083 . . . . 0.0 109.521 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.64 59.78 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.589 ' HG2' ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.139 0.495 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 8.0 p -152.09 116.51 5.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.061 -1.024 . . . . 0.0 110.455 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 93.0 m-85 -100.69 100.19 10.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 0.0 109.554 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.535 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 5.6 t -94.37 166.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.017 . . . . 0.0 110.247 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' CA ' ' HB2' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.79 124.84 12.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' N ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER 42.77 63.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 109.586 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.532 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.1 m -130.9 -179.12 5.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 111.114 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.5 mt-10 -145.3 103.77 3.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.571 -0.705 . . . . 0.0 109.216 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 35' ' ' THR . 13.9 m -112.4 130.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 2.7 t80 -118.27 94.63 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.902 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.96 33.18 55.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.563 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 19.2 m -108.66 147.23 32.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -1.189 . . . . 0.0 110.208 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.485 ' N ' HG21 ' A' ' 35' ' ' THR . 8.1 t -97.94 150.8 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 19.8 p -135.44 58.2 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 110.138 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 m -66.21 -108.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.811 -1.18 . . . . 0.0 109.726 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.97 66.37 3.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.462 ' HB2' ' CB ' ' A' ' 53' ' ' THR . 7.8 t -144.05 168.16 20.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -1.18 . . . . 0.0 110.758 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 3.9 tpt180 -138.85 124.53 19.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.535 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.2 m-85 -104.48 177.53 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 10.0 t0 173.39 108.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 56.45 67.34 2.27 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.541 ' CG2' HG21 ' A' ' 57' ' ' ILE . 16.5 t -145.76 125.13 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -1.039 . . . . 0.0 111.419 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -103.44 96.1 6.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 108.659 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.563 ' CD1' ' CG2' ' A' ' 35' ' ' THR . 1.1 pt -111.14 167.15 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 110.698 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.96 112.47 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER 38.08 72.3 0.13 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.433 -0.792 . . . . 0.0 111.288 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 35' ' ' THR . 44.3 t -140.13 139.96 35.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 110.786 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 67' ' ' CYS . 29.8 p -103.85 50.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.918 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -89.86 54.7 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.817 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 40' ' ' SER . 10.1 p -84.21 173.46 11.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 110.152 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 94.21 -18.57 56.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.518 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 1.2 p -124.63 154.67 40.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 ttm180 -91.97 114.41 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.541 HG21 ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -101.2 146.55 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 111.301 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -147.31 152.35 38.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.653 -0.655 . . . . 0.0 109.716 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 166.03 124.4 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.24 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -5.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.74 1.389 . . . . 0.0 108.761 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.93 32.12 0.46 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 1.9 t -72.51 139.09 47.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.527 -0.984 . . . . 0.0 110.658 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -132.18 110.55 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.464 -0.772 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.53 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 5.9 tt -100.35 172.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.175 -0.953 . . . . 0.0 109.967 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 66' ' ' THR . 16.0 m -151.93 94.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.017 -1.052 . . . . 0.0 110.962 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 45.59 105.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 179.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 17.1 t -133.53 163.84 28.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 69' ' ' ILE . 2.9 mp -80.52 167.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 0.0 110.897 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 10.0 mt -84.63 120.97 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 109.395 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -148.54 139.16 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 110.617 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -82.28 58.12 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.803 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -128.69 156.38 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.511 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 36.4 t -147.59 87.69 1.65 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 90.95 60.15 1.35 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 82' ' ' ILE . 49.9 m -142.55 156.39 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -112.5 157.9 20.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.044 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.448 ' O ' ' HB2' ' A' ' 88' ' ' SER . 1.9 m-85 -144.89 161.69 38.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.868 -1.145 . . . . 0.0 110.66 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 176.47 56.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 42.56 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 109.825 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 40' ' ' SER . 1.5 p-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.903 0.383 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 17' ' ' CYS . 14.6 t -137.06 47.05 2.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.963 -1.086 . . . . 0.0 110.795 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.41 90.98 2.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.531 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 14.5 p -98.44 41.27 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 168.31 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.369 0.604 . . . . 0.0 109.665 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 34.3 m -108.19 -163.71 0.91 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 110.583 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.55 120.67 18.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.702 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 17' ' ' CYS . 8.0 tp -88.15 21.67 2.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 11' ' ' LEU . 10.6 t 64.64 5.88 2.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.642 -0.661 . . . . 0.0 111.118 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.13 21.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 110.072 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -154.0 14.05 0.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -112.46 -156.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HB2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -108.09 148.27 30.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.018 . . . . 0.0 110.055 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 7.2 p -123.05 68.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.505 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.322 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.491 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 5.5 m-20 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.057 0.456 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.0 OUTLIER -157.9 122.61 4.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 110.955 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.542 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -87.3 102.32 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 108.757 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 18.8 t -100.85 163.84 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.922 -1.111 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 37.6 t0 -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 12.8 tttt 43.27 68.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.885 -1.134 . . . . 0.0 109.989 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.527 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.5 m -133.74 -171.05 2.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.061 . . . . 0.0 111.655 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -144.33 103.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.7 t -106.13 151.09 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.937 -1.102 . . . . 0.0 110.968 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.505 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 2.3 t80 -140.37 76.65 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.898 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.98 61.35 5.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 37' ' ' CYS . 3.4 m -111.41 149.26 31.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 109.978 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.511 ' OG1' ' N ' ' A' ' 37' ' ' CYS . 18.2 p -67.38 -68.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.313 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' CE1' ' A' ' 42' ' ' PHE . 0.6 OUTLIER 51.42 42.42 29.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.099 -1.001 . . . . 0.0 109.988 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -85.15 36.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.726 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.502 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 152.08 54.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.543 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.57 -176.24 5.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.118 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -131.68 134.24 45.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.726 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.575 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.5 m-85 -111.97 150.85 29.97 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.894 -1.129 . . . . 0.0 110.416 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 14.4 t0 -166.15 119.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.491 -0.756 . . . . 0.0 109.105 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.42 68.89 1.03 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.562 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.3 t -145.85 135.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -1.165 . . . . 0.0 111.036 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 m -115.43 90.61 3.38 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.525 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.34 172.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 110.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 5.1 t -129.14 -155.21 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 1.3 m -58.62 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 48' ' ' THR . 8.6 t -139.13 -175.6 4.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 67' ' ' CYS . 3.6 t -133.78 61.61 1.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.292 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -112.07 100.28 8.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.543 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 3.5 p -131.21 -164.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.03 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . 94.1 -68.26 1.43 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.447 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.573 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -101.66 -169.58 1.7 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.155 -1.203 . . . . 0.0 111.722 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.539 ' N ' ' OG ' ' A' ' 55' ' ' SER . 3.7 ppt_? -107.6 139.59 41.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.735 -0.603 . . . . 0.0 110.131 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.562 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.7 mt -107.75 160.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.531 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.553 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -146.65 148.54 32.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.11 124.0 0.73 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.393 -1.385 . . . . 0.0 110.597 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.35 -1.26 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.746 1.393 . . . . 0.0 108.905 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -173.21 38.15 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.41 155.57 39.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 111.05 5.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.629 -0.67 . . . . 0.0 109.786 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.457 HG23 ' HB ' ' A' ' 47' ' ' ILE . 4.5 tt -101.71 165.14 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 109.406 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.503 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 2.0 t -152.16 86.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.058 . . . . 0.0 110.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.2 p 55.02 114.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.543 -0.723 . . . . 0.0 110.3 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 51' ' ' THR . 60.5 m -143.23 -143.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 110.532 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 68' ' ' ILE . 10.0 mm -132.32 165.59 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 70' ' ' THR . 40.6 mt -45.85 151.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.0 . . . . 0.0 109.863 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -123.84 -144.78 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.74 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.573 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 115.22 57.84 0.35 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.43 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -123.19 151.8 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.541 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.481 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 15.6 m -147.44 103.98 3.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 83.84 48.19 5.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.48 159.6 38.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -1.193 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.494 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -120.08 163.09 18.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.453 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 86' ' ' THR . 4.0 m-85 -134.61 161.73 34.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.085 -1.01 . . . . 0.0 109.973 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 55' ' ' SER . 0.3 OUTLIER 175.09 124.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 110.45 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 55' ' ' SER . . . -42.01 146.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 1.6 t30 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.887 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 17' ' ' CYS . 1.9 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.077 0.465 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 t -146.23 19.33 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -89.48 57.52 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.519 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 75.2 p -98.63 105.47 17.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.382 -0.824 . . . . 0.0 109.438 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 7' ' ' THR . 14.2 m-20 67.09 6.04 4.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.86 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.43 178.7 6.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 10.8 tt0 -131.32 112.29 12.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.969 -1.082 . . . . 0.0 110.566 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 12' ' ' SER . 5.3 tp -100.7 29.89 4.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.827 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 11' ' ' LEU . 9.1 t 65.3 6.34 3.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.596 -0.69 . . . . 0.0 110.797 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 44.59 24.05 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.069 -1.019 . . . . 0.0 110.473 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.2 t30 -158.52 17.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 110.727 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 1.8 p -106.4 -140.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -120.67 124.14 44.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.926 -1.109 . . . . 0.0 109.81 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 8.9 m -97.12 61.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.69 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.535 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.145 . . . . 0.0 110.237 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.7 m -144.56 110.59 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 110.807 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.536 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 26.5 m-85 -105.65 104.91 14.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 6.7 t -106.29 159.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.759 -1.213 . . . . 0.0 110.841 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.467 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 1.7 t0 -142.89 123.37 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.283 -0.885 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' N ' ' OG ' ' A' ' 12' ' ' SER . 1.8 tttt 38.3 66.68 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 110.094 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' SER . 2.1 m -133.31 -167.47 1.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -143.29 103.67 4.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.407 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 77.4 t -105.59 127.61 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.093 -1.004 . . . . 0.0 110.878 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -107.51 -139.08 0.37 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -66.47 61.6 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.5 m -107.07 164.55 12.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 110.141 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 51' ' ' THR . 19.6 p -104.82 174.61 5.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 119.73 7.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -140.39 -36.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 54' ' ' GLY . . . -172.17 65.12 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.552 ' HB2' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -137.62 179.96 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -1.097 . . . . 0.0 110.24 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -141.27 130.2 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.544 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.555 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 5.4 m-85 -109.79 162.41 14.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.8 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 9.4 t0 177.95 112.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 52.18 66.34 2.68 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.315 -2.314 . . . . 0.0 107.315 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 57' ' ' ILE . 3.8 t -145.24 117.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -1.101 . . . . 0.0 110.422 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.518 HG21 ' CE ' ' A' ' 63' ' ' LYS . 10.6 m -98.85 90.91 4.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 64' ' ' ILE . 1.1 pt -110.51 167.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.448 -0.782 . . . . 0.0 109.957 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -122.77 -160.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.107 -0.995 . . . . 0.0 110.121 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 48' ' ' THR . 44.1 m -49.13 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 109.941 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.516 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 3.5 t -139.99 132.31 28.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.034 -1.041 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.454 ' HA ' HG23 ' A' ' 36' ' ' THR . 33.2 p -85.38 59.71 5.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 109.658 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 t -119.59 126.5 51.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 110.02 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -169.81 75.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -0.974 . . . . 0.0 110.723 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.552 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -133.5 -54.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB3' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -104.7 -171.32 1.9 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -1.088 . . . . 0.0 109.959 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 37.4 ptt180 -105.31 136.47 44.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.306 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.542 HG23 ' CG2' ' A' ' 45' ' ' VAL . 1.8 mt -109.59 157.54 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.521 ' N ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.71 156.92 43.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.718 . . . . 0.0 110.292 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 157.33 124.42 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.552 -1.308 . . . . 0.0 110.575 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.03 -7.89 22.26 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.594 1.313 . . . . 0.0 108.76 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.48 33.05 0.64 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 2.8 t -71.68 137.98 48.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -1.035 . . . . 0.0 110.165 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.518 ' CE ' HG21 ' A' ' 46' ' ' THR . 1.6 mtpt -137.22 118.41 14.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.87 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG21 ' HB ' ' A' ' 47' ' ' ILE . 2.5 tt -104.26 170.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.479 ' O ' ' OG1' ' A' ' 66' ' ' THR . 1.2 t -143.36 77.93 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.108 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 7.2 p 52.9 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 110.971 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' ' 64' ' ' ILE . 74.0 m -124.21 -149.8 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 69' ' ' ILE . 43.4 mm -131.09 169.4 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -57.83 136.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -147.24 90.28 1.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 111.028 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.423 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . -74.38 65.04 2.06 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.53 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 3.5 mmtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.367 0.604 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.454 HD11 HG13 ' A' ' 64' ' ' ILE . 7.8 tp -138.57 156.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 109.845 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.9 m -154.21 125.91 7.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.183 -0.948 . . . . 0.0 110.055 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 56.53 55.29 30.52 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.469 ' O ' ' CE2' ' A' ' 87' ' ' PHE . 88.4 m -133.14 140.46 47.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -1.092 . . . . 0.0 111.064 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -101.95 166.38 10.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.079 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CD1' ' O ' ' A' ' 86' ' ' THR . 1.9 m-85 -152.8 157.26 40.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.835 -1.165 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER 177.48 132.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.526 ' CA ' ' HA3' ' A' ' 72' ' ' GLY . . . -41.79 136.7 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.424 ' OD1' ' C ' ' A' ' 40' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.365 0.602 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 5' ' ' THR . 8.1 t -96.46 57.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.477 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -149.01 111.75 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 9.5 p -98.4 111.05 23.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 73.9 -0.71 3.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 109.902 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -110.94 -177.18 3.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 109.599 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -143.47 99.69 3.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' A' ' 15' ' ' SER . 4.4 tp -90.36 25.81 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 t 54.65 93.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.123 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -37.99 -28.54 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.761 . . . . 0.0 111.318 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 29' ' ' LYS . 9.1 p30 -83.48 11.41 7.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -99.68 -149.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 0.0 109.522 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -113.82 99.63 7.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.023 -1.048 . . . . 0.0 109.781 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.3 m -73.97 55.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 110.104 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.212 179.642 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -149.45 107.41 3.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.064 -1.023 . . . . 0.0 110.386 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 10.3 m-85 -106.9 88.28 2.71 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' CG1' ' OG ' ' A' ' 30' ' ' SER . 11.0 t -93.73 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 111.371 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.59 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 7.5 t0 -150.07 126.5 10.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.0 109.852 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER 41.66 56.6 3.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.006 -1.059 . . . . 0.0 110.181 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 15' ' ' SER . 15.4 m -122.37 176.95 5.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.92 . . . . 0.0 110.77 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 47' ' ' ILE . 21.8 mt-10 -144.06 100.39 3.55 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 108.789 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 16' ' ' LYS . 16.0 m -106.55 152.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.551 ' O ' ' CA ' ' A' ' 49' ' ' THR . 32.9 t80 -134.57 85.93 2.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.02 43.78 13.21 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 48' ' ' THR . 1.9 m -104.69 166.23 10.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -1.083 . . . . 0.0 110.286 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -130.47 134.38 47.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 5.0 p -121.55 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 110.441 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -86.77 7.01 28.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.18 76.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.535 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 2.2 p -159.24 179.62 8.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.176 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.547 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -146.07 117.73 8.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 0.0 109.927 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.472 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.5 m-30 -98.94 150.52 21.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.036 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -145.83 71.79 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 109.589 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 88.33 73.68 1.28 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 47' ' ' ILE . 3.1 t -145.55 138.85 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -1.159 . . . . 0.0 111.103 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 18.8 m -112.76 91.94 3.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.978 . . . . 0.0 109.112 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.533 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -112.3 170.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.501 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 14.6 t -118.18 -145.76 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.82 -1.175 . . . . 0.0 109.969 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.551 ' CA ' ' O ' ' A' ' 33' ' ' TYR . 39.9 m -64.81 80.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 35' ' ' THR . 3.0 p -137.59 149.98 47.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.299 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 67' ' ' CYS . 9.0 t -112.64 66.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 0.0 110.202 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.46 91.46 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 62.4 p -123.5 141.32 52.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.139 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.68 -32.29 1.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.44 ' HB3' ' C ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -122.32 160.57 25.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 110.525 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 110.22 21.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.579 HG21 ' CE1' ' A' ' 87' ' ' PHE . 7.3 pt -106.95 159.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.074 -1.017 . . . . 0.0 112.424 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 5.5 t -146.12 -173.72 4.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 151.49 119.79 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.669 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.57 -7.5 21.33 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.699 1.368 . . . . 0.0 108.645 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.4 37.28 0.3 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.9 t -71.83 144.25 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.499 -1.001 . . . . 0.0 110.581 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 46' ' ' THR . 18.3 mtpt -144.41 117.93 9.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.622 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 47' ' ' ILE . 3.7 tt -105.03 174.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.89 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.524 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -147.01 84.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.914 179.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' SER . 0.2 OUTLIER 60.07 135.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.468 ' O ' HG22 ' A' ' 51' ' ' THR . 42.3 t -167.15 167.93 13.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 69' ' ' ILE . 5.6 mt -99.88 179.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 110.027 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' ILE . 1.5 pt -45.51 171.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.113 -0.992 . . . . 0.0 110.039 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -133.32 -137.65 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 111.02 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.13 43.87 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.056 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 4.7 mmtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.489 HG13 ' SG ' ' A' ' 85' ' ' CYS . 2.1 tp -140.6 147.65 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.995 . . . . 0.0 110.542 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 m -145.27 111.78 5.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.278 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 76.99 57.07 3.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.489 ' SG ' HG13 ' A' ' 82' ' ' ILE . 69.8 m -138.85 153.9 48.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -105.4 157.75 17.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.489 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CE1' HG21 ' A' ' 57' ' ' ILE . 35.5 m-85 -144.28 146.66 32.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.101 -0.999 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER 174.1 118.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.74 . . . . 0.0 109.408 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -33.93 125.35 0.45 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.8 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.41 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.1 t30 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.254 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.15 0.5 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.485 ' CB ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 m -143.57 32.33 1.31 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -112.42 59.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 11.2 p -99.57 105.84 17.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.076 -1.015 . . . . 0.0 110.306 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 7' ' ' THR . 4.2 t-20 66.65 6.78 4.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -129.85 -165.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.023 -1.048 . . . . 0.0 110.395 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -142.99 104.47 4.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' SER . 30.3 tp -91.38 21.21 4.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.324 -0.86 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER 71.5 0.77 3.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.472 -0.768 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.68 19.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.012 . . . . 0.0 109.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.6 t30 -157.4 13.71 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.996 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -101.15 -145.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.761 -1.212 . . . . 0.0 109.703 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' VAL . 1.8 tptt -104.0 131.7 50.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.01 . . . . 0.0 109.227 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' ' CB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.22 65.39 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 111.087 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.06 -1.025 . . . . 0.0 109.791 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.297 0.57 . . . . 0.0 110.978 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 9' ' ' SER . 54.7 m -154.73 110.74 3.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.672 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 28.6 m-85 -101.86 122.26 43.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.76 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.574 ' CG1' ' HB3' ' A' ' 42' ' ' PHE . 3.6 t -120.35 167.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 110.308 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.542 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.1 m-20 -146.95 113.81 6.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 18.2 tttt 47.43 68.6 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.872 -1.143 . . . . 0.0 110.037 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 15' ' ' SER . 1.6 m -133.86 -171.02 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.158 -0.964 . . . . 0.0 111.346 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.22 100.84 3.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 33' ' ' TYR . 71.1 t -101.42 157.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 111.15 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.57 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.34 -140.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.24 58.78 1.11 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 50' ' ' SER . 0.8 OUTLIER -96.96 -144.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.394 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 31.0 p -139.53 -158.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.956 -1.09 . . . . 0.0 110.99 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.472 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 36.1 t 178.7 53.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.94 48.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.74 88.14 2.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.537 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 67.3 p -169.95 174.13 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -1.109 . . . . 0.0 110.391 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.521 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -137.91 138.64 39.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.453 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.574 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.7 m-85 -118.29 168.79 10.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.911 -1.118 . . . . 0.0 110.398 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.2 OUTLIER 176.57 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 108.739 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.44 68.05 1.31 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.597 ' CG1' ' CG2' ' A' ' 47' ' ' ILE . 15.0 t -143.02 109.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.363 -1.08 . . . . 0.0 111.265 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 5.7 m -94.89 86.27 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.896 -1.128 . . . . 0.0 108.595 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.597 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -112.41 163.37 9.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.563 -0.711 . . . . 0.0 110.451 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.57 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 1.4 t -115.29 -152.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.04 -1.038 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.527 ' N ' ' CG2' ' A' ' 48' ' ' THR . 8.8 m -58.87 87.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.688 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 0.7 OUTLIER -138.59 -162.26 1.29 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.966 -1.084 . . . . 0.0 110.835 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 36' ' ' THR . 0.4 OUTLIER -144.01 67.21 1.27 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.8 79.41 2.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.328 -0.858 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.537 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 28.9 p -121.57 175.11 6.38 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 110.684 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.45 -34.43 4.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.54 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -129.85 163.84 25.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -1.133 . . . . 0.0 110.386 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.7 ptm180 -96.02 136.75 36.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.559 ' CG2' ' SG ' ' A' ' 85' ' ' CYS . 2.2 mt -110.73 163.94 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -0.96 . . . . 0.0 111.312 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.2 OUTLIER -147.31 149.82 33.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 167.01 116.24 0.35 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.415 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.93 -5.92 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.651 1.343 . . . . 0.0 108.819 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.11 38.51 0.34 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.8 t -71.41 155.16 40.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -1.118 . . . . 0.0 110.711 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.34 107.86 4.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.481 -0.762 . . . . 0.0 109.56 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 4.9 tt -104.49 168.59 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 0.0 109.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -150.74 97.93 2.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 0.0 110.628 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 2.2 p 55.63 108.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.336 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.76 -156.35 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.513 HG23 HD11 ' A' ' 68' ' ' ILE . 24.1 mt -146.78 140.83 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.525 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -52.8 112.14 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 110.369 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' THR . 2.9 m -148.51 135.69 20.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.925 -1.109 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.71 77.44 0.64 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.28 0.562 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.443 ' C ' HD11 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -122.58 157.34 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.849 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.3 t -151.76 101.83 2.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 81.59 57.85 2.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.88 150.51 34.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -1.136 . . . . 0.0 111.239 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.585 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 9.0 t -110.7 160.68 16.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.432 -0.793 . . . . 0.0 109.004 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.3 m-85 -131.18 154.22 48.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.804 -1.185 . . . . 0.0 110.839 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 87' ' ' PHE . 4.0 m -174.05 120.05 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.716 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.35 139.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.416 -0.802 . . . . 0.0 110.576 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.512 ' OD1' ' CB ' ' A' ' 41' ' ' ARG . 7.3 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.034 0.445 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 17' ' ' CYS . 3.6 t -122.09 19.5 10.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.02 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.18 52.22 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.842 . . . . 0.0 109.934 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 11.0 t -98.67 92.51 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 109.786 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.8 OUTLIER 69.91 3.51 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.795 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.32 149.32 40.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.399 -0.813 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 27' ' ' VAL . 1.3 mt-30 -107.92 88.04 2.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 109.987 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 3.3 tp -88.58 25.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 7.7 t 53.67 103.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.45 -23.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.3 t-20 -89.86 14.91 10.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 111.707 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -113.56 -164.08 0.9 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.567 -1.333 . . . . 0.0 110.141 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.542 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -114.66 147.49 39.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.14 -0.975 . . . . 0.0 109.724 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 6.6 p -123.11 72.75 1.12 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.724 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.063 -1.023 . . . . 0.0 109.842 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.7 t30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 87.0 m -153.33 114.39 4.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.903 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 27.9 m-85 -107.91 92.65 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.799 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.581 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 12.7 t -93.56 167.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.247 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.7 t0 -148.28 122.12 9.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 109.596 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 44.12 61.65 2.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 0.0 109.565 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.531 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.4 m -131.78 -174.88 3.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 111.222 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -145.17 104.46 3.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.706 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 HD11 ' A' ' 11' ' ' LEU . 2.9 m -117.46 136.24 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.805 -1.184 . . . . 0.0 110.112 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.579 ' HB2' ' N ' ' A' ' 49' ' ' THR . 4.0 m-85 -97.87 -137.65 0.28 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.45 59.46 0.11 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.561 ' N ' ' O ' ' A' ' 33' ' ' TYR . 2.3 m -95.1 162.07 13.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -1.169 . . . . 0.0 110.043 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.478 ' N ' HG21 ' A' ' 35' ' ' THR . 13.5 p -100.61 -169.38 1.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.401 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 0.1 OUTLIER -168.51 140.25 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.767 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 1.8 t 178.55 43.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.27 41.0 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.481 ' CB ' ' CA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -131.12 171.87 12.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 109.955 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 2.2 tpt85 -146.46 129.71 16.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 109.948 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.581 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.8 m-85 -109.13 170.48 8.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.905 -1.122 . . . . 0.0 110.715 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -174.85 80.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.015 . . . . 0.0 110.176 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 83.71 66.72 1.49 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 57' ' ' ILE . 2.3 t -146.97 136.71 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.808 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.5 m -107.77 93.2 4.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.513 HG21 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.93 171.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 110.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 49' ' ' THR . 1.6 t -118.69 -162.14 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.426 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.579 ' N ' ' HB2' ' A' ' 33' ' ' TYR . 20.2 m -54.71 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 66.4 m -128.49 146.72 50.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 86.4 m -100.03 48.3 0.93 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.536 -0.728 . . . . 0.0 109.317 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 3.1 t -111.35 100.32 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -144.39 99.76 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.501 ' N ' ' HB ' ' A' ' 70' ' ' THR . . . -161.63 -48.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.537 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -101.57 -168.16 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.459 -1.024 . . . . 0.0 109.782 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.527 ' N ' ' OG ' ' A' ' 55' ' ' SER . 1.9 mtp85 -91.11 141.09 29.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.742 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.589 ' CG2' ' CG2' ' A' ' 45' ' ' VAL . 3.2 mm -113.1 127.27 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 110.155 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.3 152.96 40.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.245 -0.909 . . . . 0.0 110.012 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 118.0 0.42 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.7 -2.48 11.47 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.569 1.299 . . . . 0.0 109.704 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.85 30.76 0.18 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 84' ' ' GLY . 7.2 t -73.02 152.89 41.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -1.068 . . . . 0.0 111.157 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.31 108.84 4.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.642 -0.661 . . . . 0.0 109.778 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 67' ' ' CYS . 2.0 tt -99.02 176.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.062 -1.024 . . . . 0.0 110.123 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -151.77 75.21 1.14 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.906 -1.122 . . . . 0.0 110.953 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 0.2 OUTLIER 59.88 73.48 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 110.837 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 64' ' ' ILE . 88.1 m -100.33 -178.26 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 52' ' ' SER . 1.1 tt -89.76 -178.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.658 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 51' ' ' THR . 5.1 pt -51.05 -174.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.501 ' HB ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -142.37 -148.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 110.701 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . 113.24 34.92 1.7 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.035 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.326 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.374 0.607 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.562 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -143.29 146.38 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 -179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.443 ' O ' ' SG ' ' A' ' 85' ' ' CYS . 1.7 t -157.11 136.99 12.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.85 -1.156 . . . . 0.0 111.283 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 52.37 61.98 6.17 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 87' ' ' PHE . 55.9 m -135.46 168.53 19.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.283 . . . . 0.0 111.07 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.64 123.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.627 -0.671 . . . . 0.0 109.201 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 10.8 m-85 -126.98 160.51 30.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.857 -1.152 . . . . 0.0 111.478 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 89' ' ' ALA . 7.0 p -166.58 129.03 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -34.48 142.41 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 110.892 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.537 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.4 t-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.099 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.271 0.558 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 5' ' ' THR . 20.7 m -126.32 60.64 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.126 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.98 65.76 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.394 -0.816 . . . . 0.0 110.003 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' SER . 9.8 t -102.53 -139.23 0.35 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.31 -0.869 . . . . 0.0 110.419 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -41.73 -23.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.223 -0.923 . . . . 0.0 110.967 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -107.78 162.97 13.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.0 110.557 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.406 ' OE1' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.51 106.87 17.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.828 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 12' ' ' SER . 4.0 tp -88.57 32.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 11' ' ' LEU . 8.6 t 67.3 2.8 2.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.53 -0.731 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 45.4 22.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.956 -1.09 . . . . 0.0 110.497 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' SER . 41.4 t30 -160.8 15.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 12' ' ' SER . 19.1 m -96.82 -136.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.091 -1.005 . . . . 0.0 109.168 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -115.0 123.76 49.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.871 -1.143 . . . . 0.0 109.87 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.03 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 0.0 110.529 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.538 ' CB ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.89 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 3.3 m -155.25 111.6 3.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.048 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CD1' ' NH2' ' A' ' 41' ' ' ARG . 3.7 t80 -111.09 101.72 10.23 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.078 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 11.4 t -104.27 164.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -145.63 122.73 11.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 109.713 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 44.12 64.96 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.013 . . . . 0.0 109.525 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.537 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.4 m -134.26 -169.8 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 111.613 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 21.1 tt0 -145.06 98.39 3.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 62.1 t -105.62 138.84 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.847 -1.158 . . . . 0.0 110.43 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' THR . 1.8 t80 -142.75 129.21 20.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.93 40.71 9.87 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.545 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 14.0 m -103.94 165.73 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -1.136 . . . . 0.0 110.247 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 51' ' ' THR . 6.8 p -105.05 -170.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 110.015 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.505 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 36.3 t -172.53 128.31 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.576 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.468 ' O ' HG21 ' A' ' 38' ' ' THR . 19.4 m -163.02 33.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 109.689 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.505 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 123.92 62.62 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.512 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 28.7 p -143.0 170.81 15.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.572 ' NH2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -139.48 127.47 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.067 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.577 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.7 m-85 -109.06 169.69 8.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' HG21 ' A' ' 45' ' ' VAL . 5.7 t70 178.99 112.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 52.87 62.72 5.64 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.573 ' CG2' HG23 ' A' ' 57' ' ' ILE . 14.5 t -142.83 123.14 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -1.014 . . . . 0.0 110.772 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 41.8 m -101.47 98.6 8.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.096 -1.003 . . . . 0.0 109.354 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.528 ' HB ' ' CG2' ' A' ' 64' ' ' ILE . 1.3 pt -113.38 156.58 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.191 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.447 HG21 ' OG1' ' A' ' 49' ' ' THR . 0.6 OUTLIER -135.78 127.73 29.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.847 . . . . 0.0 109.805 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER 40.85 79.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.876 . . . . 0.0 110.013 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.2 t -138.98 148.91 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.071 -1.018 . . . . 0.0 110.773 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.469 ' HA ' HG21 ' A' ' 36' ' ' THR . 4.1 p -115.97 41.23 2.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.474 ' O ' HG22 ' A' ' 53' ' ' THR . 1.2 t -104.89 116.65 32.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 110.177 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.512 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 0.9 OUTLIER -146.28 112.25 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 110.225 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 165.32 -31.31 0.23 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.538 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 2.7 p -113.09 163.07 15.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.044 -1.268 . . . . 0.0 110.707 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -91.78 120.22 32.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.0 109.591 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.573 HG23 ' CG2' ' A' ' 45' ' ' VAL . 1.3 mt -99.71 156.73 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.078 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -147.11 142.49 27.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.695 -0.628 . . . . 0.0 109.897 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 163.59 114.14 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.383 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.59 -7.48 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 N-CA-C 108.427 -1.413 . . . . 0.0 108.427 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.93 26.91 1.61 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.4 t -72.03 147.27 47.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.406 -1.055 . . . . 0.0 110.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 115.24 9.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.528 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 7.5 tt -104.94 174.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.493 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.48 99.03 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.565 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 67' ' ' CYS . 1.2 p 69.24 -68.17 0.2 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.664 -0.647 . . . . 0.0 110.719 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.547 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.5 OUTLIER 65.63 -153.84 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.066 . . . . 0.0 110.526 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 69' ' ' ILE . 1.3 tt 172.54 95.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ILE . 5.1 mt 59.88 134.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.308 -0.87 . . . . 0.0 110.062 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -113.28 -71.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.979 -1.076 . . . . 0.0 111.105 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 70' ' ' THR . . . 45.23 71.6 0.47 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.745 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.469 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 23.3 mmtt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.473 0.654 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.482 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 3.2 tp -128.92 151.65 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.85 . . . . 0.0 110.399 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 104.99 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.11 5.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.482 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 56.8 m -134.5 153.81 51.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -1.193 . . . . 0.0 110.464 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -109.4 163.48 13.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 86' ' ' THR . 3.2 m-85 -138.88 159.68 41.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.15 -0.969 . . . . 0.0 110.06 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -176.48 38.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 110.21 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 41.82 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.296 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.961 -179.216 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.254 0.55 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.502 HG22 ' CB ' ' A' ' 17' ' ' CYS . 13.2 t -144.63 35.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -99.67 57.95 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 1.8 t -98.34 95.61 7.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.904 . . . . 0.0 109.542 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 7' ' ' THR . 6.4 t-20 70.4 7.03 6.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -126.7 179.92 5.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.486 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 8.7 tt0 -134.47 95.6 3.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.949 . . . . 0.0 110.043 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 12.5 tp -88.53 31.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.975 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.538 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 68.52 3.54 3.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 0.0 110.551 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.09 25.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.608 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' SER . 28.6 t30 -162.29 19.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.621 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 30' ' ' SER . 2.0 m -104.61 -144.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 14.6 mmtm -114.14 91.55 3.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.836 -1.165 . . . . 0.0 110.155 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.502 ' CB ' HG22 ' A' ' 5' ' ' THR . 9.1 p -65.62 67.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -0.784 . . . . 0.0 110.642 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.487 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 14.0 mm-40 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.274 0.559 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.56 112.32 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 110.764 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.5 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 27.2 m-85 -101.8 96.46 7.08 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -100.6 163.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 111.115 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.538 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 3.8 t0 -141.44 119.01 11.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.532 -0.73 . . . . 0.0 109.379 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 28' ' ' ASP . 4.5 ttmm 39.98 70.45 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.21 -0.932 . . . . 0.0 109.926 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 15' ' ' SER . 2.0 m -131.76 -178.79 5.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.9 . . . . 0.0 110.886 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -144.97 97.53 3.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 1.9 m -104.2 153.15 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.966 -1.084 . . . . 0.0 110.576 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 49' ' ' THR . 10.2 t80 -139.48 138.33 36.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.169 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 38.26 40.04 0.83 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.476 ' CG2' ' N ' ' A' ' 36' ' ' THR . 2.4 m -94.66 167.61 11.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.149 -1.206 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 35' ' ' THR . 10.9 p -105.39 -52.31 2.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.857 . . . . 0.0 110.157 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 59.74 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.0 110.075 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.479 ' N ' HG22 ' A' ' 53' ' ' THR . 8.0 t -173.51 64.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 117.42 32.76 1.42 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.57 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -133.77 -178.18 4.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -1.144 . . . . 0.0 110.039 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.5 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 3.2 tpt180 -142.71 125.71 16.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 108.764 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.556 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.6 m-85 -103.96 162.09 13.43 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.469 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 3.5 t0 -170.09 103.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.539 -0.726 . . . . 0.0 109.144 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 61.39 67.69 2.0 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' CG1' HG22 ' A' ' 47' ' ' ILE . 4.6 t -145.58 127.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 110.835 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 m -108.43 87.78 2.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 108.815 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.543 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.76 154.75 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.653 -0.654 . . . . 0.0 110.427 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' SER . 1.5 t -108.65 -150.26 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 87.9 m -45.1 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.134 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -139.71 135.95 33.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 111.307 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.469 ' CG2' HG22 ' A' ' 36' ' ' THR . 97.5 m -108.35 61.24 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 29.3 m -114.91 113.68 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 110.766 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 34.7 p -131.91 -151.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.371 -0.83 . . . . 0.0 109.642 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 90' ' ' ASN . . . 76.55 -65.87 2.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -101.89 171.53 7.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.286 -1.126 . . . . 0.0 109.448 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -104.96 158.7 16.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.775 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.536 HG21 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -123.33 155.07 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.689 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.531 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.73 157.67 43.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.259 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 160.29 127.32 0.89 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.146 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.55 -5.5 17.17 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.673 1.354 . . . . 0.0 108.871 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.98 35.13 0.36 Allowed Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 10.1 t -71.76 147.45 47.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.757 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.71 120.02 10.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.01 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.508 ' HB ' HG21 ' A' ' 47' ' ' ILE . 3.8 tt -104.25 178.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.289 -0.882 . . . . 0.0 109.938 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 66' ' ' THR . 3.2 t -150.8 58.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.889 -1.132 . . . . 0.0 111.14 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 1.6 m 66.83 83.85 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 111.349 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.48 -149.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 109.371 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.431 HD11 ' HA ' ' A' ' 68' ' ' ILE . 7.6 mm -120.85 158.21 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.91 -1.119 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 3.7 tt -52.35 144.77 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 110.229 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.498 ' O ' ' HB3' ' A' ' 55' ' ' SER . 3.4 t -148.66 107.68 3.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.471 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -92.69 62.08 2.33 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.475 ' HA3' ' CB ' ' A' ' 89' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.464 HD11 HG13 ' A' ' 64' ' ' ILE . 10.5 tp -127.95 142.65 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -142.87 125.28 15.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 63.65 62.64 5.11 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 82' ' ' ILE . 59.2 m -145.39 148.45 33.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 111.079 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.531 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 13.5 t -116.74 157.66 25.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.34 152.14 50.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.769 -1.207 . . . . 0.0 110.602 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.6 m -170.54 124.77 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.352 -0.842 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 55' ' ' SER . . . -45.1 147.65 0.68 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 110.559 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.492 ' OD1' ' CB ' ' A' ' 41' ' ' ARG . 1.1 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.051 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.262 0.553 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.487 ' CG2' HD21 ' A' ' 11' ' ' LEU . 5.1 t -122.31 56.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.13 93.28 5.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.331 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 9' ' ' SER . 10.1 t -134.66 -138.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.63 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 7' ' ' THR . 11.6 m-20 -39.47 -27.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.811 . . . . 0.0 110.606 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 7' ' ' THR . 4.7 m -108.49 -164.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.149 -0.97 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -140.75 127.56 20.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.487 HD21 ' CG2' ' A' ' 5' ' ' THR . 21.4 tp -88.27 24.02 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.7 t 61.03 11.25 3.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.49 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' SER . 10.7 t30 -161.04 15.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 111.03 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.2 m -98.79 -139.0 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.392 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -114.78 141.15 48.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.3 93.54 2.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 110.599 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.527 ' CB ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 110.437 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.428 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.9 m120 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.135 0.493 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.498 ' O ' HG22 ' A' ' 27' ' ' VAL . 11.9 m -155.35 31.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.557 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -45.78 119.7 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 110.024 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 30.4 t -119.13 161.25 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 110.609 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -142.03 118.87 11.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 109.672 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.8 mmtp 43.26 68.12 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.505 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 2.7 m -133.47 -172.09 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 111.115 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 11.2 tt0 -143.81 99.21 3.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 18' ' ' GLU . 40.2 t -101.06 150.06 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.052 . . . . 0.0 110.575 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -143.16 116.19 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 43.33 51.44 6.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.522 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 2.4 m -107.08 156.5 18.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 35' ' ' THR . 19.4 p -91.04 -173.14 3.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' C ' ' OG1' ' A' ' 38' ' ' THR . 0.8 OUTLIER -157.87 124.28 4.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.362 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -163.98 55.87 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.981 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 96.79 96.21 1.87 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.539 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 14.1 p -177.98 173.38 1.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -1.152 . . . . 0.0 110.28 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CB ' ' ND2' ' A' ' 90' ' ' ASN . 6.3 tpt180 -146.97 131.81 18.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 109.649 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.55 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.9 m-85 -109.35 169.86 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 2.9 t70 178.33 116.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 109.136 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.75 65.37 2.45 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.526 ' CG2' HG21 ' A' ' 57' ' ' ILE . 3.0 t -145.33 138.06 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -1.09 . . . . 0.0 110.83 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.461 HG23 ' OE1' ' A' ' 31' ' ' GLU . 81.5 m -116.61 94.68 4.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 109.228 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.517 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.3 pt -114.08 172.39 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 49' ' ' THR . 2.0 t -131.38 -146.52 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.378 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.538 ' N ' ' CG2' ' A' ' 48' ' ' THR . 6.6 m -54.91 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 11.3 p -139.61 158.29 44.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -0.921 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -118.04 45.31 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.854 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -95.72 103.49 15.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 110.13 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.539 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 3.0 p -138.6 112.93 8.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 110.416 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 176.3 -54.89 0.11 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -102.63 -173.54 2.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.817 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.497 ' N ' ' OG ' ' A' ' 55' ' ' SER . 7.8 ttp180 -104.02 125.96 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.096 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.545 HG21 ' N ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -100.49 153.62 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.965 . . . . 0.0 110.308 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.545 ' N ' HG21 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -146.57 160.64 41.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.647 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 154.09 122.56 0.86 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.22 -5.62 17.41 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.692 1.364 . . . . 0.0 109.036 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.53 34.12 0.33 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -72.26 154.9 40.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 110.206 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.54 113.19 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -96.68 172.26 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.058 -1.026 . . . . 0.0 109.161 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 11.0 t -149.04 67.81 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.898 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.9 m 64.01 98.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 111.06 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.452 ' SG ' HG12 ' A' ' 64' ' ' ILE . 76.8 m -107.92 -144.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.413 -0.804 . . . . 0.0 109.246 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.26 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.77 -1.206 . . . . 0.0 110.581 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 tp -151.17 158.39 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.8 -154.22 0.61 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.431 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . 105.39 38.33 2.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 -179.272 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.446 0.641 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.415 HD13 HG13 ' A' ' 64' ' ' ILE . 6.9 tp -127.41 156.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -154.39 116.79 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.02 . . . . 0.0 110.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.15 46.78 33.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.24 159.99 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.028 -1.277 . . . . 0.0 111.361 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.402 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -116.96 154.82 30.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 85' ' ' CYS . 9.0 m-85 -133.13 147.91 52.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.927 -1.108 . . . . 0.0 110.401 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' ALA . 29.1 t -173.39 124.25 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.97 141.68 0.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.548 ' ND2' ' CB ' ' A' ' 41' ' ' ARG . 4.4 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.084 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.342 0.591 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 5' ' ' THR . 10.5 t -141.59 53.49 1.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.885 . . . . 0.0 109.998 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.432 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 1.8 m120 -146.64 139.54 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 9' ' ' SER . 17.1 p -103.47 -135.49 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -42.71 -15.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.251 -0.905 . . . . 0.0 111.668 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.5 p -103.99 160.73 14.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.701 -1.249 . . . . 0.0 108.74 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG2' ' N ' ' A' ' 11' ' ' LEU . 38.9 tt0 -107.13 155.13 20.2 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.024 -1.048 . . . . 0.0 111.899 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 12' ' ' SER . 31.9 tp -108.77 41.94 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.666 . . . . 0.0 109.292 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 18.4 t 58.57 12.78 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.792 . . . . 0.0 110.864 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 41.07 25.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.688 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' SER . 31.4 t30 -170.7 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.973 -1.079 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -103.67 -147.02 0.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.99 -1.068 . . . . 0.0 109.539 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.566 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -112.99 142.26 45.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.827 -1.171 . . . . 0.0 109.871 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HA ' HG21 ' A' ' 5' ' ' THR . 72.5 m -69.35 100.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.454 -0.779 . . . . 0.0 111.209 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 16.5 pm0 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.216 0.532 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.8 m -155.14 111.76 3.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -110.25 96.2 6.07 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 42' ' ' PHE . 3.9 t -98.6 164.45 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 111.178 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 29' ' ' LYS . 41.5 m-20 -144.78 124.94 13.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.502 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 11.1 tttp 42.82 67.47 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.82 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 2.5 m -133.34 -174.07 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 111.239 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.1 tt0 -143.37 103.33 4.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 18' ' ' GLU . 47.7 t -105.47 142.86 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.012 -1.055 . . . . 0.0 110.071 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 49' ' ' THR . 2.6 t80 -140.09 102.93 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 51.89 53.36 30.36 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 47' ' ' ILE . 55.2 m -114.23 154.79 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -1.168 . . . . 0.0 110.238 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 p -86.22 140.28 30.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.18 43.42 2.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -77.85 3.81 13.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 166.26 97.12 0.11 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.503 ' HB3' ' OG1' ' A' ' 53' ' ' THR . 38.2 p -177.6 167.65 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -1.196 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -138.52 123.0 18.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 179.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.588 ' CB ' ' CG1' ' A' ' 27' ' ' VAL . 3.2 m-85 -104.46 170.5 7.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.825 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 11.7 t70 178.7 98.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 65.65 58.33 9.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 57' ' ' ILE . 17.1 t -139.98 126.79 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.523 -0.986 . . . . 0.0 110.736 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 54.1 m -109.47 94.96 5.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.512 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.4 pt -113.28 175.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' SER . 1.3 t -132.51 -153.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.986 -1.071 . . . . 0.0 110.673 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 48' ' ' THR . 28.3 m -53.68 85.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' THR . 18.7 m -139.87 144.7 37.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 110.595 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.479 ' O ' HG21 ' A' ' 69' ' ' ILE . 97.7 m -90.04 39.94 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -91.23 127.69 36.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.763 . . . . 0.0 110.632 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.91 130.55 0.11 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 148.82 -42.09 0.84 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB2' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -101.87 -168.59 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -1.14 . . . . 0.0 110.236 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' N ' ' OG ' ' A' ' 55' ' ' SER . 20.0 ttt180 -114.44 120.24 39.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.75 154.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.968 . . . . 0.0 110.341 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.465 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -146.52 160.41 42.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.347 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 156.26 127.34 1.01 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.337 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.07 -7.58 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.803 1.422 . . . . 0.0 108.503 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.06 38.33 0.46 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.6 t -71.64 127.55 32.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -1.054 . . . . 0.0 110.805 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.87 111.15 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.767 . . . . 0.0 109.268 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.483 HG22 HG22 ' A' ' 47' ' ' ILE . 4.6 tt -104.72 162.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 110.59 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.475 ' O ' ' OG1' ' A' ' 66' ' ' THR . 17.6 t -144.79 88.21 1.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.4 p 54.15 74.58 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 52' ' ' SER . 0.5 OUTLIER -148.03 149.36 31.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.051 -1.03 . . . . 0.0 110.617 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 52' ' ' SER . 18.5 mm 59.59 158.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.878 . . . . 0.0 110.643 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 68' ' ' ILE . 1.3 pt -160.42 16.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.848 -0.533 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.505 ' C ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -155.09 -149.54 0.27 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 110.67 -179.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -65.99 -150.77 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.53 ' N ' ' HB2' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.382 0.61 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.544 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -133.41 135.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 110.008 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -141.75 105.44 4.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 75.35 51.46 7.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.544 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 99.2 m -126.2 141.43 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -103.25 152.6 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.042 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.448 ' O ' ' OG ' ' A' ' 88' ' ' SER . 3.7 m-85 -134.89 141.13 46.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.002 -1.061 . . . . 0.0 110.212 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 87' ' ' PHE . 1.5 m 178.29 135.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.109 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.05 148.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.382 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.441 ' N ' ' HA ' ' A' ' 55' ' ' SER . 27.9 p-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.318 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.43 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 17.2 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.822 0.344 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 17' ' ' CYS . 6.5 t -142.04 41.55 1.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.782 -1.199 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 9.3 p30 -136.92 111.66 8.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 110.67 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 45.8 p -98.39 43.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.03 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER 165.27 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.711 -0.618 . . . . 0.0 109.579 -179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.21 -163.54 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.047 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -143.34 104.34 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 8.8 tp -88.47 21.36 2.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 109.743 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 12.5 t 56.69 107.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.362 -0.836 . . . . 0.0 109.837 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.43 -22.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.28 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -82.81 6.61 17.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 110.377 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -106.16 -163.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.836 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.521 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -107.29 123.06 47.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 111.022 -178.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 5' ' ' THR . 5.9 m -90.51 57.64 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.482 -0.761 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 1.4 tm-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.672 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 1.6 m -156.6 120.27 4.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -119.66 88.13 2.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.348 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.574 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 4.3 t -94.08 170.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 111.023 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.4 m-20 -150.14 114.7 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 6.3 tttm 45.19 67.86 0.65 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 15' ' ' SER . 14.9 m -130.67 -164.39 1.42 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.006 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 45' ' ' VAL . 20.4 tt0 -144.93 100.1 3.44 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.258 -0.902 . . . . 0.0 108.696 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 73.5 t -105.18 133.63 48.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.496 -0.753 . . . . 0.0 110.595 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.525 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -133.55 125.51 29.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 41.5 39.96 2.63 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 96.7 m -94.69 171.19 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -1.212 . . . . 0.0 110.04 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.8 p -99.06 -51.66 3.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.569 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 1.0 OUTLIER 57.6 42.56 23.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.35 71.87 2.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.325 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.23 65.13 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 99.5 p -162.55 162.89 27.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 110.249 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -123.53 125.46 44.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.657 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.574 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.2 m-85 -104.97 168.99 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.056 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD2' ' NE ' ' A' ' 41' ' ' ARG . 1.1 m-20 -175.4 98.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.071 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 64.3 68.35 1.69 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG11 ' CG2' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -145.25 150.14 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.193 . . . . 0.0 110.558 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 52.2 m -122.04 90.9 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.184 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.511 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.07 167.69 6.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.525 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 3.1 t -125.27 -151.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.057 -1.027 . . . . 0.0 110.013 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 3.2 m -57.03 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.896 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 3.5 p -138.27 142.41 39.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.893 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -92.77 50.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.87 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.78 142.69 35.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.17 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 175.96 134.33 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.894 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 140.87 -22.6 2.64 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.496 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 88.1 p -121.05 179.39 4.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.335 -1.097 . . . . 0.0 110.067 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.536 ' O ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 mtp85 -91.7 114.57 27.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 108.773 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.566 ' CG2' HG11 ' A' ' 45' ' ' VAL . 1.3 mm -98.03 130.35 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.909 -1.119 . . . . 0.0 110.859 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.526 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.97 164.08 33.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.946 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 154.38 116.12 0.58 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.217 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.36 -6.38 19.04 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.699 1.368 . . . . 0.0 109.132 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.44 26.79 0.77 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 11.1 t -72.42 144.44 48.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -1.113 . . . . 0.0 110.628 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 7.9 mmtt -136.09 106.07 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 109.303 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -104.63 155.85 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.605 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.3 OUTLIER -146.47 100.17 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.534 -0.728 . . . . 0.0 109.707 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 4.1 p 54.86 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.469 -0.769 . . . . 0.0 110.097 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.413 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.05 -150.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 110.292 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.2 tt -131.22 143.1 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 109.989 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 69' ' ' ILE . 1.1 tt -81.74 108.06 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 110.616 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.415 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.9 m -148.22 160.34 43.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.219 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 69.57 3.29 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.416 0.627 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -118.99 158.37 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 21.1 t -155.73 112.34 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.926 -1.109 . . . . 0.0 111.02 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 73.63 60.14 3.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.46 163.23 29.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -1.226 . . . . 0.0 110.014 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.12 110.2 5.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 109.663 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -141.88 164.87 29.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 111.032 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -169.58 71.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 88' ' ' SER . . . 58.29 144.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.825 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.809 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.296 0.569 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.499 ' CG2' ' O ' ' A' ' 5' ' ' THR . 14.9 t -145.11 64.05 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.659 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 27.5 p30 -162.95 102.71 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 110.494 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 3.3 p -104.48 34.39 3.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.226 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 7' ' ' THR . 10.3 t30 174.89 -21.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 p -107.16 -161.69 0.8 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -140.41 122.47 15.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.588 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.526 ' O ' ' CB ' ' A' ' 12' ' ' SER . 11.3 tp -98.62 29.39 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER 70.92 -0.81 2.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 110.77 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.64 22.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.026 . . . . 0.0 109.665 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -156.11 9.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.975 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.9 m -105.18 -144.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 0.0 109.643 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -118.09 137.02 53.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.114 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 27.9 p -117.05 60.68 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.23 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 mm-40 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.427 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m-20 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.25 0.548 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 57.8 m -150.01 116.49 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 t80 -96.63 98.12 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 109.137 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 5.4 t -94.36 165.41 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 110.535 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 11.4 t0 -141.07 121.3 13.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 37.32 69.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.427 -0.796 . . . . 0.0 110.32 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' SER . 5.6 m -130.34 -170.71 2.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.923 . . . . 0.0 111.187 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 46' ' ' THR . 25.8 mt-10 -143.54 101.59 3.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 33' ' ' TYR . 70.9 t -108.94 145.23 16.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.261 -0.9 . . . . 0.0 111.197 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.546 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -115.91 -140.5 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.487 ' O ' HG21 ' A' ' 49' ' ' THR . . . -65.43 65.94 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 33' ' ' TYR . 84.9 m -105.91 153.18 22.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.073 -1.251 . . . . 0.0 110.433 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.489 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER -115.45 117.92 31.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.433 -0.792 . . . . 0.0 109.896 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.0 OUTLIER -82.63 155.34 24.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.759 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.502 ' CB ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -167.18 43.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -0.797 . . . . 0.0 109.607 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.87 75.2 1.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.445 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -156.14 177.97 10.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.163 . . . . 0.0 110.621 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 12.6 tpp85 -141.19 124.14 16.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.56 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.3 m-85 -105.44 167.46 9.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.767 -1.208 . . . . 0.0 110.43 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 45' ' ' VAL . 3.7 t0 -178.39 114.23 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.477 -0.764 . . . . 0.0 109.027 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.31 67.2 1.97 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.532 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.6 t -145.27 127.57 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -1.089 . . . . 0.0 110.572 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . 93.2 m -106.93 91.16 3.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.474 ' HB ' HG22 ' A' ' 64' ' ' ILE . 1.1 pt -109.08 161.92 7.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.58 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.546 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 2.3 t -111.03 -153.92 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 110.555 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.533 ' N ' HG23 ' A' ' 48' ' ' THR . 17.2 m -61.35 77.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 109.918 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.526 ' HB2' ' CA ' ' A' ' 66' ' ' THR . 1.3 p -139.74 172.56 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.085 -1.009 . . . . 0.0 110.686 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.489 ' HB ' ' CG2' ' A' ' 36' ' ' THR . 0.6 OUTLIER -126.89 94.81 4.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.039 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -125.45 70.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 40' ' ' SER . 67.1 p -103.93 -172.45 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 91.88 -36.67 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.468 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -133.52 161.54 34.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -1.048 . . . . 0.0 109.583 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 ptp85 -93.58 151.02 19.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.532 HG22 ' CG2' ' A' ' 45' ' ' VAL . 3.5 mt -122.33 165.63 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.887 . . . . 0.0 110.834 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.527 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.09 147.15 30.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.809 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 163.03 110.56 0.25 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.06 -8.55 23.82 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 N-CA-C 108.461 -1.4 . . . . 0.0 108.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.84 29.43 1.27 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.6 OUTLIER -72.05 147.69 46.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.48 -1.012 . . . . 0.0 110.195 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 104.08 4.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.758 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.474 HG22 ' HB ' ' A' ' 47' ' ' ILE . 4.6 tt -95.86 166.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.872 . . . . 0.0 109.963 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.486 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -146.72 97.79 2.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.526 ' CA ' ' HB2' ' A' ' 50' ' ' SER . 24.1 p 48.96 102.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 110.597 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.19 -142.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.783 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 68' ' ' ILE . 2.7 tt -154.48 134.51 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.502 HD12 ' CB ' ' A' ' 38' ' ' THR . 3.0 tt -54.35 114.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.5 t -148.23 135.19 20.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.459 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -70.72 64.94 0.85 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 6.8 mmpt? . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.541 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -127.2 159.69 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.04 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.504 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 0.7 OUTLIER -151.95 102.91 2.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 69.07 52.97 20.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 43.6 m -133.19 151.09 51.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -1.19 . . . . 0.0 110.492 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.569 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -105.33 164.24 12.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.023 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.1 m-85 -135.41 166.54 22.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 2.6 t 168.03 114.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 0.0 110.022 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -43.73 134.88 4.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' HA ' ' A' ' 55' ' ' SER . 4.2 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.218 0.533 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 5' ' ' THR . 5.5 t -145.06 28.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -101.01 79.16 1.99 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 3.9 t -98.31 105.06 17.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.4 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 7' ' ' THR . 12.5 m120 60.6 13.1 4.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.663 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 1.5 t -128.63 -167.57 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.54 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -143.66 115.32 8.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.019 . . . . 0.0 110.555 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.493 HD22 ' OG ' ' A' ' 15' ' ' SER . 5.6 tp -110.23 20.38 17.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.95 . . . . 0.0 109.686 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 6.0 t 54.21 99.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -41.18 -26.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 110.723 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 12' ' ' SER . 11.4 m-20 -80.85 3.64 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -101.28 -159.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.831 -1.168 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' N ' ' OG ' ' A' ' 15' ' ' SER . 5.1 mttp -116.2 134.0 55.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.455 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 26.9 p -99.58 78.06 2.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.193 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 18.3 mm-40 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.292 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.425 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.11 0.481 . . . . 0.0 110.401 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 10.2 m -143.79 108.76 4.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 110.437 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 45.2 m-85 -103.36 96.28 6.65 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 5.0 t -103.32 167.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 111.312 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.453 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.3 t0 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.743 . . . . 0.0 109.667 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 48.08 67.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.007 . . . . 0.0 109.862 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.528 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 2.1 m -133.34 -173.32 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.266 -0.896 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 32.8 tt0 -139.75 101.28 4.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 77.2 t -100.76 137.17 29.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.488 -0.758 . . . . 0.0 111.069 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.536 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -137.47 122.4 18.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 39.94 47.19 3.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.472 ' HB ' HG11 ' A' ' 32' ' ' VAL . 18.6 m -103.28 166.92 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -1.167 . . . . 0.0 110.433 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.466 ' CG2' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -136.01 90.69 2.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.396 -0.815 . . . . 0.0 110.075 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 27.4 p -97.47 96.31 8.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.8 p -78.82 -28.68 44.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.125 -0.984 . . . . 0.0 109.606 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . -164.5 68.6 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.463 ' HB3' ' OG1' ' A' ' 53' ' ' THR . 57.6 p -135.81 174.8 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -1.124 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -136.39 123.85 22.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.912 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.555 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.3 m-85 -101.4 168.76 9.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 110.717 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' O ' HG22 ' A' ' 45' ' ' VAL . 2.9 t0 -173.68 109.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.38 69.71 0.96 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG2' HG21 ' A' ' 57' ' ' ILE . 3.1 t -145.15 131.9 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -1.127 . . . . 0.0 110.922 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 4.4 m -109.05 96.35 6.25 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.395 -0.816 . . . . 0.0 109.346 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 64' ' ' ILE . 1.1 pt -114.32 176.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 1.9 t -136.24 -147.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.511 ' N ' ' CG2' ' A' ' 48' ' ' THR . 3.7 m -60.26 80.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.321 -0.862 . . . . 0.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 48' ' ' THR . 1.4 m -139.34 142.97 37.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.263 -0.898 . . . . 0.0 110.507 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.466 HG22 ' CG2' ' A' ' 36' ' ' THR . 4.0 p -91.55 53.19 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' CB ' ' A' ' 67' ' ' CYS . 5.3 t -94.97 122.38 37.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -172.16 135.85 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 144.6 -28.56 1.91 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.471 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -130.36 178.56 6.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -1.05 . . . . 0.0 109.933 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -94.34 138.6 32.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.134 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.571 HG21 ' N ' ' A' ' 58' ' ' SER . 1.1 mt -115.79 155.5 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.571 ' N ' HG21 ' A' ' 57' ' ' ILE . 1.1 m -147.28 145.3 29.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 112.57 0.26 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.106 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -7.04 20.21 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.697 1.367 . . . . 0.0 109.068 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.65 32.58 0.48 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -72.25 155.57 40.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -1.018 . . . . 0.0 110.102 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 105.31 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 tt -102.05 154.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.92 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -145.91 108.22 4.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.482 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 10.7 p 50.62 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 52' ' ' SER . 0.0 OUTLIER -127.59 -151.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.85 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.3 tp -134.9 139.38 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 110.522 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 53' ' ' THR . 7.8 tt -70.41 105.08 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.028 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.43 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.2 m -148.48 148.04 29.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.362 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.38 57.89 1.57 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.566 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -132.73 139.28 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.541 ' N ' HD11 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -144.27 79.07 1.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 96.11 45.94 2.72 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -131.99 160.54 35.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.12 -1.224 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.585 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 9.8 t -117.07 157.49 25.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.7 m-85 -137.37 137.56 39.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.881 -1.137 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 89' ' ' ALA . 12.2 t -171.11 136.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.53 139.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.374 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.471 ' N ' ' HA ' ' A' ' 55' ' ' SER . 13.0 p30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.199 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 5' ' ' THR . 7.2 t -130.83 30.94 4.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 109.797 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.95 70.06 8.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 103.84 15.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.979 . . . . 0.0 110.356 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 44.72 24.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 110.044 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.02 -162.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.883 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.489 ' OE1' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -143.65 107.52 4.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.043 -1.036 . . . . 0.0 110.502 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 12' ' ' SER . 18.4 tp -100.32 21.72 12.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.653 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.487 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 22.0 t 61.34 12.41 4.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.584 -0.697 . . . . 0.0 110.273 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.98 28.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 110.273 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.1 t30 -162.25 19.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 110.922 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -112.17 -149.16 0.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.05 -1.031 . . . . 0.0 109.43 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -108.81 127.86 54.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.955 -1.091 . . . . 0.0 110.056 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 29.3 p -106.43 69.11 0.78 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 110.354 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 18.5 tp10 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.151 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.271 0.557 . . . . 0.0 109.77 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 11.1 m -155.26 117.44 4.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.0 110.862 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.551 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 3.6 m-85 -109.39 94.8 5.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.568 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 12.0 t -99.8 165.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.904 -1.123 . . . . 0.0 111.31 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 7.8 t0 -146.54 109.59 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.707 . . . . 0.0 109.332 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.96 69.59 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.979 -1.076 . . . . 0.0 109.742 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.535 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 9.7 m -131.83 -167.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.923 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -142.13 101.61 3.96 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.449 HG12 ' HB ' ' A' ' 35' ' ' THR . 80.9 t -102.06 125.84 56.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 110.856 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.547 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -132.84 123.0 25.25 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 41.97 42.52 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 36' ' ' THR . 52.1 m -104.24 162.14 13.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -1.067 . . . . 0.0 110.195 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 35' ' ' THR . 24.4 p -98.56 178.22 5.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.991 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.481 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -158.95 65.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.367 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -110.88 40.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.877 . . . . 0.0 110.314 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.445 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 118.46 91.19 1.42 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.481 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 10.8 p -172.17 178.55 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -1.203 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.551 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -146.67 122.44 10.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.881 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.3 m-85 -102.07 166.3 10.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.518 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.8 t70 -176.13 111.26 0.1 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.71 66.32 2.35 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.571 ' CG2' HG23 ' A' ' 57' ' ' ILE . 2.7 t -144.1 129.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -1.064 . . . . 0.0 110.957 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.8 m -110.37 90.89 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.247 -0.908 . . . . 0.0 109.122 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.55 HG21 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -111.4 164.86 6.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 109.86 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.547 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 1.5 t -122.41 -154.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 109.94 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 3.2 m -48.25 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' THR . 12.6 p -139.26 154.43 47.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 36' ' ' THR . 19.6 p -110.42 53.34 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -111.51 110.05 20.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 110.522 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -151.49 113.7 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.272 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 169.36 -42.94 0.21 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.226 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.531 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -110.0 177.04 4.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.237 . . . . 0.0 110.382 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -97.25 126.89 42.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.573 ' CG2' ' SG ' ' A' ' 85' ' ' CYS . 1.8 mt -104.75 158.42 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 110.844 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.568 ' N ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.72 155.1 40.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 110.534 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.1 125.13 0.75 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.728 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -74.95 -5.61 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.01 39.33 0.24 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -71.88 151.48 43.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.463 -1.022 . . . . 0.0 110.536 -179.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' OG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -145.03 113.52 6.67 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.474 HG23 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -104.49 166.71 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.526 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.3 OUTLIER -147.35 96.71 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 110.251 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 65' ' ' SER . 19.3 p 50.16 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.04 -146.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.933 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 tt -143.66 -177.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.1 pp -46.21 123.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.015 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 53' ' ' THR . 2.4 m -92.08 -134.53 0.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 89.86 24.66 29.4 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.331 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 9.6 mmtt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.341 0.591 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.852 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.579 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 0.9 OUTLIER -156.23 83.52 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.522 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 77.02 59.2 3.21 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.573 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.46 159.34 42.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -1.147 . . . . 0.0 110.716 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -106.86 154.64 20.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.607 -0.683 . . . . 0.0 110.07 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.5 m-85 -134.28 141.88 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 89' ' ' ALA . 21.4 t -177.7 121.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 110.367 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.13 139.63 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.52 -0.738 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.531 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.304 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.302 0.573 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 5' ' ' THR . 0.9 OUTLIER -141.05 92.96 2.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 108.978 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 11' ' ' LEU . 2.4 t30 175.89 111.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 3.9 p -101.25 107.01 18.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.1 OUTLIER 69.4 8.33 6.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 110.667 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.2 -170.47 1.65 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.019 . . . . 0.0 110.359 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -141.83 99.71 3.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 109.268 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 17' ' ' CYS . 0.4 OUTLIER -92.63 38.02 1.01 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.13 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 18.2 t 58.47 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.678 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.59 22.64 2.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 110.461 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -157.4 19.35 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.131 -0.981 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 10.5 p -100.17 -162.74 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.914 -1.116 . . . . 0.0 109.348 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 19.8 tptt -108.25 112.33 24.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 29.6 p -97.31 86.33 3.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.512 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.111 -0.993 . . . . 0.0 109.425 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.111 0.481 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -155.09 111.75 3.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.435 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.2 m-85 -100.77 129.1 46.61 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -125.1 160.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.916 -1.115 . . . . 0.0 110.979 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -149.29 115.55 5.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 0.0 109.416 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 mttt 52.03 65.43 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 109.823 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.474 ' OG ' HG13 ' A' ' 27' ' ' VAL . 2.7 m -133.45 -170.49 2.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 111.122 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 16' ' ' LYS . 2.6 tm-20 -143.26 99.36 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 16' ' ' LYS . 97.3 t -105.23 149.81 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.955 . . . . 0.0 111.689 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.3 OUTLIER -127.35 -143.6 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 49' ' ' THR . . . -66.41 68.16 0.16 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.4 m -114.91 157.78 22.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -1.133 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -112.36 170.83 7.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 53' ' ' THR . 36.9 t -133.75 140.28 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.819 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 38' ' ' THR . 32.8 m -155.3 19.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 132.18 67.47 0.09 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -151.63 -178.81 6.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.124 -1.221 . . . . 0.0 110.247 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -147.3 138.08 23.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.751 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.556 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 6.0 m-85 -110.1 161.62 15.36 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.537 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' HG21 ' A' ' 45' ' ' VAL . 1.6 t70 -179.09 113.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 49.49 64.33 3.48 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.525 ' CG2' HG21 ' A' ' 57' ' ' ILE . 3.1 t -145.8 136.47 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -1.012 . . . . 0.0 110.426 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -116.03 97.96 6.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.532 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.492 ' HA ' HG23 ' A' ' 64' ' ' ILE . 1.6 pt -114.93 174.39 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.401 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -122.04 -160.09 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 110.537 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.514 ' N ' ' HB3' ' A' ' 33' ' ' TYR . 8.7 m -61.62 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.882 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.892 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 10.5 p -95.83 57.46 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.25 133.24 55.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.551 -0.718 . . . . 0.0 110.454 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.53 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.4 75.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.855 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -132.22 -61.48 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.545 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 61.1 p -103.61 -159.62 0.73 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.489 -1.006 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.453 ' HG3' ' CG ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -115.21 123.48 48.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.401 -0.812 . . . . 0.0 110.188 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 HG21 ' CG2' ' A' ' 45' ' ' VAL . 2.0 mt -98.98 163.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 109.959 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.519 ' N ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.71 151.36 37.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.701 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 159.55 115.28 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.03 -2.8 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.743 1.391 . . . . 0.0 108.657 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.25 28.59 0.63 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.51 153.7 41.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.444 -1.033 . . . . 0.0 110.711 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.35 111.03 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.797 . . . . 0.0 110.05 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.492 HG23 ' HA ' ' A' ' 47' ' ' ILE . 3.6 tt -103.88 167.65 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.971 . . . . 0.0 109.226 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -144.83 100.55 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.346 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 65' ' ' SER . 81.0 p 46.39 56.39 6.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.556 -0.715 . . . . 0.0 110.712 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.04 162.34 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 69' ' ' ILE . 79.4 mt -108.32 171.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.513 ' N ' HG22 ' A' ' 68' ' ' ILE . 1.7 mp -38.75 121.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 0.0 110.415 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 72' ' ' GLY . 89.6 m -130.32 61.1 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.992 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.545 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -65.78 74.43 0.11 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.539 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.556 0.693 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.49 ' CD1' HG13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -147.92 129.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.599 -0.688 . . . . 0.0 109.347 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -142.53 116.24 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.943 . . . . 0.0 110.528 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.44 48.77 8.84 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.42 149.36 49.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 0.0 110.506 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -104.17 163.06 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.149 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 86' ' ' THR . 6.3 m-85 -132.62 144.49 50.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.466 ' C ' ' HB2' ' A' ' 55' ' ' SER . 2.0 t -176.08 116.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 109.75 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 55' ' ' SER . . . -37.76 155.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.496 -0.753 . . . . 0.0 110.882 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.463 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.877 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.358 0.599 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.4 ' CG2' HD21 ' A' ' 11' ' ' LEU . 3.0 t -133.42 7.08 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -69.69 73.14 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 110.494 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 50.1 p -98.29 99.32 10.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.0 109.499 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 7' ' ' THR . 9.5 m120 58.15 15.95 3.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.694 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -130.89 172.84 11.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.472 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -116.16 114.26 24.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' O ' ' HB3' ' A' ' 12' ' ' SER . 15.7 tp -102.45 28.39 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.769 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 21.8 t 64.22 6.25 2.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.731 -0.606 . . . . 0.0 110.914 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.0 25.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.06 -1.025 . . . . 0.0 109.44 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' SER . 37.5 t30 -163.47 17.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.416 -0.803 . . . . 0.0 110.491 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -104.29 -147.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.425 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' N ' ' OG ' ' A' ' 15' ' ' SER . 3.4 tmtm? -114.94 119.04 35.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.796 -1.19 . . . . 0.0 110.493 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.01 66.14 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.718 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.521 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.7 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.984 0.421 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 88.5 m -149.68 123.26 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 111.182 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.57 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 20.1 m-85 -115.58 96.65 5.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.588 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 12.2 t -94.32 163.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.912 . . . . 0.0 111.315 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.91 120.53 9.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.548 -0.72 . . . . 0.0 109.467 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tptm 47.92 59.76 4.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.275 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 15' ' ' SER . 1.7 m -133.58 178.19 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.184 -0.947 . . . . 0.0 110.982 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.6 tt0 -143.61 109.58 5.28 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 16' ' ' LYS . 5.7 m -116.05 164.98 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.892 -1.13 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.2 OUTLIER -121.53 -139.17 0.33 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.456 ' CA ' HG23 ' A' ' 49' ' ' THR . . . -65.97 66.87 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' TYR . 19.6 m -99.36 163.58 12.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.518 ' CG2' HG23 ' A' ' 51' ' ' THR . 6.7 p -106.88 -170.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.119 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 0.9 OUTLIER -141.15 -87.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.912 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 m 46.13 37.14 3.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.362 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 102.03 109.49 3.28 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.49 ' CB ' HG23 ' A' ' 53' ' ' THR . 47.0 t 177.87 161.89 0.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.419 -1.047 . . . . 0.0 110.184 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -141.7 128.61 20.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.991 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.588 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 5.0 m-85 -110.67 167.11 10.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.467 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -177.73 112.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.098 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.79 70.49 0.84 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG2' HG23 ' A' ' 57' ' ' ILE . 7.4 t -145.52 127.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.413 -1.051 . . . . 0.0 111.126 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -106.92 91.13 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.238 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.525 HG21 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -114.35 170.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.375 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.537 HG22 ' N ' ' A' ' 49' ' ' THR . 5.3 t -118.46 -151.21 0.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.549 ' CA ' ' HB3' ' A' ' 33' ' ' TYR . 3.2 m -63.5 86.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.378 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 7.9 t -139.37 144.72 38.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 110.759 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.518 HG23 ' CG2' ' A' ' 36' ' ' THR . 43.9 p -96.72 61.4 1.88 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.28 111.26 23.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -142.66 162.75 34.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.883 . . . . 0.0 110.142 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 116.24 -56.9 0.51 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.482 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -101.86 -179.6 4.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -1.133 . . . . 0.0 111.213 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 6.1 ttp85 -109.69 128.05 54.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.552 ' CG2' ' SG ' ' A' ' 85' ' ' CYS . 1.5 mt -103.57 161.18 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 111.006 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.65 146.3 30.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.13 118.05 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.437 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.94 -6.98 20.41 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 N-CA-C 108.69 -1.312 . . . . 0.0 108.69 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.95 38.61 0.29 Allowed Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -71.85 159.4 34.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.446 -1.032 . . . . 0.0 110.139 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 62' ' ' CYS . 5.1 mmtm -143.11 109.51 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.757 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.503 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.6 tt -102.6 172.45 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.003 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.477 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.6 t -151.17 76.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.17 . . . . 0.0 110.78 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 4.1 p 55.24 113.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.456 ' N ' ' OG ' ' A' ' 50' ' ' SER . 30.0 m -139.36 -157.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.97 -149.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.166 -0.959 . . . . 0.0 109.898 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.0 mt -61.3 144.72 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' GLY . 75.2 m -123.7 -13.76 7.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.948 -1.095 . . . . 0.0 110.938 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -36.12 94.2 0.01 OUTLIER Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.466 0.651 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.545 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -125.11 155.94 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.46 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 43.6 t -146.8 114.75 6.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.385 -0.822 . . . . 0.0 110.407 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 70.47 48.79 34.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.552 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -132.79 148.22 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -1.045 . . . . 0.0 110.804 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -109.27 153.91 23.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.392 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 88' ' ' SER . 10.3 m-85 -127.13 160.6 30.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.575 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 171.03 127.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.798 . . . . 0.0 109.877 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -42.58 141.46 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.493 ' CG ' ' CB ' ' A' ' 41' ' ' ARG . 2.4 t30 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.044 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.36 0.6 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -134.31 35.68 3.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.5 68.84 3.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 1.9 t -99.05 94.09 6.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.437 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 67.4 4.68 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.711 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -114.18 -168.5 1.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 99.74 3.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 4.5 tp -88.42 27.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.932 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 1.1 p 71.67 1.28 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.464 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.14 24.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.77 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 12' ' ' SER . 17.8 p30 -157.28 16.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.535 ' OG ' ' CD2' ' A' ' 11' ' ' LEU . 22.1 p -105.73 -138.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.29 98.43 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 15.4 p -82.76 50.01 1.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 110.402 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.955 -1.091 . . . . 0.0 110.456 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.002 0.429 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.62 123.47 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.932 -1.105 . . . . 0.0 111.365 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.476 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -109.77 93.86 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 4.5 t -93.67 167.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 110.643 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.2 OUTLIER -149.49 120.63 7.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.956 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 44.46 60.76 2.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 109.763 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 15' ' ' SER . 1.4 m -128.1 -169.19 2.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.69 104.57 4.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 99.5 t -110.99 137.89 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 111.47 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -107.09 -139.68 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.563 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -68.16 61.68 0.39 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.2 m -111.43 156.84 21.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -1.143 . . . . 0.0 110.189 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -106.42 -173.18 2.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 0.8 OUTLIER -150.84 76.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.649 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -90.97 47.31 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.24 95.31 2.22 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.535 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 25.1 p -174.06 173.04 3.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.331 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.507 ' CD ' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -135.81 133.78 38.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.221 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.56 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 5.7 m-85 -112.92 163.15 15.01 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.953 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 8.7 t70 -177.19 111.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.9 . . . . 0.0 109.122 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 50.63 66.67 2.29 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 57' ' ' ILE . 2.6 t -144.42 127.99 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.084 . . . . 0.0 111.033 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 22.1 m -104.76 96.01 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.352 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.537 ' HB ' ' CG2' ' A' ' 64' ' ' ILE . 1.1 pp -114.44 169.06 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 49' ' ' THR . 1.3 t -112.78 -150.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.564 ' N ' ' CG2' ' A' ' 48' ' ' THR . 34.8 m -73.41 94.37 2.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.195 -0.941 . . . . 0.0 110.016 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.507 ' HB3' ' CA ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -139.9 157.86 45.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 111.394 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.479 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 27.5 m -104.09 50.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.592 -0.692 . . . . 0.0 109.372 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.504 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -102.7 102.81 13.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.344 -0.848 . . . . 0.0 110.594 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.535 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 82.1 p -141.19 113.94 8.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 166.14 -27.09 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 72.6 p -118.85 162.01 19.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -91.36 119.08 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.867 . . . . 0.0 108.997 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.554 HG21 ' N ' ' A' ' 58' ' ' SER . 1.0 OUTLIER -99.64 152.29 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 0.0 111.65 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.554 ' N ' HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -146.63 140.73 26.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.814 -0.554 . . . . 0.0 109.906 179.032 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 171.21 120.23 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.114 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.09 -5.32 16.86 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.719 1.379 . . . . 0.0 108.899 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.61 33.88 0.32 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 1.7 t -72.02 160.1 33.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.98 -1.306 . . . . 0.0 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' CYS . 17.5 mmtt -141.51 110.79 6.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.537 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 6.6 tt -99.45 171.53 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.016 -1.052 . . . . 0.0 109.314 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.484 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.2 t -152.94 87.83 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.507 ' CA ' ' HB3' ' A' ' 50' ' ' SER . 10.2 p 52.21 104.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 110.948 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 82.0 m -119.55 -152.73 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.49 -0.756 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -138.59 170.85 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.913 -1.117 . . . . 0.0 110.58 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.526 ' N ' ' CD1' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.96 137.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 0.0 109.402 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.48 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.1 t -145.42 -166.5 2.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 111.039 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -172.63 30.8 0.11 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.588 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.315 0.579 . . . . 0.0 110.098 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 1.6 tp -132.46 151.35 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.457 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -140.82 118.76 11.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.168 -0.958 . . . . 0.0 110.679 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.04 46.13 37.77 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.552 ' HB3' ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -128.15 154.27 45.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.232 -1.158 . . . . 0.0 111.43 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.579 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.74 165.81 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 0.0 109.056 178.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -155.4 155.67 34.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.784 -1.197 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -175.76 41.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 111.145 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.554 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.8 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 110.843 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.164 0.507 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' ASN . . . -107.19 68.2 0.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 8.3 t 49.14 78.75 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 0.0 110.206 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.1 OUTLIER 68.65 -75.06 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.466 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.503 ' CG2' ' HB2' ' A' ' 17' ' ' CYS . 5.8 t -145.46 13.59 1.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 0.0 110.453 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 2.3 m120 -97.05 96.41 8.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -113.77 20.18 16.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 22' ' ' LEU . 1.2 t-20 -177.33 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.431 ' HB2' HG23 ' A' ' 21' ' ' THR . 2.3 m -108.73 -151.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.967 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -143.36 110.19 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.439 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' SER . 25.6 tp -94.15 36.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 68.92 2.19 3.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.737 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 46.56 23.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.941 -1.1 . . . . 0.0 109.639 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -159.91 12.12 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.945 . . . . 0.0 111.465 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.473 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . 4.3 m -98.65 -144.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.788 -1.195 . . . . 0.0 109.537 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 18' ' ' GLU . 1.4 tptt -107.41 89.97 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 29.7 p -65.55 64.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 0.0 110.746 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 16' ' ' LYS . 33.2 mm-40 -100.21 25.07 7.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.031 -1.043 . . . . 0.0 110.115 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -171.33 133.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.71 -163.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.431 HG23 ' HB2' ' A' ' 9' ' ' SER . 0.1 OUTLIER -147.7 162.73 38.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 23' ' ' THR . 0.2 OUTLIER -95.29 -83.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 9.2 m -165.03 24.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.109 -0.994 . . . . 0.0 110.775 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 38' ' ' THR . 36.4 m-80 -157.49 76.45 0.82 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -155.79 128.02 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -136.23 91.95 2.73 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.562 ' CG1' ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -94.4 164.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 110.776 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.8 t0 -137.42 117.04 12.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ASP . 6.7 tttt 40.29 71.3 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.064 -1.023 . . . . 0.0 110.189 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.534 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.6 m -131.51 -175.01 3.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -144.13 100.8 3.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.612 -0.68 . . . . 0.0 109.996 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 10.4 m -110.22 151.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.637 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.547 ' O ' ' CA ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -125.85 94.45 4.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.099 -1.0 . . . . 0.0 110.348 -179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 19' ' ' LYS . . . 60.97 46.11 95.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 6.2 m -102.45 146.43 28.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -1.092 . . . . 0.0 110.369 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.449 ' O ' HG22 ' A' ' 53' ' ' THR . 2.7 t -90.32 159.7 16.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.431 -0.793 . . . . 0.0 110.39 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 38' ' ' THR . 1.2 m -113.87 -79.79 0.59 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.488 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.1 m 68.25 -68.39 0.17 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.124 -0.985 . . . . 0.0 110.405 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 53' ' ' THR . . . -155.61 104.34 0.25 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.547 ' HB2' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -178.34 179.56 0.78 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -1.132 . . . . 0.0 109.924 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' CG ' ' HG2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.46 127.56 13.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 110.104 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.562 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 4.6 m-85 -109.17 172.85 6.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.398 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 58' ' ' SER . 0.9 OUTLIER 177.21 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.821 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 66.07 66.48 2.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG12 ' CG2' ' A' ' 57' ' ' ILE . 2.4 t -146.28 148.83 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 110.564 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.504 ' N ' HG13 ' A' ' 45' ' ' VAL . 13.3 m -122.25 89.7 3.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.447 -0.783 . . . . 0.0 109.312 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.524 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.65 168.92 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 5.4 t -115.89 -164.88 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.547 ' CA ' ' O ' ' A' ' 33' ' ' TYR . 2.0 m -49.63 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.918 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 6.2 p -132.21 137.46 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.052 -1.03 . . . . 0.0 111.253 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.435 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 26.3 m -87.86 40.13 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.587 -0.696 . . . . 0.0 109.268 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -102.17 103.01 13.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.149 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.505 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 6.0 p -146.28 95.56 2.63 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.547 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -156.0 -53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' N ' ' A' ' 89' ' ' ALA . 2.6 p -105.73 -162.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 11.4 mtp180 -95.84 137.62 34.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.519 -0.738 . . . . 0.0 109.917 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CG2' HG12 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -118.3 128.57 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.993 . . . . 0.0 110.186 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -145.68 157.4 43.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.48 125.6 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.2 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.635 1.334 . . . . 0.0 109.4 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.07 33.63 0.2 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.3 t -72.89 146.25 46.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.353 -1.087 . . . . 0.0 110.646 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 111.28 9.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.446 -0.784 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 5.4 tt -104.39 171.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 110.611 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.506 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.3 OUTLIER -142.97 96.35 2.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.32 -0.863 . . . . 0.0 110.046 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 16.7 p 54.64 -93.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.691 -0.631 . . . . 0.0 110.597 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.514 ' N ' ' OG1' ' A' ' 66' ' ' THR . 3.9 m 70.3 -167.5 0.16 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.044 -1.035 . . . . 0.0 109.994 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 52' ' ' SER . 0.5 OUTLIER -130.59 -169.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' ILE . 5.4 mt -42.47 167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.333 -0.854 . . . . 0.0 110.703 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -137.61 -139.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 108.87 44.41 1.12 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.528 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . 62.71 18.02 58.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 70' ' ' THR . 9.7 m -116.71 150.53 45.85 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.682 -0.893 . . . . 0.0 110.504 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.79 -47.8 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.988 1.52 . . . . 0.0 110.159 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.459 ' HB1' ' CG2' ' A' ' 68' ' ' ILE . . . 60.78 173.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.34 53.31 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.967 1.509 . . . . 0.0 110.342 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -117.12 22.2 12.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.31 -22.9 2.0 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.07 -8.56 58.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 77' ' ' SER . 8.2 t -71.02 149.06 46.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 110.252 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -111.9 103.34 11.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.944 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.545 HD11 ' CE2' ' A' ' 87' ' ' PHE . 1.1 tt -120.66 124.18 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.73 123.53 23.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 71.9 60.8 4.05 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 82' ' ' ILE . 56.3 m -138.79 146.12 40.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 111.25 13.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 109.607 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.545 ' CE2' HD11 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -142.69 160.13 40.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.948 . . . . 0.0 110.58 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -176.02 94.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' N ' ' CB ' ' A' ' 55' ' ' SER . . . 50.89 172.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.523 ' HA ' ' CD ' ' A' ' 56' ' ' ARG . 28.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.217 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.234 0.54 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -111.25 101.58 1.34 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 64.45 -69.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.096 . . . . 0.0 110.505 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' GLY . 0.6 OUTLIER -133.76 -75.42 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.467 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 5' ' ' THR . 5.5 t -127.96 53.34 1.79 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.009 -1.057 . . . . 0.0 109.577 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.65 70.45 1.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 111.001 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 4.4 t -98.97 21.82 11.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.086 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 7' ' ' THR . 2.7 m-20 168.49 -17.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.652 -0.655 . . . . 0.0 110.808 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -108.02 -160.44 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 0.0 110.068 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.14 117.34 11.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 110.713 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 1.8 tp -111.24 19.93 17.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 17.1 t 53.34 104.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.901 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.71 -24.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 110.429 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.2 m-20 -87.46 2.54 50.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 111.361 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.2 OUTLIER -101.12 -162.98 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.619 -1.301 . . . . 0.0 110.547 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -111.55 162.75 14.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.461 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 28.6 p -128.92 71.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.69 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.527 ' OE2' ' CZ ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -105.32 53.99 0.71 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 110.516 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.53 ' CD ' HG11 ' A' ' 32' ' ' VAL . 13.9 ptmt -169.97 -175.49 2.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.404 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -98.36 -31.93 11.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 20' ' ' SER . 24.6 m 60.21 139.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.531 ' O ' ' CG2' ' A' ' 23' ' ' THR . 8.2 mp -95.52 -83.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -171.39 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.259 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -157.32 67.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -153.84 113.9 3.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.802 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.504 ' HB2' ' HD3' ' A' ' 41' ' ' ARG . 37.7 m-85 -108.98 110.62 21.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 3.4 t -114.64 164.33 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.816 -1.177 . . . . 0.0 111.041 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.3 t70 -149.29 110.3 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.462 -0.774 . . . . 0.0 109.865 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.8 OUTLIER 54.95 63.45 2.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 110.061 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.9 m -133.88 -167.81 2.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 111.324 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.3 tt0 -143.28 104.03 4.21 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.53 HG11 ' CD ' ' A' ' 19' ' ' LYS . 53.1 t -103.94 142.19 18.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.97 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.54 ' HB3' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -114.25 -152.6 0.51 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.364 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 18' ' ' GLU . . . -66.69 67.55 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 33' ' ' TYR . 2.9 m -110.2 159.56 17.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -1.144 . . . . 0.0 110.801 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 51' ' ' THR . 1.3 p -89.2 -168.81 2.28 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.484 -0.76 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 30.6 t -174.33 102.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.1 m -118.42 1.33 11.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.477 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 151.16 77.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.489 ' HB2' ' CA ' ' A' ' 53' ' ' THR . 11.7 t -149.93 170.63 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -1.197 . . . . 0.0 110.515 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.504 ' HD3' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -132.99 133.07 42.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.625 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.55 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 2.8 m-85 -111.4 160.79 16.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 110.455 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.466 ' O ' HG21 ' A' ' 45' ' ' VAL . 8.5 t0 -171.74 116.13 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.68 67.34 1.58 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.538 HG23 ' CG2' ' A' ' 57' ' ' ILE . 2.7 t -144.86 126.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.442 -1.034 . . . . 0.0 110.537 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 25.3 m -106.86 96.28 6.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.288 -0.883 . . . . 0.0 109.194 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.528 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pt -113.72 160.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.493 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.535 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -106.01 -162.31 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.54 ' N ' ' HB3' ' A' ' 33' ' ' TYR . 55.1 m -64.16 91.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' THR . 13.7 p -139.24 164.5 29.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.684 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 36' ' ' THR . 13.1 p -108.68 72.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 109.83 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.454 ' O ' HG21 ' A' ' 53' ' ' THR . 5.5 t -124.16 105.8 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.14 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.544 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -151.07 117.84 5.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.215 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 168.51 -30.74 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.447 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -122.8 167.6 13.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.556 -0.967 . . . . 0.0 109.555 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.471 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 9.9 ttm180 -91.56 136.4 33.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.767 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 3.3 mt -114.66 163.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.4 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.551 ' N ' HG23 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -148.3 145.84 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.764 -0.585 . . . . 0.0 110.052 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 165.74 109.67 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.42 -1.371 . . . . 0.0 110.494 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.01 -4.77 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.758 1.399 . . . . 0.0 108.748 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.98 30.08 0.6 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.3 t -72.07 157.85 37.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -1.063 . . . . 0.0 110.608 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' HG2' ' C ' ' A' ' 62' ' ' CYS . 2.7 mmtp -144.5 110.98 5.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.659 -0.65 . . . . 0.0 109.653 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.492 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 6.9 tt -101.1 170.52 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.905 -1.122 . . . . 0.0 109.812 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.74 91.1 1.52 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.124 . . . . 0.0 111.387 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 65' ' ' SER . 13.3 p 46.08 109.81 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.654 0.74 . . . . 0.0 111.576 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.4 ' O ' ' OG1' ' A' ' 51' ' ' THR . 66.8 m -140.24 145.4 37.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.396 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 pt -55.36 -179.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 0.0 109.9 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 70' ' ' THR . 14.0 mt -54.79 153.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.522 ' N ' HG22 ' A' ' 69' ' ' ILE . 5.7 m -98.33 -122.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.916 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 95.29 35.59 5.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.93 65.02 0.99 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.588 HG22 ' CE2' ' A' ' 87' ' ' PHE . 5.2 m -88.58 168.36 16.25 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.175 -1.191 . . . . 0.0 109.879 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 45.8 Cg_endo -73.41 168.98 23.38 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.718 1.378 . . . . 0.0 111.107 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -77.6 -46.79 2.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.805 . . . . 0.0 111.483 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 41.8 Cg_endo -69.41 -25.45 30.2 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.375 1.197 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 76' ' ' PRO . 1.4 m 42.5 62.58 1.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.709 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.18 -21.13 4.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.069 -1.019 . . . . 0.0 108.375 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.6 -71.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.535 0.683 . . . . 0.0 110.111 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 2.7 t -64.99 155.28 35.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 110.63 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 109.12 20.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.44 -0.787 . . . . 0.0 109.639 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.45 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -125.83 158.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 110.161 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.41 96.58 2.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 0.0 110.883 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.1 55.14 4.92 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.545 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -132.02 158.2 42.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.167 . . . . 0.0 110.881 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.582 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -111.06 161.04 16.3 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 57' ' ' ILE . 7.5 m-85 -146.43 162.22 38.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 111.276 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 1.2 t 169.19 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -37.62 138.01 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.447 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.853 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.25 0.548 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -131.34 120.78 2.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 2' ' ' GLY . 0.7 OUTLIER 62.74 -72.18 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.319 -1.106 . . . . 0.0 110.07 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 2' ' ' GLY . 8.1 t -155.55 -62.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.826 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.476 HG23 ' HA ' ' A' ' 17' ' ' CYS . 7.3 t -134.08 50.78 2.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.791 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 9' ' ' SER . 6.6 m120 -140.64 106.68 5.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.97 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -98.62 28.55 4.16 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.953 0.882 . . . . 0.0 108.64 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.71 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.297 0.57 . . . . 0.0 109.596 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 19.3 m -107.74 -165.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 109.277 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.73 115.94 7.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.786 -1.196 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 1.7 tp -91.63 140.71 29.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -0.945 . . . . 0.0 109.096 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.504 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -54.07 139.09 35.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -12.48 9.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.342 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -115.61 17.4 16.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.977 . . . . 0.0 110.702 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.2 p -94.28 -147.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.52 ' CB ' ' HG3' ' A' ' 31' ' ' GLU . 4.0 tttt -121.41 120.4 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.18 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.476 ' HA ' HG23 ' A' ' 5' ' ' THR . 1.6 t -56.21 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 110.329 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' CB ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.44 -145.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.484 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -149.17 149.5 31.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.505 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.4 m 68.3 113.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.292 -0.88 . . . . 0.0 110.978 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 20' ' ' SER . 24.4 m -166.16 137.24 3.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.369 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -168.68 64.99 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 0.0 111.017 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -167.98 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.343 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.43 ' N ' ' OG1' ' A' ' 23' ' ' THR . 68.7 m-80 -155.21 106.66 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.971 -1.081 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 12.9 m -141.97 109.26 5.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 110.31 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.482 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 6.6 t80 -100.8 103.86 15.09 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.536 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 8.0 t -101.69 164.62 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -142.47 119.29 11.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.421 -0.799 . . . . 0.0 109.452 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 26.2 tttt 42.78 67.75 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 109.835 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.535 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 2.1 m -132.96 -168.04 2.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.52 ' HG3' ' CB ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -144.8 96.91 2.94 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.13 -0.982 . . . . 0.0 109.784 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 18' ' ' GLU . 61.3 t -102.33 138.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 110.086 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 49' ' ' THR . 4.6 t80 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.085 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 42.26 48.58 5.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.457 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 22.5 m -104.9 163.92 12.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -1.134 . . . . 0.0 109.771 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 53' ' ' THR . 28.3 p -99.79 174.63 6.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.848 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 0.1 OUTLIER -157.5 143.35 17.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.722 . . . . 0.0 109.872 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -166.62 37.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.13 62.03 0.38 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 9.2 t -142.91 176.17 9.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.482 ' HD3' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -145.75 124.16 12.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.536 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.3 m-85 -99.65 172.69 7.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.235 -0.916 . . . . 0.0 110.139 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.453 ' HB3' ' OG ' ' A' ' 58' ' ' SER . 7.8 t70 179.0 95.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 68.7 67.66 1.89 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 57' ' ' ILE . 1.1 t -145.88 159.42 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 110.603 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.51 ' N ' HG11 ' A' ' 45' ' ' VAL . 27.4 m -130.33 88.26 2.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.543 -0.723 . . . . 0.0 109.617 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.522 ' CB ' HG22 ' A' ' 64' ' ' ILE . 1.1 pp -111.08 165.59 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -129.88 -157.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.085 . . . . 0.0 110.788 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.503 ' N ' ' CG2' ' A' ' 48' ' ' THR . 5.6 m -46.45 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 110.858 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.3 m -140.5 -167.05 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.068 -1.02 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -150.03 72.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.376 -0.828 . . . . 0.0 109.84 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 8.4 t -131.79 112.47 12.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.567 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -151.65 121.75 7.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 168.48 -25.98 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.438 ' HA ' ' C ' ' A' ' 89' ' ' ALA . 26.0 p -122.7 -170.15 2.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -1.11 . . . . 0.0 109.918 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 28.1 mtp180 -94.87 115.94 28.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.843 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.589 ' CG2' ' CG2' ' A' ' 45' ' ' VAL . 1.2 mm -98.98 122.52 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.076 . . . . 0.0 109.965 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.453 ' OG ' ' HB3' ' A' ' 43' ' ' ASP . 44.9 m -145.78 168.3 21.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 110.46 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 151.02 123.05 1.08 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.5 -5.68 17.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.691 1.363 . . . . 0.0 109.416 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 23.72 0.87 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 5.1 t -73.17 143.44 47.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.499 -1.001 . . . . 0.0 110.648 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 113.22 7.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.0 109.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.522 HG22 ' CB ' ' A' ' 47' ' ' ILE . 3.0 tt -104.04 168.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 15.2 t -152.26 89.88 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 65' ' ' SER . 2.2 p 56.71 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.459 ' O ' HG22 ' A' ' 51' ' ' THR . 83.5 m -146.5 -159.09 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.0 155.72 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.929 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.481 ' O ' ' CG1' ' A' ' 69' ' ' ILE . 1.8 pp -92.51 121.85 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.438 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.7 m -148.41 150.77 34.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.39 51.32 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 135.44 90.55 0.32 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.493 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 21.2 m -86.83 165.6 31.34 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.266 -1.138 . . . . 0.0 110.144 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 43.4 Cg_endo -71.12 178.49 5.35 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.85 1.447 . . . . 0.0 110.759 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -81.48 -50.56 0.91 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 111.397 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 45.9 Cg_endo -72.9 -38.21 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.568 1.299 . . . . 0.0 110.953 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.448 ' CB ' HG23 ' A' ' 82' ' ' ILE . 0.8 OUTLIER 61.45 41.42 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.063 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -42.64 -28.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 108.972 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -80.91 -68.11 0.72 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.546 0.688 . . . . 0.0 109.39 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 2.2 t -63.97 159.92 18.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 110.021 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 65' ' ' SER . 3.6 mptp? -105.29 90.44 3.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.804 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.97 154.76 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.48 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -148.05 89.77 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.781 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 97.19 61.67 0.93 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.598 ' HB3' ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -138.39 171.95 13.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -1.224 . . . . 0.0 110.563 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.11 119.06 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.767 . . . . 0.0 109.554 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -147.4 149.6 33.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.174 . . . . 0.0 111.614 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.5 p -163.72 73.08 0.29 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.735 -0.603 . . . . 0.0 109.688 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.438 ' C ' ' HA ' ' A' ' 55' ' ' SER . . . 59.75 162.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 0.0 109.937 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.351 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.337 0.589 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.92 -107.85 1.0 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 14.5 t -71.82 -14.64 62.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -1.195 . . . . 0.0 109.868 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 3' ' ' SER . 1.6 p 169.71 -51.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 109.865 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 5' ' ' THR . 9.9 t -145.81 49.02 1.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.425 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 2.8 m120 -138.85 117.83 12.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.113 -0.992 . . . . 0.0 110.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 40.6 p -102.17 106.16 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.366 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER 74.01 -1.47 3.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.378 -0.826 . . . . 0.0 110.023 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.62 177.43 4.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.673 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -131.06 112.32 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.169 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.503 ' HG ' ' OG ' ' A' ' 15' ' ' SER . 7.3 tp -88.63 54.57 3.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 110.053 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.53 ' HB2' ' CA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 63.06 8.17 3.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 0.0 110.961 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 54.05 16.98 1.26 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER 174.75 30.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.98 -1.075 . . . . 0.0 110.918 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -92.44 -146.24 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.05 . . . . 0.0 109.564 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.571 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -104.69 103.83 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.967 -1.083 . . . . 0.0 109.521 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.64 59.78 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.589 ' HG2' ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -85.84 54.85 3.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 110.061 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.8 mtmm 54.5 -170.09 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 63.79 83.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 m -162.92 152.52 15.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tp -117.63 -121.11 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.057 -1.027 . . . . 0.0 110.309 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 8' ' ' ASN . 4.2 t -151.93 37.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.84 -1.163 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -155.91 52.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 110.493 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 8.0 p -152.09 116.51 5.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.061 -1.024 . . . . 0.0 110.455 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 93.0 m-85 -100.69 100.19 10.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 0.0 109.554 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.535 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 5.6 t -94.37 166.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.017 . . . . 0.0 110.247 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' CA ' ' HB2' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.79 124.84 12.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' N ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER 42.77 63.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 109.586 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.532 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.1 m -130.9 -179.12 5.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 111.114 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.5 mt-10 -145.3 103.77 3.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.571 -0.705 . . . . 0.0 109.216 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' A' ' 35' ' ' THR . 13.9 m -112.4 130.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.589 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 2.7 t80 -118.27 94.63 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.902 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 20' ' ' SER . . . 74.96 33.18 55.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.563 ' CG2' ' CD1' ' A' ' 47' ' ' ILE . 19.2 m -108.66 147.23 32.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -1.189 . . . . 0.0 110.208 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.485 ' N ' HG21 ' A' ' 35' ' ' THR . 8.1 t -97.94 150.8 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 19.8 p -135.44 58.2 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 110.138 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 m -66.21 -108.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.811 -1.18 . . . . 0.0 109.726 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.97 66.37 3.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.462 ' HB2' ' CB ' ' A' ' 53' ' ' THR . 7.8 t -144.05 168.16 20.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -1.18 . . . . 0.0 110.758 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 3.9 tpt180 -138.85 124.53 19.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.535 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.2 m-85 -104.48 177.53 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 10.0 t0 173.39 108.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 56.45 67.34 2.27 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.541 ' CG2' HG21 ' A' ' 57' ' ' ILE . 16.5 t -145.76 125.13 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -1.039 . . . . 0.0 111.419 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -103.44 96.1 6.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 108.659 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.563 ' CD1' ' CG2' ' A' ' 35' ' ' THR . 1.1 pt -111.14 167.15 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 110.698 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.96 112.47 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER 38.08 72.3 0.13 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.433 -0.792 . . . . 0.0 111.288 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 35' ' ' THR . 44.3 t -140.13 139.96 35.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 110.786 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 67' ' ' CYS . 29.8 p -103.85 50.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.918 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -89.86 54.7 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.817 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 40' ' ' SER . 10.1 p -84.21 173.46 11.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 110.152 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 94.21 -18.57 56.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.518 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 1.2 p -124.63 154.67 40.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 ttm180 -91.97 114.41 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.541 HG21 ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -101.2 146.55 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 111.301 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -147.31 152.35 38.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.653 -0.655 . . . . 0.0 109.716 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 166.03 124.4 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.24 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -5.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.74 1.389 . . . . 0.0 108.761 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.93 32.12 0.46 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 1.9 t -72.51 139.09 47.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.527 -0.984 . . . . 0.0 110.658 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -132.18 110.55 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.464 -0.772 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.53 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 5.9 tt -100.35 172.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.175 -0.953 . . . . 0.0 109.967 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 66' ' ' THR . 16.0 m -151.93 94.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.017 -1.052 . . . . 0.0 110.962 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 45.59 105.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 179.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 17.1 t -133.53 163.84 28.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 69' ' ' ILE . 2.9 mp -80.52 167.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 0.0 110.897 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 68' ' ' ILE . 10.0 mt -84.63 120.97 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 109.395 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -148.54 139.16 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 110.617 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -82.28 58.12 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 134.15 89.23 0.34 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.547 ' CG2' ' HD2' ' A' ' 74' ' ' PRO . 3.3 p -86.48 148.41 46.63 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.252 -1.146 . . . . 0.0 109.525 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 73' ' ' VAL . 42.5 Cg_endo -68.71 175.72 6.85 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.841 1.443 . . . . 0.0 111.017 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -75.5 -56.17 1.91 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.4 -0.812 . . . . 0.0 111.077 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 42.4 Cg_endo -70.06 -26.47 26.15 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.804 1.423 . . . . 0.0 110.888 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.461 ' HA ' ' HG2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER 47.29 43.95 15.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.05 -1.031 . . . . 0.0 110.579 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -44.42 -25.93 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.121 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 77' ' ' SER . . . -79.35 -76.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.535 -0.728 . . . . 0.0 109.67 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m -63.95 176.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 110.316 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -115.67 107.85 15.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.948 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -128.69 156.38 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.511 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 36.4 t -147.59 87.69 1.65 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 90.95 60.15 1.35 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' A' ' 82' ' ' ILE . 49.9 m -142.55 156.39 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -112.5 157.9 20.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.044 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' HB3' HG11 ' A' ' 73' ' ' VAL . 1.9 m-85 -144.89 161.69 38.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.868 -1.145 . . . . 0.0 110.66 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 176.47 56.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 42.56 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 109.825 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 40' ' ' SER . 1.5 p-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.411 ' HA ' HG21 ' A' ' 7' ' ' THR . 11.2 t70 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.233 0.539 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.78 -108.55 2.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 7.6 p -94.99 86.38 4.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -1.11 . . . . 0.0 110.217 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.8 OUTLIER 73.0 -72.17 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.475 -0.766 . . . . 0.0 110.698 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.499 ' OG1' ' CG ' ' A' ' 19' ' ' LYS . 14.6 t -137.06 47.05 2.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.963 -1.086 . . . . 0.0 110.795 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.41 90.98 2.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.531 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 14.5 p -98.44 41.27 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 168.31 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.369 0.604 . . . . 0.0 109.665 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 34.3 m -108.19 -163.71 0.91 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 110.583 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.55 120.67 18.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.702 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CD2' ' HB3' ' A' ' 17' ' ' CYS . 8.0 tp -88.15 21.67 2.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 11' ' ' LEU . 10.6 t 64.64 5.88 2.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.642 -0.661 . . . . 0.0 111.118 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.13 21.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 110.072 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -154.0 14.05 0.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 30' ' ' SER . 1.0 OUTLIER -112.46 -156.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.42 ' HB2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -108.09 148.27 30.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.018 . . . . 0.0 110.055 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 11' ' ' LEU . 7.2 p -123.05 68.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.32 67.44 3.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.322 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' CG ' ' OG1' ' A' ' 5' ' ' THR . 0.0 OUTLIER -179.48 -169.82 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.219 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -170.77 96.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.258 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.518 ' CG2' ' OG1' ' A' ' 23' ' ' THR . 4.9 t -168.87 -175.61 2.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.19 33.36 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.52 ' O ' ' OG ' ' A' ' 9' ' ' SER . 2.0 m -53.28 115.7 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.635 -0.666 . . . . 0.0 110.23 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.491 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 5.5 m-20 -84.29 103.24 13.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 110.405 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.0 OUTLIER -157.9 122.61 4.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 110.955 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.542 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -87.3 102.32 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 108.757 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 18.8 t -100.85 163.84 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.922 -1.111 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 37.6 t0 -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 12.8 tttt 43.27 68.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.885 -1.134 . . . . 0.0 109.989 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.527 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.5 m -133.74 -171.05 2.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.061 . . . . 0.0 111.655 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -144.33 103.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.7 t -106.13 151.09 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.937 -1.102 . . . . 0.0 110.968 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.505 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 2.3 t80 -140.37 76.65 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.898 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 19' ' ' LYS . . . 65.98 61.35 5.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 37' ' ' CYS . 3.4 m -111.41 149.26 31.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 109.978 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.511 ' OG1' ' N ' ' A' ' 37' ' ' CYS . 18.2 p -67.38 -68.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.313 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' CE1' ' A' ' 42' ' ' PHE . 0.6 OUTLIER 51.42 42.42 29.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.099 -1.001 . . . . 0.0 109.988 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -85.15 36.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.726 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 152.08 54.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.543 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.57 -176.24 5.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.118 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -131.68 134.24 45.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.726 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.575 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.5 m-85 -111.97 150.85 29.97 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.894 -1.129 . . . . 0.0 110.416 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 14.4 t0 -166.15 119.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.491 -0.756 . . . . 0.0 109.105 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.42 68.89 1.03 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.562 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.3 t -145.85 135.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -1.165 . . . . 0.0 111.036 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.5 m -115.43 90.61 3.38 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.525 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.34 172.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 110.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.486 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 5.1 t -129.14 -155.21 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 1.3 m -58.62 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 48' ' ' THR . 8.6 t -139.13 -175.6 4.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 67' ' ' CYS . 3.6 t -133.78 61.61 1.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.292 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -112.07 100.28 8.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 3.5 p -131.21 -164.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.03 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . 94.1 -68.26 1.43 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.447 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.573 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -101.66 -169.58 1.7 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.155 -1.203 . . . . 0.0 111.722 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.539 ' N ' ' OG ' ' A' ' 55' ' ' SER . 3.7 ppt_? -107.6 139.59 41.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.735 -0.603 . . . . 0.0 110.131 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.562 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.7 mt -107.75 160.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.531 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.553 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -146.65 148.54 32.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.11 124.0 0.73 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.393 -1.385 . . . . 0.0 110.597 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.35 -1.26 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.746 1.393 . . . . 0.0 108.905 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -173.21 38.15 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.41 155.57 39.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 111.05 5.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.629 -0.67 . . . . 0.0 109.786 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.457 HG23 ' HB ' ' A' ' 47' ' ' ILE . 4.5 tt -101.71 165.14 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 109.406 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.503 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 2.0 t -152.16 86.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.058 . . . . 0.0 110.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.2 p 55.02 114.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.543 -0.723 . . . . 0.0 110.3 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.526 ' O ' ' CG2' ' A' ' 51' ' ' THR . 60.5 m -143.23 -143.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 110.532 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 68' ' ' ILE . 10.0 mm -132.32 165.59 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 70' ' ' THR . 40.6 mt -45.85 151.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.0 . . . . 0.0 109.863 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -123.84 -144.78 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.74 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.573 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 115.22 57.84 0.35 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.43 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . 63.92 15.53 58.24 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.476 ' O ' ' HD2' ' A' ' 76' ' ' PRO . 3.7 m -128.28 83.93 64.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.724 -0.869 . . . . 0.0 110.349 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.62 8.56 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.983 1.517 . . . . 0.0 110.317 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -72.03 -49.83 9.75 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.364 -0.835 . . . . 0.0 111.163 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 46.0 Cg_endo -73.99 4.18 4.44 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.736 1.388 . . . . 0.0 111.308 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 80' ' ' CYS . 24.8 m -122.06 13.26 10.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.883 -1.135 . . . . 0.0 110.269 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.17 -22.78 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 108.965 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.415 ' O ' ' HE3' ' A' ' 81' ' ' LYS . . . -87.69 7.19 31.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.623 -0.673 . . . . 0.0 110.012 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.435 ' N ' ' O ' ' A' ' 77' ' ' SER . 18.3 t -81.23 150.05 28.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 111.118 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -103.83 94.52 5.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.413 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -123.19 151.8 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.541 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.481 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 15.6 m -147.44 103.98 3.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 83.84 48.19 5.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.48 159.6 38.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -1.193 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.494 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -120.08 163.09 18.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.453 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 86' ' ' THR . 4.0 m-85 -134.61 161.73 34.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.085 -1.01 . . . . 0.0 109.973 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 55' ' ' SER . 0.3 OUTLIER 175.09 124.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 110.45 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 55' ' ' SER . . . -42.01 146.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.486 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 1.6 t30 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.887 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.411 0.624 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.73 -142.4 8.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -49.46 -26.94 3.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.737 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 3' ' ' SER . 1.9 p 173.16 -51.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 109.91 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.3 t -146.23 19.33 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -89.48 57.52 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.519 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 75.2 p -98.63 105.47 17.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.382 -0.824 . . . . 0.0 109.438 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 7' ' ' THR . 14.2 m-20 67.09 6.04 4.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.86 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.43 178.7 6.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 10.8 tt0 -131.32 112.29 12.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.969 -1.082 . . . . 0.0 110.566 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.485 ' O ' ' HB3' ' A' ' 12' ' ' SER . 5.3 tp -100.7 29.89 4.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.827 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 11' ' ' LEU . 9.1 t 65.3 6.34 3.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.596 -0.69 . . . . 0.0 110.797 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 44.59 24.05 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.069 -1.019 . . . . 0.0 110.473 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.2 t30 -158.52 17.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 110.727 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 1.8 p -106.4 -140.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -120.67 124.14 44.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.926 -1.109 . . . . 0.0 109.81 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 8.9 m -97.12 61.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.69 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.535 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.67 39.75 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.145 . . . . 0.0 110.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER 174.35 143.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 109.904 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 p -72.09 178.59 3.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.952 . . . . 0.0 110.517 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.11 -161.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.498 ' O ' ' HB ' ' A' ' 23' ' ' THR . 9.9 tp -130.25 -70.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 t 171.79 36.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.411 -0.806 . . . . 0.0 109.804 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.99 52.77 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.7 m -144.56 110.59 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 110.807 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.536 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 26.5 m-85 -105.65 104.91 14.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 6.7 t -106.29 159.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.759 -1.213 . . . . 0.0 110.841 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 1.7 t0 -142.89 123.37 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.283 -0.885 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' N ' ' OG ' ' A' ' 12' ' ' SER . 1.8 tttt 38.3 66.68 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 110.094 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 15' ' ' SER . 2.1 m -133.31 -167.47 1.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -143.29 103.67 4.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.407 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 77.4 t -105.59 127.61 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.093 -1.004 . . . . 0.0 110.878 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -107.51 -139.08 0.37 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -66.47 61.6 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.5 m -107.07 164.55 12.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 110.141 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.454 HG23 ' HA ' ' A' ' 51' ' ' THR . 19.6 p -104.82 174.61 5.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 119.73 7.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -140.39 -36.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 54' ' ' GLY . . . -172.17 65.12 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.552 ' HB2' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -137.62 179.96 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -1.097 . . . . 0.0 110.24 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.543 ' HD2' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -141.27 130.2 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.544 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.555 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 5.4 m-85 -109.79 162.41 14.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.8 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 9.4 t0 177.95 112.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 52.18 66.34 2.68 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.315 -2.314 . . . . 0.0 107.315 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 57' ' ' ILE . 3.8 t -145.24 117.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -1.101 . . . . 0.0 110.422 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.518 HG21 ' CE ' ' A' ' 63' ' ' LYS . 10.6 m -98.85 90.91 4.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.486 ' HB ' HG21 ' A' ' 64' ' ' ILE . 1.1 pt -110.51 167.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.448 -0.782 . . . . 0.0 109.957 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.513 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 0.6 OUTLIER -122.77 -160.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.107 -0.995 . . . . 0.0 110.121 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.492 ' N ' ' CG2' ' A' ' 48' ' ' THR . 44.1 m -49.13 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 109.941 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.516 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 3.5 t -139.99 132.31 28.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.034 -1.041 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.454 ' HA ' HG23 ' A' ' 36' ' ' THR . 33.2 p -85.38 59.71 5.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 109.658 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 t -119.59 126.5 51.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 110.02 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -169.81 75.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -0.974 . . . . 0.0 110.723 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.552 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -133.5 -54.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB3' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -104.7 -171.32 1.9 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -1.088 . . . . 0.0 109.959 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.499 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 37.4 ptt180 -105.31 136.47 44.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.306 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.542 HG23 ' CG2' ' A' ' 45' ' ' VAL . 1.8 mt -109.59 157.54 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.521 ' N ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.71 156.92 43.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.718 . . . . 0.0 110.292 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 157.33 124.42 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.552 -1.308 . . . . 0.0 110.575 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.03 -7.89 22.26 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.594 1.313 . . . . 0.0 108.76 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.48 33.05 0.64 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 2.8 t -71.68 137.98 48.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -1.035 . . . . 0.0 110.165 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.518 ' CE ' HG21 ' A' ' 46' ' ' THR . 1.6 mtpt -137.22 118.41 14.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.87 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG21 ' HB ' ' A' ' 47' ' ' ILE . 2.5 tt -104.26 170.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.479 ' O ' ' OG1' ' A' ' 66' ' ' THR . 1.2 t -143.36 77.93 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.108 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 7.2 p 52.9 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 110.971 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 80' ' ' CYS . 74.0 m -124.21 -149.8 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 69' ' ' ILE . 43.4 mm -131.09 169.4 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.441 HG21 HG21 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -57.83 136.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.519 ' OG1' ' CG2' ' A' ' 73' ' ' VAL . 0.8 OUTLIER -147.24 90.28 1.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 111.028 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.423 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . -74.38 65.04 2.06 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . 68.51 52.25 26.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.519 ' CG2' ' OG1' ' A' ' 70' ' ' THR . 3.3 m -95.71 166.64 14.14 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.673 -0.898 . . . . 0.0 110.415 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 40.6 Cg_endo -70.34 146.88 57.86 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.912 1.48 . . . . 0.0 110.613 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . . . 41.47 71.37 1.33 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.75 . . . . 0.0 110.092 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 77' ' ' SER . 43.1 Cg_endo -69.18 136.66 35.13 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.133 1.596 . . . . 0.0 109.506 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.52 ' CB ' ' SG ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER 61.62 14.61 6.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.979 -1.076 . . . . 0.0 108.93 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' A' ' 75' ' ' ALA . . . -53.78 -19.13 3.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.479 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . -93.01 -61.37 1.59 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.751 -0.593 . . . . 0.0 110.076 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 77' ' ' SER . 30.5 p -63.84 -155.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.765 . . . . 0.0 110.056 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 79' ' ' ALA . 3.5 mmtt -120.52 133.43 55.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.454 HD11 HG13 ' A' ' 64' ' ' ILE . 7.8 tp -138.57 156.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 109.845 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.9 m -154.21 125.91 7.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.183 -0.948 . . . . 0.0 110.055 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 56.53 55.29 30.52 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.469 ' O ' ' CE2' ' A' ' 87' ' ' PHE . 88.4 m -133.14 140.46 47.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -1.092 . . . . 0.0 111.064 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -101.95 166.38 10.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.079 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CD1' ' O ' ' A' ' 86' ' ' THR . 1.9 m-85 -152.8 157.26 40.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.835 -1.165 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER 177.48 132.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.526 ' CA ' ' HA3' ' A' ' 72' ' ' GLY . . . -41.79 136.7 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.424 ' OD1' ' C ' ' A' ' 40' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.231 0.539 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 3' ' ' SER . . . -141.25 106.44 0.47 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER 70.7 -56.34 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -1.15 . . . . 0.0 110.552 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.94 -158.4 0.88 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.065 -1.022 . . . . 0.0 110.633 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 5' ' ' THR . 8.1 t -96.46 57.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.477 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -149.01 111.75 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 9.5 p -98.4 111.05 23.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 73.9 -0.71 3.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 109.902 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -110.94 -177.18 3.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 109.599 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -143.47 99.69 3.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' A' ' 15' ' ' SER . 4.4 tp -90.36 25.81 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.59 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 t 54.65 93.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.123 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -37.99 -28.54 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.761 . . . . 0.0 111.318 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 29' ' ' LYS . 9.1 p30 -83.48 11.41 7.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -99.68 -149.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 0.0 109.522 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -113.82 99.63 7.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.023 -1.048 . . . . 0.0 109.781 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.3 m -73.97 55.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 110.104 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.21 80.15 1.74 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.212 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -171.92 -145.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.766 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.45 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -106.77 -150.0 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.355 -0.841 . . . . 0.0 110.19 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.493 ' CG2' ' OG1' ' A' ' 7' ' ' THR . 2.6 m -165.01 151.05 10.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -158.59 22.97 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 15.4 p 48.95 38.34 12.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.246 -0.909 . . . . 0.0 111.09 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 0.6 OUTLIER -157.73 53.28 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.019 -1.051 . . . . 0.0 110.271 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -149.45 107.41 3.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.064 -1.023 . . . . 0.0 110.386 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 10.3 m-85 -106.9 88.28 2.71 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' CG1' ' OG ' ' A' ' 30' ' ' SER . 11.0 t -93.73 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 111.371 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.59 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 7.5 t0 -150.07 126.5 10.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.0 109.852 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HA ' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER 41.66 56.6 3.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.006 -1.059 . . . . 0.0 110.181 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 15' ' ' SER . 15.4 m -122.37 176.95 5.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.92 . . . . 0.0 110.77 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' A' ' 47' ' ' ILE . 21.8 mt-10 -144.06 100.39 3.55 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 108.789 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 16' ' ' LYS . 16.0 m -106.55 152.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.551 ' O ' ' CA ' ' A' ' 49' ' ' THR . 32.9 t80 -134.57 85.93 2.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . 78.02 43.78 13.21 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 1.9 m -104.69 166.23 10.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -1.083 . . . . 0.0 110.286 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -130.47 134.38 47.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 5.0 p -121.55 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 110.441 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -86.77 7.01 28.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.18 76.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.535 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 2.2 p -159.24 179.62 8.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.176 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.547 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -146.07 117.73 8.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 0.0 109.927 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.472 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.5 m-30 -98.94 150.52 21.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.036 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -145.83 71.79 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 109.589 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 88.33 73.68 1.28 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 47' ' ' ILE . 3.1 t -145.55 138.85 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -1.159 . . . . 0.0 111.103 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 18.8 m -112.76 91.94 3.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.978 . . . . 0.0 109.112 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.533 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -112.3 170.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.501 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 14.6 t -118.18 -145.76 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.82 -1.175 . . . . 0.0 109.969 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.551 ' CA ' ' O ' ' A' ' 33' ' ' TYR . 39.9 m -64.81 80.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 35' ' ' THR . 3.0 p -137.59 149.98 47.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.299 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 67' ' ' CYS . 9.0 t -112.64 66.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 0.0 110.202 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.46 91.46 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 62.4 p -123.5 141.32 52.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.139 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.68 -32.29 1.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.44 ' HB3' ' C ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -122.32 160.57 25.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 110.525 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 110.22 21.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.579 HG21 ' CE1' ' A' ' 87' ' ' PHE . 7.3 pt -106.95 159.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.074 -1.017 . . . . 0.0 112.424 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 5.5 t -146.12 -173.72 4.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 151.49 119.79 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.669 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.57 -7.5 21.33 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.699 1.368 . . . . 0.0 108.645 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.4 37.28 0.3 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.9 t -71.83 144.25 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.499 -1.001 . . . . 0.0 110.581 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 46' ' ' THR . 18.3 mtpt -144.41 117.93 9.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.622 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.486 HG22 ' HA ' ' A' ' 47' ' ' ILE . 3.7 tt -105.03 174.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.89 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.524 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -147.01 84.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.914 179.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' SER . 0.2 OUTLIER 60.07 135.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.468 ' O ' HG22 ' A' ' 51' ' ' THR . 42.3 t -167.15 167.93 13.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 69' ' ' ILE . 5.6 mt -99.88 179.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 110.027 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' A' ' 68' ' ' ILE . 1.5 pt -45.51 171.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.113 -0.992 . . . . 0.0 110.039 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -133.32 -137.65 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 111.02 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.13 43.87 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.8 67.07 0.87 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.534 ' CG2' ' HD2' ' A' ' 74' ' ' PRO . 5.4 p -89.85 147.71 38.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.459 -1.024 . . . . 0.0 111.14 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 73' ' ' VAL . 44.0 Cg_endo -71.18 145.44 49.09 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 124.037 1.546 . . . . 0.0 110.908 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -50.04 -56.18 19.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.301 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 42.0 Cg_endo -70.25 70.32 1.85 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.831 1.437 . . . . 0.0 110.117 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.514 ' HB2' ' CG2' ' A' ' 82' ' ' ILE . 1.2 m -59.25 73.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 110.774 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 76' ' ' PRO . . . -57.47 -17.64 14.41 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.165 -0.959 . . . . 0.0 108.625 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -78.84 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.419 0.628 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.8 m -74.54 -172.24 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.86 . . . . 0.0 110.399 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 4.7 mmtp -114.73 113.83 24.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.386 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.514 ' CG2' ' HB2' ' A' ' 77' ' ' SER . 2.1 tp -140.6 147.65 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.995 . . . . 0.0 110.542 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 m -145.27 111.78 5.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.278 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 76.99 57.07 3.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.489 ' SG ' HG13 ' A' ' 82' ' ' ILE . 69.8 m -138.85 153.9 48.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -105.4 157.75 17.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.489 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CE1' HG21 ' A' ' 57' ' ' ILE . 35.5 m-85 -144.28 146.66 32.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.101 -0.999 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER 174.1 118.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.74 . . . . 0.0 109.408 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -33.93 125.35 0.45 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.8 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.41 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.1 t30 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.254 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 t0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.247 0.546 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.65 -125.76 1.16 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -33.51 67.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.198 . . . . 0.0 109.407 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p 176.96 -42.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.485 ' CB ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 m -143.57 32.33 1.31 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -112.42 59.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 11.2 p -99.57 105.84 17.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.076 -1.015 . . . . 0.0 110.306 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 7' ' ' THR . 4.2 t-20 66.65 6.78 4.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -129.85 -165.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.023 -1.048 . . . . 0.0 110.395 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -142.99 104.47 4.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' SER . 30.3 tp -91.38 21.21 4.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.324 -0.86 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER 71.5 0.77 3.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.472 -0.768 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.68 19.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.012 . . . . 0.0 109.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.6 t30 -157.4 13.71 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.996 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -101.15 -145.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.761 -1.212 . . . . 0.0 109.703 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' VAL . 1.8 tptt -104.0 131.7 50.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.01 . . . . 0.0 109.227 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' ' CB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.22 65.39 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 111.087 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -98.05 147.78 24.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.06 -1.025 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 57.69 158.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.57 122.38 45.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.46 HG23 ' CB ' ' A' ' 37' ' ' CYS . 3.4 m -93.55 152.96 18.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.008 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.05 54.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 109.378 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -161.04 -158.36 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.337 -0.852 . . . . 0.0 110.701 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -95.75 115.11 26.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.609 -0.682 . . . . 0.0 110.978 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 9' ' ' SER . 54.7 m -154.73 110.74 3.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.672 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 28.6 m-85 -101.86 122.26 43.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.76 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.574 ' CG1' ' HB3' ' A' ' 42' ' ' PHE . 3.6 t -120.35 167.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 110.308 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.1 m-20 -146.95 113.81 6.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 18.2 tttt 47.43 68.6 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.872 -1.143 . . . . 0.0 110.037 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 15' ' ' SER . 1.6 m -133.86 -171.02 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.158 -0.964 . . . . 0.0 111.346 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.22 100.84 3.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 33' ' ' TYR . 71.1 t -101.42 157.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 111.15 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.57 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.34 -140.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.24 58.78 1.11 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 50' ' ' SER . 0.8 OUTLIER -96.96 -144.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.394 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 37' ' ' CYS . 31.0 p -139.53 -158.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.956 -1.09 . . . . 0.0 110.99 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.472 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 36.1 t 178.7 53.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.94 48.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.74 88.14 2.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.537 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 67.3 p -169.95 174.13 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -1.109 . . . . 0.0 110.391 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.521 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -137.91 138.64 39.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.453 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.574 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.7 m-85 -118.29 168.79 10.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.911 -1.118 . . . . 0.0 110.398 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.2 OUTLIER 176.57 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 108.739 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.44 68.05 1.31 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.597 ' CG1' ' CG2' ' A' ' 47' ' ' ILE . 15.0 t -143.02 109.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.363 -1.08 . . . . 0.0 111.265 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 5.7 m -94.89 86.27 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.896 -1.128 . . . . 0.0 108.595 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.597 ' CG2' ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -112.41 163.37 9.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.563 -0.711 . . . . 0.0 110.451 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.57 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 1.4 t -115.29 -152.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.04 -1.038 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.527 ' N ' ' CG2' ' A' ' 48' ' ' THR . 8.8 m -58.87 87.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.688 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 0.7 OUTLIER -138.59 -162.26 1.29 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.966 -1.084 . . . . 0.0 110.835 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.418 HG22 HG22 ' A' ' 36' ' ' THR . 0.4 OUTLIER -144.01 67.21 1.27 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.8 79.41 2.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.328 -0.858 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.537 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 28.9 p -121.57 175.11 6.38 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 110.684 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.45 -34.43 4.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.54 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -129.85 163.84 25.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -1.133 . . . . 0.0 110.386 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.7 ptm180 -96.02 136.75 36.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.559 ' CG2' ' SG ' ' A' ' 85' ' ' CYS . 2.2 mt -110.73 163.94 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -0.96 . . . . 0.0 111.312 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.2 OUTLIER -147.31 149.82 33.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 167.01 116.24 0.35 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.415 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.93 -5.92 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.651 1.343 . . . . 0.0 108.819 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.11 38.51 0.34 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.8 t -71.41 155.16 40.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -1.118 . . . . 0.0 110.711 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.34 107.86 4.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.481 -0.762 . . . . 0.0 109.56 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 4.9 tt -104.49 168.59 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 0.0 109.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -150.74 97.93 2.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 0.0 110.628 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 2.2 p 55.63 108.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.336 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.76 -156.35 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.513 HG23 HD11 ' A' ' 68' ' ' ILE . 24.1 mt -146.78 140.83 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.525 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -52.8 112.14 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 110.369 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' THR . 2.9 m -148.51 135.69 20.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.925 -1.109 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.71 77.44 0.64 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 55' ' ' SER . . . 109.94 115.21 3.68 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.412 ' CG1' ' HD2' ' A' ' 74' ' ' PRO . 69.3 t -89.54 143.3 30.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.258 -1.142 . . . . 0.0 110.047 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD2' ' CG1' ' A' ' 73' ' ' VAL . 43.3 Cg_endo -69.88 139.31 39.51 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.035 1.545 . . . . 0.0 110.893 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -57.53 -45.24 99.88 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.512 -0.742 . . . . 0.0 111.277 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 43.1 Cg_endo -70.86 -49.59 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.244 1.128 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER 64.02 35.01 10.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.936 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.82 -23.96 0.87 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.033 -1.042 . . . . 0.0 108.905 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.87 -73.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.557 -0.714 . . . . 0.0 110.102 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -66.63 168.19 9.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -113.58 103.89 11.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.125 -0.984 . . . . 0.0 110.816 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.443 ' C ' HD11 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -122.58 157.34 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.849 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.3 t -151.76 101.83 2.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 81.59 57.85 2.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.88 150.51 34.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -1.136 . . . . 0.0 111.239 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.585 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 9.0 t -110.7 160.68 16.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.432 -0.793 . . . . 0.0 109.004 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.3 m-85 -131.18 154.22 48.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.804 -1.185 . . . . 0.0 110.839 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 87' ' ' PHE . 4.0 m -174.05 120.05 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.716 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.35 139.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.416 -0.802 . . . . 0.0 110.576 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.512 ' OD1' ' CB ' ' A' ' 41' ' ' ARG . 7.3 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.147 0.499 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.4 -129.31 6.26 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 t -45.11 -25.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.87 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 178.15 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.537 ' CG2' ' HB2' ' A' ' 17' ' ' CYS . 3.6 t -122.09 19.5 10.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.02 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.18 52.22 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.842 . . . . 0.0 109.934 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.518 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 11.0 t -98.67 92.51 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 109.786 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.8 OUTLIER 69.91 3.51 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.795 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.32 149.32 40.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.399 -0.813 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 27' ' ' VAL . 1.3 mt-30 -107.92 88.04 2.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 109.987 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 3.3 tp -88.58 25.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 7.7 t 53.67 103.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.45 -23.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.3 t-20 -89.86 14.91 10.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 111.707 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -113.56 -164.08 0.9 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.567 -1.333 . . . . 0.0 110.141 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.542 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -114.66 147.49 39.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.14 -0.975 . . . . 0.0 109.724 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.537 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 6.6 p -123.11 72.75 1.12 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.724 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -84.56 138.22 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.063 -1.023 . . . . 0.0 109.842 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 70.73 -172.9 0.17 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.187 -0.946 . . . . 0.0 110.011 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -93.03 176.5 6.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.184 -0.948 . . . . 0.0 110.391 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.4 m -152.36 149.91 29.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.112 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.2 tp -71.11 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 0.0 110.496 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 70.6 p -136.05 39.88 2.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 110.537 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.7 t30 -149.52 63.31 1.01 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 110.417 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 87.0 m -153.33 114.39 4.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.903 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 27.9 m-85 -107.91 92.65 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.799 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.581 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 12.7 t -93.56 167.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.247 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.7 t0 -148.28 122.12 9.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 109.596 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 44.12 61.65 2.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 0.0 109.565 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.531 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.4 m -131.78 -174.88 3.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 111.222 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -145.17 104.46 3.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.706 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 HD11 ' A' ' 11' ' ' LEU . 2.9 m -117.46 136.24 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.805 -1.184 . . . . 0.0 110.112 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.579 ' HB2' ' N ' ' A' ' 49' ' ' THR . 4.0 m-85 -97.87 -137.65 0.28 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 19' ' ' LYS . . . -65.45 59.46 0.11 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.561 ' N ' ' O ' ' A' ' 33' ' ' TYR . 2.3 m -95.1 162.07 13.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -1.169 . . . . 0.0 110.043 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.478 ' N ' HG21 ' A' ' 35' ' ' THR . 13.5 p -100.61 -169.38 1.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.401 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 0.1 OUTLIER -168.51 140.25 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.767 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 1.8 t 178.55 43.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.27 41.0 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.481 ' CB ' ' CA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -131.12 171.87 12.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 109.955 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 2.2 tpt85 -146.46 129.71 16.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 109.948 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.581 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.8 m-85 -109.13 170.48 8.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.905 -1.122 . . . . 0.0 110.715 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -174.85 80.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.015 . . . . 0.0 110.176 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 83.71 66.72 1.49 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 57' ' ' ILE . 2.3 t -146.97 136.71 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.808 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.5 m -107.77 93.2 4.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.513 HG21 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.93 171.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 110.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 49' ' ' THR . 1.6 t -118.69 -162.14 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.426 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.579 ' N ' ' HB2' ' A' ' 33' ' ' TYR . 20.2 m -54.71 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 66.4 m -128.49 146.72 50.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 69' ' ' ILE . 86.4 m -100.03 48.3 0.93 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.536 -0.728 . . . . 0.0 109.317 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 3.1 t -111.35 100.32 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -144.39 99.76 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.501 ' N ' ' HB ' ' A' ' 70' ' ' THR . . . -161.63 -48.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.537 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -101.57 -168.16 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.459 -1.024 . . . . 0.0 109.782 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.527 ' N ' ' OG ' ' A' ' 55' ' ' SER . 1.9 mtp85 -91.11 141.09 29.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.742 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.589 ' CG2' ' CG2' ' A' ' 45' ' ' VAL . 3.2 mm -113.1 127.27 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 110.155 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.3 152.96 40.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.245 -0.909 . . . . 0.0 110.012 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 118.0 0.42 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.7 -2.48 11.47 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.569 1.299 . . . . 0.0 109.704 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.85 30.76 0.18 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 84' ' ' GLY . 7.2 t -73.02 152.89 41.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -1.068 . . . . 0.0 111.157 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.31 108.84 4.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.642 -0.661 . . . . 0.0 109.778 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 67' ' ' CYS . 2.0 tt -99.02 176.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.062 -1.024 . . . . 0.0 110.123 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -151.77 75.21 1.14 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.906 -1.122 . . . . 0.0 110.953 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 0.2 OUTLIER 59.88 73.48 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 110.837 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 64' ' ' ILE . 88.1 m -100.33 -178.26 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 52' ' ' SER . 1.1 tt -89.76 -178.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.658 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 51' ' ' THR . 5.1 pt -51.05 -174.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.501 ' HB ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -142.37 -148.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 110.701 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . 113.24 34.92 1.7 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.04 34.43 33.55 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.564 ' HB ' ' CG ' ' A' ' 76' ' ' PRO . 20.1 m -118.39 96.65 50.08 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.482 -1.011 . . . . 0.0 110.697 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 75' ' ' ALA . 50.6 Cg_endo -79.5 -52.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.962 1.506 . . . . 0.0 111.052 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -38.12 -53.17 2.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.461 -0.774 . . . . 0.0 110.774 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' CG ' ' HB ' ' A' ' 73' ' ' VAL . 47.6 Cg_endo -74.89 162.05 38.0 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.79 1.416 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.1 OUTLIER 74.82 -6.43 1.94 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 110.458 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.85 -7.62 36.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 108.988 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.92 40.38 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.603 -0.686 . . . . 0.0 109.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 77' ' ' SER . 16.9 p -73.81 -161.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.602 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -116.4 130.41 56.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 0.0 110.25 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.562 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -143.29 146.38 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 -179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.443 ' O ' ' SG ' ' A' ' 85' ' ' CYS . 1.7 t -157.11 136.99 12.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.85 -1.156 . . . . 0.0 111.283 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 52.37 61.98 6.17 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 87' ' ' PHE . 55.9 m -135.46 168.53 19.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.283 . . . . 0.0 111.07 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.64 123.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.627 -0.671 . . . . 0.0 109.201 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 10.8 m-85 -126.98 160.51 30.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.857 -1.152 . . . . 0.0 111.478 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 89' ' ' ALA . 7.0 p -166.58 129.03 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -34.48 142.41 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 110.892 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.537 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.4 t-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.099 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.119 0.485 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -154.04 138.17 6.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t 45.89 -92.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -1.129 . . . . 0.0 110.149 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 8.1 t -128.6 -60.18 1.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 5' ' ' THR . 20.7 m -126.32 60.64 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.126 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.98 65.76 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.394 -0.816 . . . . 0.0 110.003 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' SER . 9.8 t -102.53 -139.23 0.35 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.31 -0.869 . . . . 0.0 110.419 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -41.73 -23.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.223 -0.923 . . . . 0.0 110.967 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -107.78 162.97 13.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.0 110.557 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.406 ' OE1' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.51 106.87 17.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.828 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 12' ' ' SER . 4.0 tp -88.57 32.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 11' ' ' LEU . 8.6 t 67.3 2.8 2.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.53 -0.731 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 45.4 22.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.956 -1.09 . . . . 0.0 110.497 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' SER . 41.4 t30 -160.8 15.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.491 ' OG ' ' HB3' ' A' ' 12' ' ' SER . 19.1 m -96.82 -136.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.091 -1.005 . . . . 0.0 109.168 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -115.0 123.76 49.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.871 -1.143 . . . . 0.0 109.87 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.03 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 0.0 110.529 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' CB ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.26 -154.73 0.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.89 . . . . 0.0 109.646 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -148.21 150.76 34.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.027 -1.046 . . . . 0.0 110.845 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 3.0 t 68.94 95.4 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.82 . . . . 0.0 110.827 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.471 ' O ' ' OG1' ' A' ' 23' ' ' THR . 26.0 m -151.0 -93.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.407 ' N ' ' CG2' ' A' ' 21' ' ' THR . 0.7 OUTLIER 53.17 37.43 25.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -144.23 -151.53 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.102 -0.999 . . . . 0.0 110.698 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -93.34 110.26 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.401 -0.812 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.428 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 3.3 m -155.25 111.6 3.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.048 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CD1' ' NH2' ' A' ' 41' ' ' ARG . 3.7 t80 -111.09 101.72 10.23 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.078 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.577 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 11.4 t -104.27 164.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -145.63 122.73 11.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 109.713 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 44.12 64.96 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.013 . . . . 0.0 109.525 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.537 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 1.4 m -134.26 -169.8 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 111.613 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 21.1 tt0 -145.06 98.39 3.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.545 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 62.1 t -105.62 138.84 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.847 -1.158 . . . . 0.0 110.43 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' THR . 1.8 t80 -142.75 129.21 20.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.93 40.71 9.87 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.545 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 14.0 m -103.94 165.73 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -1.136 . . . . 0.0 110.247 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 51' ' ' THR . 6.8 p -105.05 -170.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 110.015 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.505 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 36.3 t -172.53 128.31 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.576 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.5 ' HA ' ' CG2' ' A' ' 23' ' ' THR . 19.4 m -163.02 33.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 109.689 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.505 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 123.92 62.62 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.512 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 28.7 p -143.0 170.81 15.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.572 ' NH2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -139.48 127.47 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.067 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.577 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.7 m-85 -109.06 169.69 8.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' HG21 ' A' ' 45' ' ' VAL . 5.7 t70 178.99 112.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 52.87 62.72 5.64 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.573 ' CG2' HG23 ' A' ' 57' ' ' ILE . 14.5 t -142.83 123.14 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -1.014 . . . . 0.0 110.772 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 41.8 m -101.47 98.6 8.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.096 -1.003 . . . . 0.0 109.354 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.528 ' HB ' ' CG2' ' A' ' 64' ' ' ILE . 1.3 pt -113.38 156.58 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.191 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.447 HG21 ' OG1' ' A' ' 49' ' ' THR . 0.6 OUTLIER -135.78 127.73 29.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.847 . . . . 0.0 109.805 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER 40.85 79.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.876 . . . . 0.0 110.013 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.2 t -138.98 148.91 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.071 -1.018 . . . . 0.0 110.773 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.469 ' HA ' HG21 ' A' ' 36' ' ' THR . 4.1 p -115.97 41.23 2.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.474 ' O ' HG22 ' A' ' 53' ' ' THR . 1.2 t -104.89 116.65 32.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 110.177 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.512 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 0.9 OUTLIER -146.28 112.25 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 110.225 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 165.32 -31.31 0.23 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.538 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 2.7 p -113.09 163.07 15.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.044 -1.268 . . . . 0.0 110.707 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -91.78 120.22 32.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.0 109.591 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.573 HG23 ' CG2' ' A' ' 45' ' ' VAL . 1.3 mt -99.71 156.73 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.078 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.51 ' N ' HG23 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -147.11 142.49 27.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.695 -0.628 . . . . 0.0 109.897 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 163.59 114.14 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.383 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.59 -7.48 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 N-CA-C 108.427 -1.413 . . . . 0.0 108.427 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.93 26.91 1.61 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.496 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.4 t -72.03 147.27 47.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.406 -1.055 . . . . 0.0 110.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 115.24 9.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.528 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 7.5 tt -104.94 174.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.493 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.48 99.03 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.565 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 67' ' ' CYS . 1.2 p 69.24 -68.17 0.2 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.664 -0.647 . . . . 0.0 110.719 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.547 ' N ' ' OG1' ' A' ' 66' ' ' THR . 0.5 OUTLIER 65.63 -153.84 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.066 . . . . 0.0 110.526 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 69' ' ' ILE . 1.3 tt 172.54 95.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ILE . 5.1 mt 59.88 134.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.308 -0.87 . . . . 0.0 110.062 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.504 ' CG2' HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -113.28 -71.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.979 -1.076 . . . . 0.0 111.105 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' C ' ' O ' ' A' ' 70' ' ' THR . . . 45.23 71.6 0.47 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 46.63 83.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.504 HG13 ' CG2' ' A' ' 70' ' ' THR . 24.0 m -84.99 163.07 47.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.103 -1.234 . . . . 0.0 110.39 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.51 150.09 21.73 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.157 1.609 . . . . 0.0 110.65 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' CB ' ' CD ' ' A' ' 76' ' ' PRO . . . -46.79 -60.01 4.41 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.181 -0.95 . . . . 0.0 109.755 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 75' ' ' ALA . 49.9 Cg_endo -73.13 83.98 1.38 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.027 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ALA . 8.0 p -43.81 -50.7 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.461 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.74 25.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.056 -1.027 . . . . 0.0 108.839 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -160.43 -69.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.533 -0.73 . . . . 0.0 109.826 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 2.4 t -73.05 165.29 25.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.574 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.49 ' N ' ' SG ' ' A' ' 80' ' ' CYS . 23.3 mmtt -99.2 94.51 6.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.482 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 3.2 tp -128.92 151.65 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.85 . . . . 0.0 110.399 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 104.99 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.11 5.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.482 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 56.8 m -134.5 153.81 51.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -1.193 . . . . 0.0 110.464 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -109.4 163.48 13.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 86' ' ' THR . 3.2 m-85 -138.88 159.68 41.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.15 -0.969 . . . . 0.0 110.06 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -176.48 38.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 110.21 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 41.82 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.296 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.961 -179.216 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.8 p-10 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.243 0.544 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 3' ' ' SER . . . -166.85 111.47 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.52 ' HB2' ' CB ' ' A' ' 6' ' ' ASN . 69.3 m 43.25 65.55 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -1.111 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.502 HG22 ' CB ' ' A' ' 17' ' ' CYS . 13.2 t -144.63 35.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.52 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 1.1 t-20 -99.67 57.95 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 1.8 t -98.34 95.61 7.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.904 . . . . 0.0 109.542 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 7' ' ' THR . 6.4 t-20 70.4 7.03 6.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.522 ' CB ' ' CG2' ' A' ' 21' ' ' THR . 4.8 m -126.7 179.92 5.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.486 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 8.7 tt0 -134.47 95.6 3.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.949 . . . . 0.0 110.043 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 12.5 tp -88.53 31.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.975 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.538 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 68.52 3.54 3.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 0.0 110.551 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.09 25.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.608 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' SER . 28.6 t30 -162.29 19.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.621 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 30' ' ' SER . 2.0 m -104.61 -144.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 14.6 mmtm -114.14 91.55 3.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.836 -1.165 . . . . 0.0 110.155 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.502 ' CB ' HG22 ' A' ' 5' ' ' THR . 9.1 p -65.62 67.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -0.784 . . . . 0.0 110.642 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.487 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 14.0 mm-40 -88.4 54.55 3.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.77 81.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.477 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 1.6 m -151.59 -62.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.448 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' CB ' ' A' ' 9' ' ' SER . 80.5 m -46.74 166.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.6 -74.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.639 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.408 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 5.0 t -154.2 13.5 0.44 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.157 -0.964 . . . . 0.0 110.933 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.36 65.17 0.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.826 -1.171 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.56 112.32 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 110.764 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.5 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 27.2 m-85 -101.8 96.46 7.08 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -100.6 163.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 111.115 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.538 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 3.8 t0 -141.44 119.01 11.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.532 -0.73 . . . . 0.0 109.379 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 28' ' ' ASP . 4.5 ttmm 39.98 70.45 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.21 -0.932 . . . . 0.0 109.926 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 15' ' ' SER . 2.0 m -131.76 -178.79 5.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.9 . . . . 0.0 110.886 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -144.97 97.53 3.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 1.9 m -104.2 153.15 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.966 -1.084 . . . . 0.0 110.576 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.552 ' O ' ' HA ' ' A' ' 49' ' ' THR . 10.2 t80 -139.48 138.33 36.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.169 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 38.26 40.04 0.83 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 2.4 m -94.66 167.61 11.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.149 -1.206 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.476 ' N ' ' CG2' ' A' ' 35' ' ' THR . 10.9 p -105.39 -52.31 2.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.857 . . . . 0.0 110.157 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 36' ' ' THR . 0.1 OUTLIER 59.74 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.0 110.075 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.479 ' N ' HG22 ' A' ' 53' ' ' THR . 8.0 t -173.51 64.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 117.42 32.76 1.42 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.57 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -133.77 -178.18 4.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -1.144 . . . . 0.0 110.039 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.5 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 3.2 tpt180 -142.71 125.71 16.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 108.764 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.556 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 3.6 m-85 -103.96 162.09 13.43 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 3.5 t0 -170.09 103.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.539 -0.726 . . . . 0.0 109.144 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 61.39 67.69 2.0 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' CG1' HG22 ' A' ' 47' ' ' ILE . 4.6 t -145.58 127.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 110.835 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 m -108.43 87.78 2.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 108.815 178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.543 HG22 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.76 154.75 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.653 -0.654 . . . . 0.0 110.427 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' SER . 1.5 t -108.65 -150.26 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 87.9 m -45.1 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.134 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -139.71 135.95 33.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 111.307 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.469 ' CG2' HG22 ' A' ' 36' ' ' THR . 97.5 m -108.35 61.24 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 29.3 m -114.91 113.68 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 110.766 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 34.7 p -131.91 -151.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.371 -0.83 . . . . 0.0 109.642 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 90' ' ' ASN . . . 76.55 -65.87 2.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.5 ' HB2' ' HA ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -101.89 171.53 7.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.286 -1.126 . . . . 0.0 109.448 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -104.96 158.7 16.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.775 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.536 HG21 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -123.33 155.07 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.689 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.531 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.73 157.67 43.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.259 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 160.29 127.32 0.89 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.146 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.55 -5.5 17.17 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.673 1.354 . . . . 0.0 108.871 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.98 35.13 0.36 Allowed Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 10.1 t -71.76 147.45 47.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.757 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.71 120.02 10.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.01 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.508 ' HB ' HG21 ' A' ' 47' ' ' ILE . 3.8 tt -104.25 178.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.289 -0.882 . . . . 0.0 109.938 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 66' ' ' THR . 3.2 t -150.8 58.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.889 -1.132 . . . . 0.0 111.14 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 1.6 m 66.83 83.85 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 111.349 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.48 -149.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 109.371 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.431 HD11 ' HA ' ' A' ' 68' ' ' ILE . 7.6 mm -120.85 158.21 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.91 -1.119 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.509 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 3.7 tt -52.35 144.77 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 110.229 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.498 ' O ' ' HB3' ' A' ' 55' ' ' SER . 3.4 t -148.66 107.68 3.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.541 ' N ' HG21 ' A' ' 73' ' ' VAL . . . -92.69 62.08 2.33 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.475 ' HA3' ' CB ' ' A' ' 89' ' ' ALA . . . 81.47 34.97 24.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.541 HG21 ' N ' ' A' ' 71' ' ' GLY . 4.1 m -132.99 163.14 53.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.941 -0.741 . . . . 0.0 110.587 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -80.18 -42.69 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.73 1.384 . . . . 0.0 109.519 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 61.04 153.48 0.1 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.737 . . . . 0.0 110.254 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.52 59.1 3.95 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.178 1.62 . . . . 0.0 110.955 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.97 11.45 13.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 110.013 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.18 -23.87 0.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.361 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.91 -3.57 48.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 110.105 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.6 -178.44 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.027 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 105.15 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.464 HD11 HG13 ' A' ' 64' ' ' ILE . 10.5 tp -127.95 142.65 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -142.87 125.28 15.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 63.65 62.64 5.11 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 82' ' ' ILE . 59.2 m -145.39 148.45 33.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 111.079 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.531 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 13.5 t -116.74 157.66 25.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.34 152.14 50.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.769 -1.207 . . . . 0.0 110.602 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.6 m -170.54 124.77 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.352 -0.842 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 55' ' ' SER . . . -45.1 147.65 0.68 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 110.559 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.492 ' OD1' ' CB ' ' A' ' 41' ' ' ARG . 1.1 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.051 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 1' ' ' ASP . 63.6 t0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.207 0.527 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 3' ' ' SER . . . -161.62 -158.81 9.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 2' ' ' GLY . 28.0 t -41.87 -53.27 3.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -1.075 . . . . 0.0 110.458 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.61 -79.53 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.487 ' CG2' HD21 ' A' ' 11' ' ' LEU . 5.1 t -122.31 56.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.13 93.28 5.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.331 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 9' ' ' SER . 10.1 t -134.66 -138.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.63 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 7' ' ' THR . 11.6 m-20 -39.47 -27.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.811 . . . . 0.0 110.606 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 7' ' ' THR . 4.7 m -108.49 -164.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.149 -0.97 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -140.75 127.56 20.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.487 HD21 ' CG2' ' A' ' 5' ' ' THR . 21.4 tp -88.27 24.02 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.48 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.7 t 61.03 11.25 3.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.49 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' SER . 10.7 t30 -161.04 15.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 111.03 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.2 m -98.79 -139.0 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.392 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -114.78 141.15 48.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.3 93.54 2.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 110.599 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.527 ' CB ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.19 -145.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 110.437 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -76.66 -161.53 0.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 110.087 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 171.4 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.463 ' O ' HD21 ' A' ' 22' ' ' LEU . 17.7 m -138.09 142.54 40.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.888 . . . . 0.0 110.15 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 21' ' ' THR . 0.2 OUTLIER -136.59 28.64 2.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.468 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -156.87 -149.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 110.317 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.428 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.9 m120 -87.44 122.85 31.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.266 -0.896 . . . . 0.0 109.985 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.498 ' O ' HG22 ' A' ' 27' ' ' VAL . 11.9 m -155.35 31.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.557 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.474 ' CD1' ' HB3' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -45.78 119.7 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 110.024 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 30.4 t -119.13 161.25 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 110.609 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -142.03 118.87 11.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 109.672 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.8 mmtp 43.26 68.12 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.505 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 2.7 m -133.47 -172.09 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 111.115 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 11.2 tt0 -143.81 99.21 3.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.527 HG13 ' CB ' ' A' ' 18' ' ' GLU . 40.2 t -101.06 150.06 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.052 . . . . 0.0 110.575 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -143.16 116.19 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 43.33 51.44 6.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.522 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 2.4 m -107.08 156.5 18.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 35' ' ' THR . 19.4 p -91.04 -173.14 3.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 21' ' ' THR . 0.8 OUTLIER -157.87 124.28 4.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.362 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -163.98 55.87 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.981 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 96.79 96.21 1.87 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.539 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 14.1 p -177.98 173.38 1.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -1.152 . . . . 0.0 110.28 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CB ' ' ND2' ' A' ' 90' ' ' ASN . 6.3 tpt180 -146.97 131.81 18.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 109.649 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.55 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.9 m-85 -109.35 169.86 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 2.9 t70 178.33 116.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 109.136 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.75 65.37 2.45 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.526 ' CG2' HG21 ' A' ' 57' ' ' ILE . 3.0 t -145.33 138.06 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -1.09 . . . . 0.0 110.83 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.461 HG23 ' OE1' ' A' ' 31' ' ' GLU . 81.5 m -116.61 94.68 4.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 109.228 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.517 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.3 pt -114.08 172.39 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 49' ' ' THR . 2.0 t -131.38 -146.52 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.378 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.538 ' N ' ' CG2' ' A' ' 48' ' ' THR . 6.6 m -54.91 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 11.3 p -139.61 158.29 44.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -0.921 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -118.04 45.31 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.854 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -95.72 103.49 15.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 110.13 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.539 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 3.0 p -138.6 112.93 8.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 110.416 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 176.3 -54.89 0.11 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -102.63 -173.54 2.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.817 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.497 ' N ' ' OG ' ' A' ' 55' ' ' SER . 7.8 ttp180 -104.02 125.96 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.096 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.545 HG21 ' N ' ' A' ' 58' ' ' SER . 0.9 OUTLIER -100.49 153.62 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.965 . . . . 0.0 110.308 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.545 ' N ' HG21 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -146.57 160.64 41.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.647 179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 154.09 122.56 0.86 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.22 -5.62 17.41 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.692 1.364 . . . . 0.0 109.036 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.53 34.12 0.33 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -72.26 154.9 40.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 110.206 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.54 113.19 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -96.68 172.26 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.058 -1.026 . . . . 0.0 109.161 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.463 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 11.0 t -149.04 67.81 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.898 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.9 m 64.01 98.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 111.06 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.452 ' SG ' HG12 ' A' ' 64' ' ' ILE . 76.8 m -107.92 -144.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.413 -0.804 . . . . 0.0 109.246 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.26 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.77 -1.206 . . . . 0.0 110.581 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 tp -151.17 158.39 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.436 ' C ' HG21 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -125.8 -154.22 0.61 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.431 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . 105.39 38.33 2.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.55 33.36 47.92 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 HG21 ' C ' ' A' ' 70' ' ' THR . 6.3 m -129.0 91.66 41.98 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.481 -1.011 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.32 -29.55 1.89 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.479 . . . . 0.0 109.797 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -49.49 -55.41 22.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.505 -0.747 . . . . 0.0 110.727 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 44.0 Cg_endo -70.51 156.83 60.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.777 1.409 . . . . 0.0 110.389 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER 69.26 4.76 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.155 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.84 -21.38 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.002 . . . . 0.0 109.136 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.95 59.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.669 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.402 ' C ' ' HD2' ' A' ' 81' ' ' LYS . 19.0 t -71.61 170.32 13.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -114.68 111.44 21.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.564 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.415 HD13 HG13 ' A' ' 64' ' ' ILE . 6.9 tp -127.41 156.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -154.39 116.79 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.02 . . . . 0.0 110.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.15 46.78 33.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.24 159.99 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.028 -1.277 . . . . 0.0 111.361 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.402 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -116.96 154.82 30.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 85' ' ' CYS . 9.0 m-85 -133.13 147.91 52.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.927 -1.108 . . . . 0.0 110.401 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' ALA . 29.1 t -173.39 124.25 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.97 141.68 0.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.548 ' ND2' ' CB ' ' A' ' 41' ' ' ARG . 4.4 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.084 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.239 0.542 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.97 -109.47 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t -59.95 -62.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.2 t -147.02 -61.18 0.29 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 5' ' ' THR . 10.5 t -141.59 53.49 1.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.885 . . . . 0.0 109.998 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.432 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 1.8 m120 -146.64 139.54 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 9' ' ' SER . 17.1 p -103.47 -135.49 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -42.71 -15.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.251 -0.905 . . . . 0.0 111.668 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.5 p -103.99 160.73 14.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.701 -1.249 . . . . 0.0 108.74 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG2' ' N ' ' A' ' 11' ' ' LEU . 38.9 tt0 -107.13 155.13 20.2 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.024 -1.048 . . . . 0.0 111.899 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' O ' ' HB3' ' A' ' 12' ' ' SER . 31.9 tp -108.77 41.94 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.666 . . . . 0.0 109.292 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 18.4 t 58.57 12.78 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.792 . . . . 0.0 110.864 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 41.07 25.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.688 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' SER . 31.4 t30 -170.7 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.973 -1.079 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -103.67 -147.02 0.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.99 -1.068 . . . . 0.0 109.539 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.566 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -112.99 142.26 45.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.827 -1.171 . . . . 0.0 109.871 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' HA ' HG21 ' A' ' 5' ' ' THR . 72.5 m -69.35 100.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.454 -0.779 . . . . 0.0 111.209 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HB3' ' CG1' ' A' ' 32' ' ' VAL . 16.5 pm0 -83.22 -141.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -151.07 145.2 25.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 110.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.56 105.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.815 . . . . 0.0 110.522 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -137.4 143.86 42.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 109.951 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.484 ' CB ' ' HA ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -84.13 -140.71 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.972 . . . . 0.0 110.39 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.449 HG21 ' OG1' ' A' ' 7' ' ' THR . 0.6 OUTLIER -129.62 27.08 5.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -143.99 75.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.056 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.8 m -155.14 111.76 3.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -110.25 96.2 6.07 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 42' ' ' PHE . 3.9 t -98.6 164.45 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 111.178 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 29' ' ' LYS . 41.5 m-20 -144.78 124.94 13.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.502 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 11.1 tttp 42.82 67.47 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.82 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 2.5 m -133.34 -174.07 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 111.239 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 3.1 tt0 -143.37 103.33 4.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 18' ' ' GLU . 47.7 t -105.47 142.86 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.012 -1.055 . . . . 0.0 110.071 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.477 ' O ' ' HA ' ' A' ' 49' ' ' THR . 2.6 t80 -140.09 102.93 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 51.89 53.36 30.36 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 47' ' ' ILE . 55.2 m -114.23 154.79 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -1.168 . . . . 0.0 110.238 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.8 p -86.22 140.28 30.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.18 43.42 2.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' CB ' ' A' ' 22' ' ' LEU . 17.9 p -77.85 3.81 13.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 166.26 97.12 0.11 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.503 ' HB3' ' OG1' ' A' ' 53' ' ' THR . 38.2 p -177.6 167.65 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -1.196 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -138.52 123.0 18.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 179.06 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.588 ' CB ' ' CG1' ' A' ' 27' ' ' VAL . 3.2 m-85 -104.46 170.5 7.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.825 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 11.7 t70 178.7 98.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 65.65 58.33 9.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 57' ' ' ILE . 17.1 t -139.98 126.79 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.523 -0.986 . . . . 0.0 110.736 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 54.1 m -109.47 94.96 5.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.512 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.4 pt -113.28 175.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.517 ' O ' ' N ' ' A' ' 50' ' ' SER . 1.3 t -132.51 -153.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.986 -1.071 . . . . 0.0 110.673 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.485 ' N ' ' CG2' ' A' ' 48' ' ' THR . 28.3 m -53.68 85.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 48' ' ' THR . 18.7 m -139.87 144.7 37.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 110.595 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.479 ' O ' HG21 ' A' ' 69' ' ' ILE . 97.7 m -90.04 39.94 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.8 OUTLIER -91.23 127.69 36.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.763 . . . . 0.0 110.632 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.91 130.55 0.11 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 148.82 -42.09 0.84 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HB2' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -101.87 -168.59 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -1.14 . . . . 0.0 110.236 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' N ' ' OG ' ' A' ' 55' ' ' SER . 20.0 ttt180 -114.44 120.24 39.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.531 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.75 154.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.968 . . . . 0.0 110.341 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.465 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -146.52 160.41 42.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.347 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 156.26 127.34 1.01 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.337 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.07 -7.58 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.803 1.422 . . . . 0.0 108.503 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.06 38.33 0.46 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.6 t -71.64 127.55 32.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -1.054 . . . . 0.0 110.805 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.87 111.15 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.767 . . . . 0.0 109.268 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.483 HG22 HG22 ' A' ' 47' ' ' ILE . 4.6 tt -104.72 162.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 110.59 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.475 ' O ' ' OG1' ' A' ' 66' ' ' THR . 17.6 t -144.79 88.21 1.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.4 p 54.15 74.58 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 52' ' ' SER . 0.5 OUTLIER -148.03 149.36 31.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.051 -1.03 . . . . 0.0 110.617 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.56 ' O ' ' HA ' ' A' ' 52' ' ' SER . 18.5 mm 59.59 158.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.878 . . . . 0.0 110.643 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 68' ' ' ILE . 1.3 pt -160.42 16.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.848 -0.533 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.525 ' HB ' ' CG2' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -155.09 -149.54 0.27 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 110.67 -179.332 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -65.99 -150.77 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' N ' ' HB2' ' A' ' 55' ' ' SER . . . -67.59 61.53 0.3 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.525 ' CG2' ' HB ' ' A' ' 70' ' ' THR . 8.0 m -121.36 115.36 31.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.443 -1.034 . . . . 0.0 110.826 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 75' ' ' ALA . 44.1 Cg_endo -71.93 72.29 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.827 1.435 . . . . 0.0 109.552 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . . . -45.84 175.62 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.623 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 75' ' ' ALA . 43.6 Cg_endo -69.83 63.39 1.83 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.034 1.544 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.451 ' O ' ' SG ' ' A' ' 80' ' ' CYS . 17.0 m -132.08 31.09 4.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.76 -15.35 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.228 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.19 -10.9 45.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.523 -0.736 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 77' ' ' SER . 15.7 p -63.83 -158.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.182 -0.949 . . . . 0.0 110.132 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.18 121.69 16.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.001 -1.062 . . . . 0.0 110.681 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.544 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -133.41 135.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 110.008 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -141.75 105.44 4.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 75.35 51.46 7.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.544 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 99.2 m -126.2 141.43 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -103.25 152.6 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.042 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.448 ' O ' ' OG ' ' A' ' 88' ' ' SER . 3.7 m-85 -134.89 141.13 46.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.002 -1.061 . . . . 0.0 110.212 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 87' ' ' PHE . 1.5 m 178.29 135.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.109 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.05 148.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.382 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.441 ' N ' ' HA ' ' A' ' 55' ' ' SER . 27.9 p-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.318 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.43 -175.58 47.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 1.9 m -43.79 113.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.144 . . . . 0.0 110.077 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 3' ' ' SER . 17.2 t 63.15 -120.11 0.56 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 0.0 110.278 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 17' ' ' CYS . 6.5 t -142.04 41.55 1.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.782 -1.199 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.508 ' CB ' HG22 ' A' ' 21' ' ' THR . 9.3 p30 -136.92 111.66 8.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 110.67 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 45.8 p -98.39 43.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.03 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER 165.27 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.711 -0.618 . . . . 0.0 109.579 -179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 21' ' ' THR . 0.2 OUTLIER -108.21 -163.54 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.047 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -143.34 104.34 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 16' ' ' LYS . 8.8 tp -88.47 21.36 2.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 109.743 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 12.5 t 56.69 107.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.362 -0.836 . . . . 0.0 109.837 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.43 -22.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.28 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -82.81 6.61 17.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 110.377 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -106.16 -163.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.836 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.521 ' O ' ' CD2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -107.29 123.06 47.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 111.022 -178.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.404 ' HB3' ' HB ' ' A' ' 5' ' ' THR . 5.9 m -90.51 57.64 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.482 -0.761 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 1.4 tm-20 -87.94 46.0 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.672 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 20' ' ' SER . 2.6 mptt 58.36 109.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.465 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -173.83 -66.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.118 -0.989 . . . . 0.0 110.534 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.525 ' CG2' ' HB2' ' A' ' 9' ' ' SER . 69.5 m -42.28 138.67 1.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 110.74 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -111.09 -51.02 2.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.807 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -164.12 -61.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 110.231 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.84 91.03 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 0.0 110.011 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 1.6 m -156.6 120.27 4.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.542 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -119.66 88.13 2.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.348 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.574 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 4.3 t -94.08 170.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 111.023 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.4 m-20 -150.14 114.7 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 6.3 tttm 45.19 67.86 0.65 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 15' ' ' SER . 14.9 m -130.67 -164.39 1.42 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.006 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 45' ' ' VAL . 20.4 tt0 -144.93 100.1 3.44 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.258 -0.902 . . . . 0.0 108.696 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 35' ' ' THR . 73.5 t -105.18 133.63 48.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.496 -0.753 . . . . 0.0 110.595 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.525 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -133.55 125.51 29.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 41.5 39.96 2.63 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.533 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 96.7 m -94.69 171.19 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -1.212 . . . . 0.0 110.04 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 29.8 p -99.06 -51.66 3.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.569 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 1.0 OUTLIER 57.6 42.56 23.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.35 71.87 2.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.325 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.23 65.13 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 99.5 p -162.55 162.89 27.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 110.249 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -123.53 125.46 44.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.657 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.574 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.2 m-85 -104.97 168.99 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.056 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD2' ' NE ' ' A' ' 41' ' ' ARG . 1.1 m-20 -175.4 98.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.071 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 64.3 68.35 1.69 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG11 ' CG2' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -145.25 150.14 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.193 . . . . 0.0 110.558 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.503 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 52.2 m -122.04 90.9 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.184 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.511 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.07 167.69 6.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.525 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 3.1 t -125.27 -151.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.057 -1.027 . . . . 0.0 110.013 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 3.2 m -57.03 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.896 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 3.5 p -138.27 142.41 39.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.893 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -92.77 50.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.87 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.78 142.69 35.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.17 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER 175.96 134.33 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.894 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 140.87 -22.6 2.64 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.496 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 88.1 p -121.05 179.39 4.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.335 -1.097 . . . . 0.0 110.067 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.536 ' O ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 mtp85 -91.7 114.57 27.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 108.773 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.566 ' CG2' HG11 ' A' ' 45' ' ' VAL . 1.3 mm -98.03 130.35 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.909 -1.119 . . . . 0.0 110.859 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.526 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.97 164.08 33.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.946 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 154.38 116.12 0.58 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.217 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.36 -6.38 19.04 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.699 1.368 . . . . 0.0 109.132 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.44 26.79 0.77 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 11.1 t -72.42 144.44 48.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -1.113 . . . . 0.0 110.628 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 7.9 mmtt -136.09 106.07 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 109.303 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 0.5 OUTLIER -104.63 155.85 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.605 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.476 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.3 OUTLIER -146.47 100.17 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.534 -0.728 . . . . 0.0 109.707 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 4.1 p 54.86 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.469 -0.769 . . . . 0.0 110.097 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.413 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.05 -150.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 110.292 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.2 tt -131.22 143.1 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 109.989 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 69' ' ' ILE . 1.1 tt -81.74 108.06 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 110.616 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.415 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.9 m -148.22 160.34 43.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.219 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 69.57 3.29 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . 115.02 98.42 2.2 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.497 HG23 ' CZ ' ' A' ' 87' ' ' PHE . 31.6 m -86.28 164.38 38.54 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.177 -1.19 . . . . 0.0 110.238 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HG2' ' HA ' ' A' ' 77' ' ' SER . 46.3 Cg_endo -71.49 163.02 40.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.019 1.536 . . . . 0.0 110.793 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.521 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -78.96 -53.44 1.13 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.305 -0.872 . . . . 0.0 110.963 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 47.8 Cg_endo -73.79 -25.98 13.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.755 1.397 . . . . 0.0 110.897 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER 68.27 -60.28 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.993 . . . . 0.0 110.513 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.515 ' N ' ' OG ' ' A' ' 77' ' ' SER . . . 44.01 26.79 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -160.14 -62.03 0.06 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.527 -0.733 . . . . 0.0 109.482 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.444 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 16.4 t -74.04 166.43 23.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.688 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -104.01 82.79 2.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.327 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -118.99 158.37 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.434 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 21.1 t -155.73 112.34 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.926 -1.109 . . . . 0.0 111.02 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 73.63 60.14 3.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.46 163.23 29.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -1.226 . . . . 0.0 110.014 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.12 110.2 5.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 109.663 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 56' ' ' ARG . 0.2 OUTLIER -141.88 164.87 29.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 111.032 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -169.58 71.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 88' ' ' SER . . . 58.29 144.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.825 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.809 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.273 0.558 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -175.1 99.96 0.14 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER 65.4 -63.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER -148.75 -77.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.53 HG21 ' CD1' ' A' ' 22' ' ' LEU . 14.9 t -145.11 64.05 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.659 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.431 ' N ' ' OD1' ' A' ' 6' ' ' ASN . 27.5 p30 -162.95 102.71 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 110.494 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 3.3 p -104.48 34.39 3.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.226 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 7' ' ' THR . 10.3 t30 174.89 -21.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.483 ' OG ' ' CB ' ' A' ' 22' ' ' LEU . 2.0 p -107.16 -161.69 0.8 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -140.41 122.47 15.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.588 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.526 ' O ' ' CB ' ' A' ' 12' ' ' SER . 11.3 tp -98.62 29.39 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.526 ' CB ' ' O ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER 70.92 -0.81 2.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 110.77 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.64 22.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.026 . . . . 0.0 109.665 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -156.11 9.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.975 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.9 m -105.18 -144.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 0.0 109.643 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -118.09 137.02 53.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.114 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 27.9 p -117.05 60.68 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.23 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 mm-40 -92.2 36.21 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 33' ' ' TYR . 1.4 ptmt -127.99 -142.86 0.27 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.1 -1.0 . . . . 0.0 110.257 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.457 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 1.4 t -115.11 -66.23 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 110.415 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -142.25 161.9 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.873 . . . . 0.0 110.29 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.53 ' CD1' HG21 ' A' ' 5' ' ' THR . 0.3 OUTLIER -109.68 -17.78 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.4 -0.812 . . . . 0.0 109.699 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 85.3 m 58.31 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 110.346 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 22' ' ' LEU . 3.8 m-20 -139.3 85.39 2.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.23 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.448 ' HB2' HD23 ' A' ' 22' ' ' LEU . 57.8 m -150.01 116.49 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 t80 -96.63 98.12 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 109.137 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 5.4 t -94.36 165.41 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 110.535 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 11.4 t0 -141.07 121.3 13.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 37.32 69.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.427 -0.796 . . . . 0.0 110.32 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' SER . 5.6 m -130.34 -170.71 2.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.923 . . . . 0.0 111.187 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 46' ' ' THR . 25.8 mt-10 -143.54 101.59 3.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.48 HG12 ' HD2' ' A' ' 19' ' ' LYS . 70.9 t -108.94 145.23 16.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.261 -0.9 . . . . 0.0 111.197 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.546 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -115.91 -140.5 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.487 ' O ' HG21 ' A' ' 49' ' ' THR . . . -65.43 65.94 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 33' ' ' TYR . 84.9 m -105.91 153.18 22.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.073 -1.251 . . . . 0.0 110.433 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.489 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER -115.45 117.92 31.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.433 -0.792 . . . . 0.0 109.896 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.0 OUTLIER -82.63 155.34 24.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.759 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.502 ' CB ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -167.18 43.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -0.797 . . . . 0.0 109.607 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.87 75.2 1.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.445 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -156.14 177.97 10.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.163 . . . . 0.0 110.621 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.53 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 12.6 tpp85 -141.19 124.14 16.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.56 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.3 m-85 -105.44 167.46 9.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.767 -1.208 . . . . 0.0 110.43 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 45' ' ' VAL . 3.7 t0 -178.39 114.23 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.477 -0.764 . . . . 0.0 109.027 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.31 67.2 1.97 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.532 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.6 t -145.27 127.57 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -1.089 . . . . 0.0 110.572 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.472 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . 93.2 m -106.93 91.16 3.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.474 ' HB ' HG22 ' A' ' 64' ' ' ILE . 1.1 pt -109.08 161.92 7.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.58 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.546 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 2.3 t -111.03 -153.92 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 110.555 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.533 ' N ' HG23 ' A' ' 48' ' ' THR . 17.2 m -61.35 77.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 109.918 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.526 ' HB2' ' CA ' ' A' ' 66' ' ' THR . 1.3 p -139.74 172.56 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.085 -1.009 . . . . 0.0 110.686 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.489 ' HB ' ' CG2' ' A' ' 36' ' ' THR . 0.6 OUTLIER -126.89 94.81 4.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.039 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -125.45 70.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 40' ' ' SER . 67.1 p -103.93 -172.45 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 91.88 -36.67 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.468 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -133.52 161.54 34.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -1.048 . . . . 0.0 109.583 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 ptp85 -93.58 151.02 19.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.532 HG22 ' CG2' ' A' ' 45' ' ' VAL . 3.5 mt -122.33 165.63 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.887 . . . . 0.0 110.834 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.527 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.09 147.15 30.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.809 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 163.03 110.56 0.25 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.06 -8.55 23.82 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 N-CA-C 108.461 -1.4 . . . . 0.0 108.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.84 29.43 1.27 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.6 OUTLIER -72.05 147.69 46.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.48 -1.012 . . . . 0.0 110.195 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 104.08 4.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.758 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.474 HG22 ' HB ' ' A' ' 47' ' ' ILE . 4.6 tt -95.86 166.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.872 . . . . 0.0 109.963 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.486 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -146.72 97.79 2.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.526 ' CA ' ' HB2' ' A' ' 50' ' ' SER . 24.1 p 48.96 102.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 110.597 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.19 -142.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.783 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 68' ' ' ILE . 2.7 tt -154.48 134.51 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.502 HD12 ' CB ' ' A' ' 38' ' ' THR . 3.0 tt -54.35 114.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.5 t -148.23 135.19 20.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.459 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -70.72 64.94 0.85 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 55' ' ' SER . . . 126.84 117.39 2.1 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.533 ' CG1' ' HD2' ' A' ' 74' ' ' PRO . 60.5 t -96.55 146.15 30.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -1.095 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.533 ' HD2' ' CG1' ' A' ' 73' ' ' VAL . 42.8 Cg_endo -69.72 153.82 68.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.865 1.456 . . . . 0.0 110.858 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -66.72 -49.94 47.36 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 110.729 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 44.4 Cg_endo -74.05 -50.15 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.735 1.387 . . . . 0.0 110.561 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.0 t 67.17 30.54 7.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.405 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -43.84 -26.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.35 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -81.35 -74.17 0.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.588 -0.695 . . . . 0.0 109.812 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.6 t -63.14 163.72 9.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.419 -0.801 . . . . 0.0 109.982 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 6.8 mmpt? -104.17 107.9 19.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.541 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -127.2 159.69 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.04 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.504 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 0.7 OUTLIER -151.95 102.91 2.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 69.07 52.97 20.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.541 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 43.6 m -133.19 151.09 51.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -1.19 . . . . 0.0 110.492 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.569 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -105.33 164.24 12.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.023 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.1 m-85 -135.41 166.54 22.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 2.6 t 168.03 114.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 0.0 110.022 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -43.73 134.88 4.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' HA ' ' A' ' 55' ' ' SER . 4.2 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.281 0.562 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.79 -86.43 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 88.0 p -78.48 -17.24 56.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 174.59 -79.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' HG21 ' A' ' 5' ' ' THR . 5.5 t -145.06 28.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -101.01 79.16 1.99 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 3.9 t -98.31 105.06 17.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.4 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.515 ' CB ' HG22 ' A' ' 23' ' ' THR . 12.5 m120 60.6 13.1 4.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.663 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 1.5 t -128.63 -167.57 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.54 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -143.66 115.32 8.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.019 . . . . 0.0 110.555 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.493 HD22 ' OG ' ' A' ' 15' ' ' SER . 5.6 tp -110.23 20.38 17.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.95 . . . . 0.0 109.686 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 6.0 t 54.21 99.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -41.18 -26.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 110.723 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 12' ' ' SER . 11.4 m-20 -80.85 3.64 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -101.28 -159.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.831 -1.168 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' N ' ' OG ' ' A' ' 15' ' ' SER . 5.1 mttp -116.2 134.0 55.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.455 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.45 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 26.9 p -99.58 78.06 2.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.193 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 18.3 mm-40 -101.01 50.25 0.87 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.292 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.01 94.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' THR . 0.1 OUTLIER -179.61 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.124 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.503 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 84.5 m -146.72 139.14 24.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 110.219 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CD2' ' HA ' ' A' ' 38' ' ' THR . 1.1 tp -134.31 40.99 2.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.944 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.515 HG22 ' CB ' ' A' ' 8' ' ' ASN . 35.9 m 59.61 25.15 14.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.425 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -157.42 52.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.401 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 10.2 m -143.79 108.76 4.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 110.437 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.513 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 45.2 m-85 -103.36 96.28 6.65 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 5.0 t -103.32 167.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 111.312 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.453 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.3 t0 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.743 . . . . 0.0 109.667 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 48.08 67.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.007 . . . . 0.0 109.862 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.528 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 2.1 m -133.34 -173.32 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.266 -0.896 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 32.8 tt0 -139.75 101.28 4.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 77.2 t -100.76 137.17 29.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.488 -0.758 . . . . 0.0 111.069 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.536 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -137.47 122.4 18.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 39.94 47.19 3.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.472 ' HB ' HG11 ' A' ' 32' ' ' VAL . 18.6 m -103.28 166.92 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -1.167 . . . . 0.0 110.433 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.466 ' CG2' HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -136.01 90.69 2.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.396 -0.815 . . . . 0.0 110.075 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 27.4 p -97.47 96.31 8.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.497 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 82.8 p -78.82 -28.68 44.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.125 -0.984 . . . . 0.0 109.606 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . -164.5 68.6 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.463 ' HB3' ' OG1' ' A' ' 53' ' ' THR . 57.6 p -135.81 174.8 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -1.124 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -136.39 123.85 22.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.912 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.555 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.3 m-85 -101.4 168.76 9.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 110.717 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' O ' HG22 ' A' ' 45' ' ' VAL . 2.9 t0 -173.68 109.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.38 69.71 0.96 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.546 ' CG2' HG21 ' A' ' 57' ' ' ILE . 3.1 t -145.15 131.9 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -1.127 . . . . 0.0 110.922 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 4.4 m -109.05 96.35 6.25 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.395 -0.816 . . . . 0.0 109.346 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 64' ' ' ILE . 1.1 pt -114.32 176.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 1.9 t -136.24 -147.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.511 ' N ' ' CG2' ' A' ' 48' ' ' THR . 3.7 m -60.26 80.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.321 -0.862 . . . . 0.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 48' ' ' THR . 1.4 m -139.34 142.97 37.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.263 -0.898 . . . . 0.0 110.507 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.466 HG22 ' CG2' ' A' ' 36' ' ' THR . 4.0 p -91.55 53.19 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' CB ' ' A' ' 67' ' ' CYS . 5.3 t -94.97 122.38 37.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -172.16 135.85 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 144.6 -28.56 1.91 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.471 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -130.36 178.56 6.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -1.05 . . . . 0.0 109.933 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -94.34 138.6 32.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.134 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.571 HG21 ' N ' ' A' ' 58' ' ' SER . 1.1 mt -115.79 155.5 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.571 ' N ' HG21 ' A' ' 57' ' ' ILE . 1.1 m -147.28 145.3 29.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 112.57 0.26 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.106 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -7.04 20.21 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.697 1.367 . . . . 0.0 109.068 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.65 32.58 0.48 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -72.25 155.57 40.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -1.018 . . . . 0.0 110.102 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 105.31 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 tt -102.05 154.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.92 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.529 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -145.91 108.22 4.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.482 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 10.7 p 50.62 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.424 ' CB ' ' HB2' ' A' ' 52' ' ' SER . 0.0 OUTLIER -127.59 -151.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.85 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.452 HG23 ' O ' ' A' ' 68' ' ' ILE . 1.3 tp -134.9 139.38 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 110.522 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.431 HD11 HG21 ' A' ' 53' ' ' THR . 7.8 tt -70.41 105.08 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.028 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.43 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.2 m -148.48 148.04 29.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.362 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.38 57.89 1.57 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . 138.25 113.16 1.14 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.543 ' HB ' ' CG ' ' A' ' 87' ' ' PHE . 5.3 t -96.84 145.2 29.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 110.099 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HD2' ' CG1' ' A' ' 73' ' ' VAL . 43.4 Cg_endo -71.91 137.61 29.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.963 1.507 . . . . 0.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -62.43 -52.37 66.4 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.81 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 42.6 Cg_endo -69.97 -32.84 16.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.628 1.33 . . . . 0.0 110.364 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER 66.11 -59.33 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.893 . . . . 0.0 111.002 179.378 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' OG ' ' A' ' 77' ' ' SER . . . 47.26 24.96 0.49 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 108.513 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.84 -57.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.5 t -84.38 168.19 15.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.645 -0.66 . . . . 0.0 109.547 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -99.85 115.88 30.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.541 HD11 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -132.73 139.28 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.541 ' N ' HD11 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -144.27 79.07 1.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 96.11 45.94 2.72 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -131.99 160.54 35.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.12 -1.224 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.585 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 9.8 t -117.07 157.49 25.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.7 m-85 -137.37 137.56 39.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.881 -1.137 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 89' ' ' ALA . 12.2 t -171.11 136.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.53 139.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.374 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.471 ' N ' ' HA ' ' A' ' 55' ' ' SER . 13.0 p30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.199 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.4 t70 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.233 0.539 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -123.51 131.43 8.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 1.0 OUTLIER 49.88 -89.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.346 -1.091 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 2' ' ' GLY . 9.0 t -130.62 -68.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 5' ' ' THR . 7.2 t -130.83 30.94 4.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 109.797 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.95 70.06 8.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 103.84 15.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.979 . . . . 0.0 110.356 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 2.0 t-20 44.72 24.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 110.044 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.43 ' OG ' HG21 ' A' ' 21' ' ' THR . 1.0 OUTLIER -131.02 -162.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.883 179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.489 ' OE1' ' CE1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -143.65 107.52 4.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.043 -1.036 . . . . 0.0 110.502 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 12' ' ' SER . 18.4 tp -100.32 21.72 12.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.653 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.487 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 22.0 t 61.34 12.41 4.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.584 -0.697 . . . . 0.0 110.273 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.98 28.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 110.273 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.1 t30 -162.25 19.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 110.922 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -112.17 -149.16 0.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.05 -1.031 . . . . 0.0 109.43 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -108.81 127.86 54.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.955 -1.091 . . . . 0.0 110.056 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.457 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 29.3 p -106.43 69.11 0.78 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 110.354 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 18.5 tp10 -84.62 55.4 3.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.151 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 45.29 74.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.038 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.474 ' OG ' ' N ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.84 66.96 0.31 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.264 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.43 HG21 ' OG ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -156.15 155.26 32.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.65 -77.28 0.56 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.235 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.494 ' CB ' ' HB3' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -172.13 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.265 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -155.32 67.48 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.77 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 11.1 m -155.26 117.44 4.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.0 110.862 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.551 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 3.6 m-85 -109.39 94.8 5.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.568 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 12.0 t -99.8 165.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.904 -1.123 . . . . 0.0 111.31 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 7.8 t0 -146.54 109.59 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.707 . . . . 0.0 109.332 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.96 69.59 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.979 -1.076 . . . . 0.0 109.742 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.535 ' OG ' ' CG1' ' A' ' 27' ' ' VAL . 9.7 m -131.83 -167.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.923 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -142.13 101.61 3.96 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.05 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.449 HG12 ' HB ' ' A' ' 35' ' ' THR . 80.9 t -102.06 125.84 56.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 110.856 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.547 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -132.84 123.0 25.25 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 41.97 42.52 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 36' ' ' THR . 52.1 m -104.24 162.14 13.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -1.067 . . . . 0.0 110.195 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 35' ' ' THR . 24.4 p -98.56 178.22 5.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.991 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.481 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -158.95 65.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.367 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -110.88 40.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.877 . . . . 0.0 110.314 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.445 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 118.46 91.19 1.42 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.481 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 10.8 p -172.17 178.55 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -1.203 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.551 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -146.67 122.44 10.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.881 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 3.3 m-85 -102.07 166.3 10.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.518 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.427 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.8 t70 -176.13 111.26 0.1 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.71 66.32 2.35 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.571 ' CG2' HG23 ' A' ' 57' ' ' ILE . 2.7 t -144.1 129.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -1.064 . . . . 0.0 110.957 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.8 m -110.37 90.89 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.247 -0.908 . . . . 0.0 109.122 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.55 HG21 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -111.4 164.86 6.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 109.86 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.547 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 1.5 t -122.41 -154.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 109.94 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' TYR . 3.2 m -48.25 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' THR . 12.6 p -139.26 154.43 47.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 36' ' ' THR . 19.6 p -110.42 53.34 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -111.51 110.05 20.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 110.522 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -151.49 113.7 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.272 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 169.36 -42.94 0.21 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.226 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.531 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -110.0 177.04 4.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.237 . . . . 0.0 110.382 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -97.25 126.89 42.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.573 ' CG2' ' SG ' ' A' ' 85' ' ' CYS . 1.8 mt -104.75 158.42 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 110.844 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.568 ' N ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.72 155.1 40.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 110.534 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.1 125.13 0.75 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.728 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -74.95 -5.61 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.01 39.33 0.24 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -71.88 151.48 43.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.463 -1.022 . . . . 0.0 110.536 -179.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' O ' ' OG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -145.03 113.52 6.67 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.474 HG23 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -104.49 166.71 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.526 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.49 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.3 OUTLIER -147.35 96.71 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 110.251 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 65' ' ' SER . 19.3 p 50.16 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.04 -146.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.933 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 tt -143.66 -177.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.1 pp -46.21 123.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.015 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.53 ' CG2' HG11 ' A' ' 73' ' ' VAL . 2.4 m -92.08 -134.53 0.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.508 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 89.86 24.66 29.4 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 115.0 68.13 0.45 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.53 HG11 ' CG2' ' A' ' 70' ' ' THR . 24.5 m -86.35 164.22 39.03 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.323 -1.104 . . . . 0.0 110.573 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 43.0 Cg_endo -68.3 129.41 19.14 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.149 1.605 . . . . 0.0 110.353 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.559 ' CB ' ' HD3' ' A' ' 76' ' ' PRO . . . -44.17 -58.61 4.68 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 109.494 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 75' ' ' ALA . 51.6 Cg_endo -77.16 92.25 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.903 1.475 . . . . 0.0 109.58 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 80' ' ' CYS . 0.2 OUTLIER -79.81 55.92 2.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.797 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.25 -24.92 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 108.977 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.405 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . -81.36 -76.49 0.24 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.592 0.711 . . . . 0.0 109.688 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 3.3 t -63.11 168.9 3.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.757 -0.589 . . . . 0.0 109.501 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 80' ' ' CYS . 9.6 mmtt -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.007 . . . . 0.0 110.228 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.852 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.579 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 0.9 OUTLIER -156.23 83.52 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.522 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 77.02 59.2 3.21 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.573 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.46 159.34 42.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -1.147 . . . . 0.0 110.716 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -106.86 154.64 20.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.607 -0.683 . . . . 0.0 110.07 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.5 m-85 -134.28 141.88 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 89' ' ' ALA . 21.4 t -177.7 121.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 110.367 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.13 139.63 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.52 -0.738 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.531 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.304 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.34 -136.57 4.02 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.128 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 55.8 m -63.79 -22.47 66.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.346 -1.091 . . . . 0.0 110.192 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' SER . 1.8 p 173.71 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.408 -0.808 . . . . 0.0 109.626 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 5' ' ' THR . 0.9 OUTLIER -141.05 92.96 2.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 108.978 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 11' ' ' LEU . 2.4 t30 175.89 111.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 3.9 p -101.25 107.01 18.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.1 OUTLIER 69.4 8.33 6.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 110.667 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.2 -170.47 1.65 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.019 . . . . 0.0 110.359 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -141.83 99.71 3.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 109.268 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' CD2' ' HA ' ' A' ' 17' ' ' CYS . 0.4 OUTLIER -92.63 38.02 1.01 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.13 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 18.2 t 58.47 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.678 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.59 22.64 2.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 110.461 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -157.4 19.35 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.131 -0.981 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 10.5 p -100.17 -162.74 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.914 -1.116 . . . . 0.0 109.348 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.445 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 19.8 tptt -108.25 112.33 24.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.521 ' HA ' ' CD2' ' A' ' 11' ' ' LEU . 29.6 p -97.31 86.33 3.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.512 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -107.56 127.04 53.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.111 -0.993 . . . . 0.0 109.425 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 7.8 tttt 69.92 119.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.1 145.81 35.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 110.359 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.4 HG21 ' HA ' ' A' ' 6' ' ' ASN . 12.2 t -90.86 -146.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mp -111.4 -81.72 0.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.613 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -179.76 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.18 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -157.12 60.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.534 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -155.09 111.75 3.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.435 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.2 m-85 -100.77 129.1 46.61 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -125.1 160.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.916 -1.115 . . . . 0.0 110.979 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -149.29 115.55 5.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 0.0 109.416 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 mttt 52.03 65.43 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 109.823 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.474 ' OG ' HG13 ' A' ' 27' ' ' VAL . 2.7 m -133.45 -170.49 2.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 111.122 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 16' ' ' LYS . 2.6 tm-20 -143.26 99.36 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 16' ' ' LYS . 97.3 t -105.23 149.81 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.955 . . . . 0.0 111.689 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.3 OUTLIER -127.35 -143.6 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' HA2' ' HD2' ' A' ' 19' ' ' LYS . . . -66.41 68.16 0.16 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.4 m -114.91 157.78 22.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -1.133 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -112.36 170.83 7.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 53' ' ' THR . 36.9 t -133.75 140.28 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.819 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 38' ' ' THR . 32.8 m -155.3 19.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 132.18 67.47 0.09 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -151.63 -178.81 6.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.124 -1.221 . . . . 0.0 110.247 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -147.3 138.08 23.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.751 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.556 ' HB3' ' CG1' ' A' ' 27' ' ' VAL . 6.0 m-85 -110.1 161.62 15.36 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.537 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' HG21 ' A' ' 45' ' ' VAL . 1.6 t70 -179.09 113.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 49.49 64.33 3.48 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.525 ' CG2' HG21 ' A' ' 57' ' ' ILE . 3.1 t -145.8 136.47 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -1.012 . . . . 0.0 110.426 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 87.7 m -116.03 97.96 6.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.532 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.492 ' HA ' HG23 ' A' ' 64' ' ' ILE . 1.6 pt -114.93 174.39 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.401 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.493 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -122.04 -160.09 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 110.537 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.514 ' N ' ' HB3' ' A' ' 33' ' ' TYR . 8.7 m -61.62 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.882 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.892 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 10.5 p -95.83 57.46 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.25 133.24 55.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.551 -0.718 . . . . 0.0 110.454 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.53 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.4 75.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.855 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.525 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -132.22 -61.48 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.545 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 61.1 p -103.61 -159.62 0.73 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.489 -1.006 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.453 ' HG3' ' CG ' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -115.21 123.48 48.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.401 -0.812 . . . . 0.0 110.188 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 HG21 ' CG2' ' A' ' 45' ' ' VAL . 2.0 mt -98.98 163.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 109.959 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.519 ' N ' HG21 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.71 151.36 37.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.701 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 159.55 115.28 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.03 -2.8 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.743 1.391 . . . . 0.0 108.657 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.25 28.59 0.63 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.51 153.7 41.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.444 -1.033 . . . . 0.0 110.711 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.35 111.03 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.797 . . . . 0.0 110.05 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.492 HG23 ' HA ' ' A' ' 47' ' ' ILE . 3.6 tt -103.88 167.65 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.971 . . . . 0.0 109.226 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -144.83 100.55 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.346 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 65' ' ' SER . 81.0 p 46.39 56.39 6.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.556 -0.715 . . . . 0.0 110.712 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.04 162.34 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 69' ' ' ILE . 79.4 mt -108.32 171.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.513 ' N ' HG22 ' A' ' 68' ' ' ILE . 1.7 mp -38.75 121.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 0.0 110.415 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 72' ' ' GLY . 89.6 m -130.32 61.1 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.992 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.545 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -65.78 74.43 0.11 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.539 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . 61.72 26.17 66.51 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.517 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 2.9 m -132.73 82.31 56.42 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.971 -0.723 . . . . 0.0 110.652 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 77' ' ' SER . 53.6 Cg_endo -77.83 -23.83 9.11 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.97 1.511 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -42.61 -52.87 10.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.206 -0.934 . . . . 0.0 111.017 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 44.8 Cg_endo -71.58 -10.97 27.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.656 1.345 . . . . 0.0 110.448 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' PRO . 23.0 p -112.57 13.93 20.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.9 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.31 -14.68 12.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.89 -19.14 30.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.742 . . . . 0.0 109.981 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 3.3 t -82.64 167.86 17.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -105.6 137.81 42.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.711 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.49 ' CD1' HG13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -147.92 129.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.599 -0.688 . . . . 0.0 109.347 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -142.53 116.24 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.943 . . . . 0.0 110.528 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.44 48.77 8.84 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.42 149.36 49.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 0.0 110.506 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -104.17 163.06 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.149 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 86' ' ' THR . 6.3 m-85 -132.62 144.49 50.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.466 ' C ' ' HB2' ' A' ' 55' ' ' SER . 2.0 t -176.08 116.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 109.75 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 55' ' ' SER . . . -37.76 155.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.496 -0.753 . . . . 0.0 110.882 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.463 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.877 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.489 ' HB3' ' CG2' ' A' ' 7' ' ' THR . 9.4 p-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.098 0.475 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.66 -71.15 0.09 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -39.56 90.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.29 -1.123 . . . . 0.0 110.609 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.27 -70.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.441 ' OG1' ' N ' ' A' ' 21' ' ' THR . 3.0 t -133.42 7.08 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -69.69 73.14 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 110.494 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.489 ' CG2' ' HB3' ' A' ' 1' ' ' ASP . 50.1 p -98.29 99.32 10.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.0 109.499 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 7' ' ' THR . 9.5 m120 58.15 15.95 3.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.694 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -130.89 172.84 11.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.472 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.43 ' HB2' ' CD2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -116.16 114.26 24.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' O ' ' HB3' ' A' ' 12' ' ' SER . 15.7 tp -102.45 28.39 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.769 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 21.8 t 64.22 6.25 2.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.731 -0.606 . . . . 0.0 110.914 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.0 25.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.06 -1.025 . . . . 0.0 109.44 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' SER . 37.5 t30 -163.47 17.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.416 -0.803 . . . . 0.0 110.491 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.6 OUTLIER -104.29 -147.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.425 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' N ' ' OG ' ' A' ' 15' ' ' SER . 3.4 tmtm? -114.94 119.04 35.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.796 -1.19 . . . . 0.0 110.493 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.01 66.14 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.718 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -84.13 157.6 21.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp 48.15 -94.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.863 . . . . 0.0 110.332 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 18' ' ' GLU . 17.3 p -168.86 173.86 6.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.038 -1.039 . . . . 0.0 110.561 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.462 HG22 ' N ' ' A' ' 22' ' ' LEU . 2.7 m -136.48 153.54 51.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.772 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.468 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.4 OUTLIER -89.08 -140.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 p -131.42 48.23 2.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.774 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.7 m-20 -157.6 46.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.826 . . . . 0.0 110.134 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 88.5 m -149.68 123.26 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 111.182 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.57 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 20.1 m-85 -115.58 96.65 5.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.588 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 12.2 t -94.32 163.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.912 . . . . 0.0 111.315 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.91 120.53 9.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.548 -0.72 . . . . 0.0 109.467 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tptm 47.92 59.76 4.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.275 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 15' ' ' SER . 1.7 m -133.58 178.19 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.184 -0.947 . . . . 0.0 110.982 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.6 tt0 -143.61 109.58 5.28 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 16' ' ' LYS . 5.7 m -116.05 164.98 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.892 -1.13 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.558 ' O ' ' N ' ' A' ' 35' ' ' THR . 0.2 OUTLIER -121.53 -139.17 0.33 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.456 ' CA ' HG23 ' A' ' 49' ' ' THR . . . -65.97 66.87 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' TYR . 19.6 m -99.36 163.58 12.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.518 ' CG2' HG23 ' A' ' 51' ' ' THR . 6.7 p -106.88 -170.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.119 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 0.9 OUTLIER -141.15 -87.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.912 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 m 46.13 37.14 3.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.362 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 102.03 109.49 3.28 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.49 ' CB ' HG23 ' A' ' 53' ' ' THR . 47.0 t 177.87 161.89 0.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.419 -1.047 . . . . 0.0 110.184 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -141.7 128.61 20.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.991 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.588 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 5.0 m-85 -110.67 167.11 10.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.467 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -177.73 112.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.098 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.79 70.49 0.84 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.527 ' CG2' HG23 ' A' ' 57' ' ' ILE . 7.4 t -145.52 127.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.413 -1.051 . . . . 0.0 111.126 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -106.92 91.13 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.238 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.525 HG21 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -114.35 170.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.375 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.537 HG22 ' N ' ' A' ' 49' ' ' THR . 5.3 t -118.46 -151.21 0.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.549 ' CA ' ' HB3' ' A' ' 33' ' ' TYR . 3.2 m -63.5 86.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.378 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 7.9 t -139.37 144.72 38.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 110.759 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.518 HG23 ' CG2' ' A' ' 36' ' ' THR . 43.9 p -96.72 61.4 1.88 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.28 111.26 23.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' CG2' ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -142.66 162.75 34.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.883 . . . . 0.0 110.142 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 116.24 -56.9 0.51 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.482 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -101.86 -179.6 4.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -1.133 . . . . 0.0 111.213 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 6.1 ttp85 -109.69 128.05 54.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.552 ' CG2' ' SG ' ' A' ' 85' ' ' CYS . 1.5 mt -103.57 161.18 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 111.006 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.508 ' N ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.65 146.3 30.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.13 118.05 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.437 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.94 -6.98 20.41 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 N-CA-C 108.69 -1.312 . . . . 0.0 108.69 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.95 38.61 0.29 Allowed Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -71.85 159.4 34.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.446 -1.032 . . . . 0.0 110.139 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 62' ' ' CYS . 5.1 mmtm -143.11 109.51 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.757 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.503 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.6 tt -102.6 172.45 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.003 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.477 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.6 t -151.17 76.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.17 . . . . 0.0 110.78 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 4.1 p 55.24 113.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 30.0 m -139.36 -157.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.9 mt -121.97 -149.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.166 -0.959 . . . . 0.0 109.898 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 37.0 mt -61.3 144.72 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' GLY . 75.2 m -123.7 -13.76 7.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.948 -1.095 . . . . 0.0 110.938 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' O ' ' CG1' ' A' ' 73' ' ' VAL . . . -36.12 94.2 0.01 OUTLIER Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 70' ' ' THR . . . 40.05 28.71 0.17 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 71' ' ' GLY . 17.9 m -127.61 75.21 77.85 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HA ' ' OG ' ' A' ' 77' ' ' SER . 49.3 Cg_endo -78.21 -20.46 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.881 1.464 . . . . 0.0 110.149 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -62.48 -50.03 80.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 111.139 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 43.2 Cg_endo -70.02 -2.93 11.18 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.399 1.21 . . . . 0.0 110.704 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 2.3 p -116.84 10.46 14.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.924 -1.11 . . . . 0.0 109.199 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.49 -9.1 59.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.835 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 77' ' ' SER . 6.8 t -72.06 149.44 44.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.412 -0.805 . . . . 0.0 109.997 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -104.79 103.68 13.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.938 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.545 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -125.11 155.94 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.46 ' N ' ' CD1' ' A' ' 82' ' ' ILE . 43.6 t -146.8 114.75 6.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.385 -0.822 . . . . 0.0 110.407 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 70.47 48.79 34.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.552 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -132.79 148.22 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -1.045 . . . . 0.0 110.804 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -109.27 153.91 23.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.392 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 88' ' ' SER . 10.3 m-85 -127.13 160.6 30.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.575 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 171.03 127.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.798 . . . . 0.0 109.877 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -42.58 141.46 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.493 ' CG ' ' CB ' ' A' ' 41' ' ' ARG . 2.4 t30 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.044 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.421 ' CG ' ' HA ' ' A' ' 7' ' ' THR . 10.7 t70 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.238 0.542 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.55 -104.07 2.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -76.37 -58.81 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.117 . . . . 0.0 109.848 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 3.7 m -142.14 -49.53 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -0.86 . . . . 0.0 109.625 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -134.31 35.68 3.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 1' ' ' ASP . 2.2 t-20 -94.5 68.84 3.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.471 ' CG2' ' O ' ' A' ' 22' ' ' LEU . 1.9 t -99.05 94.09 6.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.437 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 67.4 4.68 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.711 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -114.18 -168.5 1.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 99.74 3.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 4.5 tp -88.42 27.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.932 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 1.1 p 71.67 1.28 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.464 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.14 24.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.77 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 12' ' ' SER . 17.8 p30 -157.28 16.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.535 ' OG ' ' CD2' ' A' ' 11' ' ' LEU . 22.1 p -105.73 -138.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.29 98.43 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 15.4 p -82.76 50.01 1.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 110.402 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -90.1 141.2 28.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.955 -1.091 . . . . 0.0 110.456 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' CD ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER 68.87 -156.9 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.345 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -123.32 -168.1 1.71 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.464 ' CG2' ' N ' ' A' ' 22' ' ' LEU . 6.6 t -166.6 -145.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.471 ' O ' ' CG2' ' A' ' 7' ' ' THR . 0.4 OUTLIER -114.37 -142.85 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.153 -0.967 . . . . 0.0 110.672 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -137.73 44.26 2.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.341 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' THR . 2.7 m120 -158.24 69.44 0.51 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.05 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.62 123.47 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.932 -1.105 . . . . 0.0 111.365 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.476 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -109.77 93.86 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.56 ' CG2' ' HB2' ' A' ' 42' ' ' PHE . 4.5 t -93.67 167.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 110.643 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.2 OUTLIER -149.49 120.63 7.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.956 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 44.46 60.76 2.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 109.763 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 15' ' ' SER . 1.4 m -128.1 -169.19 2.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.69 104.57 4.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 99.5 t -110.99 137.89 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 111.47 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -107.09 -139.68 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.563 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.501 ' HA2' ' CD ' ' A' ' 19' ' ' LYS . . . -68.16 61.68 0.39 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.2 m -111.43 156.84 21.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -1.143 . . . . 0.0 110.189 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -106.42 -173.18 2.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 0.8 OUTLIER -150.84 76.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.649 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.435 ' HA ' HD23 ' A' ' 22' ' ' LEU . 1.9 m -90.97 47.31 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.24 95.31 2.22 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.535 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 25.1 p -174.06 173.04 3.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.331 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.507 ' CD ' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -135.81 133.78 38.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.221 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.56 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . 5.7 m-85 -112.92 163.15 15.01 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.953 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 8.7 t70 -177.19 111.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.9 . . . . 0.0 109.122 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 50.63 66.67 2.29 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.543 ' CG2' HG21 ' A' ' 57' ' ' ILE . 2.6 t -144.42 127.99 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.084 . . . . 0.0 111.033 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 22.1 m -104.76 96.01 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.352 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.537 ' HB ' ' CG2' ' A' ' 64' ' ' ILE . 1.1 pp -114.44 169.06 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 49' ' ' THR . 1.3 t -112.78 -150.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.564 ' N ' ' CG2' ' A' ' 48' ' ' THR . 34.8 m -73.41 94.37 2.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.195 -0.941 . . . . 0.0 110.016 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.507 ' HB3' ' CA ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -139.9 157.86 45.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 111.394 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.479 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 27.5 m -104.09 50.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.592 -0.692 . . . . 0.0 109.372 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.504 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -102.7 102.81 13.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.344 -0.848 . . . . 0.0 110.594 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.535 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 82.1 p -141.19 113.94 8.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 166.14 -27.09 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.554 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 72.6 p -118.85 162.01 19.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -91.36 119.08 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.867 . . . . 0.0 108.997 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.554 HG21 ' N ' ' A' ' 58' ' ' SER . 1.0 OUTLIER -99.64 152.29 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 0.0 111.65 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.554 ' N ' HG21 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -146.63 140.73 26.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.814 -0.554 . . . . 0.0 109.906 179.032 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 171.21 120.23 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.114 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.09 -5.32 16.86 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.719 1.379 . . . . 0.0 108.899 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.61 33.88 0.32 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 1.7 t -72.02 160.1 33.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.98 -1.306 . . . . 0.0 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 62' ' ' CYS . 17.5 mmtt -141.51 110.79 6.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.537 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 6.6 tt -99.45 171.53 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.016 -1.052 . . . . 0.0 109.314 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.484 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.2 t -152.94 87.83 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.507 ' CA ' ' HB3' ' A' ' 50' ' ' SER . 10.2 p 52.21 104.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 110.948 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 82.0 m -119.55 -152.73 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.49 -0.756 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -138.59 170.85 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.913 -1.117 . . . . 0.0 110.58 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.526 ' N ' ' CD1' ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.96 137.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 0.0 109.402 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.48 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.1 t -145.42 -166.5 2.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 111.039 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -172.63 30.8 0.11 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 128.2 78.79 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.2 m -94.22 124.28 56.31 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.231 -1.158 . . . . 0.0 110.564 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -74.74 152.35 42.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.022 1.538 . . . . 0.0 110.44 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' CB ' ' HD2' ' A' ' 76' ' ' PRO . . . 64.32 179.02 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.579 ' HA ' ' CE1' ' A' ' 87' ' ' PHE . 46.0 Cg_endo -73.85 63.52 4.9 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.934 1.491 . . . . 0.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER 71.42 -49.7 0.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.166 -0.959 . . . . 0.0 111.223 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 50.77 24.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 108.073 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.16 -60.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 66' ' ' THR . 7.8 t -83.44 179.04 7.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.638 -0.664 . . . . 0.0 109.571 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -102.33 104.12 14.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 1.6 tp -132.46 151.35 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.457 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -140.82 118.76 11.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.168 -0.958 . . . . 0.0 110.679 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.04 46.13 37.77 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.552 ' HB3' ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -128.15 154.27 45.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.232 -1.158 . . . . 0.0 111.43 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.579 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.74 165.81 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 0.0 109.056 178.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -155.4 155.67 34.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.784 -1.197 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -175.76 41.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 111.145 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.554 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.8 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 110.843 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.075 0.464 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 17' ' ' CYS . 5.8 t -145.46 13.59 1.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 0.0 110.453 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -97.05 96.41 8.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -113.77 20.18 16.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.33 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -108.73 -151.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.967 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -143.36 110.19 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.439 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 27' ' ' VAL . 25.6 tp -94.15 36.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.625 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 68.92 2.19 3.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.737 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 46.56 23.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.941 -1.1 . . . . 0.0 109.639 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -159.91 12.12 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.945 . . . . 0.0 111.465 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' SER . 4.3 m -98.65 -144.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.788 -1.195 . . . . 0.0 109.537 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 18' ' ' GLU . 1.4 tptt -107.41 89.97 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 29.7 p -65.55 64.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 0.0 110.746 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 16' ' ' LYS . 33.2 mm-40 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.031 -1.043 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 38' ' ' THR . 36.4 m-80 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.049 0.452 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -155.79 128.02 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -136.23 91.95 2.73 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.102 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -94.4 164.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 110.776 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.625 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.8 t0 -137.42 117.04 12.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ASP . 6.7 tttt 40.29 71.3 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.064 -1.023 . . . . 0.0 110.189 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.831 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -131.51 -175.01 3.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -144.13 100.8 3.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.612 -0.68 . . . . 0.0 109.996 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 10.4 m -110.22 151.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.637 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.547 ' O ' ' CA ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -125.85 94.45 4.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.099 -1.0 . . . . 0.0 110.348 -179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.688 ' O ' HG23 ' A' ' 49' ' ' THR . . . 60.97 46.11 95.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 50' ' ' SER . 6.2 m -102.45 146.43 28.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -1.092 . . . . 0.0 110.369 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.483 ' O ' HG21 ' A' ' 53' ' ' THR . 2.7 t -90.32 159.7 16.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.431 -0.793 . . . . 0.0 110.39 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 38' ' ' THR . 1.2 m -113.87 -79.79 0.59 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.488 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.1 m 68.25 -68.39 0.17 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.124 -0.985 . . . . 0.0 110.405 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 53' ' ' THR . . . -155.61 104.34 0.25 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -178.34 179.56 0.78 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -1.132 . . . . 0.0 109.924 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.46 127.56 13.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 110.104 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.102 ' HB3' HG13 ' A' ' 27' ' ' VAL . 4.6 m-85 -109.17 172.85 6.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.398 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 58' ' ' SER . 0.9 OUTLIER 177.21 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.821 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 66.07 66.48 2.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.976 HG21 HG22 ' A' ' 57' ' ' ILE . 2.4 t -146.28 148.83 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 110.564 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 46' ' ' THR . 13.3 m -122.25 89.7 3.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.447 -0.783 . . . . 0.0 109.312 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.71 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.65 168.92 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 5.4 t -115.89 -164.88 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 34' ' ' GLY . 2.0 m -49.63 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.918 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 35' ' ' THR . 6.2 p -132.21 137.46 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.052 -1.03 . . . . 0.0 111.253 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 51' ' ' THR . 26.3 m -87.86 40.13 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.587 -0.696 . . . . 0.0 109.268 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -102.17 103.01 13.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.149 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.584 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 6.0 p -146.28 95.56 2.63 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.563 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -156.0 -53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' N ' ' A' ' 89' ' ' ALA . 2.6 p -105.73 -162.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 11.4 mtp180 -95.84 137.62 34.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.519 -0.738 . . . . 0.0 109.917 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.976 HG22 HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -118.3 128.57 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.993 . . . . 0.0 110.186 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.692 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.68 157.4 43.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.48 125.6 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.2 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.635 1.334 . . . . 0.0 109.4 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.07 33.63 0.2 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.3 t -72.89 146.25 46.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.353 -1.087 . . . . 0.0 110.646 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 111.28 9.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.446 -0.784 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.929 HG13 HD12 ' A' ' 82' ' ' ILE . 5.4 tt -104.39 171.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 110.611 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -142.97 96.35 2.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.32 -0.863 . . . . 0.0 110.046 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 67' ' ' CYS . 16.7 p 54.64 -93.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.691 -0.631 . . . . 0.0 110.597 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.552 ' N ' ' OG1' ' A' ' 66' ' ' THR . 3.9 m 70.3 -167.5 0.16 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.044 -1.035 . . . . 0.0 109.994 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -130.59 -169.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 70' ' ' THR . 5.4 mt -42.47 167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.333 -0.854 . . . . 0.0 110.703 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.525 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -137.61 -139.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 108.87 44.41 1.12 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.536 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.485 1.922 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.193 0.52 . . . . 0.0 109.944 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.929 HD12 HG13 ' A' ' 64' ' ' ILE . 1.1 tt -120.66 124.18 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.73 123.53 23.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 71.9 60.8 4.05 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.484 ' SG ' HG13 ' A' ' 82' ' ' ILE . 56.3 m -138.79 146.12 40.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 111.25 13.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 109.607 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.543 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -142.69 160.13 40.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.948 . . . . 0.0 110.58 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -176.02 94.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' N ' ' CB ' ' A' ' 55' ' ' SER . . . 50.89 172.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 56' ' ' ARG . 28.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.217 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.023 0.439 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 5' ' ' THR . 5.5 t -127.96 53.34 1.79 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.009 -1.057 . . . . 0.0 109.577 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.65 70.45 1.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 111.001 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 4.4 t -98.97 21.82 11.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.086 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 7' ' ' THR . 2.7 m-20 168.49 -17.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.652 -0.655 . . . . 0.0 110.808 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -108.02 -160.44 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 0.0 110.068 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -140.14 117.34 11.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 110.713 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.837 HD21 ' O ' ' A' ' 16' ' ' LYS . 1.8 tp -111.24 19.93 17.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 17.1 t 53.34 104.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.901 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.71 -24.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 110.429 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.2 m-20 -87.46 2.54 50.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 111.361 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.742 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -101.12 -162.98 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.619 -1.301 . . . . 0.0 110.547 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.837 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -111.55 162.75 14.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 28.6 p -128.92 71.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.69 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 110.516 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.476 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.118 0.485 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -153.84 113.9 3.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.802 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HB2' ' HD3' ' A' ' 41' ' ' ARG . 37.7 m-85 -108.98 110.62 21.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.017 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -114.64 164.33 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.816 -1.177 . . . . 0.0 111.041 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.3 t70 -149.29 110.3 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.462 -0.774 . . . . 0.0 109.865 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.8 OUTLIER 54.95 63.45 2.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 110.061 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.9 m -133.88 -167.81 2.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 111.324 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.3 tt0 -143.28 104.03 4.21 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.1 t -103.94 142.19 18.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.97 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.25 -152.6 0.51 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.364 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 49' ' ' THR . . . -66.69 67.55 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 50' ' ' SER . 2.9 m -110.2 159.56 17.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -1.144 . . . . 0.0 110.801 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 35' ' ' THR . 1.3 p -89.2 -168.81 2.28 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.484 -0.76 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.926 ' HA ' HG21 ' A' ' 53' ' ' THR . 30.6 t -174.33 102.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.1 m -118.42 1.33 11.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 151.16 77.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 53' ' ' THR . 11.7 t -149.93 170.63 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -1.197 . . . . 0.0 110.515 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -132.99 133.07 42.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.625 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.017 ' HB3' HG13 ' A' ' 27' ' ' VAL . 2.8 m-85 -111.4 160.79 16.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 110.455 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.5 t0 -171.74 116.13 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.68 67.34 1.58 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.63 ' CG1' HG23 ' A' ' 47' ' ' ILE . 2.7 t -144.86 126.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.442 -1.034 . . . . 0.0 110.537 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 25.3 m -106.86 96.28 6.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.288 -0.883 . . . . 0.0 109.194 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.63 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pt -113.72 160.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.493 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.594 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -106.01 -162.31 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.594 ' N ' HG23 ' A' ' 48' ' ' THR . 55.1 m -64.16 91.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 35' ' ' THR . 13.7 p -139.24 164.5 29.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.684 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -108.68 72.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 109.83 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.5 t -124.16 105.8 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.14 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.926 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -151.07 117.84 5.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.215 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 168.51 -30.74 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.467 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -122.8 167.6 13.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.556 -0.967 . . . . 0.0 109.555 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 9.9 ttm180 -91.56 136.4 33.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.767 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 3.3 mt -114.66 163.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.4 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.575 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -148.3 145.84 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.764 -0.585 . . . . 0.0 110.052 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 165.74 109.67 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.42 -1.371 . . . . 0.0 110.494 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.01 -4.77 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.758 1.399 . . . . 0.0 108.748 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.98 30.08 0.6 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.3 t -72.07 157.85 37.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -1.063 . . . . 0.0 110.608 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HG2' ' C ' ' A' ' 62' ' ' CYS . 2.7 mmtp -144.5 110.98 5.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.659 -0.65 . . . . 0.0 109.653 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.559 HG21 ' HB ' ' A' ' 47' ' ' ILE . 6.9 tt -101.1 170.52 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.905 -1.122 . . . . 0.0 109.812 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.74 91.1 1.52 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.124 . . . . 0.0 111.387 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 65' ' ' SER . 13.3 p 46.08 109.81 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.654 0.74 . . . . 0.0 111.576 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.8 m -140.24 145.4 37.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.396 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.421 ' H ' HG23 ' A' ' 68' ' ' ILE . 1.3 pt -55.36 -179.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 0.0 109.9 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.0 mt -54.79 153.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 53' ' ' THR . 5.7 m -98.33 -122.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.916 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 95.29 35.59 5.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.252 0.549 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.719 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -125.83 158.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 110.161 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.719 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -147.41 96.58 2.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 0.0 110.883 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.1 55.14 4.92 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.559 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.02 158.2 42.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.167 . . . . 0.0 110.881 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.582 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -111.06 161.04 16.3 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 57' ' ' ILE . 7.5 m-85 -146.43 162.22 38.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 111.276 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 1.2 t 169.19 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -37.62 138.01 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.467 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.853 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.386 0.612 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.561 HG21 ' H ' ' A' ' 18' ' ' GLU . 7.3 t -134.08 50.78 2.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.791 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 9' ' ' SER . 6.6 m120 -140.64 106.68 5.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.97 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -98.62 28.55 4.16 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.953 0.882 . . . . 0.0 108.64 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.71 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.297 0.57 . . . . 0.0 109.596 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 19.3 m -107.74 -165.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 109.277 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.73 115.94 7.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.786 -1.196 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 1.7 tp -91.63 140.71 29.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -0.945 . . . . 0.0 109.096 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -54.07 139.09 35.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -12.48 9.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.342 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -115.61 17.4 16.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.977 . . . . 0.0 110.702 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.2 p -94.28 -147.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 4.0 tttt -121.41 120.4 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.18 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -56.21 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 110.329 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.851 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.484 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 68.7 m-80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.289 0.566 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 12.9 m -141.97 109.26 5.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 110.31 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 6.6 t80 -100.8 103.86 15.09 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.928 HG13 ' HB3' ' A' ' 42' ' ' PHE . 8.0 t -101.69 164.62 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -142.47 119.29 11.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.421 -0.799 . . . . 0.0 109.452 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 26.2 tttt 42.78 67.75 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 109.835 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.724 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.1 m -132.96 -168.04 2.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -144.8 96.91 2.94 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.13 -0.982 . . . . 0.0 109.784 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.851 HG12 ' CB ' ' A' ' 18' ' ' GLU . 61.3 t -102.33 138.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 110.086 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 49' ' ' THR . 4.6 t80 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.085 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 42.26 48.58 5.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.457 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 22.5 m -104.9 163.92 12.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -1.134 . . . . 0.0 109.771 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.3 p -99.79 174.63 6.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.848 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.966 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -157.5 143.35 17.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.722 . . . . 0.0 109.872 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -166.62 37.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.13 62.03 0.38 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 9.2 t -142.91 176.17 9.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -145.75 124.16 12.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.928 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -99.65 172.69 7.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.235 -0.916 . . . . 0.0 110.139 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' SER . 7.8 t70 179.0 95.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 68.7 67.66 1.89 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.084 HG21 HG22 ' A' ' 57' ' ' ILE . 1.1 t -145.88 159.42 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 110.603 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 27.4 m -130.33 88.26 2.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.543 -0.723 . . . . 0.0 109.617 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.786 HG23 HG13 ' A' ' 45' ' ' VAL . 1.1 pp -111.08 165.59 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.753 HG23 ' N ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -129.88 -157.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.085 . . . . 0.0 110.788 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.753 ' N ' HG23 ' A' ' 48' ' ' THR . 5.6 m -46.45 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 110.858 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.3 m -140.5 -167.05 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.068 -1.02 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -150.03 72.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.376 -0.828 . . . . 0.0 109.84 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 8.4 t -131.79 112.47 12.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.567 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.966 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -151.65 121.75 7.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 168.48 -25.98 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.463 ' HA ' ' C ' ' A' ' 89' ' ' ALA . 26.0 p -122.7 -170.15 2.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -1.11 . . . . 0.0 109.918 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 28.1 mtp180 -94.87 115.94 28.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.843 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.084 HG22 HG21 ' A' ' 45' ' ' VAL . 1.2 mm -98.98 122.52 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.076 . . . . 0.0 109.965 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.477 ' CA ' HG23 ' A' ' 45' ' ' VAL . 44.9 m -145.78 168.3 21.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 110.46 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 151.02 123.05 1.08 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.5 -5.68 17.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.691 1.363 . . . . 0.0 109.416 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 23.72 0.87 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 5.1 t -73.17 143.44 47.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.499 -1.001 . . . . 0.0 110.648 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 113.22 7.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.0 109.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.589 ' HB ' HG22 ' A' ' 47' ' ' ILE . 3.0 tt -104.04 168.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 15.2 t -152.26 89.88 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 49' ' ' THR . 2.2 p 56.71 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.815 ' O ' HG23 ' A' ' 51' ' ' THR . 83.5 m -146.5 -159.09 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.0 155.72 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.929 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.8 pp -92.51 121.85 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.428 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.7 m -148.41 150.77 34.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.39 51.32 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 65' ' ' SER . 3.6 mptp? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.369 0.604 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.854 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.97 154.76 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.854 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.6 OUTLIER -148.05 89.77 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.781 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 97.19 61.67 0.93 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.655 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -138.39 171.95 13.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -1.224 . . . . 0.0 110.563 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.11 119.06 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.767 . . . . 0.0 109.554 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -147.4 149.6 33.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.174 . . . . 0.0 111.614 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 34.5 p -163.72 73.08 0.29 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.735 -0.603 . . . . 0.0 109.688 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 59.75 162.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 0.0 109.937 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.351 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.117 0.484 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 5' ' ' THR . 9.9 t -145.81 49.02 1.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 2.8 m120 -138.85 117.83 12.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.113 -0.992 . . . . 0.0 110.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 40.6 p -102.17 106.16 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.366 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER 74.01 -1.47 3.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.378 -0.826 . . . . 0.0 110.023 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.62 177.43 4.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.673 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -131.06 112.32 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.169 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HG ' ' OG ' ' A' ' 15' ' ' SER . 7.3 tp -88.63 54.57 3.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 110.053 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.615 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER 63.06 8.17 3.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 0.0 110.961 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 54.05 16.98 1.26 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 12' ' ' SER . 3.2 p30 174.75 30.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.98 -1.075 . . . . 0.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -92.44 -146.24 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.05 . . . . 0.0 109.564 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.571 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -104.69 103.83 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.967 -1.083 . . . . 0.0 109.521 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.64 59.78 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.594 ' HG2' ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.139 0.495 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 8.0 p -152.09 116.51 5.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.061 -1.024 . . . . 0.0 110.455 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 93.0 m-85 -100.69 100.19 10.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 0.0 109.554 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.055 HG13 ' HB3' ' A' ' 42' ' ' PHE . 5.6 t -94.37 166.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.017 . . . . 0.0 110.247 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.54 ' CA ' ' HB2' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.79 124.84 12.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER 42.77 63.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 109.586 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.848 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.1 m -130.9 -179.12 5.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 111.114 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.5 mt-10 -145.3 103.77 3.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.571 -0.705 . . . . 0.0 109.216 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.518 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.9 m -112.4 130.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 2.7 t80 -118.27 94.63 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.902 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 74.96 33.18 55.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 1.092 HG23 ' O ' ' A' ' 50' ' ' SER . 19.2 m -108.66 147.23 32.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -1.189 . . . . 0.0 110.208 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 51' ' ' THR . 8.1 t -97.94 150.8 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 19.8 p -135.44 58.2 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 110.138 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 m -66.21 -108.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.811 -1.18 . . . . 0.0 109.726 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.97 66.37 3.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 7.8 t -144.05 168.16 20.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -1.18 . . . . 0.0 110.758 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 3.9 tpt180 -138.85 124.53 19.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.055 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.48 177.53 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 10.0 t0 173.39 108.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 56.45 67.34 2.27 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 47' ' ' ILE . 16.5 t -145.76 125.13 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -1.039 . . . . 0.0 111.419 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -103.44 96.1 6.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 108.659 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.907 ' CD1' HG21 ' A' ' 35' ' ' THR . 1.1 pt -111.14 167.15 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 110.698 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.96 112.47 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER 38.08 72.3 0.13 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.433 -0.792 . . . . 0.0 111.288 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 1.092 ' O ' HG23 ' A' ' 35' ' ' THR . 44.3 t -140.13 139.96 35.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 110.786 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.486 ' HA ' HG22 ' A' ' 36' ' ' THR . 29.8 p -103.85 50.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.918 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -89.86 54.7 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.817 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 40' ' ' SER . 10.1 p -84.21 173.46 11.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 110.152 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 94.21 -18.57 56.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 1.2 p -124.63 154.67 40.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 ttm180 -91.97 114.41 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.683 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -101.2 146.55 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 111.301 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -147.31 152.35 38.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.653 -0.655 . . . . 0.0 109.716 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 166.03 124.4 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.24 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -5.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.74 1.389 . . . . 0.0 108.761 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.93 32.12 0.46 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.534 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 1.9 t -72.51 139.09 47.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.527 -0.984 . . . . 0.0 110.658 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -132.18 110.55 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.464 -0.772 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 5.9 tt -100.35 172.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.175 -0.953 . . . . 0.0 109.967 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 16.0 m -151.93 94.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.017 -1.052 . . . . 0.0 110.962 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 45.59 105.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 179.283 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 17.1 t -133.53 163.84 28.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 69' ' ' ILE . 2.9 mp -80.52 167.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 0.0 110.897 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.537 ' N ' HG22 ' A' ' 68' ' ' ILE . 10.0 mt -84.63 120.97 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 109.395 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -148.54 139.16 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 110.617 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -82.28 58.12 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.803 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -128.69 156.38 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.895 ' N ' HD13 ' A' ' 82' ' ' ILE . 36.4 t -147.59 87.69 1.65 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 90.95 60.15 1.35 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.578 ' N ' HD11 ' A' ' 82' ' ' ILE . 49.9 m -142.55 156.39 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -112.5 157.9 20.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.044 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 1.9 m-85 -144.89 161.69 38.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.868 -1.145 . . . . 0.0 110.66 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 176.47 56.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 42.56 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 109.825 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.903 0.383 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 5' ' ' THR . 14.6 t -137.06 47.05 2.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.963 -1.086 . . . . 0.0 110.795 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.41 90.98 2.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.531 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 14.5 p -98.44 41.27 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER 168.31 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.369 0.604 . . . . 0.0 109.665 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 34.3 m -108.19 -163.71 0.91 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 110.583 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.55 120.67 18.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.702 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 16' ' ' LYS . 8.0 tp -88.15 21.67 2.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 10.6 t 64.64 5.88 2.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.642 -0.661 . . . . 0.0 111.118 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.13 21.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 110.072 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -154.0 14.05 0.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -112.46 -156.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.711 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -108.09 148.27 30.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.018 . . . . 0.0 110.055 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' HD22 ' A' ' 11' ' ' LEU . 7.2 p -123.05 68.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.322 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.545 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.057 0.456 . . . . 0.0 110.405 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.0 OUTLIER -157.9 122.61 4.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 110.955 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.542 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -87.3 102.32 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 108.757 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.021 HG22 ' HB2' ' A' ' 42' ' ' PHE . 18.8 t -100.85 163.84 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.922 -1.111 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.536 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 37.6 t0 -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' N ' ' OG ' ' A' ' 12' ' ' SER . 12.8 tttt 43.27 68.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.885 -1.134 . . . . 0.0 109.989 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.569 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.5 m -133.74 -171.05 2.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.061 . . . . 0.0 111.655 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -144.33 103.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.7 t -106.13 151.09 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.937 -1.102 . . . . 0.0 110.968 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.536 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 2.3 t80 -140.37 76.65 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.898 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.98 61.35 5.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -111.41 149.26 31.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 109.978 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 37' ' ' CYS . 18.2 p -67.38 -68.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.313 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.587 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER 51.42 42.42 29.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.099 -1.001 . . . . 0.0 109.988 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -85.15 36.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.726 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.502 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 152.08 54.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.57 -176.24 5.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.118 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -131.68 134.24 45.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.726 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.021 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.5 m-85 -111.97 150.85 29.97 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.894 -1.129 . . . . 0.0 110.416 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 14.4 t0 -166.15 119.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.491 -0.756 . . . . 0.0 109.105 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.42 68.89 1.03 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.711 ' CG1' HG23 ' A' ' 47' ' ' ILE . 2.3 t -145.85 135.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -1.165 . . . . 0.0 111.036 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 31' ' ' GLU . 65.5 m -115.43 90.61 3.38 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.711 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.34 172.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 110.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 49' ' ' THR . 5.1 t -129.14 -155.21 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.577 ' N ' HG23 ' A' ' 48' ' ' THR . 1.3 m -58.62 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 48' ' ' THR . 8.6 t -139.13 -175.6 4.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 67' ' ' CYS . 3.6 t -133.78 61.61 1.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.292 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -112.07 100.28 8.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 37' ' ' CYS . 3.5 p -131.21 -164.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.03 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.54 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . 94.1 -68.26 1.43 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.447 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.579 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -101.66 -169.58 1.7 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.155 -1.203 . . . . 0.0 111.722 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 3.7 ppt_? -107.6 139.59 41.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.735 -0.603 . . . . 0.0 110.131 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.683 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.7 mt -107.75 160.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.531 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.442 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -146.65 148.54 32.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.11 124.0 0.73 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.393 -1.385 . . . . 0.0 110.597 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.35 -1.26 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.746 1.393 . . . . 0.0 108.905 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -173.21 38.15 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.41 155.57 39.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 111.05 5.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.629 -0.67 . . . . 0.0 109.786 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -101.71 165.14 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 109.406 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.506 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 2.0 t -152.16 86.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.058 . . . . 0.0 110.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.2 p 55.02 114.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.543 -0.723 . . . . 0.0 110.3 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.575 ' O ' HD13 ' A' ' 68' ' ' ILE . 60.5 m -143.23 -143.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 110.532 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 67' ' ' CYS . 10.0 mm -132.32 165.59 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -45.85 151.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.0 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.424 ' CB ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -123.84 -144.78 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.74 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 115.22 57.84 0.35 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.433 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.88 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.19 151.8 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.541 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.88 ' N ' HD13 ' A' ' 82' ' ' ILE . 15.6 m -147.44 103.98 3.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 83.84 48.19 5.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.704 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.48 159.6 38.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -1.193 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.494 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -120.08 163.09 18.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.453 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 86' ' ' THR . 4.0 m-85 -134.61 161.73 34.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.085 -1.01 . . . . 0.0 109.973 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 55' ' ' SER . 0.3 OUTLIER 175.09 124.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 110.45 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 55' ' ' SER . . . -42.01 146.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 1.6 t30 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.887 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 17' ' ' CYS . 1.9 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.077 0.465 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.569 ' CG2' HD22 ' A' ' 11' ' ' LEU . 13.3 t -146.23 19.33 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -89.48 57.52 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.519 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 75.2 p -98.63 105.47 17.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.382 -0.824 . . . . 0.0 109.438 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' THR . 14.2 m-20 67.09 6.04 4.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.86 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.43 178.7 6.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 10.8 tt0 -131.32 112.29 12.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.969 -1.082 . . . . 0.0 110.566 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.569 HD22 ' CG2' ' A' ' 5' ' ' THR . 5.3 tp -100.7 29.89 4.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.827 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 9.1 t 65.3 6.34 3.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.596 -0.69 . . . . 0.0 110.797 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 44.59 24.05 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.069 -1.019 . . . . 0.0 110.473 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.2 t30 -158.52 17.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 110.727 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 1.8 p -106.4 -140.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -120.67 124.14 44.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.926 -1.109 . . . . 0.0 109.81 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 8.9 m -97.12 61.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.69 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.585 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.145 . . . . 0.0 110.237 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.7 m -144.56 110.59 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 110.807 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.536 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 26.5 m-85 -105.65 104.91 14.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.023 HG13 ' HB3' ' A' ' 42' ' ' PHE . 6.7 t -106.29 159.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.759 -1.213 . . . . 0.0 110.841 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 1.7 t0 -142.89 123.37 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.283 -0.885 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' N ' ' OG ' ' A' ' 12' ' ' SER . 1.8 tttt 38.3 66.68 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 110.094 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 15' ' ' SER . 2.1 m -133.31 -167.47 1.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 47' ' ' ILE . 39.4 mt-10 -143.29 103.67 4.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 77.4 t -105.59 127.61 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.093 -1.004 . . . . 0.0 110.878 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.9 OUTLIER -107.51 -139.08 0.37 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.483 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -66.47 61.6 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.5 m -107.07 164.55 12.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 110.141 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.596 HG23 ' HA ' ' A' ' 51' ' ' THR . 19.6 p -104.82 174.61 5.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 119.73 7.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -140.39 -36.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 54' ' ' GLY . . . -172.17 65.12 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.58 ' HB2' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -137.62 179.96 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -1.097 . . . . 0.0 110.24 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HD2' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -141.27 130.2 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.544 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.023 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.4 m-85 -109.79 162.41 14.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.8 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 9.4 t0 177.95 112.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 52.18 66.34 2.68 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.315 -2.314 . . . . 0.0 107.315 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 57' ' ' ILE . 3.8 t -145.24 117.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -1.101 . . . . 0.0 110.422 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 63' ' ' LYS . 10.6 m -98.85 90.91 4.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.674 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -110.51 167.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.448 -0.782 . . . . 0.0 109.957 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.736 HG23 ' N ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -122.77 -160.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.107 -0.995 . . . . 0.0 110.121 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.861 ' O ' HG22 ' A' ' 66' ' ' THR . 44.1 m -49.13 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 109.941 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.523 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 3.5 t -139.99 132.31 28.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.034 -1.041 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.596 ' HA ' HG23 ' A' ' 36' ' ' THR . 33.2 p -85.38 59.71 5.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 109.658 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 t -119.59 126.5 51.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 110.02 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -169.81 75.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -0.974 . . . . 0.0 110.723 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -133.5 -54.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.528 ' HB3' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -104.7 -171.32 1.9 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -1.088 . . . . 0.0 109.959 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 37.4 ptt180 -105.31 136.47 44.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.306 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.692 HG22 HG22 ' A' ' 45' ' ' VAL . 1.8 mt -109.59 157.54 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.71 156.92 43.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.718 . . . . 0.0 110.292 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 157.33 124.42 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.552 -1.308 . . . . 0.0 110.575 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.03 -7.89 22.26 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.594 1.313 . . . . 0.0 108.76 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.48 33.05 0.64 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.513 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 2.8 t -71.68 137.98 48.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -1.035 . . . . 0.0 110.165 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' THR . 1.6 mtpt -137.22 118.41 14.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.87 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 47' ' ' ILE . 2.5 tt -104.26 170.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.2 t -143.36 77.93 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.108 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 49' ' ' THR . 7.2 p 52.9 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 110.971 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 64' ' ' ILE . 74.0 m -124.21 -149.8 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 69' ' ' ILE . 43.4 mm -131.09 169.4 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.528 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -57.83 136.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -147.24 90.28 1.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 111.028 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . -74.38 65.04 2.06 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' A' ' 89' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 3.5 mmtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.367 0.604 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.559 HD11 ' SG ' ' A' ' 85' ' ' CYS . 7.8 tp -138.57 156.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 109.845 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.9 m -154.21 125.91 7.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.183 -0.948 . . . . 0.0 110.055 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 56.53 55.29 30.52 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 82' ' ' ILE . 88.4 m -133.14 140.46 47.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -1.092 . . . . 0.0 111.064 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -101.95 166.38 10.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.079 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CD1' ' O ' ' A' ' 86' ' ' THR . 1.9 m-85 -152.8 157.26 40.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.835 -1.165 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER 177.48 132.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.656 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . . . -41.79 136.7 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.434 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.365 0.602 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 5' ' ' THR . 8.1 t -96.46 57.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.477 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 11' ' ' LEU . 7.9 m120 -149.01 111.75 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 9.5 p -98.4 111.05 23.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 73.9 -0.71 3.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 109.902 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -110.94 -177.18 3.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 109.599 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -143.47 99.69 3.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.604 HD12 HG21 ' A' ' 27' ' ' VAL . 4.4 tp -90.36 25.81 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.643 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 t 54.65 93.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.123 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -37.99 -28.54 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.761 . . . . 0.0 111.318 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 12' ' ' SER . 9.1 p30 -83.48 11.41 7.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -99.68 -149.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 0.0 109.522 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -113.82 99.63 7.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.023 -1.048 . . . . 0.0 109.781 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.3 m -73.97 55.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 110.104 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.212 179.642 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -149.45 107.41 3.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.064 -1.023 . . . . 0.0 110.386 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 10.3 m-85 -106.9 88.28 2.71 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.854 HG13 ' CB ' ' A' ' 42' ' ' PHE . 11.0 t -93.73 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 111.371 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 7.5 t0 -150.07 126.5 10.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.0 109.852 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER 41.66 56.6 3.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.006 -1.059 . . . . 0.0 110.181 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.665 ' OG ' HG12 ' A' ' 27' ' ' VAL . 15.4 m -122.37 176.95 5.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.92 . . . . 0.0 110.77 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.812 ' HB2' HG23 ' A' ' 46' ' ' THR . 21.8 mt-10 -144.06 100.39 3.55 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 108.789 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.58 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.0 m -106.55 152.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 32.9 t80 -134.57 85.93 2.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.02 43.78 13.21 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 50' ' ' SER . 1.9 m -104.69 166.23 10.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -1.083 . . . . 0.0 110.286 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -130.47 134.38 47.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HA ' HG21 ' A' ' 53' ' ' THR . 5.0 p -121.55 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 110.441 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -86.77 7.01 28.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.18 76.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 2.2 p -159.24 179.62 8.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.176 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.547 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -146.07 117.73 8.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 0.0 109.927 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.854 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.5 m-30 -98.94 150.52 21.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.036 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -145.83 71.79 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 109.589 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 88.33 73.68 1.28 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 HD12 ' A' ' 57' ' ' ILE . 3.1 t -145.55 138.85 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -1.159 . . . . 0.0 111.103 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.812 HG23 ' HB2' ' A' ' 31' ' ' GLU . 18.8 m -112.76 91.94 3.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.978 . . . . 0.0 109.112 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.751 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -112.3 170.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 14.6 t -118.18 -145.76 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.82 -1.175 . . . . 0.0 109.969 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.551 ' CA ' ' O ' ' A' ' 33' ' ' TYR . 39.9 m -64.81 80.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' THR . 3.0 p -137.59 149.98 47.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.299 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 67' ' ' CYS . 9.0 t -112.64 66.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 0.0 110.202 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.46 91.46 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 37' ' ' CYS . 62.4 p -123.5 141.32 52.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.139 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.68 -32.29 1.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB3' ' C ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -122.32 160.57 25.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 110.525 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 110.22 21.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.829 HD12 HG21 ' A' ' 45' ' ' VAL . 7.3 pt -106.95 159.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.074 -1.017 . . . . 0.0 112.424 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 5.5 t -146.12 -173.72 4.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 151.49 119.79 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.669 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.57 -7.5 21.33 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.699 1.368 . . . . 0.0 108.645 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.4 37.28 0.3 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.9 t -71.83 144.25 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.499 -1.001 . . . . 0.0 110.581 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' THR . 18.3 mtpt -144.41 117.93 9.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.622 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.68 ' HB ' HG22 ' A' ' 47' ' ' ILE . 3.7 tt -105.03 174.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.89 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -147.01 84.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.914 179.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' SER . 0.2 OUTLIER 60.07 135.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.765 ' O ' HG22 ' A' ' 51' ' ' THR . 42.3 t -167.15 167.93 13.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 69' ' ' ILE . 5.6 mt -99.88 179.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 110.027 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.552 ' H ' HG22 ' A' ' 68' ' ' ILE . 1.5 pt -45.51 171.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.113 -0.992 . . . . 0.0 110.039 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -133.32 -137.65 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 111.02 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.13 43.87 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.056 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.543 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 4.7 mmtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.504 HD12 HG13 ' A' ' 64' ' ' ILE . 2.1 tp -140.6 147.65 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.995 . . . . 0.0 110.542 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 m -145.27 111.78 5.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.278 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.99 57.07 3.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.503 ' SG ' HG13 ' A' ' 82' ' ' ILE . 69.8 m -138.85 153.9 48.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -105.4 157.75 17.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.489 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.5 m-85 -144.28 146.66 32.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.101 -0.999 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER 174.1 118.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.74 . . . . 0.0 109.408 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -33.93 125.35 0.45 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.8 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.1 t30 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.254 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.15 0.5 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.485 ' CB ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 m -143.57 32.33 1.31 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -112.42 59.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 11.2 p -99.57 105.84 17.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.076 -1.015 . . . . 0.0 110.306 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 7' ' ' THR . 4.2 t-20 66.65 6.78 4.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -129.85 -165.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.023 -1.048 . . . . 0.0 110.395 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -142.99 104.47 4.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 16' ' ' LYS . 30.3 tp -91.38 21.21 4.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.324 -0.86 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER 71.5 0.77 3.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.472 -0.768 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.68 19.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.012 . . . . 0.0 109.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.6 t30 -157.4 13.71 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.996 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -101.15 -145.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.761 -1.212 . . . . 0.0 109.703 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.628 ' O ' HD21 ' A' ' 11' ' ' LEU . 1.8 tptt -104.0 131.7 50.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.01 . . . . 0.0 109.227 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' ' CB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.22 65.39 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 111.087 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.06 -1.025 . . . . 0.0 109.791 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.297 0.57 . . . . 0.0 110.978 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 9' ' ' SER . 54.7 m -154.73 110.74 3.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.672 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 28.6 m-85 -101.86 122.26 43.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.76 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.109 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.6 t -120.35 167.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 110.308 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.607 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.1 m-20 -146.95 113.81 6.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 47.43 68.6 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.872 -1.143 . . . . 0.0 110.037 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.721 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -133.86 -171.02 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.158 -0.964 . . . . 0.0 111.346 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.22 100.84 3.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 71.1 t -101.42 157.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 111.15 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.654 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.34 -140.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 49' ' ' THR . . . -71.24 58.78 1.11 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 50' ' ' SER . 0.8 OUTLIER -96.96 -144.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.394 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.791 HG21 HG23 ' A' ' 51' ' ' THR . 31.0 p -139.53 -158.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.956 -1.09 . . . . 0.0 110.99 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 36' ' ' THR . 36.1 t 178.7 53.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.94 48.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.74 88.14 2.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.557 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 67.3 p -169.95 174.13 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -1.109 . . . . 0.0 110.391 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -137.91 138.64 39.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.453 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.109 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.7 m-85 -118.29 168.79 10.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.911 -1.118 . . . . 0.0 110.398 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER 176.57 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 108.739 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.44 68.05 1.31 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.755 ' CG1' HG23 ' A' ' 47' ' ' ILE . 15.0 t -143.02 109.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.363 -1.08 . . . . 0.0 111.265 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' THR . 5.7 m -94.89 86.27 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.896 -1.128 . . . . 0.0 108.595 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.755 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -112.41 163.37 9.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.563 -0.711 . . . . 0.0 110.451 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.783 HG23 ' N ' ' A' ' 49' ' ' THR . 1.4 t -115.29 -152.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.04 -1.038 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.783 ' N ' HG23 ' A' ' 48' ' ' THR . 8.8 m -58.87 87.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.688 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 0.7 OUTLIER -138.59 -162.26 1.29 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.966 -1.084 . . . . 0.0 110.835 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.791 HG23 HG21 ' A' ' 36' ' ' THR . 0.4 OUTLIER -144.01 67.21 1.27 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.8 79.41 2.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.328 -0.858 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 28.9 p -121.57 175.11 6.38 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 110.684 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.45 -34.43 4.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.536 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -129.85 163.84 25.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -1.133 . . . . 0.0 110.386 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.7 ptm180 -96.02 136.75 36.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.739 HG22 HG22 ' A' ' 45' ' ' VAL . 2.2 mt -110.73 163.94 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -0.96 . . . . 0.0 111.312 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.2 OUTLIER -147.31 149.82 33.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 167.01 116.24 0.35 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.415 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.93 -5.92 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.651 1.343 . . . . 0.0 108.819 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.11 38.51 0.34 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.8 t -71.41 155.16 40.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -1.118 . . . . 0.0 110.711 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 83' ' ' SER . 0.1 OUTLIER -143.34 107.86 4.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.481 -0.762 . . . . 0.0 109.56 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 4.9 tt -104.49 168.59 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 0.0 109.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -150.74 97.93 2.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 0.0 110.628 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 2.2 p 55.63 108.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.336 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.76 -156.35 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 68' ' ' ILE . 24.1 mt -146.78 140.83 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.525 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -52.8 112.14 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 110.369 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' THR . 2.9 m -148.51 135.69 20.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.925 -1.109 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.71 77.44 0.64 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.28 0.562 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -122.58 157.34 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.849 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 11.3 t -151.76 101.83 2.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 81.59 57.85 2.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.88 150.51 34.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -1.136 . . . . 0.0 111.239 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.585 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 9.0 t -110.7 160.68 16.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.432 -0.793 . . . . 0.0 109.004 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.3 m-85 -131.18 154.22 48.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.804 -1.185 . . . . 0.0 110.839 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' ARG . 4.0 m -174.05 120.05 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.716 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.35 139.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.416 -0.802 . . . . 0.0 110.576 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.523 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.3 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.034 0.445 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.591 HG22 ' CB ' ' A' ' 17' ' ' CYS . 3.6 t -122.09 19.5 10.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.02 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.18 52.22 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.842 . . . . 0.0 109.934 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 7' ' ' THR . 11.0 t -98.67 92.51 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 109.786 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.8 OUTLIER 69.91 3.51 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.795 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.32 149.32 40.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.399 -0.813 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 27' ' ' VAL . 1.3 mt-30 -107.92 88.04 2.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 109.987 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.052 HD21 ' O ' ' A' ' 16' ' ' LYS . 3.3 tp -88.58 25.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 7.7 t 53.67 103.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.45 -23.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.3 t-20 -89.86 14.91 10.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 111.707 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 0.0 OUTLIER -113.56 -164.08 0.9 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.567 -1.333 . . . . 0.0 110.141 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 1.052 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -114.66 147.49 39.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.14 -0.975 . . . . 0.0 109.724 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' HB3' HD22 ' A' ' 11' ' ' LEU . 6.6 p -123.11 72.75 1.12 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.724 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.063 -1.023 . . . . 0.0 109.842 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.7 t30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 87.0 m -153.33 114.39 4.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.903 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 27.9 m-85 -107.91 92.65 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.799 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.976 HG13 ' HB3' ' A' ' 42' ' ' PHE . 12.7 t -93.56 167.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.247 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.7 t0 -148.28 122.12 9.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 109.596 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 44.12 61.65 2.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 0.0 109.565 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.739 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -131.78 -174.88 3.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 111.222 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -145.17 104.46 3.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.706 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 11' ' ' LEU . 2.9 m -117.46 136.24 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.805 -1.184 . . . . 0.0 110.112 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.606 ' HB2' ' N ' ' A' ' 49' ' ' THR . 4.0 m-85 -97.87 -137.65 0.28 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 49' ' ' THR . . . -65.45 59.46 0.11 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.561 ' N ' ' O ' ' A' ' 33' ' ' TYR . 2.3 m -95.1 162.07 13.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -1.169 . . . . 0.0 110.043 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.443 HG21 HG23 ' A' ' 51' ' ' THR . 13.5 p -100.61 -169.38 1.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.401 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.886 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -168.51 140.25 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.767 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 1.8 t 178.55 43.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.27 41.0 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.789 ' OG ' HG22 ' A' ' 53' ' ' THR . 0.9 OUTLIER -131.12 171.87 12.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 109.955 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 2.2 tpt85 -146.46 129.71 16.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 109.948 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.976 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.8 m-85 -109.13 170.48 8.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.905 -1.122 . . . . 0.0 110.715 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -174.85 80.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.015 . . . . 0.0 110.176 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 83.71 66.72 1.49 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.059 HG21 HG22 ' A' ' 57' ' ' ILE . 2.3 t -146.97 136.71 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.808 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.5 m -107.77 93.2 4.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.763 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.93 171.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 110.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 49' ' ' THR . 1.6 t -118.69 -162.14 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.426 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 66' ' ' THR . 20.2 m -54.71 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' THR . 66.4 m -128.49 146.72 50.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 51' ' ' THR . 86.4 m -100.03 48.3 0.93 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.536 -0.728 . . . . 0.0 109.317 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 3.1 t -111.35 100.32 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.886 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -144.39 99.76 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.511 ' N ' ' HB ' ' A' ' 70' ' ' THR . . . -161.63 -48.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.561 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -101.57 -168.16 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.459 -1.024 . . . . 0.0 109.782 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.9 mtp85 -91.11 141.09 29.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.742 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.059 HG22 HG21 ' A' ' 45' ' ' VAL . 3.2 mm -113.1 127.27 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 110.155 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.418 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.3 152.96 40.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.245 -0.909 . . . . 0.0 110.012 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 118.0 0.42 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.7 -2.48 11.47 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.569 1.299 . . . . 0.0 109.704 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.85 30.76 0.18 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 7.2 t -73.02 152.89 41.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -1.068 . . . . 0.0 111.157 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.31 108.84 4.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.642 -0.661 . . . . 0.0 109.778 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.727 HG13 HD12 ' A' ' 82' ' ' ILE . 2.0 tt -99.02 176.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.062 -1.024 . . . . 0.0 110.123 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -151.77 75.21 1.14 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.906 -1.122 . . . . 0.0 110.953 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER 59.88 73.48 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 110.837 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' A' ' 64' ' ' ILE . 88.1 m -100.33 -178.26 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 69' ' ' ILE . 1.1 tt -89.76 -178.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.658 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 5.1 pt -51.05 -174.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.511 ' HB ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -142.37 -148.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 110.701 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 70' ' ' THR . . . 113.24 34.92 1.7 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.487 2.035 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.374 0.607 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.727 HD12 HG13 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -143.29 146.38 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 -179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.443 ' O ' ' SG ' ' A' ' 85' ' ' CYS . 1.7 t -157.11 136.99 12.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.85 -1.156 . . . . 0.0 111.283 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 52.37 61.98 6.17 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 87' ' ' PHE . 55.9 m -135.46 168.53 19.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.283 . . . . 0.0 111.07 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.64 123.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.627 -0.671 . . . . 0.0 109.201 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.726 ' CD1' HD13 ' A' ' 57' ' ' ILE . 10.8 m-85 -126.98 160.51 30.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.857 -1.152 . . . . 0.0 111.478 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 89' ' ' ALA . 7.0 p -166.58 129.03 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -34.48 142.41 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 110.892 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.561 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.4 t-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.099 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.271 0.558 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.753 ' O ' HG22 ' A' ' 5' ' ' THR . 20.7 m -126.32 60.64 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.126 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -133.98 65.76 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.394 -0.816 . . . . 0.0 110.003 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 8' ' ' ASN . 9.8 t -102.53 -139.23 0.35 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.31 -0.869 . . . . 0.0 110.419 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -41.73 -23.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.223 -0.923 . . . . 0.0 110.967 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -107.78 162.97 13.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.0 110.557 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.406 ' OE1' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.51 106.87 17.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.828 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 12' ' ' SER . 4.0 tp -88.57 32.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.6 t 67.3 2.8 2.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.53 -0.731 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 45.4 22.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.956 -1.09 . . . . 0.0 110.497 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' SER . 41.4 t30 -160.8 15.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.1 m -96.82 -136.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.091 -1.005 . . . . 0.0 109.168 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -115.0 123.76 49.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.871 -1.143 . . . . 0.0 109.87 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.03 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 0.0 110.529 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.856 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.89 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 3.3 m -155.25 111.6 3.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.048 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CD1' ' NH2' ' A' ' 41' ' ' ARG . 3.7 t80 -111.09 101.72 10.23 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.078 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.061 HG13 ' HB3' ' A' ' 42' ' ' PHE . 11.4 t -104.27 164.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.537 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -145.63 122.73 11.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 109.713 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 44.12 64.96 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.013 . . . . 0.0 109.525 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.743 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -134.26 -169.8 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 111.613 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 21.1 tt0 -145.06 98.39 3.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.856 HG12 ' CB ' ' A' ' 18' ' ' GLU . 62.1 t -105.62 138.84 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.847 -1.158 . . . . 0.0 110.43 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' THR . 1.8 t80 -142.75 129.21 20.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.93 40.71 9.87 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.553 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 14.0 m -103.94 165.73 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -1.136 . . . . 0.0 110.247 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.88 HG21 HG22 ' A' ' 51' ' ' THR . 6.8 p -105.05 -170.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 110.015 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.945 ' HA ' HG21 ' A' ' 53' ' ' THR . 36.3 t -172.53 128.31 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.576 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 38' ' ' THR . 19.4 m -163.02 33.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 109.689 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 123.92 62.62 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.531 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 28.7 p -143.0 170.81 15.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.572 ' NH2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -139.48 127.47 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.067 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.061 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.7 m-85 -109.06 169.69 8.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 45' ' ' VAL . 5.7 t70 178.99 112.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 52.87 62.72 5.64 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.819 HG12 HG23 ' A' ' 47' ' ' ILE . 14.5 t -142.83 123.14 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -1.014 . . . . 0.0 110.772 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 41.8 m -101.47 98.6 8.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.096 -1.003 . . . . 0.0 109.354 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.819 HG23 HG12 ' A' ' 45' ' ' VAL . 1.3 pt -113.38 156.58 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.191 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -135.78 127.73 29.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.847 . . . . 0.0 109.805 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER 40.85 79.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.876 . . . . 0.0 110.013 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.2 t -138.98 148.91 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.071 -1.018 . . . . 0.0 110.773 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.88 HG22 HG21 ' A' ' 36' ' ' THR . 4.1 p -115.97 41.23 2.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 1.2 t -104.89 116.65 32.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 110.177 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.945 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -146.28 112.25 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 110.225 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 165.32 -31.31 0.23 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.7 p -113.09 163.07 15.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.044 -1.268 . . . . 0.0 110.707 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -91.78 120.22 32.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.0 109.591 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -99.71 156.73 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.078 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -147.11 142.49 27.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.695 -0.628 . . . . 0.0 109.897 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 163.59 114.14 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.383 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.59 -7.48 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 N-CA-C 108.427 -1.413 . . . . 0.0 108.427 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.93 26.91 1.61 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.4 t -72.03 147.27 47.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.406 -1.055 . . . . 0.0 110.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 115.24 9.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.539 HG13 HD12 ' A' ' 82' ' ' ILE . 7.5 tt -104.94 174.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.734 ' C ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.48 99.03 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.565 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.734 HG23 ' C ' ' A' ' 65' ' ' SER . 1.2 p 69.24 -68.17 0.2 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.664 -0.647 . . . . 0.0 110.719 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.581 ' C ' HG22 ' A' ' 68' ' ' ILE . 0.5 OUTLIER 65.63 -153.84 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.066 . . . . 0.0 110.526 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.581 HG22 ' C ' ' A' ' 67' ' ' CYS . 1.3 tt 172.54 95.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ILE . 5.1 mt 59.88 134.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.308 -0.87 . . . . 0.0 110.062 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -113.28 -71.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.979 -1.076 . . . . 0.0 111.105 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' H ' ' HA3' ' A' ' 54' ' ' GLY . . . 45.23 71.6 0.47 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 89' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 23.3 mmtt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.473 0.654 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.557 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.2 tp -128.92 151.65 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.85 . . . . 0.0 110.399 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 104.99 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.11 5.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.557 ' SG ' HD11 ' A' ' 82' ' ' ILE . 56.8 m -134.5 153.81 51.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -1.193 . . . . 0.0 110.464 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -109.4 163.48 13.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 86' ' ' THR . 3.2 m-85 -138.88 159.68 41.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.15 -0.969 . . . . 0.0 110.06 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -176.48 38.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 110.21 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 41.82 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.296 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 54' ' ' GLY . 1.5 t-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.961 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.254 0.55 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.872 ' CG2' HD22 ' A' ' 11' ' ' LEU . 13.2 t -144.63 35.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -99.67 57.95 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 1.8 t -98.34 95.61 7.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.904 . . . . 0.0 109.542 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 7' ' ' THR . 6.4 t-20 70.4 7.03 6.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -126.7 179.92 5.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 8.7 tt0 -134.47 95.6 3.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.949 . . . . 0.0 110.043 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.872 HD22 ' CG2' ' A' ' 5' ' ' THR . 12.5 tp -88.53 31.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.975 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 68.52 3.54 3.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 0.0 110.551 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.09 25.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.608 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' SER . 28.6 t30 -162.29 19.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.621 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' SER . 2.0 m -104.61 -144.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 14.6 mmtm -114.14 91.55 3.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.836 -1.165 . . . . 0.0 110.155 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 p -65.62 67.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -0.784 . . . . 0.0 110.642 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 14.0 mm-40 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.274 0.559 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.56 112.32 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 110.764 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 27.2 m-85 -101.8 96.46 7.08 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.107 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -100.6 163.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 111.115 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.591 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 3.8 t0 -141.44 119.01 11.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.532 -0.73 . . . . 0.0 109.379 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 28' ' ' ASP . 4.5 ttmm 39.98 70.45 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.21 -0.932 . . . . 0.0 109.926 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.768 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.0 m -131.76 -178.79 5.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.9 . . . . 0.0 110.886 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -144.97 97.53 3.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 1.9 m -104.2 153.15 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.966 -1.084 . . . . 0.0 110.576 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 10.2 t80 -139.48 138.33 36.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.169 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 38.26 40.04 0.83 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.476 ' CG2' ' N ' ' A' ' 36' ' ' THR . 2.4 m -94.66 167.61 11.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.149 -1.206 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.823 HG21 HG23 ' A' ' 51' ' ' THR . 10.9 p -105.39 -52.31 2.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.857 . . . . 0.0 110.157 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.1 OUTLIER 59.74 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.0 110.075 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.722 HG22 HG21 ' A' ' 53' ' ' THR . 8.0 t -173.51 64.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 117.42 32.76 1.42 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.614 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -133.77 -178.18 4.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -1.144 . . . . 0.0 110.039 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 26' ' ' TYR . 3.2 tpt180 -142.71 125.71 16.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 108.764 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.107 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.6 m-85 -103.96 162.09 13.43 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 3.5 t0 -170.09 103.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.539 -0.726 . . . . 0.0 109.144 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 61.39 67.69 2.0 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.742 ' CG1' HG23 ' A' ' 47' ' ' ILE . 4.6 t -145.58 127.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 110.835 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 31' ' ' GLU . 61.7 m -108.43 87.78 2.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 108.815 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.742 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.76 154.75 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.653 -0.654 . . . . 0.0 110.427 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.78 HG23 ' N ' ' A' ' 49' ' ' THR . 1.5 t -108.65 -150.26 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.78 ' N ' HG23 ' A' ' 48' ' ' THR . 87.9 m -45.1 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.134 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -139.71 135.95 33.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 111.307 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.823 HG23 HG21 ' A' ' 36' ' ' THR . 97.5 m -108.35 61.24 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 29.3 m -114.91 113.68 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 110.766 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.722 HG21 HG22 ' A' ' 38' ' ' THR . 34.7 p -131.91 -151.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.371 -0.83 . . . . 0.0 109.642 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 90' ' ' ASN . . . 76.55 -65.87 2.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -101.89 171.53 7.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.286 -1.126 . . . . 0.0 109.448 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -104.96 158.7 16.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.775 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.706 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -123.33 155.07 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.689 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.531 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.73 157.67 43.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.259 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 160.29 127.32 0.89 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.146 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.55 -5.5 17.17 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.673 1.354 . . . . 0.0 108.871 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.98 35.13 0.36 Allowed Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.514 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 10.1 t -71.76 147.45 47.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.757 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.71 120.02 10.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.01 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.519 HG21 ' HB ' ' A' ' 47' ' ' ILE . 3.8 tt -104.25 178.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.289 -0.882 . . . . 0.0 109.938 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 66' ' ' THR . 3.2 t -150.8 58.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.889 -1.132 . . . . 0.0 111.14 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 65' ' ' SER . 1.6 m 66.83 83.85 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 111.349 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.48 -149.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 109.371 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 68' ' ' ILE . 7.6 mm -120.85 158.21 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.91 -1.119 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 3.7 tt -52.35 144.77 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 110.229 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 70' ' ' THR . 3.4 t -148.66 107.68 3.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.481 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -92.69 62.08 2.33 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.905 ' HA3' ' HB2' ' A' ' 89' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.581 HD11 ' SG ' ' A' ' 85' ' ' CYS . 10.5 tp -127.95 142.65 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -142.87 125.28 15.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 63.65 62.64 5.11 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 82' ' ' ILE . 59.2 m -145.39 148.45 33.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 111.079 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.531 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 13.5 t -116.74 157.66 25.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.34 152.14 50.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.769 -1.207 . . . . 0.0 110.602 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.6 m -170.54 124.77 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.352 -0.842 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.905 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . . . -45.1 147.65 0.68 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 110.559 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 41' ' ' ARG . 1.1 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.051 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.262 0.553 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.798 ' CG2' HD22 ' A' ' 11' ' ' LEU . 5.1 t -122.31 56.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -99.13 93.28 5.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.331 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 9' ' ' SER . 10.1 t -134.66 -138.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.63 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 7' ' ' THR . 11.6 m-20 -39.47 -27.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.811 . . . . 0.0 110.606 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 4.7 m -108.49 -164.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.149 -0.97 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -140.75 127.56 20.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.798 HD22 ' CG2' ' A' ' 5' ' ' THR . 21.4 tp -88.27 24.02 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.7 t 61.03 11.25 3.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.49 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' SER . 26.3 t-20 -161.04 15.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 111.03 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.2 m -98.79 -139.0 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.392 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 3.7 tptt -114.78 141.15 48.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.3 93.54 2.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 110.599 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.642 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 110.437 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.428 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.9 m120 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.135 0.493 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.846 ' O ' HG23 ' A' ' 27' ' ' VAL . 11.9 m -155.35 31.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.557 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' HB3' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -45.78 119.7 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 110.024 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.904 HG22 ' HB2' ' A' ' 42' ' ' PHE . 30.4 t -119.13 161.25 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 110.609 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -142.03 118.87 11.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 109.672 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.8 mmtp 43.26 68.12 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.511 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.7 m -133.47 -172.09 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 111.115 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' HB3' HG23 ' A' ' 46' ' ' THR . 11.2 tt0 -143.81 99.21 3.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.66 HG13 HD11 ' A' ' 47' ' ' ILE . 40.2 t -101.06 150.06 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.052 . . . . 0.0 110.575 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -143.16 116.19 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 43.33 51.44 6.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.528 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 2.4 m -107.08 156.5 18.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 35' ' ' THR . 19.4 p -91.04 -173.14 3.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.721 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.8 OUTLIER -157.87 124.28 4.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.362 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -163.98 55.87 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.981 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.439 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 96.79 96.21 1.87 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.564 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 14.1 p -177.98 173.38 1.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -1.152 . . . . 0.0 110.28 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' A' ' 56' ' ' ARG . 6.3 tpt180 -146.97 131.81 18.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 109.649 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.904 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.9 m-85 -109.35 169.86 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.9 t70 178.33 116.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 109.136 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.75 65.37 2.45 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.859 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.0 t -145.33 138.06 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -1.09 . . . . 0.0 110.83 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 31' ' ' GLU . 81.5 m -116.61 94.68 4.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 109.228 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.707 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.3 pt -114.08 172.39 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.833 HG23 ' N ' ' A' ' 49' ' ' THR . 2.0 t -131.38 -146.52 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.378 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.833 ' N ' HG23 ' A' ' 48' ' ' THR . 6.6 m -54.91 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 11.3 p -139.61 158.29 44.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -0.921 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -118.04 45.31 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.854 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -95.72 103.49 15.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 110.13 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 37' ' ' CYS . 3.0 p -138.6 112.93 8.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 110.416 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 176.3 -54.89 0.11 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.543 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -102.63 -173.54 2.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.817 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 7.8 ttp180 -104.02 125.96 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.096 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.859 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.49 153.62 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.965 . . . . 0.0 110.308 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.57 160.64 41.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 154.09 122.56 0.86 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.22 -5.62 17.41 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.692 1.364 . . . . 0.0 109.036 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.53 34.12 0.33 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -72.26 154.9 40.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 110.206 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.54 113.19 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -96.68 172.26 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.058 -1.026 . . . . 0.0 109.161 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 11.0 t -149.04 67.81 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.898 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.9 m 64.01 98.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 111.06 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 64' ' ' ILE . 76.8 m -107.92 -144.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.413 -0.804 . . . . 0.0 109.246 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.26 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.77 -1.206 . . . . 0.0 110.581 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 tp -151.17 158.39 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 55' ' ' SER . 0.2 OUTLIER -125.8 -154.22 0.61 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.431 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . 105.39 38.33 2.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.446 0.641 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 82' ' ' ILE . 6.9 tp -127.41 156.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -154.39 116.79 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.02 . . . . 0.0 110.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.15 46.78 33.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.24 159.99 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.028 -1.277 . . . . 0.0 111.361 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.402 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -116.96 154.82 30.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 85' ' ' CYS . 9.0 m-85 -133.13 147.91 52.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.927 -1.108 . . . . 0.0 110.401 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' ALA . 29.1 t -173.39 124.25 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.97 141.68 0.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.543 ' N ' ' HA ' ' A' ' 55' ' ' SER . 3.8 t-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.084 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.342 0.591 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 5' ' ' THR . 10.5 t -141.59 53.49 1.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.885 . . . . 0.0 109.998 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 1.8 m120 -146.64 139.54 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 9' ' ' SER . 17.1 p -103.47 -135.49 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -42.71 -15.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.251 -0.905 . . . . 0.0 111.668 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.5 p -103.99 160.73 14.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.701 -1.249 . . . . 0.0 108.74 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HG2' ' N ' ' A' ' 11' ' ' LEU . 38.9 tt0 -107.13 155.13 20.2 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.024 -1.048 . . . . 0.0 111.899 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 31.9 tp -108.77 41.94 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.666 . . . . 0.0 109.292 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 18.4 t 58.57 12.78 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.792 . . . . 0.0 110.864 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 41.07 25.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.688 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' SER . 31.4 t30 -170.7 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.973 -1.079 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -103.67 -147.02 0.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.99 -1.068 . . . . 0.0 109.539 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.99 142.26 45.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.827 -1.171 . . . . 0.0 109.871 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.35 100.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.454 -0.779 . . . . 0.0 111.209 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.863 ' CB ' HG12 ' A' ' 32' ' ' VAL . 16.5 pm0 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.216 0.532 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' SER . 4.8 m -155.14 111.76 3.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -110.25 96.2 6.07 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.088 HG13 ' CB ' ' A' ' 42' ' ' PHE . 3.9 t -98.6 164.45 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 111.178 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 29' ' ' LYS . 41.5 m-20 -144.78 124.94 13.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.502 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 11.1 tttp 42.82 67.47 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.82 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.786 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.5 m -133.34 -174.07 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 111.239 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CB ' HG23 ' A' ' 46' ' ' THR . 3.1 tt0 -143.37 103.33 4.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.863 HG12 ' CB ' ' A' ' 18' ' ' GLU . 47.7 t -105.47 142.86 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.012 -1.055 . . . . 0.0 110.071 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t80 -140.09 102.93 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 51.89 53.36 30.36 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.538 HG21 ' CD1' ' A' ' 47' ' ' ILE . 55.2 m -114.23 154.79 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -1.168 . . . . 0.0 110.238 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.414 HG21 HG23 ' A' ' 51' ' ' THR . 22.8 p -86.22 140.28 30.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.18 43.42 2.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -77.85 3.81 13.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 166.26 97.12 0.11 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.518 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 38.2 p -177.6 167.65 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -1.196 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -138.52 123.0 18.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 179.06 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.088 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.46 170.5 7.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.825 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 11.7 t70 178.7 98.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 65.65 58.33 9.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.784 HG22 HG22 ' A' ' 57' ' ' ILE . 17.1 t -139.98 126.79 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.523 -0.986 . . . . 0.0 110.736 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.583 HG23 ' CB ' ' A' ' 31' ' ' GLU . 54.1 m -109.47 94.96 5.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 35' ' ' THR . 1.4 pt -113.28 175.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.756 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -132.51 -153.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.986 -1.071 . . . . 0.0 110.673 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.756 ' N ' HG23 ' A' ' 48' ' ' THR . 28.3 m -53.68 85.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' THR . 18.7 m -139.87 144.7 37.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 110.595 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 51' ' ' THR . 97.7 m -90.04 39.94 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -91.23 127.69 36.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.763 . . . . 0.0 110.632 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.518 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.91 130.55 0.11 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 148.82 -42.09 0.84 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -101.87 -168.59 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -1.14 . . . . 0.0 110.236 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' N ' ' OG ' ' A' ' 55' ' ' SER . 20.0 ttt180 -114.44 120.24 39.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.784 HG22 HG22 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.75 154.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.968 . . . . 0.0 110.341 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -146.52 160.41 42.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.347 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 156.26 127.34 1.01 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.337 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.07 -7.58 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.803 1.422 . . . . 0.0 108.503 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.06 38.33 0.46 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.503 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 3.6 t -71.64 127.55 32.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -1.054 . . . . 0.0 110.805 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.87 111.15 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.767 . . . . 0.0 109.268 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.467 ' HB ' HG22 ' A' ' 47' ' ' ILE . 4.6 tt -104.72 162.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 110.59 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 66' ' ' THR . 17.6 t -144.79 88.21 1.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.4 p 54.15 74.58 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 52' ' ' SER . 0.5 OUTLIER -148.03 149.36 31.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.051 -1.03 . . . . 0.0 110.617 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.61 ' C ' HG23 ' A' ' 69' ' ' ILE . 18.5 mm 59.59 158.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.878 . . . . 0.0 110.643 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.61 HG23 ' C ' ' A' ' 68' ' ' ILE . 1.3 pt -160.42 16.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.848 -0.533 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.505 ' C ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -155.09 -149.54 0.27 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 110.67 -179.332 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -65.99 -150.77 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.559 ' N ' ' HB2' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.382 0.61 . . . . 0.0 110.681 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.555 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -133.41 135.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 110.008 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -141.75 105.44 4.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 75.35 51.46 7.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.555 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 99.2 m -126.2 141.43 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -103.25 152.6 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.042 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' A' ' 88' ' ' SER . 3.7 m-85 -134.89 141.13 46.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.002 -1.061 . . . . 0.0 110.212 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' PHE . 1.5 m 178.29 135.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.109 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.05 148.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.382 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.476 ' N ' ' HA ' ' A' ' 55' ' ' SER . 27.9 p-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.318 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.438 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 17.2 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.822 0.344 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 5' ' ' THR . 6.5 t -142.04 41.55 1.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.782 -1.199 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 9.3 p30 -136.92 111.66 8.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 110.67 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 45.8 p -98.39 43.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.03 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER 165.27 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.711 -0.618 . . . . 0.0 109.579 -179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -108.21 -163.54 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.047 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -143.34 104.34 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.748 HD21 ' O ' ' A' ' 16' ' ' LYS . 8.8 tp -88.47 21.36 2.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 109.743 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 12.5 t 56.69 107.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.362 -0.836 . . . . 0.0 109.837 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.43 -22.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.28 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -82.81 6.61 17.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 110.377 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -106.16 -163.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.836 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.748 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -107.29 123.06 47.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 111.022 -178.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' A' ' 5' ' ' THR . 5.9 m -90.51 57.64 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.482 -0.761 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 1.4 tm-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.672 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 1.6 m -156.6 120.27 4.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -119.66 88.13 2.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.348 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 42' ' ' PHE . 4.3 t -94.08 170.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 111.023 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 1.4 m-20 -150.14 114.7 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 12' ' ' SER . 6.3 tttm 45.19 67.86 0.65 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 15' ' ' SER . 14.9 m -130.67 -164.39 1.42 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.006 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 20.4 tt0 -144.93 100.1 3.44 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.258 -0.902 . . . . 0.0 108.696 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.636 HG21 HD11 ' A' ' 11' ' ' LEU . 73.5 t -105.18 133.63 48.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.496 -0.753 . . . . 0.0 110.595 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -133.55 125.51 29.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 41.5 39.96 2.63 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.559 HG22 ' N ' ' A' ' 36' ' ' THR . 96.7 m -94.69 171.19 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -1.212 . . . . 0.0 110.04 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.559 ' N ' HG22 ' A' ' 35' ' ' THR . 29.8 p -99.06 -51.66 3.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.569 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 1.0 OUTLIER 57.6 42.56 23.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.556 ' N ' HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -97.35 71.87 2.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.325 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.23 65.13 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.865 ' OG ' HG22 ' A' ' 53' ' ' THR . 99.5 p -162.55 162.89 27.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 110.249 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -123.53 125.46 44.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.657 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.01 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.97 168.99 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.056 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD2' ' NE ' ' A' ' 41' ' ' ARG . 1.1 m-20 -175.4 98.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.071 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 64.3 68.35 1.69 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.063 HG21 HG22 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -145.25 150.14 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.193 . . . . 0.0 110.558 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 52.2 m -122.04 90.9 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.184 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.761 HG23 HG13 ' A' ' 45' ' ' VAL . 1.1 pt -114.07 167.69 6.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.704 HG23 ' N ' ' A' ' 49' ' ' THR . 3.1 t -125.27 -151.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.057 -1.027 . . . . 0.0 110.013 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.704 ' N ' HG23 ' A' ' 48' ' ' THR . 3.2 m -57.03 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.896 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 3.5 p -138.27 142.41 39.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.893 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 36' ' ' THR . 0.1 OUTLIER -92.77 50.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.87 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.78 142.69 35.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.17 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.865 HG22 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 175.96 134.33 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.894 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 140.87 -22.6 2.64 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 88.1 p -121.05 179.39 4.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.335 -1.097 . . . . 0.0 110.067 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 mtp85 -91.7 114.57 27.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 108.773 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.063 HG22 HG21 ' A' ' 45' ' ' VAL . 1.3 mm -98.03 130.35 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.909 -1.119 . . . . 0.0 110.859 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.643 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.97 164.08 33.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.946 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 154.38 116.12 0.58 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.217 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.36 -6.38 19.04 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.699 1.368 . . . . 0.0 109.132 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.44 26.79 0.77 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 11.1 t -72.42 144.44 48.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -1.113 . . . . 0.0 110.628 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 7.9 mmtt -136.09 106.07 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 109.303 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.621 ' HB ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -104.63 155.85 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.605 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -146.47 100.17 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.534 -0.728 . . . . 0.0 109.707 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 4.1 p 54.86 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.469 -0.769 . . . . 0.0 110.097 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.422 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.05 -150.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 110.292 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.2 tt -131.22 143.1 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 109.989 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.772 HD12 ' OG1' ' A' ' 53' ' ' THR . 1.1 tt -81.74 108.06 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 110.616 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.405 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.9 m -148.22 160.34 43.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.219 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 69.57 3.29 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.416 0.627 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.734 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -118.99 158.37 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.69 ' N ' HD13 ' A' ' 82' ' ' ILE . 21.1 t -155.73 112.34 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.926 -1.109 . . . . 0.0 111.02 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 73.63 60.14 3.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.46 163.23 29.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -1.226 . . . . 0.0 110.014 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.12 110.2 5.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 109.663 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.557 ' HD2' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.88 164.87 29.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 111.032 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -169.58 71.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 58.29 144.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.825 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.3 t30 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.809 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.296 0.569 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 5' ' ' THR . 14.9 t -145.11 64.05 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.659 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 6' ' ' ASN . 27.5 p30 -162.95 102.71 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 110.494 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 3.3 p -104.48 34.39 3.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.226 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' THR . 10.3 t30 174.89 -21.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.401 ' CB ' ' H ' ' A' ' 25' ' ' CYS . 2.0 p -107.16 -161.69 0.8 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -140.41 122.47 15.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.588 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD21 ' O ' ' A' ' 16' ' ' LYS . 11.3 tp -98.62 29.39 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER 70.92 -0.81 2.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 110.77 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.64 22.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.026 . . . . 0.0 109.665 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -156.11 9.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.975 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.9 m -105.18 -144.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 0.0 109.643 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' O ' HD21 ' A' ' 11' ' ' LEU . 15.2 tttm -118.09 137.02 53.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.114 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 27.9 p -117.05 60.68 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.23 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 mm-40 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.427 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m-20 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.25 0.548 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 57.8 m -150.01 116.49 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 t80 -96.63 98.12 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 109.137 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.039 HG13 ' HB3' ' A' ' 42' ' ' PHE . 5.4 t -94.36 165.41 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 110.535 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 11.4 t0 -141.07 121.3 13.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 37.32 69.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.427 -0.796 . . . . 0.0 110.32 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.574 ' OG ' HG12 ' A' ' 27' ' ' VAL . 5.6 m -130.34 -170.71 2.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.923 . . . . 0.0 111.187 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 46' ' ' THR . 25.8 mt-10 -143.54 101.59 3.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 47' ' ' ILE . 70.9 t -108.94 145.23 16.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.261 -0.9 . . . . 0.0 111.197 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -115.91 -140.5 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.559 ' HA3' HG23 ' A' ' 49' ' ' THR . . . -65.43 65.94 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.896 HG23 ' O ' ' A' ' 50' ' ' SER . 84.9 m -105.91 153.18 22.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.073 -1.251 . . . . 0.0 110.433 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.497 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER -115.45 117.92 31.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.433 -0.792 . . . . 0.0 109.896 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -82.63 155.34 24.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.759 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.448 ' CB ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -167.18 43.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -0.797 . . . . 0.0 109.607 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.87 75.2 1.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -156.14 177.97 10.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.163 . . . . 0.0 110.621 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 12.6 tpp85 -141.19 124.14 16.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.039 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -105.44 167.46 9.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.767 -1.208 . . . . 0.0 110.43 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -178.39 114.23 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.477 -0.764 . . . . 0.0 109.027 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.31 67.2 1.97 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.68 ' CG1' HG23 ' A' ' 47' ' ' ILE . 3.6 t -145.27 127.57 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -1.089 . . . . 0.0 110.572 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . 93.2 m -106.93 91.16 3.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.68 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.08 161.92 7.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.58 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.695 HG23 ' N ' ' A' ' 49' ' ' THR . 2.3 t -111.03 -153.92 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 110.555 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.695 ' N ' HG23 ' A' ' 48' ' ' THR . 17.2 m -61.35 77.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 109.918 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.896 ' O ' HG23 ' A' ' 35' ' ' THR . 1.3 p -139.74 172.56 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.085 -1.009 . . . . 0.0 110.686 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 36' ' ' THR . 0.6 OUTLIER -126.89 94.81 4.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.039 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -125.45 70.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.647 HG21 ' HA ' ' A' ' 37' ' ' CYS . 67.1 p -103.93 -172.45 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.466 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 91.88 -36.67 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -133.52 161.54 34.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -1.048 . . . . 0.0 109.583 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 ptp85 -93.58 151.02 19.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 58' ' ' SER . 3.5 mt -122.33 165.63 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.887 . . . . 0.0 110.834 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.551 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.09 147.15 30.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.809 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 163.03 110.56 0.25 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.06 -8.55 23.82 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 N-CA-C 108.461 -1.4 . . . . 0.0 108.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.84 29.43 1.27 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -72.05 147.69 46.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.48 -1.012 . . . . 0.0 110.195 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 104.08 4.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.758 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.452 ' HB ' HG22 ' A' ' 47' ' ' ILE . 4.6 tt -95.86 166.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.872 . . . . 0.0 109.963 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.511 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -146.72 97.79 2.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.548 ' CA ' ' HB2' ' A' ' 50' ' ' SER . 24.1 p 48.96 102.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 110.597 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.19 -142.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.783 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 68' ' ' ILE . 2.7 tt -154.48 134.51 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.448 HD12 ' CB ' ' A' ' 38' ' ' THR . 3.0 tt -54.35 114.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.5 t -148.23 135.19 20.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -70.72 64.94 0.85 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 6.8 mmpt? . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -127.2 159.69 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.04 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.828 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -151.95 102.91 2.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 69.07 52.97 20.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.545 ' H ' HD11 ' A' ' 82' ' ' ILE . 43.6 m -133.19 151.09 51.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -1.19 . . . . 0.0 110.492 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.569 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -105.33 164.24 12.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.023 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.1 m-85 -135.41 166.54 22.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 2.6 t 168.03 114.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 0.0 110.022 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -43.73 134.88 4.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' N ' ' HA ' ' A' ' 55' ' ' SER . 4.2 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.218 0.533 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 5' ' ' THR . 5.5 t -145.06 28.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -101.01 79.16 1.99 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 7' ' ' THR . 3.9 t -98.31 105.06 17.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.4 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 7' ' ' THR . 12.5 m120 60.6 13.1 4.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.663 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 1.5 t -128.63 -167.57 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.54 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -143.66 115.32 8.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.019 . . . . 0.0 110.555 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.926 HD21 ' O ' ' A' ' 16' ' ' LYS . 5.6 tp -110.23 20.38 17.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.95 . . . . 0.0 109.686 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 6.0 t 54.21 99.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -41.18 -26.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 110.723 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 12' ' ' SER . 11.4 m-20 -80.85 3.64 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -101.28 -159.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.831 -1.168 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.926 ' O ' HD21 ' A' ' 11' ' ' LEU . 5.1 mttp -116.2 134.0 55.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.455 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 26.9 p -99.58 78.06 2.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.193 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 18.3 mm-40 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.292 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.428 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.11 0.481 . . . . 0.0 110.401 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 10.2 m -143.79 108.76 4.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 110.437 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.512 ' O ' ' NH1' ' A' ' 41' ' ' ARG . 45.2 m-85 -103.36 96.28 6.65 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.988 HG13 ' CB ' ' A' ' 42' ' ' PHE . 5.0 t -103.32 167.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 111.312 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.3 t0 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.743 . . . . 0.0 109.667 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 48.08 67.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.007 . . . . 0.0 109.862 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.708 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.1 m -133.34 -173.32 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.266 -0.896 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 32.8 tt0 -139.75 101.28 4.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 11' ' ' LEU . 77.2 t -100.76 137.17 29.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.488 -0.758 . . . . 0.0 111.069 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.59 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -137.47 122.4 18.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 39.94 47.19 3.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 36' ' ' THR . 18.6 m -103.28 166.92 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -1.167 . . . . 0.0 110.433 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.935 HG21 HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -136.01 90.69 2.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.396 -0.815 . . . . 0.0 110.075 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 27.4 p -97.47 96.31 8.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.8 p -78.82 -28.68 44.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.125 -0.984 . . . . 0.0 109.606 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . -164.5 68.6 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.466 ' HB3' ' OG1' ' A' ' 53' ' ' THR . 57.6 p -135.81 174.8 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -1.124 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -136.39 123.85 22.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.912 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.988 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -101.4 168.76 9.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 110.717 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.9 t0 -173.68 109.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.38 69.71 0.96 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.795 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.1 t -145.15 131.9 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -1.127 . . . . 0.0 110.922 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.531 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 4.4 m -109.05 96.35 6.25 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.395 -0.816 . . . . 0.0 109.346 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.706 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.32 176.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.803 HG23 ' N ' ' A' ' 49' ' ' THR . 1.9 t -136.24 -147.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.803 ' N ' HG23 ' A' ' 48' ' ' THR . 3.7 m -60.26 80.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.321 -0.862 . . . . 0.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 48' ' ' THR . 1.4 m -139.34 142.97 37.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.263 -0.898 . . . . 0.0 110.507 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.935 HG22 HG21 ' A' ' 36' ' ' THR . 4.0 p -91.55 53.19 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.438 ' C ' HG22 ' A' ' 53' ' ' THR . 5.3 t -94.97 122.38 37.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.511 HG23 HG13 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -172.16 135.85 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 144.6 -28.56 1.91 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.501 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -130.36 178.56 6.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -1.05 . . . . 0.0 109.933 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -94.34 138.6 32.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.134 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.795 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.1 mt -115.79 155.5 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.547 ' H ' HG22 ' A' ' 86' ' ' THR . 1.1 m -147.28 145.3 29.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 112.57 0.26 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.106 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -7.04 20.21 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.697 1.367 . . . . 0.0 109.068 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.65 32.58 0.48 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.484 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -72.25 155.57 40.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -1.018 . . . . 0.0 110.102 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 105.31 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.545 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 tt -102.05 154.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.92 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.553 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -145.91 108.22 4.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.482 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 10.7 p 50.62 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 52' ' ' SER . 0.0 OUTLIER -127.59 -151.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.85 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -134.9 139.38 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 69' ' ' ILE . 7.8 tt -70.41 105.08 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.028 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.2 m -148.48 148.04 29.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.362 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.38 57.89 1.57 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.566 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.773 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -132.73 139.28 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.653 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -144.27 79.07 1.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 96.11 45.94 2.72 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -131.99 160.54 35.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.12 -1.224 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.585 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 9.8 t -117.07 157.49 25.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.7 m-85 -137.37 137.56 39.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.881 -1.137 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ARG . 12.2 t -171.11 136.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.53 139.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.374 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.501 ' N ' ' HA ' ' A' ' 55' ' ' SER . 13.0 p30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.199 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.654 ' CG2' HD22 ' A' ' 11' ' ' LEU . 7.2 t -130.83 30.94 4.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 109.797 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.95 70.06 8.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 103.84 15.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.979 . . . . 0.0 110.356 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 44.72 24.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 110.044 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.02 -162.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.883 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.493 ' CB ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -143.65 107.52 4.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.043 -1.036 . . . . 0.0 110.502 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.654 HD22 ' CG2' ' A' ' 5' ' ' THR . 18.4 tp -100.32 21.72 12.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.653 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 22.0 t 61.34 12.41 4.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.584 -0.697 . . . . 0.0 110.273 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.98 28.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 110.273 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.1 t30 -162.25 19.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 110.922 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -112.17 -149.16 0.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.05 -1.031 . . . . 0.0 109.43 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -108.81 127.86 54.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.955 -1.091 . . . . 0.0 110.056 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 29.3 p -106.43 69.11 0.78 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 110.354 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 18.5 tp10 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.151 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.271 0.557 . . . . 0.0 109.77 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 11.1 m -155.26 117.44 4.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.0 110.862 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.551 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 3.6 m-85 -109.39 94.8 5.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.96 HG22 ' HB2' ' A' ' 42' ' ' PHE . 12.0 t -99.8 165.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.904 -1.123 . . . . 0.0 111.31 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 7.8 t0 -146.54 109.59 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.707 . . . . 0.0 109.332 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.96 69.59 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.979 -1.076 . . . . 0.0 109.742 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.551 ' OG ' HG12 ' A' ' 27' ' ' VAL . 9.7 m -131.83 -167.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.923 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -142.13 101.61 3.96 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.05 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.665 HG13 ' HB ' ' A' ' 35' ' ' THR . 80.9 t -102.06 125.84 56.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 110.856 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.591 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -132.84 123.0 25.25 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 41.97 42.52 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.665 ' HB ' HG13 ' A' ' 32' ' ' VAL . 52.1 m -104.24 162.14 13.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -1.067 . . . . 0.0 110.195 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.423 ' N ' HG22 ' A' ' 35' ' ' THR . 24.4 p -98.56 178.22 5.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.991 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.413 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -158.95 65.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.367 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -110.88 40.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.877 . . . . 0.0 110.314 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 118.46 91.19 1.42 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.515 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 10.8 p -172.17 178.55 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -1.203 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.551 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -146.67 122.44 10.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.881 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.96 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.3 m-85 -102.07 166.3 10.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.518 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.8 t70 -176.13 111.26 0.1 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.71 66.32 2.35 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.715 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.7 t -144.1 129.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -1.064 . . . . 0.0 110.957 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.403 HG23 ' CB ' ' A' ' 31' ' ' GLU . 45.8 m -110.37 90.89 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.247 -0.908 . . . . 0.0 109.122 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.671 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -111.4 164.86 6.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 109.86 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.725 HG23 ' N ' ' A' ' 49' ' ' THR . 1.5 t -122.41 -154.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 109.94 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.725 ' N ' HG23 ' A' ' 48' ' ' THR . 3.2 m -48.25 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' THR . 12.6 p -139.26 154.43 47.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.6 p -110.42 53.34 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -111.51 110.05 20.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 110.522 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -151.49 113.7 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.272 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 169.36 -42.94 0.21 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.226 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.549 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -110.0 177.04 4.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.237 . . . . 0.0 110.382 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -97.25 126.89 42.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.715 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.8 mt -104.75 158.42 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 110.844 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.545 ' CB ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -148.72 155.1 40.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 110.534 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.1 125.13 0.75 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.728 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -74.95 -5.61 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.01 39.33 0.24 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -71.88 151.48 43.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.463 -1.022 . . . . 0.0 110.536 -179.286 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -145.03 113.52 6.67 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.472 HG22 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -104.49 166.71 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.526 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -147.35 96.71 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 110.251 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 65' ' ' SER . 19.3 p 50.16 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.04 -146.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.933 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 tt -143.66 -177.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.1 pp -46.21 123.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.015 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 55' ' ' SER . 2.4 m -92.08 -134.53 0.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.502 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 89.86 24.66 29.4 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.331 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 9.6 mmtt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.341 0.591 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.956 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.852 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.956 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -156.23 83.52 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.522 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 77.02 59.2 3.21 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.573 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.46 159.34 42.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -1.147 . . . . 0.0 110.716 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -106.86 154.64 20.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.607 -0.683 . . . . 0.0 110.07 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.5 m-85 -134.28 141.88 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 89' ' ' ALA . 21.4 t -177.7 121.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 110.367 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.13 139.63 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.52 -0.738 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.549 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.304 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.302 0.573 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -141.05 92.96 2.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 108.978 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.89 111.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 3.9 p -101.25 107.01 18.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.1 OUTLIER 69.4 8.33 6.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 110.667 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.2 -170.47 1.65 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.019 . . . . 0.0 110.359 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.682 HE21 ' HE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -141.83 99.71 3.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 109.268 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD13 HG21 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -92.63 38.02 1.01 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.13 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 18.2 t 58.47 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.678 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.59 22.64 2.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 110.461 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -157.4 19.35 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.131 -0.981 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 10.5 p -100.17 -162.74 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.914 -1.116 . . . . 0.0 109.348 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 19.8 tptt -108.25 112.33 24.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 29.6 p -97.31 86.33 3.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.512 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.485 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.111 -0.993 . . . . 0.0 109.425 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.111 0.481 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -155.09 111.75 3.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.435 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.682 ' HE2' HE21 ' A' ' 10' ' ' GLN . 1.2 m-85 -100.77 129.1 46.61 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.096 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -125.1 160.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.916 -1.115 . . . . 0.0 110.979 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -149.29 115.55 5.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 0.0 109.416 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 mttt 52.03 65.43 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 109.823 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.611 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.7 m -133.45 -170.49 2.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 111.122 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CB ' HG23 ' A' ' 46' ' ' THR . 2.6 tm-20 -143.26 99.36 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 16' ' ' LYS . 97.3 t -105.23 149.81 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.955 . . . . 0.0 111.689 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.582 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -127.35 -143.6 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 49' ' ' THR . . . -66.41 68.16 0.16 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.4 m -114.91 157.78 22.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -1.133 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.581 ' CG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -112.36 170.83 7.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 53' ' ' THR . 36.9 t -133.75 140.28 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.819 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.57 ' H ' ' HG1' ' A' ' 53' ' ' THR . 32.8 m -155.3 19.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.495 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 132.18 67.47 0.09 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -151.63 -178.81 6.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.124 -1.221 . . . . 0.0 110.247 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG3' ' HG3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.3 138.08 23.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.751 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.096 ' HB3' HG13 ' A' ' 27' ' ' VAL . 6.0 m-85 -110.1 161.62 15.36 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.537 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 45' ' ' VAL . 1.6 t70 -179.09 113.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 49.49 64.33 3.48 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.582 ' CG1' HG23 ' A' ' 47' ' ' ILE . 3.1 t -145.8 136.47 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -1.012 . . . . 0.0 110.426 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 31' ' ' GLU . 87.7 m -116.03 97.96 6.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.532 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.582 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.6 pt -114.93 174.39 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.401 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.72 HG23 ' N ' ' A' ' 49' ' ' THR . 1.0 OUTLIER -122.04 -160.09 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 110.537 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.72 ' N ' HG23 ' A' ' 48' ' ' THR . 8.7 m -61.62 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.882 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.496 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.892 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.581 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 10.5 p -95.83 57.46 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.444 ' C ' HG22 ' A' ' 53' ' ' THR . 0.4 OUTLIER -114.25 133.24 55.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.551 -0.718 . . . . 0.0 110.454 -179.496 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.588 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.4 75.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.855 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -132.22 -61.48 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.554 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 61.1 p -103.61 -159.62 0.73 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.489 -1.006 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -115.21 123.48 48.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.401 -0.812 . . . . 0.0 110.188 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 HG22 ' A' ' 45' ' ' VAL . 2.0 mt -98.98 163.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 109.959 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.71 151.36 37.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.701 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 159.55 115.28 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.03 -2.8 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.743 1.391 . . . . 0.0 108.657 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.25 28.59 0.63 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.51 153.7 41.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.444 -1.033 . . . . 0.0 110.711 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.35 111.03 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.797 . . . . 0.0 110.05 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.939 HG13 HD12 ' A' ' 82' ' ' ILE . 3.6 tt -103.88 167.65 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.971 . . . . 0.0 109.226 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -144.83 100.55 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.346 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 81.0 p 46.39 56.39 6.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.556 -0.715 . . . . 0.0 110.712 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.04 162.34 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 69' ' ' ILE . 79.4 mt -108.32 171.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 68' ' ' ILE . 1.7 mp -38.75 121.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 0.0 110.415 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 72' ' ' GLY . 89.6 m -130.32 61.1 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.992 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -65.78 74.43 0.11 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.556 0.693 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.939 HD12 HG13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -147.92 129.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.599 -0.688 . . . . 0.0 109.347 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -142.53 116.24 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.943 . . . . 0.0 110.528 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.44 48.77 8.84 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.42 149.36 49.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 0.0 110.506 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -104.17 163.06 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.149 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 86' ' ' THR . 6.3 m-85 -132.62 144.49 50.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.491 ' C ' ' HB2' ' A' ' 55' ' ' SER . 2.0 t -176.08 116.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 109.75 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HA ' ' CB ' ' A' ' 55' ' ' SER . . . -37.76 155.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.496 -0.753 . . . . 0.0 110.882 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 55' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.877 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.358 0.599 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.727 HG22 HD22 ' A' ' 11' ' ' LEU . 3.0 t -133.42 7.08 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -69.69 73.14 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 110.494 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 50.1 p -98.29 99.32 10.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.0 109.499 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 7' ' ' THR . 9.5 m120 58.15 15.95 3.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.694 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -130.89 172.84 11.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.472 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.16 114.26 24.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.727 HD22 HG22 ' A' ' 5' ' ' THR . 15.7 tp -102.45 28.39 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.769 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 21.8 t 64.22 6.25 2.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.731 -0.606 . . . . 0.0 110.914 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.0 25.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.06 -1.025 . . . . 0.0 109.44 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' SER . 37.5 t30 -163.47 17.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.416 -0.803 . . . . 0.0 110.491 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -104.29 -147.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.425 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 3.4 tmtm? -114.94 119.04 35.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.796 -1.19 . . . . 0.0 110.493 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.01 66.14 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.718 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.521 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.7 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.984 0.421 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 88.5 m -149.68 123.26 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 111.182 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 20.1 m-85 -115.58 96.65 5.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.02 HG13 ' HB3' ' A' ' 42' ' ' PHE . 12.2 t -94.32 163.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.912 . . . . 0.0 111.315 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.553 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.91 120.53 9.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.548 -0.72 . . . . 0.0 109.467 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 13.6 tptm 47.92 59.76 4.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.275 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.579 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.7 m -133.58 178.19 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.184 -0.947 . . . . 0.0 110.982 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.6 tt0 -143.61 109.58 5.28 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 47' ' ' ILE . 5.7 m -116.05 164.98 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.892 -1.13 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.57 ' HB3' ' CA ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -121.53 -139.17 0.33 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.471 ' HA3' HG23 ' A' ' 49' ' ' THR . . . -65.97 66.87 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 50' ' ' SER . 19.6 m -99.36 163.58 12.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.683 ' CG2' HG22 ' A' ' 51' ' ' THR . 6.7 p -106.88 -170.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.119 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.787 ' CA ' HG21 ' A' ' 53' ' ' THR . 0.9 OUTLIER -141.15 -87.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.912 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 m 46.13 37.14 3.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.362 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 102.03 109.49 3.28 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.601 ' CB ' HG22 ' A' ' 53' ' ' THR . 47.0 t 177.87 161.89 0.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.419 -1.047 . . . . 0.0 110.184 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.569 ' HB2' ' ND2' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -141.7 128.61 20.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.991 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.02 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.0 m-85 -110.67 167.11 10.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -177.73 112.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.098 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.79 70.49 0.84 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.717 ' CG1' HG23 ' A' ' 47' ' ' ILE . 7.4 t -145.52 127.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.413 -1.051 . . . . 0.0 111.126 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -106.92 91.13 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.238 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.717 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -114.35 170.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.375 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.646 HG23 ' N ' ' A' ' 49' ' ' THR . 5.3 t -118.46 -151.21 0.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.648 ' O ' HG22 ' A' ' 66' ' ' THR . 3.2 m -63.5 86.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.378 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 35' ' ' THR . 7.9 t -139.37 144.72 38.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 110.759 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.683 HG22 ' CG2' ' A' ' 36' ' ' THR . 43.9 p -96.72 61.4 1.88 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.28 111.26 23.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.787 HG21 ' CA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -142.66 162.75 34.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.883 . . . . 0.0 110.142 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 116.24 -56.9 0.51 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.508 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -101.86 -179.6 4.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -1.133 . . . . 0.0 111.213 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 6.1 ttp85 -109.69 128.05 54.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.5 mt -103.57 161.18 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 111.006 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.606 ' CB ' ' HG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -146.65 146.3 30.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.13 118.05 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.437 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.94 -6.98 20.41 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 N-CA-C 108.69 -1.312 . . . . 0.0 108.69 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.95 38.61 0.29 Allowed Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -71.85 159.4 34.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.446 -1.032 . . . . 0.0 110.139 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 62' ' ' CYS . 5.1 mmtm -143.11 109.51 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.757 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.507 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.6 tt -102.6 172.45 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.003 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.477 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.6 t -151.17 76.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.17 . . . . 0.0 110.78 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 49' ' ' THR . 4.1 p 55.24 113.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.456 ' N ' ' OG ' ' A' ' 50' ' ' SER . 30.0 m -139.36 -157.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 69' ' ' ILE . 1.9 mt -121.97 -149.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.166 -0.959 . . . . 0.0 109.898 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.52 ' H ' HG22 ' A' ' 68' ' ' ILE . 37.0 mt -61.3 144.72 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' GLY . 75.2 m -123.7 -13.76 7.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.948 -1.095 . . . . 0.0 110.938 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.482 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -36.12 94.2 0.01 OUTLIER Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.466 0.651 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -125.11 155.94 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.796 ' N ' HD13 ' A' ' 82' ' ' ILE . 43.6 t -146.8 114.75 6.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.385 -0.822 . . . . 0.0 110.407 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 70.47 48.79 34.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.68 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.79 148.22 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -1.045 . . . . 0.0 110.804 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.606 ' HG1' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -109.27 153.91 23.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.392 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 88' ' ' SER . 10.3 m-85 -127.13 160.6 30.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.575 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 171.03 127.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.798 . . . . 0.0 109.877 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -42.58 141.46 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 41' ' ' ARG . 1.8 t-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.044 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.36 0.6 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -134.31 35.68 3.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -94.5 68.84 3.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' THR . 1.9 t -99.05 94.09 6.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.437 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 67.4 4.68 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.711 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -114.18 -168.5 1.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 99.74 3.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 4.5 tp -88.42 27.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.932 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 p 71.67 1.28 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.464 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.14 24.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.77 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 12' ' ' SER . 17.8 p30 -157.28 16.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.535 ' OG ' ' CD2' ' A' ' 11' ' ' LEU . 22.1 p -105.73 -138.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.29 98.43 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 15.4 p -82.76 50.01 1.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 110.402 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.955 -1.091 . . . . 0.0 110.456 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.002 0.429 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.62 123.47 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.932 -1.105 . . . . 0.0 111.365 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -109.77 93.86 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 1.03 HG13 ' HB3' ' A' ' 42' ' ' PHE . 4.5 t -93.67 167.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 110.643 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.2 OUTLIER -149.49 120.63 7.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.956 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 44.46 60.76 2.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 109.763 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.749 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -128.1 -169.19 2.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.69 104.57 4.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 47' ' ' ILE . 99.5 t -110.99 137.89 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 111.47 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -107.09 -139.68 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.563 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 49' ' ' THR . . . -68.16 61.68 0.39 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.2 m -111.43 156.84 21.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -1.143 . . . . 0.0 110.189 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.781 HG21 HG23 ' A' ' 51' ' ' THR . 0.7 OUTLIER -106.42 -173.18 2.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.654 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.8 OUTLIER -150.84 76.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.649 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -90.97 47.31 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.24 95.31 2.22 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.556 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 25.1 p -174.06 173.04 3.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.331 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HD3' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -135.81 133.78 38.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.221 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.03 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.7 m-85 -112.92 163.15 15.01 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.953 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 8.7 t70 -177.19 111.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.9 . . . . 0.0 109.122 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 50.63 66.67 2.29 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.817 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.6 t -144.42 127.99 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.084 . . . . 0.0 111.033 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 22.1 m -104.76 96.01 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.352 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 32' ' ' VAL . 1.1 pp -114.44 169.06 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.821 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -112.78 -150.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.821 ' N ' HG23 ' A' ' 48' ' ' THR . 34.8 m -73.41 94.37 2.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.195 -0.941 . . . . 0.0 110.016 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.505 ' HB3' ' CA ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -139.9 157.86 45.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 111.394 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.781 HG23 HG21 ' A' ' 36' ' ' THR . 27.5 m -104.09 50.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.592 -0.692 . . . . 0.0 109.372 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.525 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -102.7 102.81 13.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.344 -0.848 . . . . 0.0 110.594 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.654 HG21 ' HA ' ' A' ' 37' ' ' CYS . 82.1 p -141.19 113.94 8.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 166.14 -27.09 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.555 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 72.6 p -118.85 162.01 19.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -91.36 119.08 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.867 . . . . 0.0 108.997 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.817 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -99.64 152.29 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 0.0 111.65 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.63 140.73 26.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.814 -0.554 . . . . 0.0 109.906 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 171.21 120.23 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.114 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.09 -5.32 16.86 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.719 1.379 . . . . 0.0 108.899 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.61 33.88 0.32 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 1.7 t -72.02 160.1 33.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.98 -1.306 . . . . 0.0 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 17.5 mmtt -141.51 110.79 6.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.592 HG21 ' HB ' ' A' ' 47' ' ' ILE . 6.6 tt -99.45 171.53 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.016 -1.052 . . . . 0.0 109.314 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 2.2 t -152.94 87.83 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.505 ' CA ' ' HB3' ' A' ' 50' ' ' SER . 10.2 p 52.21 104.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 110.948 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 82.0 m -119.55 -152.73 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.49 -0.756 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.746 ' N ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -138.59 170.85 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.913 -1.117 . . . . 0.0 110.58 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.96 137.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 0.0 109.402 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.1 t -145.42 -166.5 2.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 111.039 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -172.63 30.8 0.11 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.588 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.315 0.579 . . . . 0.0 110.098 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 1.6 tp -132.46 151.35 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.457 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -140.82 118.76 11.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.168 -0.958 . . . . 0.0 110.679 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.04 46.13 37.77 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.561 ' HB3' ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -128.15 154.27 45.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.232 -1.158 . . . . 0.0 111.43 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.579 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.74 165.81 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 0.0 109.056 178.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -155.4 155.67 34.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.784 -1.197 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -175.76 41.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 111.145 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.555 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.8 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 110.843 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.164 0.507 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' ASN . . . -107.19 68.2 0.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 8.3 t 49.14 78.75 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 0.0 110.206 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.1 OUTLIER 68.65 -75.06 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.466 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 17' ' ' CYS . 5.8 t -145.46 13.59 1.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 0.0 110.453 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 6.2 m-20 -97.05 96.41 8.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -113.77 20.18 16.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 22' ' ' LEU . 1.2 t-20 -177.33 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -108.73 -151.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.967 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -143.36 110.19 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.439 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 27' ' ' VAL . 25.6 tp -94.15 36.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.625 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 68.92 2.19 3.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.737 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 46.56 23.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.941 -1.1 . . . . 0.0 109.639 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -159.91 12.12 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.945 . . . . 0.0 111.465 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' SER . 4.3 m -98.65 -144.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.788 -1.195 . . . . 0.0 109.537 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 18' ' ' GLU . 1.4 tptt -107.41 89.97 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 29.7 p -65.55 64.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 0.0 110.746 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 16' ' ' LYS . 33.2 mm-40 -100.21 25.07 7.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.031 -1.043 . . . . 0.0 110.115 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.512 ' C ' ' HG1' ' A' ' 5' ' ' THR . 0.0 OUTLIER -171.33 133.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.71 -163.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.415 ' HB ' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -147.7 162.73 38.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -95.29 -83.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 9.2 m -165.03 24.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.109 -0.994 . . . . 0.0 110.775 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 38' ' ' THR . 10.7 m120 -157.49 76.45 0.82 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -155.79 128.02 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -136.23 91.95 2.73 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.102 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -94.4 164.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 110.776 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.625 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.8 t0 -137.42 117.04 12.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ASP . 6.7 tttt 40.29 71.3 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.064 -1.023 . . . . 0.0 110.189 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.831 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -131.51 -175.01 3.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -144.13 100.8 3.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.612 -0.68 . . . . 0.0 109.996 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 10.4 m -110.22 151.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.637 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.547 ' O ' ' CA ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -125.85 94.45 4.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.099 -1.0 . . . . 0.0 110.348 -179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.688 ' O ' HG23 ' A' ' 49' ' ' THR . . . 60.97 46.11 95.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 50' ' ' SER . 6.2 m -102.45 146.43 28.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -1.092 . . . . 0.0 110.369 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.483 ' O ' HG21 ' A' ' 53' ' ' THR . 2.7 t -90.32 159.7 16.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.431 -0.793 . . . . 0.0 110.39 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 38' ' ' THR . 1.2 m -113.87 -79.79 0.59 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.488 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.1 m 68.25 -68.39 0.17 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.124 -0.985 . . . . 0.0 110.405 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 53' ' ' THR . . . -155.61 104.34 0.25 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -178.34 179.56 0.78 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -1.132 . . . . 0.0 109.924 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.46 127.56 13.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 110.104 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.102 ' HB3' HG13 ' A' ' 27' ' ' VAL . 4.6 m-85 -109.17 172.85 6.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.398 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 58' ' ' SER . 0.9 OUTLIER 177.21 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.821 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 66.07 66.48 2.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.976 HG21 HG22 ' A' ' 57' ' ' ILE . 2.4 t -146.28 148.83 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 110.564 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 46' ' ' THR . 13.3 m -122.25 89.7 3.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.447 -0.783 . . . . 0.0 109.312 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.71 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.65 168.92 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 5.4 t -115.89 -164.88 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 34' ' ' GLY . 2.0 m -49.63 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.918 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 35' ' ' THR . 6.2 p -132.21 137.46 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.052 -1.03 . . . . 0.0 111.253 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 51' ' ' THR . 26.3 m -87.86 40.13 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.587 -0.696 . . . . 0.0 109.268 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -102.17 103.01 13.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.149 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.584 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 6.0 p -146.28 95.56 2.63 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.563 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -156.0 -53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' N ' ' A' ' 89' ' ' ALA . 2.6 p -105.73 -162.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 11.4 mtp180 -95.84 137.62 34.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.519 -0.738 . . . . 0.0 109.917 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.976 HG22 HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -118.3 128.57 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.993 . . . . 0.0 110.186 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.692 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.68 157.4 43.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.48 125.6 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.2 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.635 1.334 . . . . 0.0 109.4 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.07 33.63 0.2 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.3 t -72.89 146.25 46.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.353 -1.087 . . . . 0.0 110.646 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 111.28 9.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.446 -0.784 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.929 HG13 HD12 ' A' ' 82' ' ' ILE . 5.4 tt -104.39 171.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 110.611 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -142.97 96.35 2.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.32 -0.863 . . . . 0.0 110.046 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 67' ' ' CYS . 16.7 p 54.64 -93.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.691 -0.631 . . . . 0.0 110.597 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.552 ' N ' ' OG1' ' A' ' 66' ' ' THR . 3.9 m 70.3 -167.5 0.16 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.044 -1.035 . . . . 0.0 109.994 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -130.59 -169.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 70' ' ' THR . 5.4 mt -42.47 167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.333 -0.854 . . . . 0.0 110.703 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -137.61 -139.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 108.87 44.41 1.12 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.536 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . 62.71 18.02 58.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 70' ' ' THR . 9.7 m -116.71 150.53 45.85 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.682 -0.893 . . . . 0.0 110.504 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.545 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.6 Cg_endo -72.79 -47.8 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.988 1.52 . . . . 0.0 110.159 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.767 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . 60.78 173.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.767 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 47.4 Cg_endo -74.34 53.31 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.967 1.509 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -117.12 22.2 12.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.31 -22.9 2.0 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.07 -8.56 58.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 77' ' ' SER . 8.2 t -71.02 149.06 46.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 110.252 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -111.9 103.34 11.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.944 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.929 HD12 HG13 ' A' ' 64' ' ' ILE . 1.1 tt -120.66 124.18 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.73 123.53 23.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 71.9 60.8 4.05 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.484 ' SG ' HG13 ' A' ' 82' ' ' ILE . 56.3 m -138.79 146.12 40.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 111.25 13.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 109.607 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.543 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -142.69 160.13 40.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.948 . . . . 0.0 110.58 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -176.02 94.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' N ' ' CB ' ' A' ' 55' ' ' SER . . . 50.89 172.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 56' ' ' ARG . 28.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.217 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.234 0.54 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -111.25 101.58 1.34 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 64.45 -69.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.096 . . . . 0.0 110.505 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' GLY . 0.6 OUTLIER -133.76 -75.42 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.467 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 5' ' ' THR . 5.5 t -127.96 53.34 1.79 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.009 -1.057 . . . . 0.0 109.577 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.65 70.45 1.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 111.001 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 4.4 t -98.97 21.82 11.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.086 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.958 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 m-20 168.49 -17.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.652 -0.655 . . . . 0.0 110.808 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 23' ' ' THR . 3.2 m -108.02 -160.44 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 0.0 110.068 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -140.14 117.34 11.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 110.713 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.837 HD21 ' O ' ' A' ' 16' ' ' LYS . 1.8 tp -111.24 19.93 17.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 17.1 t 53.34 104.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.901 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.71 -24.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 110.429 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.2 m-20 -87.46 2.54 50.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 111.361 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.742 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -101.12 -162.98 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.619 -1.301 . . . . 0.0 110.547 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.837 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -111.55 162.75 14.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 28.6 p -128.92 71.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.69 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -105.32 53.99 0.71 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 110.516 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.606 ' HD3' HG11 ' A' ' 32' ' ' VAL . 13.9 ptmt -169.97 -175.49 2.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.404 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.473 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -98.36 -31.93 11.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' SER . 24.6 m 60.21 139.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.903 ' O ' HG23 ' A' ' 23' ' ' THR . 8.2 mp -95.52 -83.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.958 HG22 ' HB3' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -171.39 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.259 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.476 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -157.32 67.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -153.84 113.9 3.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.802 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HB2' ' HD3' ' A' ' 41' ' ' ARG . 37.7 m-85 -108.98 110.62 21.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.017 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -114.64 164.33 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.816 -1.177 . . . . 0.0 111.041 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.3 t70 -149.29 110.3 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.462 -0.774 . . . . 0.0 109.865 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.8 OUTLIER 54.95 63.45 2.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 110.061 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.9 m -133.88 -167.81 2.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 111.324 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.3 tt0 -143.28 104.03 4.21 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.606 HG11 ' HD3' ' A' ' 19' ' ' LYS . 53.1 t -103.94 142.19 18.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.97 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.25 -152.6 0.51 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.364 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 49' ' ' THR . . . -66.69 67.55 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 50' ' ' SER . 2.9 m -110.2 159.56 17.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -1.144 . . . . 0.0 110.801 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 35' ' ' THR . 1.3 p -89.2 -168.81 2.28 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.484 -0.76 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.926 ' HA ' HG21 ' A' ' 53' ' ' THR . 30.6 t -174.33 102.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.1 m -118.42 1.33 11.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 151.16 77.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 53' ' ' THR . 11.7 t -149.93 170.63 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -1.197 . . . . 0.0 110.515 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -132.99 133.07 42.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.625 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.017 ' HB3' HG13 ' A' ' 27' ' ' VAL . 2.8 m-85 -111.4 160.79 16.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 110.455 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.5 t0 -171.74 116.13 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.68 67.34 1.58 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.63 ' CG1' HG23 ' A' ' 47' ' ' ILE . 2.7 t -144.86 126.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.442 -1.034 . . . . 0.0 110.537 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 25.3 m -106.86 96.28 6.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.288 -0.883 . . . . 0.0 109.194 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.63 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pt -113.72 160.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.493 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.594 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -106.01 -162.31 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.594 ' N ' HG23 ' A' ' 48' ' ' THR . 55.1 m -64.16 91.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 35' ' ' THR . 13.7 p -139.24 164.5 29.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.684 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -108.68 72.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 109.83 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.5 t -124.16 105.8 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.14 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.926 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -151.07 117.84 5.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.215 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 168.51 -30.74 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.467 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -122.8 167.6 13.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.556 -0.967 . . . . 0.0 109.555 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 9.9 ttm180 -91.56 136.4 33.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.767 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 3.3 mt -114.66 163.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.4 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.575 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -148.3 145.84 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.764 -0.585 . . . . 0.0 110.052 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 165.74 109.67 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.42 -1.371 . . . . 0.0 110.494 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.01 -4.77 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.758 1.399 . . . . 0.0 108.748 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.98 30.08 0.6 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.3 t -72.07 157.85 37.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -1.063 . . . . 0.0 110.608 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HG2' ' C ' ' A' ' 62' ' ' CYS . 2.7 mmtp -144.5 110.98 5.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.659 -0.65 . . . . 0.0 109.653 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.559 HG21 ' HB ' ' A' ' 47' ' ' ILE . 6.9 tt -101.1 170.52 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.905 -1.122 . . . . 0.0 109.812 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.74 91.1 1.52 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.124 . . . . 0.0 111.387 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 65' ' ' SER . 13.3 p 46.08 109.81 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.654 0.74 . . . . 0.0 111.576 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.8 m -140.24 145.4 37.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.396 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.421 ' H ' HG23 ' A' ' 68' ' ' ILE . 1.3 pt -55.36 -179.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 0.0 109.9 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.0 mt -54.79 153.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.568 HG23 ' CG1' ' A' ' 73' ' ' VAL . 5.7 m -98.33 -122.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.916 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 95.29 35.59 5.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.93 65.02 0.99 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 87' ' ' PHE . 5.2 m -88.58 168.36 16.25 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.175 -1.191 . . . . 0.0 109.879 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 45.8 Cg_endo -73.41 168.98 23.38 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.718 1.378 . . . . 0.0 111.107 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.623 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -77.6 -46.79 2.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.805 . . . . 0.0 111.483 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 41.8 Cg_endo -69.41 -25.45 30.2 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.375 1.197 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 76' ' ' PRO . 1.4 m 42.5 62.58 1.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.709 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.18 -21.13 4.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.069 -1.019 . . . . 0.0 108.375 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.6 -71.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.535 0.683 . . . . 0.0 110.111 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 2.7 t -64.99 155.28 35.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 110.63 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 109.12 20.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.44 -0.787 . . . . 0.0 109.639 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.719 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -125.83 158.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 110.161 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.719 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -147.41 96.58 2.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 0.0 110.883 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.1 55.14 4.92 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.559 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.02 158.2 42.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.167 . . . . 0.0 110.881 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.582 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -111.06 161.04 16.3 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 73' ' ' VAL . 7.5 m-85 -146.43 162.22 38.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 111.276 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 1.2 t 169.19 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -37.62 138.01 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.467 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.853 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.25 0.548 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -131.34 120.78 2.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 2' ' ' GLY . 0.7 OUTLIER 62.74 -72.18 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.319 -1.106 . . . . 0.0 110.07 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 2' ' ' GLY . 8.1 t -155.55 -62.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.826 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.561 HG21 ' H ' ' A' ' 18' ' ' GLU . 7.3 t -134.08 50.78 2.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.791 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 9' ' ' SER . 6.6 m120 -140.64 106.68 5.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.97 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -98.62 28.55 4.16 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.953 0.882 . . . . 0.0 108.64 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER 176.71 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.297 0.57 . . . . 0.0 109.596 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 19.3 m -107.74 -165.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 109.277 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.73 115.94 7.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.786 -1.196 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 1.7 tp -91.63 140.71 29.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -0.945 . . . . 0.0 109.096 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -54.07 139.09 35.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -12.48 9.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.342 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -115.61 17.4 16.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.977 . . . . 0.0 110.702 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.2 p -94.28 -147.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 4.0 tttt -121.41 120.4 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.18 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -56.21 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 110.329 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.851 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.44 -145.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.484 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -149.17 149.5 31.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.505 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.4 m 68.3 113.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.292 -0.88 . . . . 0.0 110.978 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.736 ' C ' HD23 ' A' ' 22' ' ' LEU . 24.4 m -166.16 137.24 3.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.369 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -168.68 64.99 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 0.0 111.017 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.631 HG21 ' C ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -167.98 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.343 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' H ' HG23 ' A' ' 23' ' ' THR . 68.7 m-80 -155.21 106.66 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.971 -1.081 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 12.9 m -141.97 109.26 5.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 110.31 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 6.6 t80 -100.8 103.86 15.09 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.928 HG13 ' HB3' ' A' ' 42' ' ' PHE . 8.0 t -101.69 164.62 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -142.47 119.29 11.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.421 -0.799 . . . . 0.0 109.452 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 26.2 tttt 42.78 67.75 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 109.835 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.724 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.1 m -132.96 -168.04 2.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -144.8 96.91 2.94 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.13 -0.982 . . . . 0.0 109.784 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.851 HG12 ' CB ' ' A' ' 18' ' ' GLU . 61.3 t -102.33 138.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 110.086 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 49' ' ' THR . 4.6 t80 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.085 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 42.26 48.58 5.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.457 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 22.5 m -104.9 163.92 12.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -1.134 . . . . 0.0 109.771 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.3 p -99.79 174.63 6.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.848 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.966 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -157.5 143.35 17.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.722 . . . . 0.0 109.872 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -166.62 37.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.13 62.03 0.38 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 9.2 t -142.91 176.17 9.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -145.75 124.16 12.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.928 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -99.65 172.69 7.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.235 -0.916 . . . . 0.0 110.139 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' SER . 7.8 t70 179.0 95.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 68.7 67.66 1.89 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.084 HG21 HG22 ' A' ' 57' ' ' ILE . 1.1 t -145.88 159.42 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 110.603 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 27.4 m -130.33 88.26 2.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.543 -0.723 . . . . 0.0 109.617 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.786 HG23 HG13 ' A' ' 45' ' ' VAL . 1.1 pp -111.08 165.59 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.753 HG23 ' N ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -129.88 -157.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.085 . . . . 0.0 110.788 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.753 ' N ' HG23 ' A' ' 48' ' ' THR . 5.6 m -46.45 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 110.858 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.3 m -140.5 -167.05 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.068 -1.02 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -150.03 72.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.376 -0.828 . . . . 0.0 109.84 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 8.4 t -131.79 112.47 12.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.567 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.966 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -151.65 121.75 7.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 168.48 -25.98 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.463 ' HA ' ' C ' ' A' ' 89' ' ' ALA . 26.0 p -122.7 -170.15 2.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -1.11 . . . . 0.0 109.918 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 28.1 mtp180 -94.87 115.94 28.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.843 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.084 HG22 HG21 ' A' ' 45' ' ' VAL . 1.2 mm -98.98 122.52 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.076 . . . . 0.0 109.965 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.477 ' CA ' HG23 ' A' ' 45' ' ' VAL . 44.9 m -145.78 168.3 21.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 110.46 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 151.02 123.05 1.08 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.5 -5.68 17.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.691 1.363 . . . . 0.0 109.416 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 23.72 0.87 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 5.1 t -73.17 143.44 47.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.499 -1.001 . . . . 0.0 110.648 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 113.22 7.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.0 109.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.589 ' HB ' HG22 ' A' ' 47' ' ' ILE . 3.0 tt -104.04 168.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 15.2 t -152.26 89.88 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 49' ' ' THR . 2.2 p 56.71 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.815 ' O ' HG23 ' A' ' 51' ' ' THR . 83.5 m -146.5 -159.09 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.0 155.72 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.929 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.8 pp -92.51 121.85 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.428 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.7 m -148.41 150.77 34.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.39 51.32 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 135.44 90.55 0.32 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.513 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 21.2 m -86.83 165.6 31.34 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.266 -1.138 . . . . 0.0 110.144 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 43.4 Cg_endo -71.12 178.49 5.35 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.85 1.447 . . . . 0.0 110.759 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -81.48 -50.56 0.91 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 111.397 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.738 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 45.9 Cg_endo -72.9 -38.21 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.568 1.299 . . . . 0.0 110.953 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER 61.45 41.42 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.063 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -42.64 -28.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 108.972 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -80.91 -68.11 0.72 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.546 0.688 . . . . 0.0 109.39 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 2.2 t -63.97 159.92 18.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 110.021 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 65' ' ' SER . 3.6 mptp? -105.29 90.44 3.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.804 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.854 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.97 154.76 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.854 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.6 OUTLIER -148.05 89.77 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.781 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 97.19 61.67 0.93 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.655 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -138.39 171.95 13.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -1.224 . . . . 0.0 110.563 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.11 119.06 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.767 . . . . 0.0 109.554 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -147.4 149.6 33.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.174 . . . . 0.0 111.614 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 34.5 p -163.72 73.08 0.29 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.735 -0.603 . . . . 0.0 109.688 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 59.75 162.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 0.0 109.937 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.351 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.74 ' N ' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.337 0.589 . . . . 0.0 110.296 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.92 -107.85 1.0 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 14.5 t -71.82 -14.64 62.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -1.195 . . . . 0.0 109.868 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 3' ' ' SER . 1.6 p 169.71 -51.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 109.865 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.472 ' O ' HG21 ' A' ' 21' ' ' THR . 9.9 t -145.81 49.02 1.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.57 ' OD1' HG21 ' A' ' 21' ' ' THR . 2.8 m120 -138.85 117.83 12.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.113 -0.992 . . . . 0.0 110.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.74 HG22 ' N ' ' A' ' 1' ' ' ASP . 40.6 p -102.17 106.16 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.366 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER 74.01 -1.47 3.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.378 -0.826 . . . . 0.0 110.023 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -109.62 177.43 4.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.673 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -131.06 112.32 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.169 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HG ' ' OG ' ' A' ' 15' ' ' SER . 7.3 tp -88.63 54.57 3.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 110.053 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.615 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER 63.06 8.17 3.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 0.0 110.961 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 54.05 16.98 1.26 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 12' ' ' SER . 3.2 p30 174.75 30.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.98 -1.075 . . . . 0.0 110.918 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -92.44 -146.24 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.05 . . . . 0.0 109.564 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.571 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -104.69 103.83 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.967 -1.083 . . . . 0.0 109.521 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.64 59.78 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.594 ' HG2' ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -85.84 54.85 3.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 110.061 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.8 mtmm 54.5 -170.09 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 63.79 83.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.57 HG21 ' OD1' ' A' ' 6' ' ' ASN . 6.0 m -162.92 152.52 15.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.586 HD22 HG23 ' A' ' 38' ' ' THR . 1.2 tp -117.63 -121.11 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.057 -1.027 . . . . 0.0 110.309 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 8' ' ' ASN . 4.2 t -151.93 37.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.84 -1.163 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -155.91 52.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 110.493 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 8.0 p -152.09 116.51 5.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.061 -1.024 . . . . 0.0 110.455 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 93.0 m-85 -100.69 100.19 10.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 0.0 109.554 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.055 HG13 ' HB3' ' A' ' 42' ' ' PHE . 5.6 t -94.37 166.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.017 . . . . 0.0 110.247 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.54 ' CA ' ' HB2' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.79 124.84 12.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER 42.77 63.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 109.586 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.848 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.1 m -130.9 -179.12 5.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 111.114 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.5 mt-10 -145.3 103.77 3.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.571 -0.705 . . . . 0.0 109.216 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.518 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.9 m -112.4 130.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 2.7 t80 -118.27 94.63 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.902 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 20' ' ' SER . . . 74.96 33.18 55.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 1.092 HG23 ' O ' ' A' ' 50' ' ' SER . 19.2 m -108.66 147.23 32.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -1.189 . . . . 0.0 110.208 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 51' ' ' THR . 8.1 t -97.94 150.8 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 19.8 p -135.44 58.2 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 110.138 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 HD22 ' A' ' 22' ' ' LEU . 29.6 m -66.21 -108.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.811 -1.18 . . . . 0.0 109.726 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.97 66.37 3.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 7.8 t -144.05 168.16 20.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -1.18 . . . . 0.0 110.758 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 3.9 tpt180 -138.85 124.53 19.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.055 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.48 177.53 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 10.0 t0 173.39 108.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 56.45 67.34 2.27 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 47' ' ' ILE . 16.5 t -145.76 125.13 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -1.039 . . . . 0.0 111.419 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -103.44 96.1 6.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 108.659 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.907 ' CD1' HG21 ' A' ' 35' ' ' THR . 1.1 pt -111.14 167.15 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 110.698 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.96 112.47 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER 38.08 72.3 0.13 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.433 -0.792 . . . . 0.0 111.288 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 1.092 ' O ' HG23 ' A' ' 35' ' ' THR . 44.3 t -140.13 139.96 35.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 110.786 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.486 ' HA ' HG22 ' A' ' 36' ' ' THR . 29.8 p -103.85 50.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.918 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -89.86 54.7 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.817 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 40' ' ' SER . 10.1 p -84.21 173.46 11.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 110.152 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 94.21 -18.57 56.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 1.2 p -124.63 154.67 40.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 ttm180 -91.97 114.41 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.683 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -101.2 146.55 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 111.301 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -147.31 152.35 38.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.653 -0.655 . . . . 0.0 109.716 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 166.03 124.4 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.24 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -5.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.74 1.389 . . . . 0.0 108.761 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.93 32.12 0.46 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.534 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 1.9 t -72.51 139.09 47.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.527 -0.984 . . . . 0.0 110.658 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -132.18 110.55 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.464 -0.772 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 5.9 tt -100.35 172.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.175 -0.953 . . . . 0.0 109.967 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 16.0 m -151.93 94.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.017 -1.052 . . . . 0.0 110.962 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 45.59 105.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 179.283 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 17.1 t -133.53 163.84 28.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 69' ' ' ILE . 2.9 mp -80.52 167.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 0.0 110.897 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.537 ' N ' HG22 ' A' ' 68' ' ' ILE . 10.0 mt -84.63 120.97 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 109.395 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -148.54 139.16 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 110.617 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -82.28 58.12 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 134.15 89.23 0.34 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.735 HG23 ' HD2' ' A' ' 74' ' ' PRO . 3.3 p -86.48 148.41 46.63 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.252 -1.146 . . . . 0.0 109.525 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.735 ' HD2' HG23 ' A' ' 73' ' ' VAL . 42.5 Cg_endo -68.71 175.72 6.85 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.841 1.443 . . . . 0.0 111.017 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.877 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -75.5 -56.17 1.91 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.4 -0.812 . . . . 0.0 111.077 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 42.4 Cg_endo -70.06 -26.47 26.15 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.804 1.423 . . . . 0.0 110.888 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER 47.29 43.95 15.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.05 -1.031 . . . . 0.0 110.579 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -44.42 -25.93 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.121 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 77' ' ' SER . . . -79.35 -76.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.535 -0.728 . . . . 0.0 109.67 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m -63.95 176.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 110.316 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -115.67 107.85 15.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.948 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -128.69 156.38 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.895 ' N ' HD13 ' A' ' 82' ' ' ILE . 36.4 t -147.59 87.69 1.65 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 90.95 60.15 1.35 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.578 ' N ' HD11 ' A' ' 82' ' ' ILE . 49.9 m -142.55 156.39 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -112.5 157.9 20.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.044 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 1.9 m-85 -144.89 161.69 38.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.868 -1.145 . . . . 0.0 110.66 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 176.47 56.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 42.56 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 109.825 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.739 ' HA ' HG22 ' A' ' 7' ' ' THR . 11.2 t70 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.233 0.539 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.78 -108.55 2.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 7.6 p -94.99 86.38 4.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -1.11 . . . . 0.0 110.217 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.8 OUTLIER 73.0 -72.17 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.475 -0.766 . . . . 0.0 110.698 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 5' ' ' THR . 14.6 t -137.06 47.05 2.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.963 -1.086 . . . . 0.0 110.795 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.41 90.98 2.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.531 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.739 HG22 ' HA ' ' A' ' 1' ' ' ASP . 14.5 p -98.44 41.27 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.525 ' ND2' HD11 ' A' ' 22' ' ' LEU . 0.3 OUTLIER 168.31 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.369 0.604 . . . . 0.0 109.665 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 34.3 m -108.19 -163.71 0.91 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 110.583 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.55 120.67 18.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.702 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 16' ' ' LYS . 8.0 tp -88.15 21.67 2.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 10.6 t 64.64 5.88 2.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.642 -0.661 . . . . 0.0 111.118 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.13 21.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 110.072 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -154.0 14.05 0.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -112.46 -156.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -108.09 148.27 30.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.018 . . . . 0.0 110.055 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' HD22 ' A' ' 11' ' ' LEU . 7.2 p -123.05 68.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.32 67.44 3.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.322 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' CG ' ' OG1' ' A' ' 5' ' ' THR . 0.0 OUTLIER -179.48 -169.82 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.219 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -170.77 96.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.258 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.852 HG23 ' H ' ' A' ' 23' ' ' THR . 4.9 t -168.87 -175.61 2.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.525 HD11 ' ND2' ' A' ' 8' ' ' ASN . 1.1 tp -92.19 33.36 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.852 ' H ' HG23 ' A' ' 21' ' ' THR . 2.0 m -53.28 115.7 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.635 -0.666 . . . . 0.0 110.23 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.545 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 5.5 m-20 -84.29 103.24 13.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 110.405 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.0 OUTLIER -157.9 122.61 4.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 110.955 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.542 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -87.3 102.32 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 108.757 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.021 HG22 ' HB2' ' A' ' 42' ' ' PHE . 18.8 t -100.85 163.84 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.922 -1.111 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 37.6 t0 -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' N ' ' OG ' ' A' ' 12' ' ' SER . 12.8 tttt 43.27 68.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.885 -1.134 . . . . 0.0 109.989 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.569 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.5 m -133.74 -171.05 2.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.061 . . . . 0.0 111.655 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -144.33 103.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.449 HG11 ' NZ ' ' A' ' 19' ' ' LYS . 90.7 t -106.13 151.09 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.937 -1.102 . . . . 0.0 110.968 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.536 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 2.3 t80 -140.37 76.65 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.898 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 19' ' ' LYS . . . 65.98 61.35 5.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -111.41 149.26 31.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 109.978 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 37' ' ' CYS . 18.2 p -67.38 -68.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.313 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.587 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER 51.42 42.42 29.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.099 -1.001 . . . . 0.0 109.988 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -85.15 36.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.726 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 152.08 54.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.57 -176.24 5.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.118 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -131.68 134.24 45.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.726 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.021 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.5 m-85 -111.97 150.85 29.97 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.894 -1.129 . . . . 0.0 110.416 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 14.4 t0 -166.15 119.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.491 -0.756 . . . . 0.0 109.105 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.42 68.89 1.03 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.711 ' CG1' HG23 ' A' ' 47' ' ' ILE . 2.3 t -145.85 135.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -1.165 . . . . 0.0 111.036 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 31' ' ' GLU . 65.5 m -115.43 90.61 3.38 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.711 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.34 172.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 110.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 49' ' ' THR . 5.1 t -129.14 -155.21 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.577 ' N ' HG23 ' A' ' 48' ' ' THR . 1.3 m -58.62 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 48' ' ' THR . 8.6 t -139.13 -175.6 4.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 67' ' ' CYS . 3.6 t -133.78 61.61 1.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.292 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -112.07 100.28 8.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 37' ' ' CYS . 3.5 p -131.21 -164.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.03 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . 94.1 -68.26 1.43 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.447 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.579 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -101.66 -169.58 1.7 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.155 -1.203 . . . . 0.0 111.722 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 3.7 ppt_? -107.6 139.59 41.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.735 -0.603 . . . . 0.0 110.131 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.683 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.7 mt -107.75 160.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.531 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.442 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -146.65 148.54 32.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.11 124.0 0.73 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.393 -1.385 . . . . 0.0 110.597 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.35 -1.26 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.746 1.393 . . . . 0.0 108.905 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -173.21 38.15 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.41 155.57 39.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 111.05 5.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.629 -0.67 . . . . 0.0 109.786 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -101.71 165.14 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 109.406 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.506 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 2.0 t -152.16 86.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.058 . . . . 0.0 110.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.2 p 55.02 114.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.543 -0.723 . . . . 0.0 110.3 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.575 ' O ' HD13 ' A' ' 68' ' ' ILE . 60.5 m -143.23 -143.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 110.532 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 67' ' ' CYS . 10.0 mm -132.32 165.59 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -45.85 151.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.0 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.424 ' CB ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -123.84 -144.78 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.74 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 115.22 57.84 0.35 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.433 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . 63.92 15.53 58.24 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.506 HG22 ' C ' ' A' ' 71' ' ' GLY . 3.7 m -128.28 83.93 64.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.724 -0.869 . . . . 0.0 110.349 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.62 8.56 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.983 1.517 . . . . 0.0 110.317 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -72.03 -49.83 9.75 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.364 -0.835 . . . . 0.0 111.163 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 46.0 Cg_endo -73.99 4.18 4.44 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.736 1.388 . . . . 0.0 111.308 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 m -122.06 13.26 10.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.883 -1.135 . . . . 0.0 110.269 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.17 -22.78 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 108.965 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' ' HE3' ' A' ' 81' ' ' LYS . . . -87.69 7.19 31.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.623 -0.673 . . . . 0.0 110.012 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 18.3 t -81.23 150.05 28.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 111.118 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -103.83 94.52 5.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.413 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.88 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.19 151.8 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.541 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.88 ' N ' HD13 ' A' ' 82' ' ' ILE . 15.6 m -147.44 103.98 3.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 83.84 48.19 5.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.704 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.48 159.6 38.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -1.193 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.494 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -120.08 163.09 18.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.453 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 86' ' ' THR . 4.0 m-85 -134.61 161.73 34.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.085 -1.01 . . . . 0.0 109.973 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 55' ' ' SER . 0.3 OUTLIER 175.09 124.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 110.45 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 55' ' ' SER . . . -42.01 146.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 1.6 t30 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.887 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.411 0.624 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.73 -142.4 8.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -49.46 -26.94 3.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.737 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 17' ' ' CYS . 1.9 p 173.16 -51.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 109.91 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.569 ' CG2' HD22 ' A' ' 11' ' ' LEU . 13.3 t -146.23 19.33 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.42 HD21 ' HB2' ' A' ' 3' ' ' SER . 18.5 m-20 -89.48 57.52 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.519 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 75.2 p -98.63 105.47 17.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.382 -0.824 . . . . 0.0 109.438 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' THR . 14.2 m-20 67.09 6.04 4.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.86 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.43 178.7 6.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 10.8 tt0 -131.32 112.29 12.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.969 -1.082 . . . . 0.0 110.566 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.569 HD22 ' CG2' ' A' ' 5' ' ' THR . 5.3 tp -100.7 29.89 4.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.827 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 9.1 t 65.3 6.34 3.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.596 -0.69 . . . . 0.0 110.797 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 44.59 24.05 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.069 -1.019 . . . . 0.0 110.473 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.2 t30 -158.52 17.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 110.727 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 1.8 p -106.4 -140.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -120.67 124.14 44.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.926 -1.109 . . . . 0.0 109.81 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 8.9 m -97.12 61.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.69 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.585 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.67 39.75 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.145 . . . . 0.0 110.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER 174.35 143.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 109.904 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 p -72.09 178.59 3.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.952 . . . . 0.0 110.517 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -138.11 -161.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 110.317 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 23' ' ' THR . 9.9 tp -130.25 -70.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 t 171.79 36.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.411 -0.806 . . . . 0.0 109.804 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.99 52.77 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.7 m -144.56 110.59 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 110.807 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.536 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 26.5 m-85 -105.65 104.91 14.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.023 HG13 ' HB3' ' A' ' 42' ' ' PHE . 6.7 t -106.29 159.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.759 -1.213 . . . . 0.0 110.841 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 1.7 t0 -142.89 123.37 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.283 -0.885 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' N ' ' OG ' ' A' ' 12' ' ' SER . 1.8 tttt 38.3 66.68 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 110.094 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 15' ' ' SER . 2.1 m -133.31 -167.47 1.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 47' ' ' ILE . 39.4 mt-10 -143.29 103.67 4.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 77.4 t -105.59 127.61 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.093 -1.004 . . . . 0.0 110.878 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.9 OUTLIER -107.51 -139.08 0.37 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.483 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -66.47 61.6 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.5 m -107.07 164.55 12.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 110.141 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.596 HG23 ' HA ' ' A' ' 51' ' ' THR . 19.6 p -104.82 174.61 5.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -148.75 119.73 7.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.201 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -140.39 -36.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 54' ' ' GLY . . . -172.17 65.12 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.58 ' HB2' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -137.62 179.96 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -1.097 . . . . 0.0 110.24 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HD2' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -141.27 130.2 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.544 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.023 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.4 m-85 -109.79 162.41 14.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.8 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 9.4 t0 177.95 112.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 52.18 66.34 2.68 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.315 -2.314 . . . . 0.0 107.315 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 57' ' ' ILE . 3.8 t -145.24 117.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -1.101 . . . . 0.0 110.422 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 63' ' ' LYS . 10.6 m -98.85 90.91 4.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.674 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -110.51 167.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.448 -0.782 . . . . 0.0 109.957 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.736 HG23 ' N ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -122.77 -160.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.107 -0.995 . . . . 0.0 110.121 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.861 ' O ' HG22 ' A' ' 66' ' ' THR . 44.1 m -49.13 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 109.941 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.523 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 3.5 t -139.99 132.31 28.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.034 -1.041 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.596 ' HA ' HG23 ' A' ' 36' ' ' THR . 33.2 p -85.38 59.71 5.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 109.658 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 t -119.59 126.5 51.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 110.02 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -169.81 75.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -0.974 . . . . 0.0 110.723 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -133.5 -54.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.528 ' HB3' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -104.7 -171.32 1.9 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -1.088 . . . . 0.0 109.959 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 37.4 ptt180 -105.31 136.47 44.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.306 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.692 HG22 HG22 ' A' ' 45' ' ' VAL . 1.8 mt -109.59 157.54 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.71 156.92 43.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.718 . . . . 0.0 110.292 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 157.33 124.42 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.552 -1.308 . . . . 0.0 110.575 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.03 -7.89 22.26 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.594 1.313 . . . . 0.0 108.76 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.48 33.05 0.64 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.513 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 2.8 t -71.68 137.98 48.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -1.035 . . . . 0.0 110.165 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' THR . 1.6 mtpt -137.22 118.41 14.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.87 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 47' ' ' ILE . 2.5 tt -104.26 170.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.2 t -143.36 77.93 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.108 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 49' ' ' THR . 7.2 p 52.9 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 110.971 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 64' ' ' ILE . 74.0 m -124.21 -149.8 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 69' ' ' ILE . 43.4 mm -131.09 169.4 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.528 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -57.83 136.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.954 ' OG1' HG22 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -147.24 90.28 1.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 111.028 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . -74.38 65.04 2.06 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' A' ' 89' ' ' ALA . . . 68.51 52.25 26.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.954 HG22 ' OG1' ' A' ' 70' ' ' THR . 3.3 m -95.71 166.64 14.14 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.673 -0.898 . . . . 0.0 110.415 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 40.6 Cg_endo -70.34 146.88 57.86 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.912 1.48 . . . . 0.0 110.613 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.711 ' HB1' ' HB2' ' A' ' 78' ' ' ALA . . . 41.47 71.37 1.33 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.75 . . . . 0.0 110.092 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 77' ' ' SER . 43.1 Cg_endo -69.18 136.66 35.13 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.133 1.596 . . . . 0.0 109.506 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.52 ' CB ' ' SG ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER 61.62 14.61 6.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.979 -1.076 . . . . 0.0 108.93 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.711 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . . . -53.78 -19.13 3.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.493 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . -93.01 -61.37 1.59 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.751 -0.593 . . . . 0.0 110.076 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 77' ' ' SER . 30.5 p -63.84 -155.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.765 . . . . 0.0 110.056 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 79' ' ' ALA . 3.5 mmtt -120.52 133.43 55.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.559 HD11 ' SG ' ' A' ' 85' ' ' CYS . 7.8 tp -138.57 156.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 109.845 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.9 m -154.21 125.91 7.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.183 -0.948 . . . . 0.0 110.055 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 56.53 55.29 30.52 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 82' ' ' ILE . 88.4 m -133.14 140.46 47.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -1.092 . . . . 0.0 111.064 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -101.95 166.38 10.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.079 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CD1' ' O ' ' A' ' 86' ' ' THR . 1.9 m-85 -152.8 157.26 40.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.835 -1.165 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER 177.48 132.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.656 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . . . -41.79 136.7 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.434 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.231 0.539 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 3' ' ' SER . . . -141.25 106.44 0.47 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER 70.7 -56.34 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -1.15 . . . . 0.0 110.552 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.94 -158.4 0.88 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.065 -1.022 . . . . 0.0 110.633 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 5' ' ' THR . 8.1 t -96.46 57.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.477 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 11' ' ' LEU . 7.9 m120 -149.01 111.75 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 23' ' ' THR . 9.5 p -98.4 111.05 23.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 73.9 -0.71 3.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 109.902 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -110.94 -177.18 3.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 109.599 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -143.47 99.69 3.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.604 HD12 HG21 ' A' ' 27' ' ' VAL . 4.4 tp -90.36 25.81 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.643 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 t 54.65 93.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.123 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -37.99 -28.54 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.761 . . . . 0.0 111.318 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 12' ' ' SER . 9.1 p30 -83.48 11.41 7.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -99.68 -149.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 0.0 109.522 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -113.82 99.63 7.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.023 -1.048 . . . . 0.0 109.781 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.3 m -73.97 55.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 110.104 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.21 80.15 1.74 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.212 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -171.92 -145.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.766 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -106.77 -150.0 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.355 -0.841 . . . . 0.0 110.19 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.521 HG21 ' OG1' ' A' ' 7' ' ' THR . 2.6 m -165.01 151.05 10.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.863 HD13 HG22 ' A' ' 38' ' ' THR . 0.1 OUTLIER -158.59 22.97 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 7' ' ' THR . 15.4 p 48.95 38.34 12.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.246 -0.909 . . . . 0.0 111.09 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 0.6 OUTLIER -157.73 53.28 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.019 -1.051 . . . . 0.0 110.271 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -149.45 107.41 3.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.064 -1.023 . . . . 0.0 110.386 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 10.3 m-85 -106.9 88.28 2.71 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.854 HG13 ' CB ' ' A' ' 42' ' ' PHE . 11.0 t -93.73 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 111.371 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 7.5 t0 -150.07 126.5 10.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.0 109.852 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER 41.66 56.6 3.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.006 -1.059 . . . . 0.0 110.181 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.665 ' OG ' HG12 ' A' ' 27' ' ' VAL . 15.4 m -122.37 176.95 5.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.92 . . . . 0.0 110.77 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.812 ' HB2' HG23 ' A' ' 46' ' ' THR . 21.8 mt-10 -144.06 100.39 3.55 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 108.789 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.58 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.0 m -106.55 152.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 32.9 t80 -134.57 85.93 2.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . 78.02 43.78 13.21 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 50' ' ' SER . 1.9 m -104.69 166.23 10.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -1.083 . . . . 0.0 110.286 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -130.47 134.38 47.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HA ' HG21 ' A' ' 53' ' ' THR . 5.0 p -121.55 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 110.441 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.863 HG22 HD13 ' A' ' 22' ' ' LEU . 18.4 p -86.77 7.01 28.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.0 109.951 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.18 76.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 2.2 p -159.24 179.62 8.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.176 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.547 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -146.07 117.73 8.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 0.0 109.927 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.854 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.5 m-30 -98.94 150.52 21.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.036 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -145.83 71.79 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 109.589 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 88.33 73.68 1.28 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 HD12 ' A' ' 57' ' ' ILE . 3.1 t -145.55 138.85 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -1.159 . . . . 0.0 111.103 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.812 HG23 ' HB2' ' A' ' 31' ' ' GLU . 18.8 m -112.76 91.94 3.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.978 . . . . 0.0 109.112 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.751 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -112.3 170.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 14.6 t -118.18 -145.76 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.82 -1.175 . . . . 0.0 109.969 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.551 ' CA ' ' O ' ' A' ' 33' ' ' TYR . 39.9 m -64.81 80.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' THR . 3.0 p -137.59 149.98 47.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.299 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 67' ' ' CYS . 9.0 t -112.64 66.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 0.0 110.202 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.46 91.46 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 37' ' ' CYS . 62.4 p -123.5 141.32 52.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.139 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.68 -32.29 1.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB3' ' C ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -122.32 160.57 25.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 110.525 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 110.22 21.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.829 HD12 HG21 ' A' ' 45' ' ' VAL . 7.3 pt -106.95 159.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.074 -1.017 . . . . 0.0 112.424 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 5.5 t -146.12 -173.72 4.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 151.49 119.79 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.669 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.57 -7.5 21.33 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.699 1.368 . . . . 0.0 108.645 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.4 37.28 0.3 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.9 t -71.83 144.25 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.499 -1.001 . . . . 0.0 110.581 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' THR . 18.3 mtpt -144.41 117.93 9.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.622 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.68 ' HB ' HG22 ' A' ' 47' ' ' ILE . 3.7 tt -105.03 174.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.89 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -147.01 84.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.914 179.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' SER . 0.2 OUTLIER 60.07 135.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.765 ' O ' HG22 ' A' ' 51' ' ' THR . 42.3 t -167.15 167.93 13.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 69' ' ' ILE . 5.6 mt -99.88 179.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 110.027 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.552 ' H ' HG22 ' A' ' 68' ' ' ILE . 1.5 pt -45.51 171.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.113 -0.992 . . . . 0.0 110.039 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -133.32 -137.65 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 111.02 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.13 43.87 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.8 67.07 0.87 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.727 HG23 ' HD2' ' A' ' 74' ' ' PRO . 5.4 p -89.85 147.71 38.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.459 -1.024 . . . . 0.0 111.14 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.727 ' HD2' HG23 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -71.18 145.44 49.09 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 124.037 1.546 . . . . 0.0 110.908 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.842 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -50.04 -56.18 19.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.301 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.842 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 42.0 Cg_endo -70.25 70.32 1.85 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.831 1.437 . . . . 0.0 110.117 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 82' ' ' ILE . 1.2 m -59.25 73.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 110.774 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 76' ' ' PRO . . . -57.47 -17.64 14.41 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.165 -0.959 . . . . 0.0 108.625 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -78.84 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.419 0.628 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.8 m -74.54 -172.24 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.86 . . . . 0.0 110.399 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.543 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 4.7 mmtp -114.73 113.83 24.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.386 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.533 HG22 ' HB2' ' A' ' 77' ' ' SER . 2.1 tp -140.6 147.65 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.995 . . . . 0.0 110.542 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 m -145.27 111.78 5.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.278 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.99 57.07 3.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.503 ' SG ' HG13 ' A' ' 82' ' ' ILE . 69.8 m -138.85 153.9 48.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -105.4 157.75 17.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.489 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.5 m-85 -144.28 146.66 32.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.101 -0.999 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER 174.1 118.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.74 . . . . 0.0 109.408 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -33.93 125.35 0.45 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.8 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.1 t30 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.254 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 t0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.247 0.546 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.65 -125.76 1.16 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -33.51 67.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.198 . . . . 0.0 109.407 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p 176.96 -42.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.485 ' CB ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 m -143.57 32.33 1.31 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -112.42 59.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 11.2 p -99.57 105.84 17.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.076 -1.015 . . . . 0.0 110.306 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 7' ' ' THR . 4.2 t-20 66.65 6.78 4.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -129.85 -165.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.023 -1.048 . . . . 0.0 110.395 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -142.99 104.47 4.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 16' ' ' LYS . 30.3 tp -91.38 21.21 4.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.324 -0.86 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER 71.5 0.77 3.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.472 -0.768 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.68 19.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.012 . . . . 0.0 109.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.6 t30 -157.4 13.71 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.996 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -101.15 -145.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.761 -1.212 . . . . 0.0 109.703 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.628 ' O ' HD21 ' A' ' 11' ' ' LEU . 1.8 tptt -104.0 131.7 50.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.01 . . . . 0.0 109.227 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' ' CB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.22 65.39 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 111.087 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -98.05 147.78 24.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.06 -1.025 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 57.69 158.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.57 122.38 45.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.452 ' CG2' ' SG ' ' A' ' 37' ' ' CYS . 3.4 m -93.55 152.96 18.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.008 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.05 54.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 109.378 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -161.04 -158.36 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.337 -0.852 . . . . 0.0 110.701 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -95.75 115.11 26.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.609 -0.682 . . . . 0.0 110.978 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 9' ' ' SER . 54.7 m -154.73 110.74 3.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.672 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 28.6 m-85 -101.86 122.26 43.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.76 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.109 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.6 t -120.35 167.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 110.308 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.607 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.1 m-20 -146.95 113.81 6.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 47.43 68.6 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.872 -1.143 . . . . 0.0 110.037 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.721 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -133.86 -171.02 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.158 -0.964 . . . . 0.0 111.346 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.22 100.84 3.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 71.1 t -101.42 157.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 111.15 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.654 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.34 -140.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 49' ' ' THR . . . -71.24 58.78 1.11 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 50' ' ' SER . 0.8 OUTLIER -96.96 -144.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.394 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.791 HG21 HG23 ' A' ' 51' ' ' THR . 31.0 p -139.53 -158.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.956 -1.09 . . . . 0.0 110.99 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 36' ' ' THR . 36.1 t 178.7 53.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.94 48.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.74 88.14 2.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.557 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 67.3 p -169.95 174.13 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -1.109 . . . . 0.0 110.391 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -137.91 138.64 39.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.453 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.109 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.7 m-85 -118.29 168.79 10.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.911 -1.118 . . . . 0.0 110.398 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER 176.57 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 108.739 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.44 68.05 1.31 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.755 ' CG1' HG23 ' A' ' 47' ' ' ILE . 15.0 t -143.02 109.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.363 -1.08 . . . . 0.0 111.265 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' THR . 5.7 m -94.89 86.27 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.896 -1.128 . . . . 0.0 108.595 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.755 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -112.41 163.37 9.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.563 -0.711 . . . . 0.0 110.451 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.783 HG23 ' N ' ' A' ' 49' ' ' THR . 1.4 t -115.29 -152.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.04 -1.038 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.783 ' N ' HG23 ' A' ' 48' ' ' THR . 8.8 m -58.87 87.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.688 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 0.7 OUTLIER -138.59 -162.26 1.29 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.966 -1.084 . . . . 0.0 110.835 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.791 HG23 HG21 ' A' ' 36' ' ' THR . 0.4 OUTLIER -144.01 67.21 1.27 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.8 79.41 2.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.328 -0.858 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 28.9 p -121.57 175.11 6.38 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 110.684 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.45 -34.43 4.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.536 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -129.85 163.84 25.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -1.133 . . . . 0.0 110.386 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.7 ptm180 -96.02 136.75 36.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.739 HG22 HG22 ' A' ' 45' ' ' VAL . 2.2 mt -110.73 163.94 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -0.96 . . . . 0.0 111.312 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.2 OUTLIER -147.31 149.82 33.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 167.01 116.24 0.35 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.415 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.93 -5.92 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.651 1.343 . . . . 0.0 108.819 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.11 38.51 0.34 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.8 t -71.41 155.16 40.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -1.118 . . . . 0.0 110.711 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 83' ' ' SER . 0.1 OUTLIER -143.34 107.86 4.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.481 -0.762 . . . . 0.0 109.56 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 4.9 tt -104.49 168.59 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 0.0 109.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -150.74 97.93 2.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 0.0 110.628 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 2.2 p 55.63 108.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.336 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.76 -156.35 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 68' ' ' ILE . 24.1 mt -146.78 140.83 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.525 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -52.8 112.14 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 110.369 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' THR . 2.9 m -148.51 135.69 20.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.925 -1.109 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.71 77.44 0.64 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' A' ' 55' ' ' SER . . . 109.94 115.21 3.68 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.597 HG13 ' HD2' ' A' ' 74' ' ' PRO . 69.3 t -89.54 143.3 30.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.258 -1.142 . . . . 0.0 110.047 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.597 ' HD2' HG13 ' A' ' 73' ' ' VAL . 43.3 Cg_endo -69.88 139.31 39.51 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.035 1.545 . . . . 0.0 110.893 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.623 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -57.53 -45.24 99.88 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.512 -0.742 . . . . 0.0 111.277 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 43.1 Cg_endo -70.86 -49.59 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.244 1.128 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.423 ' OG ' HG22 ' A' ' 82' ' ' ILE . 1.0 OUTLIER 64.02 35.01 10.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.936 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.82 -23.96 0.87 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.033 -1.042 . . . . 0.0 108.905 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.87 -73.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.557 -0.714 . . . . 0.0 110.102 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -66.63 168.19 9.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -113.58 103.89 11.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.125 -0.984 . . . . 0.0 110.816 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -122.58 157.34 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.849 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 11.3 t -151.76 101.83 2.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 81.59 57.85 2.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.88 150.51 34.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -1.136 . . . . 0.0 111.239 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.585 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 9.0 t -110.7 160.68 16.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.432 -0.793 . . . . 0.0 109.004 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.3 m-85 -131.18 154.22 48.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.804 -1.185 . . . . 0.0 110.839 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' ARG . 4.0 m -174.05 120.05 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.716 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.35 139.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.416 -0.802 . . . . 0.0 110.576 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.523 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.3 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.147 0.499 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.4 -129.31 6.26 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 t -45.11 -25.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.87 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 178.15 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.591 HG22 ' CB ' ' A' ' 17' ' ' CYS . 3.6 t -122.09 19.5 10.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.02 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.18 52.22 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.842 . . . . 0.0 109.934 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 7' ' ' THR . 11.0 t -98.67 92.51 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 109.786 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.8 OUTLIER 69.91 3.51 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.795 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.32 149.32 40.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.399 -0.813 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 27' ' ' VAL . 1.3 mt-30 -107.92 88.04 2.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 109.987 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.052 HD21 ' O ' ' A' ' 16' ' ' LYS . 3.3 tp -88.58 25.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 7.7 t 53.67 103.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.45 -23.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.3 t-20 -89.86 14.91 10.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 111.707 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 0.0 OUTLIER -113.56 -164.08 0.9 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.567 -1.333 . . . . 0.0 110.141 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 1.052 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -114.66 147.49 39.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.14 -0.975 . . . . 0.0 109.724 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' HB3' HD22 ' A' ' 11' ' ' LEU . 6.6 p -123.11 72.75 1.12 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.724 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -84.56 138.22 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.063 -1.023 . . . . 0.0 109.842 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 70.73 -172.9 0.17 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.187 -0.946 . . . . 0.0 110.011 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -93.03 176.5 6.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.184 -0.948 . . . . 0.0 110.391 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.4 m -152.36 149.91 29.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.112 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 22' ' ' LEU . 9.2 tp -71.11 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 0.0 110.496 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 70.6 p -136.05 39.88 2.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 110.537 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.7 t30 -149.52 63.31 1.01 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 110.417 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 87.0 m -153.33 114.39 4.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.903 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 27.9 m-85 -107.91 92.65 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.799 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.976 HG13 ' HB3' ' A' ' 42' ' ' PHE . 12.7 t -93.56 167.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.247 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.7 t0 -148.28 122.12 9.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 109.596 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 44.12 61.65 2.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 0.0 109.565 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.739 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -131.78 -174.88 3.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 111.222 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -145.17 104.46 3.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.706 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 11' ' ' LEU . 2.9 m -117.46 136.24 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.805 -1.184 . . . . 0.0 110.112 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.606 ' HB2' ' N ' ' A' ' 49' ' ' THR . 4.0 m-85 -97.87 -137.65 0.28 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 49' ' ' THR . . . -65.45 59.46 0.11 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.561 ' N ' ' O ' ' A' ' 33' ' ' TYR . 2.3 m -95.1 162.07 13.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -1.169 . . . . 0.0 110.043 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.443 HG21 HG23 ' A' ' 51' ' ' THR . 13.5 p -100.61 -169.38 1.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.401 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.886 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -168.51 140.25 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.767 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 1.8 t 178.55 43.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.27 41.0 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.789 ' OG ' HG22 ' A' ' 53' ' ' THR . 0.9 OUTLIER -131.12 171.87 12.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 109.955 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 2.2 tpt85 -146.46 129.71 16.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 109.948 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.976 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.8 m-85 -109.13 170.48 8.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.905 -1.122 . . . . 0.0 110.715 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -174.85 80.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.015 . . . . 0.0 110.176 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 83.71 66.72 1.49 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.059 HG21 HG22 ' A' ' 57' ' ' ILE . 2.3 t -146.97 136.71 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.808 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.5 m -107.77 93.2 4.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.763 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.93 171.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 110.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 49' ' ' THR . 1.6 t -118.69 -162.14 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.426 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 66' ' ' THR . 20.2 m -54.71 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' THR . 66.4 m -128.49 146.72 50.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 51' ' ' THR . 86.4 m -100.03 48.3 0.93 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.536 -0.728 . . . . 0.0 109.317 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 3.1 t -111.35 100.32 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.886 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -144.39 99.76 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.511 ' N ' ' HB ' ' A' ' 70' ' ' THR . . . -161.63 -48.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.561 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -101.57 -168.16 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.459 -1.024 . . . . 0.0 109.782 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.9 mtp85 -91.11 141.09 29.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.742 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.059 HG22 HG21 ' A' ' 45' ' ' VAL . 3.2 mm -113.1 127.27 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 110.155 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.418 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.3 152.96 40.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.245 -0.909 . . . . 0.0 110.012 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 118.0 0.42 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.7 -2.48 11.47 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.569 1.299 . . . . 0.0 109.704 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.85 30.76 0.18 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 7.2 t -73.02 152.89 41.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -1.068 . . . . 0.0 111.157 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.31 108.84 4.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.642 -0.661 . . . . 0.0 109.778 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.727 HG13 HD12 ' A' ' 82' ' ' ILE . 2.0 tt -99.02 176.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.062 -1.024 . . . . 0.0 110.123 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -151.77 75.21 1.14 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.906 -1.122 . . . . 0.0 110.953 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER 59.88 73.48 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 110.837 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' A' ' 64' ' ' ILE . 88.1 m -100.33 -178.26 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.735 HG22 ' OG ' ' A' ' 77' ' ' SER . 1.1 tt -89.76 -178.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.658 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 5.1 pt -51.05 -174.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.511 ' HB ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -142.37 -148.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 110.701 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 70' ' ' THR . . . 113.24 34.92 1.7 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . 79.04 34.43 33.55 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.579 ' HB ' ' CG ' ' A' ' 76' ' ' PRO . 20.1 m -118.39 96.65 50.08 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.482 -1.011 . . . . 0.0 110.697 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 75' ' ' ALA . 50.6 Cg_endo -79.5 -52.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.962 1.506 . . . . 0.0 111.052 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.871 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -38.12 -53.17 2.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.461 -0.774 . . . . 0.0 110.774 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.871 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 47.6 Cg_endo -74.89 162.05 38.0 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.79 1.416 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.735 ' OG ' HG22 ' A' ' 68' ' ' ILE . 0.1 OUTLIER 74.82 -6.43 1.94 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 110.458 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.85 -7.62 36.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 108.988 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.92 40.38 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.603 -0.686 . . . . 0.0 109.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 77' ' ' SER . 16.9 p -73.81 -161.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.602 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -116.4 130.41 56.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 0.0 110.25 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.727 HD12 HG13 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -143.29 146.38 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 -179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.443 ' O ' ' SG ' ' A' ' 85' ' ' CYS . 1.7 t -157.11 136.99 12.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.85 -1.156 . . . . 0.0 111.283 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 52.37 61.98 6.17 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 87' ' ' PHE . 55.9 m -135.46 168.53 19.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.283 . . . . 0.0 111.07 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.64 123.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.627 -0.671 . . . . 0.0 109.201 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.726 ' CD1' HD13 ' A' ' 57' ' ' ILE . 10.8 m-85 -126.98 160.51 30.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.857 -1.152 . . . . 0.0 111.478 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 89' ' ' ALA . 7.0 p -166.58 129.03 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -34.48 142.41 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 110.892 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.561 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.4 t-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.099 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.119 0.485 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -154.04 138.17 6.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t 45.89 -92.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -1.129 . . . . 0.0 110.149 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 8.1 t -128.6 -60.18 1.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.753 ' O ' HG22 ' A' ' 5' ' ' THR . 20.7 m -126.32 60.64 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.126 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -133.98 65.76 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.394 -0.816 . . . . 0.0 110.003 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.634 HG21 HD22 ' A' ' 22' ' ' LEU . 9.8 t -102.53 -139.23 0.35 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.31 -0.869 . . . . 0.0 110.419 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -41.73 -23.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.223 -0.923 . . . . 0.0 110.967 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -107.78 162.97 13.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.0 110.557 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.406 ' OE1' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.51 106.87 17.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.828 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 12' ' ' SER . 4.0 tp -88.57 32.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.6 t 67.3 2.8 2.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.53 -0.731 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 45.4 22.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.956 -1.09 . . . . 0.0 110.497 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' SER . 41.4 t30 -160.8 15.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.1 m -96.82 -136.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.091 -1.005 . . . . 0.0 109.168 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -115.0 123.76 49.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.871 -1.143 . . . . 0.0 109.87 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.03 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 0.0 110.529 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.856 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.26 -154.73 0.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.89 . . . . 0.0 109.646 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -148.21 150.76 34.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.027 -1.046 . . . . 0.0 110.845 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 3.0 t 68.94 95.4 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.82 . . . . 0.0 110.827 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' N ' ' A' ' 22' ' ' LEU . 26.0 m -151.0 -93.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.634 HD22 HG21 ' A' ' 7' ' ' THR . 0.7 OUTLIER 53.17 37.43 25.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.801 HG21 ' HA ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -144.23 -151.53 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.102 -0.999 . . . . 0.0 110.698 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -93.34 110.26 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.401 -0.812 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 3.3 m -155.25 111.6 3.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.048 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CD1' ' NH2' ' A' ' 41' ' ' ARG . 3.7 t80 -111.09 101.72 10.23 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.078 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.061 HG13 ' HB3' ' A' ' 42' ' ' PHE . 11.4 t -104.27 164.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -145.63 122.73 11.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 109.713 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 44.12 64.96 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.013 . . . . 0.0 109.525 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.743 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -134.26 -169.8 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 111.613 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 21.1 tt0 -145.06 98.39 3.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.856 HG12 ' CB ' ' A' ' 18' ' ' GLU . 62.1 t -105.62 138.84 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.847 -1.158 . . . . 0.0 110.43 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' THR . 1.8 t80 -142.75 129.21 20.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.93 40.71 9.87 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.553 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 14.0 m -103.94 165.73 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -1.136 . . . . 0.0 110.247 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.88 HG21 HG22 ' A' ' 51' ' ' THR . 6.8 p -105.05 -170.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 110.015 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.945 ' HA ' HG21 ' A' ' 53' ' ' THR . 36.3 t -172.53 128.31 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.576 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.801 ' HA ' HG21 ' A' ' 23' ' ' THR . 19.4 m -163.02 33.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 109.689 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 123.92 62.62 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.531 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 28.7 p -143.0 170.81 15.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.572 ' NH2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -139.48 127.47 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.067 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.061 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.7 m-85 -109.06 169.69 8.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 45' ' ' VAL . 5.7 t70 178.99 112.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 52.87 62.72 5.64 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.819 HG12 HG23 ' A' ' 47' ' ' ILE . 14.5 t -142.83 123.14 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -1.014 . . . . 0.0 110.772 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 41.8 m -101.47 98.6 8.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.096 -1.003 . . . . 0.0 109.354 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.819 HG23 HG12 ' A' ' 45' ' ' VAL . 1.3 pt -113.38 156.58 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.191 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -135.78 127.73 29.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.847 . . . . 0.0 109.805 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER 40.85 79.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.876 . . . . 0.0 110.013 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.2 t -138.98 148.91 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.071 -1.018 . . . . 0.0 110.773 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.88 HG22 HG21 ' A' ' 36' ' ' THR . 4.1 p -115.97 41.23 2.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 1.2 t -104.89 116.65 32.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 110.177 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.945 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -146.28 112.25 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 110.225 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 165.32 -31.31 0.23 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.7 p -113.09 163.07 15.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.044 -1.268 . . . . 0.0 110.707 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -91.78 120.22 32.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.0 109.591 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -99.71 156.73 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.078 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -147.11 142.49 27.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.695 -0.628 . . . . 0.0 109.897 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 163.59 114.14 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.383 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.59 -7.48 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 N-CA-C 108.427 -1.413 . . . . 0.0 108.427 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.93 26.91 1.61 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.4 t -72.03 147.27 47.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.406 -1.055 . . . . 0.0 110.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 115.24 9.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.539 HG13 HD12 ' A' ' 82' ' ' ILE . 7.5 tt -104.94 174.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.734 ' C ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.48 99.03 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.565 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.734 HG23 ' C ' ' A' ' 65' ' ' SER . 1.2 p 69.24 -68.17 0.2 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.664 -0.647 . . . . 0.0 110.719 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.581 ' C ' HG22 ' A' ' 68' ' ' ILE . 0.5 OUTLIER 65.63 -153.84 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.066 . . . . 0.0 110.526 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.581 HG22 ' C ' ' A' ' 67' ' ' CYS . 1.3 tt 172.54 95.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ILE . 5.1 mt 59.88 134.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.308 -0.87 . . . . 0.0 110.062 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.495 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -113.28 -71.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.979 -1.076 . . . . 0.0 111.105 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' H ' ' HA3' ' A' ' 54' ' ' GLY . . . 45.23 71.6 0.47 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 89' ' ' ALA . . . 46.63 83.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.495 ' CG1' ' HA ' ' A' ' 70' ' ' THR . 24.0 m -84.99 163.07 47.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.103 -1.234 . . . . 0.0 110.39 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.51 150.09 21.73 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.157 1.609 . . . . 0.0 110.65 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.006 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -46.79 -60.01 4.41 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.181 -0.95 . . . . 0.0 109.755 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.006 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 49.9 Cg_endo -73.13 83.98 1.38 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.027 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ALA . 8.0 p -43.81 -50.7 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.461 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.74 25.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.056 -1.027 . . . . 0.0 108.839 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -160.43 -69.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.533 -0.73 . . . . 0.0 109.826 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 2.4 t -73.05 165.29 25.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.574 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 23.3 mmtt -99.2 94.51 6.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.557 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.2 tp -128.92 151.65 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.85 . . . . 0.0 110.399 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 104.99 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.11 5.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.557 ' SG ' HD11 ' A' ' 82' ' ' ILE . 56.8 m -134.5 153.81 51.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -1.193 . . . . 0.0 110.464 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -109.4 163.48 13.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 86' ' ' THR . 3.2 m-85 -138.88 159.68 41.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.15 -0.969 . . . . 0.0 110.06 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -176.48 38.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 110.21 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 41.82 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.296 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 54' ' ' GLY . 1.5 t-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.961 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 34.8 p-10 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.243 0.544 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 3' ' ' SER . . . -166.85 111.47 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.546 ' HB2' ' CB ' ' A' ' 6' ' ' ASN . 69.3 m 43.25 65.55 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -1.111 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.872 ' CG2' HD22 ' A' ' 11' ' ' LEU . 13.2 t -144.63 35.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 1.1 t-20 -99.67 57.95 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 1.8 t -98.34 95.61 7.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.904 . . . . 0.0 109.542 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 7' ' ' THR . 6.4 t-20 70.4 7.03 6.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.522 ' CB ' ' CG2' ' A' ' 21' ' ' THR . 4.8 m -126.7 179.92 5.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 8.7 tt0 -134.47 95.6 3.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.949 . . . . 0.0 110.043 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.872 HD22 ' CG2' ' A' ' 5' ' ' THR . 12.5 tp -88.53 31.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.975 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 68.52 3.54 3.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 0.0 110.551 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.09 25.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.608 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' SER . 28.6 t30 -162.29 19.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.621 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' SER . 2.0 m -104.61 -144.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 14.6 mmtm -114.14 91.55 3.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.836 -1.165 . . . . 0.0 110.155 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 p -65.62 67.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -0.784 . . . . 0.0 110.642 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 14.0 mm-40 -88.4 54.55 3.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.77 81.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 1.6 m -151.59 -62.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.448 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' CB ' ' A' ' 9' ' ' SER . 80.5 m -46.74 166.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.493 ' N ' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -145.6 -74.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.639 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.427 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 5.0 t -154.2 13.5 0.44 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.157 -0.964 . . . . 0.0 110.933 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.36 65.17 0.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.826 -1.171 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.56 112.32 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 110.764 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 27.2 m-85 -101.8 96.46 7.08 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.107 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -100.6 163.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 111.115 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.591 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 3.8 t0 -141.44 119.01 11.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.532 -0.73 . . . . 0.0 109.379 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 28' ' ' ASP . 4.5 ttmm 39.98 70.45 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.21 -0.932 . . . . 0.0 109.926 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.768 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.0 m -131.76 -178.79 5.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.9 . . . . 0.0 110.886 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -144.97 97.53 3.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 1.9 m -104.2 153.15 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.966 -1.084 . . . . 0.0 110.576 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 10.2 t80 -139.48 138.33 36.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.169 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 38.26 40.04 0.83 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 2.4 m -94.66 167.61 11.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.149 -1.206 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.823 HG21 HG23 ' A' ' 51' ' ' THR . 10.9 p -105.39 -52.31 2.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.857 . . . . 0.0 110.157 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.1 OUTLIER 59.74 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.0 110.075 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.722 HG22 HG21 ' A' ' 53' ' ' THR . 8.0 t -173.51 64.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 117.42 32.76 1.42 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.614 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -133.77 -178.18 4.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -1.144 . . . . 0.0 110.039 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 26' ' ' TYR . 3.2 tpt180 -142.71 125.71 16.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 108.764 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.107 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.6 m-85 -103.96 162.09 13.43 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 3.5 t0 -170.09 103.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.539 -0.726 . . . . 0.0 109.144 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 61.39 67.69 2.0 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.742 ' CG1' HG23 ' A' ' 47' ' ' ILE . 4.6 t -145.58 127.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 110.835 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 31' ' ' GLU . 61.7 m -108.43 87.78 2.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 108.815 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.742 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.76 154.75 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.653 -0.654 . . . . 0.0 110.427 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.78 HG23 ' N ' ' A' ' 49' ' ' THR . 1.5 t -108.65 -150.26 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.78 ' N ' HG23 ' A' ' 48' ' ' THR . 87.9 m -45.1 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.134 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -139.71 135.95 33.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 111.307 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.823 HG23 HG21 ' A' ' 36' ' ' THR . 97.5 m -108.35 61.24 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 29.3 m -114.91 113.68 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 110.766 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.722 HG21 HG22 ' A' ' 38' ' ' THR . 34.7 p -131.91 -151.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.371 -0.83 . . . . 0.0 109.642 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 90' ' ' ASN . . . 76.55 -65.87 2.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -101.89 171.53 7.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.286 -1.126 . . . . 0.0 109.448 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -104.96 158.7 16.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.775 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.706 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -123.33 155.07 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.689 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.531 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.73 157.67 43.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.259 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 160.29 127.32 0.89 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.146 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.55 -5.5 17.17 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.673 1.354 . . . . 0.0 108.871 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.98 35.13 0.36 Allowed Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.514 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 10.1 t -71.76 147.45 47.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.757 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.71 120.02 10.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.01 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.519 HG21 ' HB ' ' A' ' 47' ' ' ILE . 3.8 tt -104.25 178.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.289 -0.882 . . . . 0.0 109.938 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 66' ' ' THR . 3.2 t -150.8 58.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.889 -1.132 . . . . 0.0 111.14 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 65' ' ' SER . 1.6 m 66.83 83.85 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 111.349 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.48 -149.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 109.371 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 68' ' ' ILE . 7.6 mm -120.85 158.21 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.91 -1.119 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 3.7 tt -52.35 144.77 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 110.229 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 70' ' ' THR . 3.4 t -148.66 107.68 3.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.545 ' N ' HG22 ' A' ' 73' ' ' VAL . . . -92.69 62.08 2.33 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.905 ' HA3' ' HB2' ' A' ' 89' ' ' ALA . . . 81.47 34.97 24.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 71' ' ' GLY . 4.1 m -132.99 163.14 53.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.941 -0.741 . . . . 0.0 110.587 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 52.3 Cg_endo -80.18 -42.69 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.73 1.384 . . . . 0.0 109.519 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 74' ' ' PRO . . . 61.04 153.48 0.1 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.737 . . . . 0.0 110.254 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.52 59.1 3.95 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.178 1.62 . . . . 0.0 110.955 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.97 11.45 13.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 110.013 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.18 -23.87 0.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.361 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.91 -3.57 48.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 110.105 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.6 -178.44 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.027 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 105.15 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.581 HD11 ' SG ' ' A' ' 85' ' ' CYS . 10.5 tp -127.95 142.65 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -142.87 125.28 15.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 63.65 62.64 5.11 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 82' ' ' ILE . 59.2 m -145.39 148.45 33.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 111.079 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.531 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 13.5 t -116.74 157.66 25.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.34 152.14 50.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.769 -1.207 . . . . 0.0 110.602 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.6 m -170.54 124.77 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.352 -0.842 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.905 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . . . -45.1 147.65 0.68 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 110.559 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 41' ' ' ARG . 1.1 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.051 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 1' ' ' ASP . 63.6 t0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.207 0.527 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 3' ' ' SER . . . -161.62 -158.81 9.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 2' ' ' GLY . 28.0 t -41.87 -53.27 3.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -1.075 . . . . 0.0 110.458 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.61 -79.53 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.798 ' CG2' HD22 ' A' ' 11' ' ' LEU . 5.1 t -122.31 56.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -99.13 93.28 5.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.331 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.755 HG21 ' O ' ' A' ' 21' ' ' THR . 10.1 t -134.66 -138.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.63 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 7' ' ' THR . 11.6 m-20 -39.47 -27.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.811 . . . . 0.0 110.606 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 4.7 m -108.49 -164.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.149 -0.97 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -140.75 127.56 20.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.798 HD22 ' CG2' ' A' ' 5' ' ' THR . 21.4 tp -88.27 24.02 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.7 t 61.03 11.25 3.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.49 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' SER . 26.3 t-20 -161.04 15.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 111.03 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.2 m -98.79 -139.0 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.392 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 3.7 tptt -114.78 141.15 48.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.3 93.54 2.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 110.599 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.642 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.19 -145.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 110.437 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -76.66 -161.53 0.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 110.087 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 171.4 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.755 ' O ' HG21 ' A' ' 7' ' ' THR . 17.7 m -138.09 142.54 40.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.888 . . . . 0.0 110.15 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -136.59 28.64 2.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -156.87 -149.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 110.317 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.428 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.9 m120 -87.44 122.85 31.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.266 -0.896 . . . . 0.0 109.985 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.846 ' O ' HG23 ' A' ' 27' ' ' VAL . 11.9 m -155.35 31.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.557 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' HB3' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -45.78 119.7 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 110.024 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.904 HG22 ' HB2' ' A' ' 42' ' ' PHE . 30.4 t -119.13 161.25 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 110.609 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -142.03 118.87 11.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 109.672 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.8 mmtp 43.26 68.12 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.511 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.7 m -133.47 -172.09 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 111.115 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' HB3' HG23 ' A' ' 46' ' ' THR . 11.2 tt0 -143.81 99.21 3.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.66 HG13 HD11 ' A' ' 47' ' ' ILE . 40.2 t -101.06 150.06 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.052 . . . . 0.0 110.575 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -143.16 116.19 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 43.33 51.44 6.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.528 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 2.4 m -107.08 156.5 18.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 35' ' ' THR . 19.4 p -91.04 -173.14 3.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.721 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.8 OUTLIER -157.87 124.28 4.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.362 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.503 ' HA ' HG21 ' A' ' 23' ' ' THR . 0.7 OUTLIER -163.98 55.87 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.981 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.439 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 96.79 96.21 1.87 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.564 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 14.1 p -177.98 173.38 1.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -1.152 . . . . 0.0 110.28 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' A' ' 56' ' ' ARG . 6.3 tpt180 -146.97 131.81 18.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 109.649 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.904 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.9 m-85 -109.35 169.86 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.9 t70 178.33 116.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 109.136 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.75 65.37 2.45 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.859 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.0 t -145.33 138.06 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -1.09 . . . . 0.0 110.83 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 31' ' ' GLU . 81.5 m -116.61 94.68 4.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 109.228 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.707 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.3 pt -114.08 172.39 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.833 HG23 ' N ' ' A' ' 49' ' ' THR . 2.0 t -131.38 -146.52 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.378 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.833 ' N ' HG23 ' A' ' 48' ' ' THR . 6.6 m -54.91 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 11.3 p -139.61 158.29 44.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -0.921 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -118.04 45.31 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.854 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -95.72 103.49 15.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 110.13 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 37' ' ' CYS . 3.0 p -138.6 112.93 8.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 110.416 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 176.3 -54.89 0.11 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.543 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -102.63 -173.54 2.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.817 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 7.8 ttp180 -104.02 125.96 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.096 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.859 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.49 153.62 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.965 . . . . 0.0 110.308 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.57 160.64 41.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 154.09 122.56 0.86 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.22 -5.62 17.41 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.692 1.364 . . . . 0.0 109.036 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.53 34.12 0.33 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -72.26 154.9 40.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 110.206 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.54 113.19 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -96.68 172.26 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.058 -1.026 . . . . 0.0 109.161 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 11.0 t -149.04 67.81 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.898 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.9 m 64.01 98.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 111.06 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 64' ' ' ILE . 76.8 m -107.92 -144.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.413 -0.804 . . . . 0.0 109.246 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 77' ' ' SER . 97.0 mt -128.26 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.77 -1.206 . . . . 0.0 110.581 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 tp -151.17 158.39 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 55' ' ' SER . 0.2 OUTLIER -125.8 -154.22 0.61 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.431 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . 105.39 38.33 2.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . 76.55 33.36 47.92 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.441 ' HB ' ' CG ' ' A' ' 76' ' ' PRO . 6.3 m -129.0 91.66 41.98 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.481 -1.011 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.32 -29.55 1.89 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.479 . . . . 0.0 109.797 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.869 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -49.49 -55.41 22.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.505 -0.747 . . . . 0.0 110.727 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.869 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 44.0 Cg_endo -70.51 156.83 60.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.777 1.409 . . . . 0.0 110.389 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER 69.26 4.76 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.155 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.84 -21.38 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.002 . . . . 0.0 109.136 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.95 59.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.669 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 81' ' ' LYS . 19.0 t -71.61 170.32 13.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -114.68 111.44 21.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.564 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 82' ' ' ILE . 6.9 tp -127.41 156.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -154.39 116.79 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.02 . . . . 0.0 110.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.15 46.78 33.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.24 159.99 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.028 -1.277 . . . . 0.0 111.361 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.402 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -116.96 154.82 30.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 85' ' ' CYS . 9.0 m-85 -133.13 147.91 52.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.927 -1.108 . . . . 0.0 110.401 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' ALA . 29.1 t -173.39 124.25 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.97 141.68 0.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.543 ' N ' ' HA ' ' A' ' 55' ' ' SER . 3.8 t-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.084 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.239 0.542 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.97 -109.47 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t -59.95 -62.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.2 t -147.02 -61.18 0.29 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 5' ' ' THR . 10.5 t -141.59 53.49 1.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.885 . . . . 0.0 109.998 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 1.8 m120 -146.64 139.54 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 9' ' ' SER . 17.1 p -103.47 -135.49 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.762 ' CB ' HG22 ' A' ' 23' ' ' THR . 9.6 t-20 -42.71 -15.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.251 -0.905 . . . . 0.0 111.668 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.5 p -103.99 160.73 14.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.701 -1.249 . . . . 0.0 108.74 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HG2' ' N ' ' A' ' 11' ' ' LEU . 38.9 tt0 -107.13 155.13 20.2 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.024 -1.048 . . . . 0.0 111.899 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 31.9 tp -108.77 41.94 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.666 . . . . 0.0 109.292 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 18.4 t 58.57 12.78 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.792 . . . . 0.0 110.864 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 41.07 25.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.688 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' SER . 31.4 t30 -170.7 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.973 -1.079 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -103.67 -147.02 0.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.99 -1.068 . . . . 0.0 109.539 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.99 142.26 45.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.827 -1.171 . . . . 0.0 109.871 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.35 100.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.454 -0.779 . . . . 0.0 111.209 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.863 ' CB ' HG12 ' A' ' 32' ' ' VAL . 16.5 pm0 -83.22 -141.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -151.07 145.2 25.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 110.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.56 105.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.815 . . . . 0.0 110.522 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -137.4 143.86 42.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 109.951 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD22 ' HA ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -84.13 -140.71 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.972 . . . . 0.0 110.39 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' CB ' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -129.62 27.08 5.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -143.99 75.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.056 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' SER . 4.8 m -155.14 111.76 3.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -110.25 96.2 6.07 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.088 HG13 ' CB ' ' A' ' 42' ' ' PHE . 3.9 t -98.6 164.45 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 111.178 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 29' ' ' LYS . 41.5 m-20 -144.78 124.94 13.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.502 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 11.1 tttp 42.82 67.47 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.82 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.786 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.5 m -133.34 -174.07 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 111.239 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CB ' HG23 ' A' ' 46' ' ' THR . 3.1 tt0 -143.37 103.33 4.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.863 HG12 ' CB ' ' A' ' 18' ' ' GLU . 47.7 t -105.47 142.86 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.012 -1.055 . . . . 0.0 110.071 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t80 -140.09 102.93 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 51.89 53.36 30.36 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.538 HG21 ' CD1' ' A' ' 47' ' ' ILE . 55.2 m -114.23 154.79 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -1.168 . . . . 0.0 110.238 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.414 HG21 HG23 ' A' ' 51' ' ' THR . 22.8 p -86.22 140.28 30.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.18 43.42 2.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.632 ' HA ' HD22 ' A' ' 22' ' ' LEU . 17.9 p -77.85 3.81 13.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 166.26 97.12 0.11 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.518 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 38.2 p -177.6 167.65 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -1.196 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -138.52 123.0 18.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 179.06 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.088 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.46 170.5 7.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.825 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 11.7 t70 178.7 98.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 65.65 58.33 9.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.784 HG22 HG22 ' A' ' 57' ' ' ILE . 17.1 t -139.98 126.79 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.523 -0.986 . . . . 0.0 110.736 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.583 HG23 ' CB ' ' A' ' 31' ' ' GLU . 54.1 m -109.47 94.96 5.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 35' ' ' THR . 1.4 pt -113.28 175.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.756 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -132.51 -153.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.986 -1.071 . . . . 0.0 110.673 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.756 ' N ' HG23 ' A' ' 48' ' ' THR . 28.3 m -53.68 85.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' THR . 18.7 m -139.87 144.7 37.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 110.595 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 51' ' ' THR . 97.7 m -90.04 39.94 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -91.23 127.69 36.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.763 . . . . 0.0 110.632 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.518 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.91 130.55 0.11 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 148.82 -42.09 0.84 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -101.87 -168.59 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -1.14 . . . . 0.0 110.236 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' N ' ' OG ' ' A' ' 55' ' ' SER . 20.0 ttt180 -114.44 120.24 39.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.784 HG22 HG22 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.75 154.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.968 . . . . 0.0 110.341 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -146.52 160.41 42.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.347 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 156.26 127.34 1.01 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.337 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.07 -7.58 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.803 1.422 . . . . 0.0 108.503 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.06 38.33 0.46 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.503 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 3.6 t -71.64 127.55 32.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -1.054 . . . . 0.0 110.805 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.87 111.15 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.767 . . . . 0.0 109.268 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.467 ' HB ' HG22 ' A' ' 47' ' ' ILE . 4.6 tt -104.72 162.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 110.59 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 80' ' ' CYS . 17.6 t -144.79 88.21 1.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.4 p 54.15 74.58 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 0.5 OUTLIER -148.03 149.36 31.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.051 -1.03 . . . . 0.0 110.617 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.61 ' C ' HG23 ' A' ' 69' ' ' ILE . 18.5 mm 59.59 158.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.878 . . . . 0.0 110.643 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.61 HG23 ' C ' ' A' ' 68' ' ' ILE . 1.3 pt -160.42 16.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.848 -0.533 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.85 ' HB ' HG21 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -155.09 -149.54 0.27 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 110.67 -179.332 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -65.99 -150.77 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.559 ' N ' ' HB2' ' A' ' 55' ' ' SER . . . -67.59 61.53 0.3 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.85 HG21 ' HB ' ' A' ' 70' ' ' THR . 8.0 m -121.36 115.36 31.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.443 -1.034 . . . . 0.0 110.826 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 75' ' ' ALA . 44.1 Cg_endo -71.93 72.29 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.827 1.435 . . . . 0.0 109.552 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -45.84 175.62 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.623 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 43.6 Cg_endo -69.83 63.39 1.83 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.034 1.544 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.458 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 17.0 m -132.08 31.09 4.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.76 -15.35 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.228 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.19 -10.9 45.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.523 -0.736 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 65' ' ' SER . 15.7 p -63.83 -158.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.182 -0.949 . . . . 0.0 110.132 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -139.18 121.69 16.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.001 -1.062 . . . . 0.0 110.681 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.555 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -133.41 135.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 110.008 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -141.75 105.44 4.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 75.35 51.46 7.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.555 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 99.2 m -126.2 141.43 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -103.25 152.6 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.042 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' A' ' 88' ' ' SER . 3.7 m-85 -134.89 141.13 46.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.002 -1.061 . . . . 0.0 110.212 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' PHE . 1.5 m 178.29 135.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.109 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.05 148.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.382 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.476 ' N ' ' HA ' ' A' ' 55' ' ' SER . 27.9 p-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.318 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.43 -175.58 47.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 1.9 m -43.79 113.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.144 . . . . 0.0 110.077 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 3' ' ' SER . 17.2 t 63.15 -120.11 0.56 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 0.0 110.278 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 5' ' ' THR . 6.5 t -142.04 41.55 1.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.782 -1.199 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 9.3 p30 -136.92 111.66 8.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 110.67 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 45.8 p -98.39 43.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.03 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER 165.27 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.711 -0.618 . . . . 0.0 109.579 -179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.54 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.2 OUTLIER -108.21 -163.54 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.047 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -143.34 104.34 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.748 HD21 ' O ' ' A' ' 16' ' ' LYS . 8.8 tp -88.47 21.36 2.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 109.743 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 12.5 t 56.69 107.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.362 -0.836 . . . . 0.0 109.837 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.43 -22.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.28 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -82.81 6.61 17.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 110.377 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -106.16 -163.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.836 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.748 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -107.29 123.06 47.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 111.022 -178.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' A' ' 5' ' ' THR . 5.9 m -90.51 57.64 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.482 -0.761 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 1.4 tm-20 -87.94 46.0 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.672 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 20' ' ' SER . 2.6 mptt 58.36 109.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.489 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -173.83 -66.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.118 -0.989 . . . . 0.0 110.534 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.54 HG21 ' HB2' ' A' ' 9' ' ' SER . 69.5 m -42.28 138.67 1.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 110.74 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -111.09 -51.02 2.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.807 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -164.12 -61.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 110.231 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.84 91.03 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 0.0 110.011 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 1.6 m -156.6 120.27 4.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -119.66 88.13 2.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.348 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 42' ' ' PHE . 4.3 t -94.08 170.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 111.023 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 1.4 m-20 -150.14 114.7 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 12' ' ' SER . 6.3 tttm 45.19 67.86 0.65 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 15' ' ' SER . 14.9 m -130.67 -164.39 1.42 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.006 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 20.4 tt0 -144.93 100.1 3.44 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.258 -0.902 . . . . 0.0 108.696 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.636 HG21 HD11 ' A' ' 11' ' ' LEU . 73.5 t -105.18 133.63 48.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.496 -0.753 . . . . 0.0 110.595 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -133.55 125.51 29.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 41.5 39.96 2.63 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.559 HG22 ' N ' ' A' ' 36' ' ' THR . 96.7 m -94.69 171.19 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -1.212 . . . . 0.0 110.04 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.559 ' N ' HG22 ' A' ' 35' ' ' THR . 29.8 p -99.06 -51.66 3.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.569 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 1.0 OUTLIER 57.6 42.56 23.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.556 ' N ' HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -97.35 71.87 2.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.325 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.23 65.13 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.865 ' OG ' HG22 ' A' ' 53' ' ' THR . 99.5 p -162.55 162.89 27.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 110.249 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -123.53 125.46 44.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.657 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.01 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.97 168.99 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.056 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD2' ' NE ' ' A' ' 41' ' ' ARG . 1.1 m-20 -175.4 98.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.071 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 64.3 68.35 1.69 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.063 HG21 HG22 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -145.25 150.14 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.193 . . . . 0.0 110.558 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 52.2 m -122.04 90.9 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.184 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.761 HG23 HG13 ' A' ' 45' ' ' VAL . 1.1 pt -114.07 167.69 6.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.704 HG23 ' N ' ' A' ' 49' ' ' THR . 3.1 t -125.27 -151.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.057 -1.027 . . . . 0.0 110.013 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.704 ' N ' HG23 ' A' ' 48' ' ' THR . 3.2 m -57.03 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.896 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 3.5 p -138.27 142.41 39.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.893 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 36' ' ' THR . 0.1 OUTLIER -92.77 50.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.87 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.78 142.69 35.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.17 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.865 HG22 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 175.96 134.33 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.894 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 140.87 -22.6 2.64 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 88.1 p -121.05 179.39 4.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.335 -1.097 . . . . 0.0 110.067 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 mtp85 -91.7 114.57 27.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 108.773 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.063 HG22 HG21 ' A' ' 45' ' ' VAL . 1.3 mm -98.03 130.35 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.909 -1.119 . . . . 0.0 110.859 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.643 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.97 164.08 33.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.946 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 154.38 116.12 0.58 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.217 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.36 -6.38 19.04 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.699 1.368 . . . . 0.0 109.132 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.44 26.79 0.77 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 11.1 t -72.42 144.44 48.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -1.113 . . . . 0.0 110.628 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 7.9 mmtt -136.09 106.07 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 109.303 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.621 ' HB ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -104.63 155.85 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.605 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -146.47 100.17 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.534 -0.728 . . . . 0.0 109.707 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 4.1 p 54.86 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.469 -0.769 . . . . 0.0 110.097 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.422 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.05 -150.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 110.292 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.2 tt -131.22 143.1 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 109.989 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.772 HD12 ' OG1' ' A' ' 53' ' ' THR . 1.1 tt -81.74 108.06 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 110.616 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.405 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.9 m -148.22 160.34 43.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.219 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 69.57 3.29 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . 115.02 98.42 2.2 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.799 HG23 ' CE1' ' A' ' 87' ' ' PHE . 31.6 m -86.28 164.38 38.54 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.177 -1.19 . . . . 0.0 110.238 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 77' ' ' SER . 46.3 Cg_endo -71.49 163.02 40.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.019 1.536 . . . . 0.0 110.793 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.834 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -78.96 -53.44 1.13 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.305 -0.872 . . . . 0.0 110.963 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.834 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 47.8 Cg_endo -73.79 -25.98 13.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.755 1.397 . . . . 0.0 110.897 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER 68.27 -60.28 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.993 . . . . 0.0 110.513 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.515 ' N ' ' OG ' ' A' ' 77' ' ' SER . . . 44.01 26.79 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -160.14 -62.03 0.06 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.527 -0.733 . . . . 0.0 109.482 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.444 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 16.4 t -74.04 166.43 23.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.688 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -104.01 82.79 2.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.327 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.734 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -118.99 158.37 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.69 ' N ' HD13 ' A' ' 82' ' ' ILE . 21.1 t -155.73 112.34 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.926 -1.109 . . . . 0.0 111.02 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 73.63 60.14 3.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.46 163.23 29.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -1.226 . . . . 0.0 110.014 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.12 110.2 5.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 109.663 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.799 ' CE1' HG23 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -141.88 164.87 29.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 111.032 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -169.58 71.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 58.29 144.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.825 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.3 t30 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.809 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.273 0.558 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -175.1 99.96 0.14 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER 65.4 -63.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER -148.75 -77.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 5' ' ' THR . 14.9 t -145.11 64.05 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.659 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 6' ' ' ASN . 27.5 p30 -162.95 102.71 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 110.494 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 3.3 p -104.48 34.39 3.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.226 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' THR . 10.3 t30 174.89 -21.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 22' ' ' LEU . 2.0 p -107.16 -161.69 0.8 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -140.41 122.47 15.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.588 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.542 HD13 HD11 ' A' ' 22' ' ' LEU . 11.3 tp -98.62 29.39 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER 70.92 -0.81 2.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 110.77 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.64 22.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.026 . . . . 0.0 109.665 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -156.11 9.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.975 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.9 m -105.18 -144.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 0.0 109.643 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' O ' HD21 ' A' ' 11' ' ' LEU . 15.2 tttm -118.09 137.02 53.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.114 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 27.9 p -117.05 60.68 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.23 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 mm-40 -92.2 36.21 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.597 ' HE2' HD12 ' A' ' 22' ' ' LEU . 1.4 ptmt -127.99 -142.86 0.27 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.1 -1.0 . . . . 0.0 110.257 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.467 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 1.4 t -115.11 -66.23 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 110.415 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -142.25 161.9 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.873 . . . . 0.0 110.29 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.944 HD23 ' HB2' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -109.68 -17.78 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.4 -0.812 . . . . 0.0 109.699 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 85.3 m 58.31 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 110.346 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 22' ' ' LEU . 3.8 m-20 -139.3 85.39 2.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.23 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.944 ' HB2' HD23 ' A' ' 22' ' ' LEU . 57.8 m -150.01 116.49 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 t80 -96.63 98.12 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 109.137 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.039 HG13 ' HB3' ' A' ' 42' ' ' PHE . 5.4 t -94.36 165.41 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 110.535 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 11.4 t0 -141.07 121.3 13.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 37.32 69.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.427 -0.796 . . . . 0.0 110.32 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.574 ' OG ' HG12 ' A' ' 27' ' ' VAL . 5.6 m -130.34 -170.71 2.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.923 . . . . 0.0 111.187 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 46' ' ' THR . 25.8 mt-10 -143.54 101.59 3.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 47' ' ' ILE . 70.9 t -108.94 145.23 16.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.261 -0.9 . . . . 0.0 111.197 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -115.91 -140.5 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.559 ' HA3' HG23 ' A' ' 49' ' ' THR . . . -65.43 65.94 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.896 HG23 ' O ' ' A' ' 50' ' ' SER . 84.9 m -105.91 153.18 22.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.073 -1.251 . . . . 0.0 110.433 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.497 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER -115.45 117.92 31.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.433 -0.792 . . . . 0.0 109.896 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -82.63 155.34 24.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.759 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.448 ' CB ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -167.18 43.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -0.797 . . . . 0.0 109.607 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.87 75.2 1.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -156.14 177.97 10.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.163 . . . . 0.0 110.621 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 12.6 tpp85 -141.19 124.14 16.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.039 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -105.44 167.46 9.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.767 -1.208 . . . . 0.0 110.43 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -178.39 114.23 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.477 -0.764 . . . . 0.0 109.027 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.31 67.2 1.97 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.68 ' CG1' HG23 ' A' ' 47' ' ' ILE . 3.6 t -145.27 127.57 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -1.089 . . . . 0.0 110.572 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . 93.2 m -106.93 91.16 3.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.68 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.08 161.92 7.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.58 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.695 HG23 ' N ' ' A' ' 49' ' ' THR . 2.3 t -111.03 -153.92 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 110.555 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.695 ' N ' HG23 ' A' ' 48' ' ' THR . 17.2 m -61.35 77.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 109.918 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.896 ' O ' HG23 ' A' ' 35' ' ' THR . 1.3 p -139.74 172.56 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.085 -1.009 . . . . 0.0 110.686 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 36' ' ' THR . 0.6 OUTLIER -126.89 94.81 4.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.039 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -125.45 70.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.647 HG21 ' HA ' ' A' ' 37' ' ' CYS . 67.1 p -103.93 -172.45 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.466 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 91.88 -36.67 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -133.52 161.54 34.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -1.048 . . . . 0.0 109.583 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 ptp85 -93.58 151.02 19.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 58' ' ' SER . 3.5 mt -122.33 165.63 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.887 . . . . 0.0 110.834 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.551 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.09 147.15 30.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.809 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 163.03 110.56 0.25 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.06 -8.55 23.82 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 N-CA-C 108.461 -1.4 . . . . 0.0 108.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.84 29.43 1.27 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -72.05 147.69 46.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.48 -1.012 . . . . 0.0 110.195 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 104.08 4.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.758 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.452 ' HB ' HG22 ' A' ' 47' ' ' ILE . 4.6 tt -95.86 166.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.872 . . . . 0.0 109.963 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.511 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -146.72 97.79 2.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.548 ' CA ' ' HB2' ' A' ' 50' ' ' SER . 24.1 p 48.96 102.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 110.597 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.19 -142.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.783 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 68' ' ' ILE . 2.7 tt -154.48 134.51 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.448 HD12 ' CB ' ' A' ' 38' ' ' THR . 3.0 tt -54.35 114.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.5 t -148.23 135.19 20.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -70.72 64.94 0.85 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 55' ' ' SER . . . 126.84 117.39 2.1 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.579 HG13 ' HD2' ' A' ' 74' ' ' PRO . 60.5 t -96.55 146.15 30.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -1.095 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.579 ' HD2' HG13 ' A' ' 73' ' ' VAL . 42.8 Cg_endo -69.72 153.82 68.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.865 1.456 . . . . 0.0 110.858 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -66.72 -49.94 47.36 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 110.729 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 44.4 Cg_endo -74.05 -50.15 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.735 1.387 . . . . 0.0 110.561 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.0 t 67.17 30.54 7.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.405 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -43.84 -26.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.35 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -81.35 -74.17 0.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.588 -0.695 . . . . 0.0 109.812 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.6 t -63.14 163.72 9.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.419 -0.801 . . . . 0.0 109.982 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 6.8 mmpt? -104.17 107.9 19.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -127.2 159.69 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.04 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.828 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -151.95 102.91 2.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 69.07 52.97 20.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.545 ' H ' HD11 ' A' ' 82' ' ' ILE . 43.6 m -133.19 151.09 51.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -1.19 . . . . 0.0 110.492 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.569 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -105.33 164.24 12.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.023 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.1 m-85 -135.41 166.54 22.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 2.6 t 168.03 114.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 0.0 110.022 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -43.73 134.88 4.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' N ' ' HA ' ' A' ' 55' ' ' SER . 4.2 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.281 0.562 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.79 -86.43 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 88.0 p -78.48 -17.24 56.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 174.59 -79.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 5' ' ' THR . 5.5 t -145.06 28.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -101.01 79.16 1.99 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 7' ' ' THR . 3.9 t -98.31 105.06 17.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.4 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.923 ' CB ' HG23 ' A' ' 23' ' ' THR . 12.5 m120 60.6 13.1 4.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.663 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 1.5 t -128.63 -167.57 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.54 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -143.66 115.32 8.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.019 . . . . 0.0 110.555 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.926 HD21 ' O ' ' A' ' 16' ' ' LYS . 5.6 tp -110.23 20.38 17.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.95 . . . . 0.0 109.686 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 6.0 t 54.21 99.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -41.18 -26.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 110.723 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 12' ' ' SER . 11.4 m-20 -80.85 3.64 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -101.28 -159.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.831 -1.168 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.926 ' O ' HD21 ' A' ' 11' ' ' LEU . 5.1 mttp -116.2 134.0 55.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.455 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 26.9 p -99.58 78.06 2.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.193 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 18.3 mm-40 -101.01 50.25 0.87 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.292 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.01 94.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' THR . 0.1 OUTLIER -179.61 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.124 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 84.5 m -146.72 139.14 24.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 110.219 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.601 HD22 HG22 ' A' ' 38' ' ' THR . 1.1 tp -134.31 40.99 2.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.944 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.923 HG23 ' CB ' ' A' ' 8' ' ' ASN . 35.9 m 59.61 25.15 14.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.428 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -157.42 52.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.401 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 10.2 m -143.79 108.76 4.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 110.437 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.512 ' O ' ' NH1' ' A' ' 41' ' ' ARG . 45.2 m-85 -103.36 96.28 6.65 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.988 HG13 ' CB ' ' A' ' 42' ' ' PHE . 5.0 t -103.32 167.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 111.312 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.3 t0 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.743 . . . . 0.0 109.667 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 48.08 67.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.007 . . . . 0.0 109.862 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.708 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.1 m -133.34 -173.32 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.266 -0.896 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 32.8 tt0 -139.75 101.28 4.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 11' ' ' LEU . 77.2 t -100.76 137.17 29.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.488 -0.758 . . . . 0.0 111.069 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.59 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -137.47 122.4 18.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 39.94 47.19 3.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 36' ' ' THR . 18.6 m -103.28 166.92 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -1.167 . . . . 0.0 110.433 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.935 HG21 HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -136.01 90.69 2.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.396 -0.815 . . . . 0.0 110.075 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 27.4 p -97.47 96.31 8.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.601 HG22 HD22 ' A' ' 22' ' ' LEU . 82.8 p -78.82 -28.68 44.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.125 -0.984 . . . . 0.0 109.606 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . -164.5 68.6 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.466 ' HB3' ' OG1' ' A' ' 53' ' ' THR . 57.6 p -135.81 174.8 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -1.124 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -136.39 123.85 22.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.912 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.988 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -101.4 168.76 9.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 110.717 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.9 t0 -173.68 109.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.38 69.71 0.96 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.795 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.1 t -145.15 131.9 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -1.127 . . . . 0.0 110.922 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.531 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 4.4 m -109.05 96.35 6.25 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.395 -0.816 . . . . 0.0 109.346 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.706 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.32 176.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.803 HG23 ' N ' ' A' ' 49' ' ' THR . 1.9 t -136.24 -147.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.803 ' N ' HG23 ' A' ' 48' ' ' THR . 3.7 m -60.26 80.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.321 -0.862 . . . . 0.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 48' ' ' THR . 1.4 m -139.34 142.97 37.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.263 -0.898 . . . . 0.0 110.507 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.935 HG22 HG21 ' A' ' 36' ' ' THR . 4.0 p -91.55 53.19 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.438 ' C ' HG22 ' A' ' 53' ' ' THR . 5.3 t -94.97 122.38 37.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.511 HG23 HG13 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -172.16 135.85 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 144.6 -28.56 1.91 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.501 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -130.36 178.56 6.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -1.05 . . . . 0.0 109.933 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -94.34 138.6 32.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.134 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.795 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.1 mt -115.79 155.5 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.547 ' H ' HG22 ' A' ' 86' ' ' THR . 1.1 m -147.28 145.3 29.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 112.57 0.26 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.106 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -7.04 20.21 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.697 1.367 . . . . 0.0 109.068 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.65 32.58 0.48 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.484 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -72.25 155.57 40.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -1.018 . . . . 0.0 110.102 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 105.31 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.545 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 tt -102.05 154.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.92 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.553 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -145.91 108.22 4.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.482 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 10.7 p 50.62 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 52' ' ' SER . 0.0 OUTLIER -127.59 -151.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.85 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -134.9 139.38 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 69' ' ' ILE . 7.8 tt -70.41 105.08 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.028 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.2 m -148.48 148.04 29.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.362 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.38 57.89 1.57 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . 138.25 113.16 1.14 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.553 ' HB ' ' CG ' ' A' ' 87' ' ' PHE . 5.3 t -96.84 145.2 29.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 110.099 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 73' ' ' VAL . 43.4 Cg_endo -71.91 137.61 29.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.963 1.507 . . . . 0.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -62.43 -52.37 66.4 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.81 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 42.6 Cg_endo -69.97 -32.84 16.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.628 1.33 . . . . 0.0 110.364 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER 66.11 -59.33 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.893 . . . . 0.0 111.002 179.378 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' OG ' ' A' ' 77' ' ' SER . . . 47.26 24.96 0.49 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 108.513 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.84 -57.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.5 t -84.38 168.19 15.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.645 -0.66 . . . . 0.0 109.547 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -99.85 115.88 30.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.773 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -132.73 139.28 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.653 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -144.27 79.07 1.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 96.11 45.94 2.72 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -131.99 160.54 35.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.12 -1.224 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.585 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 9.8 t -117.07 157.49 25.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.7 m-85 -137.37 137.56 39.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.881 -1.137 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ARG . 12.2 t -171.11 136.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.53 139.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.374 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.501 ' N ' ' HA ' ' A' ' 55' ' ' SER . 13.0 p30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.199 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.4 t70 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.233 0.539 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -123.51 131.43 8.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 1.0 OUTLIER 49.88 -89.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.346 -1.091 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 2' ' ' GLY . 9.0 t -130.62 -68.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.654 ' CG2' HD22 ' A' ' 11' ' ' LEU . 7.2 t -130.83 30.94 4.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 109.797 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.95 70.06 8.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 103.84 15.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.979 . . . . 0.0 110.356 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.504 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 2.0 t-20 44.72 24.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 110.044 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.02 -162.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.883 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.493 ' CB ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -143.65 107.52 4.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.043 -1.036 . . . . 0.0 110.502 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.654 HD22 ' CG2' ' A' ' 5' ' ' THR . 18.4 tp -100.32 21.72 12.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.653 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 22.0 t 61.34 12.41 4.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.584 -0.697 . . . . 0.0 110.273 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.98 28.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 110.273 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.1 t30 -162.25 19.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 110.922 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -112.17 -149.16 0.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.05 -1.031 . . . . 0.0 109.43 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -108.81 127.86 54.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.955 -1.091 . . . . 0.0 110.056 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 29.3 p -106.43 69.11 0.78 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 110.354 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 18.5 tp10 -84.62 55.4 3.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.151 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 45.29 74.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.038 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.474 ' OG ' ' N ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.84 66.96 0.31 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.264 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.15 155.26 32.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.65 -77.28 0.56 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.235 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.504 ' CB ' ' HB3' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -172.13 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.265 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -155.32 67.48 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.77 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 11.1 m -155.26 117.44 4.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.0 110.862 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.551 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 3.6 m-85 -109.39 94.8 5.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.96 HG22 ' HB2' ' A' ' 42' ' ' PHE . 12.0 t -99.8 165.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.904 -1.123 . . . . 0.0 111.31 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 7.8 t0 -146.54 109.59 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.707 . . . . 0.0 109.332 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.96 69.59 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.979 -1.076 . . . . 0.0 109.742 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.551 ' OG ' HG12 ' A' ' 27' ' ' VAL . 9.7 m -131.83 -167.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.923 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -142.13 101.61 3.96 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.05 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.665 HG13 ' HB ' ' A' ' 35' ' ' THR . 80.9 t -102.06 125.84 56.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 110.856 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.591 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -132.84 123.0 25.25 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 41.97 42.52 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.665 ' HB ' HG13 ' A' ' 32' ' ' VAL . 52.1 m -104.24 162.14 13.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -1.067 . . . . 0.0 110.195 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.423 ' N ' HG22 ' A' ' 35' ' ' THR . 24.4 p -98.56 178.22 5.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.991 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.413 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -158.95 65.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.367 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -110.88 40.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.877 . . . . 0.0 110.314 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 118.46 91.19 1.42 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.515 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 10.8 p -172.17 178.55 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -1.203 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.551 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -146.67 122.44 10.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.881 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.96 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.3 m-85 -102.07 166.3 10.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.518 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.8 t70 -176.13 111.26 0.1 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.71 66.32 2.35 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.715 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.7 t -144.1 129.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -1.064 . . . . 0.0 110.957 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.403 HG23 ' CB ' ' A' ' 31' ' ' GLU . 45.8 m -110.37 90.89 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.247 -0.908 . . . . 0.0 109.122 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.671 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -111.4 164.86 6.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 109.86 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.725 HG23 ' N ' ' A' ' 49' ' ' THR . 1.5 t -122.41 -154.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 109.94 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.725 ' N ' HG23 ' A' ' 48' ' ' THR . 3.2 m -48.25 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' THR . 12.6 p -139.26 154.43 47.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.6 p -110.42 53.34 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -111.51 110.05 20.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 110.522 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -151.49 113.7 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.272 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 169.36 -42.94 0.21 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.226 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.549 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -110.0 177.04 4.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.237 . . . . 0.0 110.382 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -97.25 126.89 42.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.715 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.8 mt -104.75 158.42 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 110.844 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.545 ' CB ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -148.72 155.1 40.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 110.534 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.1 125.13 0.75 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.728 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -74.95 -5.61 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.01 39.33 0.24 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -71.88 151.48 43.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.463 -1.022 . . . . 0.0 110.536 -179.286 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -145.03 113.52 6.67 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.472 HG22 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -104.49 166.71 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.526 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -147.35 96.71 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 110.251 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 65' ' ' SER . 19.3 p 50.16 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.04 -146.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.933 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 tt -143.66 -177.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.1 pp -46.21 123.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.015 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 55' ' ' SER . 2.4 m -92.08 -134.53 0.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.502 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 89.86 24.66 29.4 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 115.0 68.13 0.45 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.511 ' CG1' ' HA ' ' A' ' 70' ' ' THR . 24.5 m -86.35 164.22 39.03 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.323 -1.104 . . . . 0.0 110.573 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 43.0 Cg_endo -68.3 129.41 19.14 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.149 1.605 . . . . 0.0 110.353 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.019 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -44.17 -58.61 4.68 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 109.494 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.019 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 51.6 Cg_endo -77.16 92.25 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.903 1.475 . . . . 0.0 109.58 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 80' ' ' CYS . 0.2 OUTLIER -79.81 55.92 2.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.797 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.25 -24.92 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 108.977 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . -81.36 -76.49 0.24 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.592 0.711 . . . . 0.0 109.688 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 3.3 t -63.11 168.9 3.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.757 -0.589 . . . . 0.0 109.501 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 80' ' ' CYS . 9.6 mmtt -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.007 . . . . 0.0 110.228 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.956 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.852 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.956 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -156.23 83.52 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.522 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 77.02 59.2 3.21 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.573 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.46 159.34 42.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -1.147 . . . . 0.0 110.716 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -106.86 154.64 20.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.607 -0.683 . . . . 0.0 110.07 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.5 m-85 -134.28 141.88 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 89' ' ' ALA . 21.4 t -177.7 121.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 110.367 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.13 139.63 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.52 -0.738 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.549 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.304 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.34 -136.57 4.02 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.128 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 55.8 m -63.79 -22.47 66.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.346 -1.091 . . . . 0.0 110.192 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' SER . 1.8 p 173.71 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.408 -0.808 . . . . 0.0 109.626 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -141.05 92.96 2.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 108.978 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' HA ' HG22 ' A' ' 21' ' ' THR . 0.2 OUTLIER 175.89 111.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 3.9 p -101.25 107.01 18.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.1 OUTLIER 69.4 8.33 6.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 110.667 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.2 -170.47 1.65 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.019 . . . . 0.0 110.359 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.682 HE21 ' HE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -141.83 99.71 3.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 109.268 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD13 HG21 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -92.63 38.02 1.01 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.13 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 18.2 t 58.47 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.678 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.59 22.64 2.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 110.461 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -157.4 19.35 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.131 -0.981 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 10.5 p -100.17 -162.74 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.914 -1.116 . . . . 0.0 109.348 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 19.8 tptt -108.25 112.33 24.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 29.6 p -97.31 86.33 3.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.512 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -107.56 127.04 53.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.111 -0.993 . . . . 0.0 109.425 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HD2' ' HA2' ' A' ' 34' ' ' GLY . 7.8 tttt 69.92 119.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.1 145.81 35.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 110.359 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 6' ' ' ASN . 12.2 t -90.86 -146.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' N ' HG23 ' A' ' 21' ' ' THR . 1.1 mp -111.4 -81.72 0.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.613 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -179.76 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.18 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -157.12 60.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.534 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -155.09 111.75 3.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.435 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.682 ' HE2' HE21 ' A' ' 10' ' ' GLN . 1.2 m-85 -100.77 129.1 46.61 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.096 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -125.1 160.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.916 -1.115 . . . . 0.0 110.979 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -149.29 115.55 5.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 0.0 109.416 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 mttt 52.03 65.43 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 109.823 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.611 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.7 m -133.45 -170.49 2.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 111.122 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CB ' HG23 ' A' ' 46' ' ' THR . 2.6 tm-20 -143.26 99.36 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 16' ' ' LYS . 97.3 t -105.23 149.81 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.955 . . . . 0.0 111.689 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.582 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -127.35 -143.6 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 49' ' ' THR . . . -66.41 68.16 0.16 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.4 m -114.91 157.78 22.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -1.133 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.581 ' CG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -112.36 170.83 7.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' O ' HD13 ' A' ' 22' ' ' LEU . 36.9 t -133.75 140.28 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.819 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.57 ' H ' ' HG1' ' A' ' 53' ' ' THR . 32.8 m -155.3 19.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.495 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 132.18 67.47 0.09 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -151.63 -178.81 6.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.124 -1.221 . . . . 0.0 110.247 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG3' ' HG3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.3 138.08 23.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.751 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.096 ' HB3' HG13 ' A' ' 27' ' ' VAL . 6.0 m-85 -110.1 161.62 15.36 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.537 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 45' ' ' VAL . 1.6 t70 -179.09 113.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 49.49 64.33 3.48 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.582 ' CG1' HG23 ' A' ' 47' ' ' ILE . 3.1 t -145.8 136.47 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -1.012 . . . . 0.0 110.426 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 31' ' ' GLU . 87.7 m -116.03 97.96 6.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.532 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.582 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.6 pt -114.93 174.39 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.401 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.72 HG23 ' N ' ' A' ' 49' ' ' THR . 1.0 OUTLIER -122.04 -160.09 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 110.537 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.72 ' N ' HG23 ' A' ' 48' ' ' THR . 8.7 m -61.62 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.882 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.496 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.892 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.581 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 10.5 p -95.83 57.46 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.444 ' C ' HG22 ' A' ' 53' ' ' THR . 0.4 OUTLIER -114.25 133.24 55.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.551 -0.718 . . . . 0.0 110.454 -179.496 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.588 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.4 75.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.855 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -132.22 -61.48 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.554 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 61.1 p -103.61 -159.62 0.73 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.489 -1.006 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -115.21 123.48 48.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.401 -0.812 . . . . 0.0 110.188 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 HG22 ' A' ' 45' ' ' VAL . 2.0 mt -98.98 163.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 109.959 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.71 151.36 37.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.701 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 159.55 115.28 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.03 -2.8 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.743 1.391 . . . . 0.0 108.657 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.25 28.59 0.63 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.51 153.7 41.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.444 -1.033 . . . . 0.0 110.711 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.35 111.03 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.797 . . . . 0.0 110.05 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.939 HG13 HD12 ' A' ' 82' ' ' ILE . 3.6 tt -103.88 167.65 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.971 . . . . 0.0 109.226 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -144.83 100.55 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.346 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 81.0 p 46.39 56.39 6.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.556 -0.715 . . . . 0.0 110.712 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.04 162.34 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 69' ' ' ILE . 79.4 mt -108.32 171.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 68' ' ' ILE . 1.7 mp -38.75 121.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 0.0 110.415 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.657 ' HA ' HG23 ' A' ' 73' ' ' VAL . 89.6 m -130.32 61.1 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.992 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.607 ' N ' HG22 ' A' ' 73' ' ' VAL . . . -65.78 74.43 0.11 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . 61.72 26.17 66.51 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 70' ' ' THR . 2.9 m -132.73 82.31 56.42 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.971 -0.723 . . . . 0.0 110.652 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 77' ' ' SER . 53.6 Cg_endo -77.83 -23.83 9.11 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.97 1.511 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -42.61 -52.87 10.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.206 -0.934 . . . . 0.0 111.017 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 44.8 Cg_endo -71.58 -10.97 27.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.656 1.345 . . . . 0.0 110.448 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' PRO . 23.0 p -112.57 13.93 20.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.9 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.31 -14.68 12.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.89 -19.14 30.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.742 . . . . 0.0 109.981 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 3.3 t -82.64 167.86 17.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -105.6 137.81 42.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.711 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.939 HD12 HG13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -147.92 129.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.599 -0.688 . . . . 0.0 109.347 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -142.53 116.24 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.943 . . . . 0.0 110.528 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.44 48.77 8.84 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.42 149.36 49.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 0.0 110.506 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -104.17 163.06 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.149 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 86' ' ' THR . 6.3 m-85 -132.62 144.49 50.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.491 ' C ' ' HB2' ' A' ' 55' ' ' SER . 2.0 t -176.08 116.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 109.75 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HA ' ' CB ' ' A' ' 55' ' ' SER . . . -37.76 155.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.496 -0.753 . . . . 0.0 110.882 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 55' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.877 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.818 ' HB3' HG22 ' A' ' 7' ' ' THR . 9.4 p-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.098 0.475 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.66 -71.15 0.09 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -39.56 90.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.29 -1.123 . . . . 0.0 110.609 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.27 -70.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.727 HG22 HD22 ' A' ' 11' ' ' LEU . 3.0 t -133.42 7.08 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -69.69 73.14 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 110.494 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.818 HG22 ' HB3' ' A' ' 1' ' ' ASP . 50.1 p -98.29 99.32 10.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.0 109.499 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 7' ' ' THR . 9.5 m120 58.15 15.95 3.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.694 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -130.89 172.84 11.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.472 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.16 114.26 24.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.727 HD22 HG22 ' A' ' 5' ' ' THR . 15.7 tp -102.45 28.39 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.769 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 21.8 t 64.22 6.25 2.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.731 -0.606 . . . . 0.0 110.914 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.0 25.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.06 -1.025 . . . . 0.0 109.44 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' SER . 37.5 t30 -163.47 17.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.416 -0.803 . . . . 0.0 110.491 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -104.29 -147.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.425 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 3.4 tmtm? -114.94 119.04 35.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.796 -1.19 . . . . 0.0 110.493 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.01 66.14 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.718 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -84.13 157.6 21.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp 48.15 -94.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.863 . . . . 0.0 110.332 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 18' ' ' GLU . 17.3 p -168.86 173.86 6.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.038 -1.039 . . . . 0.0 110.561 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.441 ' N ' ' OG1' ' A' ' 5' ' ' THR . 2.7 m -136.48 153.54 51.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.772 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 23' ' ' THR . 0.4 OUTLIER -89.08 -140.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.566 ' H ' HD23 ' A' ' 22' ' ' LEU . 7.3 p -131.42 48.23 2.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.774 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.7 m-20 -157.6 46.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.826 . . . . 0.0 110.134 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 88.5 m -149.68 123.26 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 111.182 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 20.1 m-85 -115.58 96.65 5.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.02 HG13 ' HB3' ' A' ' 42' ' ' PHE . 12.2 t -94.32 163.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.912 . . . . 0.0 111.315 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.553 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.91 120.53 9.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.548 -0.72 . . . . 0.0 109.467 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 13.6 tptm 47.92 59.76 4.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.275 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.579 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.7 m -133.58 178.19 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.184 -0.947 . . . . 0.0 110.982 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.6 tt0 -143.61 109.58 5.28 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 47' ' ' ILE . 5.7 m -116.05 164.98 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.892 -1.13 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.57 ' HB3' ' CA ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -121.53 -139.17 0.33 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.471 ' HA3' HG23 ' A' ' 49' ' ' THR . . . -65.97 66.87 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 50' ' ' SER . 19.6 m -99.36 163.58 12.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.683 ' CG2' HG22 ' A' ' 51' ' ' THR . 6.7 p -106.88 -170.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.119 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.787 ' CA ' HG21 ' A' ' 53' ' ' THR . 0.9 OUTLIER -141.15 -87.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.912 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 m 46.13 37.14 3.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.362 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 102.03 109.49 3.28 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.601 ' CB ' HG22 ' A' ' 53' ' ' THR . 47.0 t 177.87 161.89 0.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.419 -1.047 . . . . 0.0 110.184 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.569 ' HB2' ' ND2' ' A' ' 90' ' ' ASN . 0.5 OUTLIER -141.7 128.61 20.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.991 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.02 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.0 m-85 -110.67 167.11 10.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -177.73 112.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.098 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.79 70.49 0.84 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.717 ' CG1' HG23 ' A' ' 47' ' ' ILE . 7.4 t -145.52 127.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.413 -1.051 . . . . 0.0 111.126 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -106.92 91.13 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.238 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.717 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -114.35 170.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.375 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.646 HG23 ' N ' ' A' ' 49' ' ' THR . 5.3 t -118.46 -151.21 0.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.648 ' O ' HG22 ' A' ' 66' ' ' THR . 3.2 m -63.5 86.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.378 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 35' ' ' THR . 7.9 t -139.37 144.72 38.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 110.759 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.683 HG22 ' CG2' ' A' ' 36' ' ' THR . 43.9 p -96.72 61.4 1.88 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.28 111.26 23.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.787 HG21 ' CA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -142.66 162.75 34.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.883 . . . . 0.0 110.142 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 116.24 -56.9 0.51 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.508 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -101.86 -179.6 4.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -1.133 . . . . 0.0 111.213 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 6.1 ttp85 -109.69 128.05 54.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.5 mt -103.57 161.18 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 111.006 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.606 ' CB ' ' HG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -146.65 146.3 30.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.13 118.05 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.437 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.94 -6.98 20.41 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 N-CA-C 108.69 -1.312 . . . . 0.0 108.69 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.95 38.61 0.29 Allowed Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -71.85 159.4 34.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.446 -1.032 . . . . 0.0 110.139 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 62' ' ' CYS . 5.1 mmtm -143.11 109.51 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.757 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.507 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.6 tt -102.6 172.45 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.003 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.477 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.6 t -151.17 76.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.17 . . . . 0.0 110.78 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 49' ' ' THR . 4.1 p 55.24 113.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 30.0 m -139.36 -157.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 69' ' ' ILE . 1.9 mt -121.97 -149.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.166 -0.959 . . . . 0.0 109.898 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.52 ' H ' HG22 ' A' ' 68' ' ' ILE . 37.0 mt -61.3 144.72 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.655 ' C ' HG22 ' A' ' 73' ' ' VAL . 75.2 m -123.7 -13.76 7.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.948 -1.095 . . . . 0.0 110.938 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 1.002 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -36.12 94.2 0.01 OUTLIER Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 70' ' ' THR . . . 40.05 28.71 0.17 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.002 HG13 ' O ' ' A' ' 71' ' ' GLY . 17.9 m -127.61 75.21 77.85 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HA ' ' OG ' ' A' ' 77' ' ' SER . 49.3 Cg_endo -78.21 -20.46 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.881 1.464 . . . . 0.0 110.149 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -62.48 -50.03 80.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 111.139 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 43.2 Cg_endo -70.02 -2.93 11.18 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.399 1.21 . . . . 0.0 110.704 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 2.3 p -116.84 10.46 14.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.924 -1.11 . . . . 0.0 109.199 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.49 -9.1 59.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.835 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 77' ' ' SER . 6.8 t -72.06 149.44 44.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.412 -0.805 . . . . 0.0 109.997 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -104.79 103.68 13.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.938 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -125.11 155.94 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.796 ' N ' HD13 ' A' ' 82' ' ' ILE . 43.6 t -146.8 114.75 6.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.385 -0.822 . . . . 0.0 110.407 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 70.47 48.79 34.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.68 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.79 148.22 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -1.045 . . . . 0.0 110.804 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.606 ' HG1' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -109.27 153.91 23.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.392 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 88' ' ' SER . 10.3 m-85 -127.13 160.6 30.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.575 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 171.03 127.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.798 . . . . 0.0 109.877 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -42.58 141.46 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 41' ' ' ARG . 1.8 t-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.044 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' CG ' ' HA ' ' A' ' 7' ' ' THR . 10.7 t70 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.238 0.542 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.55 -104.07 2.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -76.37 -58.81 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.117 . . . . 0.0 109.848 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 3.7 m -142.14 -49.53 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -0.86 . . . . 0.0 109.625 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.606 ' OG1' HG22 ' A' ' 21' ' ' THR . 15.3 t -134.31 35.68 3.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 1' ' ' ASP . 18.1 t30 -94.5 68.84 3.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 22' ' ' LEU . 1.9 t -99.05 94.09 6.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.437 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 67.4 4.68 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.711 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -114.18 -168.5 1.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 99.74 3.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 4.5 tp -88.42 27.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.932 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 p 71.67 1.28 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.464 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.14 24.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.77 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 12' ' ' SER . 17.8 p30 -157.28 16.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.535 ' OG ' ' CD2' ' A' ' 11' ' ' LEU . 22.1 p -105.73 -138.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.29 98.43 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 15.4 p -82.76 50.01 1.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 110.402 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -90.1 141.2 28.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.955 -1.091 . . . . 0.0 110.456 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' CD ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER 68.87 -156.9 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.345 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -123.32 -168.1 1.71 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.696 HG23 ' N ' ' A' ' 22' ' ' LEU . 6.6 t -166.6 -145.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.696 ' N ' HG23 ' A' ' 21' ' ' THR . 0.4 OUTLIER -114.37 -142.85 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.153 -0.967 . . . . 0.0 110.672 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -137.73 44.26 2.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.341 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' THR . 2.7 m120 -158.24 69.44 0.51 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.05 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.62 123.47 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.932 -1.105 . . . . 0.0 111.365 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -109.77 93.86 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 1.03 HG13 ' HB3' ' A' ' 42' ' ' PHE . 4.5 t -93.67 167.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 110.643 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.2 OUTLIER -149.49 120.63 7.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.956 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 44.46 60.76 2.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 109.763 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.749 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -128.1 -169.19 2.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.69 104.57 4.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 47' ' ' ILE . 99.5 t -110.99 137.89 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 111.47 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -107.09 -139.68 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.563 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 49' ' ' THR . . . -68.16 61.68 0.39 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.2 m -111.43 156.84 21.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -1.143 . . . . 0.0 110.189 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.781 HG21 HG23 ' A' ' 51' ' ' THR . 0.7 OUTLIER -106.42 -173.18 2.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.674 ' O ' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -150.84 76.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.649 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.422 ' HA ' HD22 ' A' ' 22' ' ' LEU . 1.9 m -90.97 47.31 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.24 95.31 2.22 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.556 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 25.1 p -174.06 173.04 3.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.331 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HD3' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -135.81 133.78 38.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.221 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.03 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.7 m-85 -112.92 163.15 15.01 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.953 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 8.7 t70 -177.19 111.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.9 . . . . 0.0 109.122 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 50.63 66.67 2.29 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.817 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.6 t -144.42 127.99 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.084 . . . . 0.0 111.033 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 22.1 m -104.76 96.01 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.352 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 32' ' ' VAL . 1.1 pp -114.44 169.06 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.821 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -112.78 -150.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.821 ' N ' HG23 ' A' ' 48' ' ' THR . 34.8 m -73.41 94.37 2.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.195 -0.941 . . . . 0.0 110.016 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.505 ' HB3' ' CA ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -139.9 157.86 45.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 111.394 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.781 HG23 HG21 ' A' ' 36' ' ' THR . 27.5 m -104.09 50.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.592 -0.692 . . . . 0.0 109.372 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.525 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -102.7 102.81 13.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.344 -0.848 . . . . 0.0 110.594 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.654 HG21 ' HA ' ' A' ' 37' ' ' CYS . 82.1 p -141.19 113.94 8.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 166.14 -27.09 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.555 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 72.6 p -118.85 162.01 19.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -91.36 119.08 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.867 . . . . 0.0 108.997 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.817 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -99.64 152.29 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 0.0 111.65 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.63 140.73 26.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.814 -0.554 . . . . 0.0 109.906 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 171.21 120.23 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.114 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.09 -5.32 16.86 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.719 1.379 . . . . 0.0 108.899 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.61 33.88 0.32 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 1.7 t -72.02 160.1 33.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.98 -1.306 . . . . 0.0 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 17.5 mmtt -141.51 110.79 6.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.592 HG21 ' HB ' ' A' ' 47' ' ' ILE . 6.6 tt -99.45 171.53 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.016 -1.052 . . . . 0.0 109.314 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 2.2 t -152.94 87.83 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.505 ' CA ' ' HB3' ' A' ' 50' ' ' SER . 10.2 p 52.21 104.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 110.948 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 82.0 m -119.55 -152.73 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.49 -0.756 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.746 ' N ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -138.59 170.85 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.913 -1.117 . . . . 0.0 110.58 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.96 137.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 0.0 109.402 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.712 ' OG1' HG13 ' A' ' 73' ' ' VAL . 2.1 t -145.42 -166.5 2.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 111.039 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -172.63 30.8 0.11 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 128.2 78.79 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.712 HG13 ' OG1' ' A' ' 70' ' ' THR . 14.2 m -94.22 124.28 56.31 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.231 -1.158 . . . . 0.0 110.564 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.62 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 49.1 Cg_endo -74.74 152.35 42.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.022 1.538 . . . . 0.0 110.44 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.888 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . 64.32 179.02 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.888 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.0 Cg_endo -73.85 63.52 4.9 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.934 1.491 . . . . 0.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER 71.42 -49.7 0.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.166 -0.959 . . . . 0.0 111.223 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 50.77 24.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 108.073 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.16 -60.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 66' ' ' THR . 7.8 t -83.44 179.04 7.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.638 -0.664 . . . . 0.0 109.571 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -102.33 104.12 14.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 1.6 tp -132.46 151.35 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.457 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -140.82 118.76 11.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.168 -0.958 . . . . 0.0 110.679 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.04 46.13 37.77 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.561 ' HB3' ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -128.15 154.27 45.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.232 -1.158 . . . . 0.0 111.43 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.579 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.74 165.81 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 0.0 109.056 178.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -155.4 155.67 34.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.784 -1.197 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -175.76 41.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 111.145 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.555 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.8 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 110.843 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.075 0.464 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 17' ' ' CYS . 5.8 t -145.46 13.59 1.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 0.0 110.453 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.478 ' N ' ' ND2' ' A' ' 6' ' ' ASN . 2.3 m120 -97.05 96.41 8.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -113.77 20.18 16.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -177.33 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -108.73 -151.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.967 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -143.36 110.19 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.439 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 27' ' ' VAL . 25.6 tp -94.15 36.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.625 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 68.92 2.19 3.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.737 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 46.56 23.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.941 -1.1 . . . . 0.0 109.639 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -159.91 12.12 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.945 . . . . 0.0 111.465 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' SER . 4.3 m -98.65 -144.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.788 -1.195 . . . . 0.0 109.537 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 18' ' ' GLU . 1.4 tptt -107.41 89.97 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 29.7 p -65.55 64.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 0.0 110.746 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 16' ' ' LYS . 33.2 mm-40 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.031 -1.043 . . . . 0.0 110.115 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 38' ' ' THR . 36.4 m-80 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.049 0.452 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -155.79 128.02 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -136.23 91.95 2.73 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.102 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -94.4 164.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 110.776 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.625 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.8 t0 -137.42 117.04 12.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ASP . 6.7 tttt 40.29 71.3 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.064 -1.023 . . . . 0.0 110.189 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.831 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -131.51 -175.01 3.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -144.13 100.8 3.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.612 -0.68 . . . . 0.0 109.996 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 10.4 m -110.22 151.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.637 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.547 ' O ' ' CA ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -125.85 94.45 4.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.099 -1.0 . . . . 0.0 110.348 -179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.688 ' O ' HG23 ' A' ' 49' ' ' THR . . . 60.97 46.11 95.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 50' ' ' SER . 6.2 m -102.45 146.43 28.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -1.092 . . . . 0.0 110.369 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.483 ' O ' HG21 ' A' ' 53' ' ' THR . 2.7 t -90.32 159.7 16.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.431 -0.793 . . . . 0.0 110.39 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 38' ' ' THR . 1.2 m -113.87 -79.79 0.59 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.488 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.1 m 68.25 -68.39 0.17 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.124 -0.985 . . . . 0.0 110.405 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 53' ' ' THR . . . -155.61 104.34 0.25 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -178.34 179.56 0.78 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -1.132 . . . . 0.0 109.924 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.46 127.56 13.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 110.104 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.102 ' HB3' HG13 ' A' ' 27' ' ' VAL . 4.6 m-85 -109.17 172.85 6.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.398 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 58' ' ' SER . 0.9 OUTLIER 177.21 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.821 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 66.07 66.48 2.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.976 HG21 HG22 ' A' ' 57' ' ' ILE . 2.4 t -146.28 148.83 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 110.564 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 46' ' ' THR . 13.3 m -122.25 89.7 3.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.447 -0.783 . . . . 0.0 109.312 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.71 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.65 168.92 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 5.4 t -115.89 -164.88 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 34' ' ' GLY . 2.0 m -49.63 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.918 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 35' ' ' THR . 6.2 p -132.21 137.46 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.052 -1.03 . . . . 0.0 111.253 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 51' ' ' THR . 26.3 m -87.86 40.13 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.587 -0.696 . . . . 0.0 109.268 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -102.17 103.01 13.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.149 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.584 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 6.0 p -146.28 95.56 2.63 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.563 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -156.0 -53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' N ' ' A' ' 89' ' ' ALA . 2.6 p -105.73 -162.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 11.4 mtp180 -95.84 137.62 34.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.519 -0.738 . . . . 0.0 109.917 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.976 HG22 HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -118.3 128.57 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.993 . . . . 0.0 110.186 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.692 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.68 157.4 43.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.48 125.6 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.2 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.635 1.334 . . . . 0.0 109.4 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.07 33.63 0.2 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.3 t -72.89 146.25 46.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.353 -1.087 . . . . 0.0 110.646 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 111.28 9.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.446 -0.784 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.929 HG13 HD12 ' A' ' 82' ' ' ILE . 5.4 tt -104.39 171.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 110.611 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -142.97 96.35 2.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.32 -0.863 . . . . 0.0 110.046 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 67' ' ' CYS . 16.7 p 54.64 -93.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.691 -0.631 . . . . 0.0 110.597 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.552 ' N ' ' OG1' ' A' ' 66' ' ' THR . 3.9 m 70.3 -167.5 0.16 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.044 -1.035 . . . . 0.0 109.994 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -130.59 -169.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 70' ' ' THR . 5.4 mt -42.47 167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.333 -0.854 . . . . 0.0 110.703 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.525 ' N ' HG22 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -137.61 -139.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 108.87 44.41 1.12 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.536 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.485 1.922 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.193 0.52 . . . . 0.0 109.944 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.929 HD12 HG13 ' A' ' 64' ' ' ILE . 1.1 tt -120.66 124.18 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.73 123.53 23.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 71.9 60.8 4.05 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.484 ' SG ' HG13 ' A' ' 82' ' ' ILE . 56.3 m -138.79 146.12 40.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 111.25 13.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 109.607 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.543 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -142.69 160.13 40.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.948 . . . . 0.0 110.58 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -176.02 94.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' N ' ' CB ' ' A' ' 55' ' ' SER . . . 50.89 172.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 56' ' ' ARG . 28.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.217 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.023 0.439 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 5' ' ' THR . 5.5 t -127.96 53.34 1.79 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.009 -1.057 . . . . 0.0 109.577 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.65 70.45 1.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 111.001 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 4.4 t -98.97 21.82 11.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.086 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 7' ' ' THR . 2.7 m-20 168.49 -17.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.652 -0.655 . . . . 0.0 110.808 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -108.02 -160.44 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 0.0 110.068 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -140.14 117.34 11.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 110.713 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.837 HD21 ' O ' ' A' ' 16' ' ' LYS . 1.8 tp -111.24 19.93 17.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 17.1 t 53.34 104.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.901 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.71 -24.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 110.429 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.2 m-20 -87.46 2.54 50.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 111.361 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.742 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -101.12 -162.98 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.619 -1.301 . . . . 0.0 110.547 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.837 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -111.55 162.75 14.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 28.6 p -128.92 71.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.69 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 110.516 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.476 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.118 0.485 . . . . 0.0 110.118 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -153.84 113.9 3.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.802 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HB2' ' HD3' ' A' ' 41' ' ' ARG . 37.7 m-85 -108.98 110.62 21.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.017 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -114.64 164.33 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.816 -1.177 . . . . 0.0 111.041 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.3 t70 -149.29 110.3 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.462 -0.774 . . . . 0.0 109.865 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.8 OUTLIER 54.95 63.45 2.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 110.061 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.9 m -133.88 -167.81 2.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 111.324 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.3 tt0 -143.28 104.03 4.21 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.1 t -103.94 142.19 18.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.97 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.25 -152.6 0.51 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.364 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 49' ' ' THR . . . -66.69 67.55 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 50' ' ' SER . 2.9 m -110.2 159.56 17.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -1.144 . . . . 0.0 110.801 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 35' ' ' THR . 1.3 p -89.2 -168.81 2.28 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.484 -0.76 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.926 ' HA ' HG21 ' A' ' 53' ' ' THR . 30.6 t -174.33 102.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.1 m -118.42 1.33 11.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 151.16 77.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 53' ' ' THR . 11.7 t -149.93 170.63 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -1.197 . . . . 0.0 110.515 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -132.99 133.07 42.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.625 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.017 ' HB3' HG13 ' A' ' 27' ' ' VAL . 2.8 m-85 -111.4 160.79 16.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 110.455 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.5 t0 -171.74 116.13 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.68 67.34 1.58 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.63 ' CG1' HG23 ' A' ' 47' ' ' ILE . 2.7 t -144.86 126.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.442 -1.034 . . . . 0.0 110.537 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 25.3 m -106.86 96.28 6.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.288 -0.883 . . . . 0.0 109.194 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.63 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pt -113.72 160.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.493 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.594 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -106.01 -162.31 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.594 ' N ' HG23 ' A' ' 48' ' ' THR . 55.1 m -64.16 91.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 35' ' ' THR . 13.7 p -139.24 164.5 29.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.684 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -108.68 72.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 109.83 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.5 t -124.16 105.8 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.14 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.926 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -151.07 117.84 5.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.215 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 168.51 -30.74 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.467 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -122.8 167.6 13.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.556 -0.967 . . . . 0.0 109.555 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 9.9 ttm180 -91.56 136.4 33.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.767 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 3.3 mt -114.66 163.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.4 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.575 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -148.3 145.84 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.764 -0.585 . . . . 0.0 110.052 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 165.74 109.67 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.42 -1.371 . . . . 0.0 110.494 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.01 -4.77 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.758 1.399 . . . . 0.0 108.748 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.98 30.08 0.6 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.3 t -72.07 157.85 37.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -1.063 . . . . 0.0 110.608 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HG2' ' C ' ' A' ' 62' ' ' CYS . 2.7 mmtp -144.5 110.98 5.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.659 -0.65 . . . . 0.0 109.653 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.559 HG21 ' HB ' ' A' ' 47' ' ' ILE . 6.9 tt -101.1 170.52 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.905 -1.122 . . . . 0.0 109.812 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.74 91.1 1.52 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.124 . . . . 0.0 111.387 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 65' ' ' SER . 13.3 p 46.08 109.81 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.654 0.74 . . . . 0.0 111.576 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.8 m -140.24 145.4 37.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.396 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.421 ' H ' HG23 ' A' ' 68' ' ' ILE . 1.3 pt -55.36 -179.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 0.0 109.9 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.0 mt -54.79 153.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 53' ' ' THR . 5.7 m -98.33 -122.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.916 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 95.29 35.59 5.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.252 0.549 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.719 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -125.83 158.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 110.161 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.719 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -147.41 96.58 2.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 0.0 110.883 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.1 55.14 4.92 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.559 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.02 158.2 42.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.167 . . . . 0.0 110.881 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.582 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -111.06 161.04 16.3 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.622 ' CZ ' ' CD1' ' A' ' 57' ' ' ILE . 7.5 m-85 -146.43 162.22 38.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 111.276 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 1.2 t 169.19 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -37.62 138.01 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.467 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.853 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.386 0.612 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.561 HG21 ' H ' ' A' ' 18' ' ' GLU . 7.3 t -134.08 50.78 2.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.791 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 9' ' ' SER . 6.6 m120 -140.64 106.68 5.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.97 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -98.62 28.55 4.16 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.953 0.882 . . . . 0.0 108.64 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 176.71 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.297 0.57 . . . . 0.0 109.596 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 19.3 m -107.74 -165.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 109.277 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.73 115.94 7.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.786 -1.196 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 1.7 tp -91.63 140.71 29.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -0.945 . . . . 0.0 109.096 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -54.07 139.09 35.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -12.48 9.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.342 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -115.61 17.4 16.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.977 . . . . 0.0 110.702 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.2 p -94.28 -147.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 4.0 tttt -121.41 120.4 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.18 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -56.21 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 110.329 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.851 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.484 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.402 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 68.7 m-80 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.289 0.566 . . . . 0.0 109.93 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 12.9 m -141.97 109.26 5.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 110.31 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 6.6 t80 -100.8 103.86 15.09 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.928 HG13 ' HB3' ' A' ' 42' ' ' PHE . 8.0 t -101.69 164.62 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -142.47 119.29 11.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.421 -0.799 . . . . 0.0 109.452 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 26.2 tttt 42.78 67.75 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 109.835 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.724 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.1 m -132.96 -168.04 2.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -144.8 96.91 2.94 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.13 -0.982 . . . . 0.0 109.784 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.851 HG12 ' CB ' ' A' ' 18' ' ' GLU . 61.3 t -102.33 138.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 110.086 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 49' ' ' THR . 4.6 t80 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.085 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 42.26 48.58 5.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.457 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 22.5 m -104.9 163.92 12.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -1.134 . . . . 0.0 109.771 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.3 p -99.79 174.63 6.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.848 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.966 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -157.5 143.35 17.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.722 . . . . 0.0 109.872 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -166.62 37.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.13 62.03 0.38 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 9.2 t -142.91 176.17 9.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -145.75 124.16 12.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.928 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -99.65 172.69 7.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.235 -0.916 . . . . 0.0 110.139 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' SER . 7.8 t70 179.0 95.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 68.7 67.66 1.89 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.084 HG21 HG22 ' A' ' 57' ' ' ILE . 1.1 t -145.88 159.42 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 110.603 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 27.4 m -130.33 88.26 2.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.543 -0.723 . . . . 0.0 109.617 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.786 HG23 HG13 ' A' ' 45' ' ' VAL . 1.1 pp -111.08 165.59 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.753 HG23 ' N ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -129.88 -157.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.085 . . . . 0.0 110.788 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.753 ' N ' HG23 ' A' ' 48' ' ' THR . 5.6 m -46.45 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 110.858 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.3 m -140.5 -167.05 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.068 -1.02 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -150.03 72.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.376 -0.828 . . . . 0.0 109.84 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 8.4 t -131.79 112.47 12.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.567 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.966 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -151.65 121.75 7.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 168.48 -25.98 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.463 ' HA ' ' C ' ' A' ' 89' ' ' ALA . 26.0 p -122.7 -170.15 2.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -1.11 . . . . 0.0 109.918 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 28.1 mtp180 -94.87 115.94 28.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.843 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.084 HG22 HG21 ' A' ' 45' ' ' VAL . 1.2 mm -98.98 122.52 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.076 . . . . 0.0 109.965 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.477 ' CA ' HG23 ' A' ' 45' ' ' VAL . 44.9 m -145.78 168.3 21.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 110.46 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 151.02 123.05 1.08 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.5 -5.68 17.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.691 1.363 . . . . 0.0 109.416 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 23.72 0.87 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 5.1 t -73.17 143.44 47.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.499 -1.001 . . . . 0.0 110.648 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 113.22 7.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.0 109.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.589 ' HB ' HG22 ' A' ' 47' ' ' ILE . 3.0 tt -104.04 168.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 15.2 t -152.26 89.88 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 49' ' ' THR . 2.2 p 56.71 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.815 ' O ' HG23 ' A' ' 51' ' ' THR . 83.5 m -146.5 -159.09 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.0 155.72 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.929 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.8 pp -92.51 121.85 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.428 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.7 m -148.41 150.77 34.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.39 51.32 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 65' ' ' SER . 3.6 mptp? . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.369 0.604 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.854 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.97 154.76 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.854 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.6 OUTLIER -148.05 89.77 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.781 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 97.19 61.67 0.93 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.655 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -138.39 171.95 13.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -1.224 . . . . 0.0 110.563 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.11 119.06 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.767 . . . . 0.0 109.554 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -147.4 149.6 33.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.174 . . . . 0.0 111.614 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 34.5 p -163.72 73.08 0.29 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.735 -0.603 . . . . 0.0 109.688 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 59.75 162.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 0.0 109.937 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.351 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.117 0.484 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 5' ' ' THR . 9.9 t -145.81 49.02 1.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 2.8 m120 -138.85 117.83 12.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.113 -0.992 . . . . 0.0 110.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.532 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 40.6 p -102.17 106.16 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.366 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER 74.01 -1.47 3.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.378 -0.826 . . . . 0.0 110.023 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.62 177.43 4.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.673 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -131.06 112.32 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.169 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HG ' ' OG ' ' A' ' 15' ' ' SER . 7.3 tp -88.63 54.57 3.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 110.053 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.54 ' HB2' ' CA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 63.06 8.17 3.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 0.0 110.961 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 54.05 16.98 1.26 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER 174.75 30.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.98 -1.075 . . . . 0.0 110.918 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -92.44 -146.24 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.05 . . . . 0.0 109.564 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.571 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -104.69 103.83 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.967 -1.083 . . . . 0.0 109.521 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.64 59.78 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.594 ' HG2' ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 110.061 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.139 0.495 . . . . 0.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 8.0 p -152.09 116.51 5.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.061 -1.024 . . . . 0.0 110.455 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 93.0 m-85 -100.69 100.19 10.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 0.0 109.554 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.055 HG13 ' HB3' ' A' ' 42' ' ' PHE . 5.6 t -94.37 166.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.017 . . . . 0.0 110.247 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.54 ' CA ' ' HB2' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.79 124.84 12.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER 42.77 63.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 109.586 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.848 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.1 m -130.9 -179.12 5.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 111.114 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.5 mt-10 -145.3 103.77 3.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.571 -0.705 . . . . 0.0 109.216 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.518 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.9 m -112.4 130.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 2.7 t80 -118.27 94.63 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.902 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 74.96 33.18 55.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 1.092 HG23 ' O ' ' A' ' 50' ' ' SER . 19.2 m -108.66 147.23 32.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -1.189 . . . . 0.0 110.208 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 51' ' ' THR . 8.1 t -97.94 150.8 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 19.8 p -135.44 58.2 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 110.138 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 29.6 m -66.21 -108.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.811 -1.18 . . . . 0.0 109.726 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.97 66.37 3.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 7.8 t -144.05 168.16 20.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -1.18 . . . . 0.0 110.758 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 3.9 tpt180 -138.85 124.53 19.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.055 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.48 177.53 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 10.0 t0 173.39 108.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 56.45 67.34 2.27 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 47' ' ' ILE . 16.5 t -145.76 125.13 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -1.039 . . . . 0.0 111.419 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -103.44 96.1 6.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 108.659 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.907 ' CD1' HG21 ' A' ' 35' ' ' THR . 1.1 pt -111.14 167.15 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 110.698 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.96 112.47 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER 38.08 72.3 0.13 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.433 -0.792 . . . . 0.0 111.288 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 1.092 ' O ' HG23 ' A' ' 35' ' ' THR . 44.3 t -140.13 139.96 35.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 110.786 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.486 ' HA ' HG22 ' A' ' 36' ' ' THR . 29.8 p -103.85 50.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.918 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -89.86 54.7 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.817 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 40' ' ' SER . 10.1 p -84.21 173.46 11.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 110.152 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 94.21 -18.57 56.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 1.2 p -124.63 154.67 40.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 ttm180 -91.97 114.41 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.683 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -101.2 146.55 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 111.301 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -147.31 152.35 38.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.653 -0.655 . . . . 0.0 109.716 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 166.03 124.4 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.24 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -5.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.74 1.389 . . . . 0.0 108.761 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.93 32.12 0.46 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.534 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 1.9 t -72.51 139.09 47.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.527 -0.984 . . . . 0.0 110.658 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -132.18 110.55 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.464 -0.772 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 5.9 tt -100.35 172.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.175 -0.953 . . . . 0.0 109.967 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 16.0 m -151.93 94.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.017 -1.052 . . . . 0.0 110.962 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 45.59 105.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 179.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 17.1 t -133.53 163.84 28.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 69' ' ' ILE . 2.9 mp -80.52 167.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 0.0 110.897 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.537 ' N ' HG22 ' A' ' 68' ' ' ILE . 10.0 mt -84.63 120.97 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 109.395 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -148.54 139.16 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 110.617 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -82.28 58.12 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.803 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.212 0.53 . . . . 0.0 109.948 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -128.69 156.38 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.895 ' N ' HD13 ' A' ' 82' ' ' ILE . 36.4 t -147.59 87.69 1.65 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 90.95 60.15 1.35 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.578 ' N ' HD11 ' A' ' 82' ' ' ILE . 49.9 m -142.55 156.39 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -112.5 157.9 20.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.044 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 1.9 m-85 -144.89 161.69 38.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.868 -1.145 . . . . 0.0 110.66 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 176.47 56.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 42.56 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 109.825 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 40' ' ' SER . 1.5 p-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 120.903 0.383 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 5' ' ' THR . 14.6 t -137.06 47.05 2.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.963 -1.086 . . . . 0.0 110.795 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.41 90.98 2.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.531 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 14.5 p -98.44 41.27 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 168.31 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.369 0.604 . . . . 0.0 109.665 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 34.3 m -108.19 -163.71 0.91 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 110.583 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.55 120.67 18.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.702 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 16' ' ' LYS . 8.0 tp -88.15 21.67 2.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 10.6 t 64.64 5.88 2.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.642 -0.661 . . . . 0.0 111.118 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.13 21.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 110.072 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -154.0 14.05 0.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -112.46 -156.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.711 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -108.09 148.27 30.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.018 . . . . 0.0 110.055 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' HD22 ' A' ' 11' ' ' LEU . 7.2 p -123.05 68.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.322 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.545 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 5.5 m-20 . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.057 0.456 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.0 OUTLIER -157.9 122.61 4.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 110.955 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.542 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -87.3 102.32 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 108.757 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.021 HG22 ' HB2' ' A' ' 42' ' ' PHE . 18.8 t -100.85 163.84 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.922 -1.111 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.536 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 37.6 t0 -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' N ' ' OG ' ' A' ' 12' ' ' SER . 12.8 tttt 43.27 68.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.885 -1.134 . . . . 0.0 109.989 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.569 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.5 m -133.74 -171.05 2.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.061 . . . . 0.0 111.655 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -144.33 103.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.7 t -106.13 151.09 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.937 -1.102 . . . . 0.0 110.968 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.536 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 2.3 t80 -140.37 76.65 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.898 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.98 61.35 5.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -111.41 149.26 31.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 109.978 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 37' ' ' CYS . 18.2 p -67.38 -68.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.313 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.587 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER 51.42 42.42 29.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.099 -1.001 . . . . 0.0 109.988 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -85.15 36.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.726 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.502 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 152.08 54.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.57 -176.24 5.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.118 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -131.68 134.24 45.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.726 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.021 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.5 m-85 -111.97 150.85 29.97 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.894 -1.129 . . . . 0.0 110.416 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 14.4 t0 -166.15 119.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.491 -0.756 . . . . 0.0 109.105 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.42 68.89 1.03 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.711 ' CG1' HG23 ' A' ' 47' ' ' ILE . 2.3 t -145.85 135.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -1.165 . . . . 0.0 111.036 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 31' ' ' GLU . 65.5 m -115.43 90.61 3.38 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.711 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.34 172.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 110.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 49' ' ' THR . 5.1 t -129.14 -155.21 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.577 ' N ' HG23 ' A' ' 48' ' ' THR . 1.3 m -58.62 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 48' ' ' THR . 8.6 t -139.13 -175.6 4.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 67' ' ' CYS . 3.6 t -133.78 61.61 1.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.292 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -112.07 100.28 8.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 37' ' ' CYS . 3.5 p -131.21 -164.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.03 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.54 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . 94.1 -68.26 1.43 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.447 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.579 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -101.66 -169.58 1.7 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.155 -1.203 . . . . 0.0 111.722 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 3.7 ppt_? -107.6 139.59 41.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.735 -0.603 . . . . 0.0 110.131 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.683 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.7 mt -107.75 160.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.531 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.442 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -146.65 148.54 32.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.11 124.0 0.73 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.393 -1.385 . . . . 0.0 110.597 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.35 -1.26 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.746 1.393 . . . . 0.0 108.905 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -173.21 38.15 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.41 155.57 39.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 111.05 5.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.629 -0.67 . . . . 0.0 109.786 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -101.71 165.14 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 109.406 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.506 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 2.0 t -152.16 86.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.058 . . . . 0.0 110.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.2 p 55.02 114.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.543 -0.723 . . . . 0.0 110.3 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.575 ' O ' HD13 ' A' ' 68' ' ' ILE . 60.5 m -143.23 -143.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 110.532 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 67' ' ' CYS . 10.0 mm -132.32 165.59 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -45.85 151.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.0 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.424 ' CB ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -123.84 -144.78 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.74 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 115.22 57.84 0.35 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.433 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.88 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.19 151.8 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.541 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.88 ' N ' HD13 ' A' ' 82' ' ' ILE . 15.6 m -147.44 103.98 3.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 83.84 48.19 5.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.704 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.48 159.6 38.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -1.193 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.494 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -120.08 163.09 18.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.453 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 86' ' ' THR . 4.0 m-85 -134.61 161.73 34.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.085 -1.01 . . . . 0.0 109.973 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 55' ' ' SER . 0.3 OUTLIER 175.09 124.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 110.45 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 55' ' ' SER . . . -42.01 146.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 1.6 t30 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.887 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 17' ' ' CYS . 1.9 p . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.077 0.465 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.569 ' CG2' HD22 ' A' ' 11' ' ' LEU . 13.3 t -146.23 19.33 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 11' ' ' LEU . 4.8 m120 -89.48 57.52 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.519 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 75.2 p -98.63 105.47 17.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.382 -0.824 . . . . 0.0 109.438 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' THR . 14.2 m-20 67.09 6.04 4.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.86 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.43 178.7 6.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 10.8 tt0 -131.32 112.29 12.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.969 -1.082 . . . . 0.0 110.566 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.569 HD22 ' CG2' ' A' ' 5' ' ' THR . 5.3 tp -100.7 29.89 4.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.827 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 9.1 t 65.3 6.34 3.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.596 -0.69 . . . . 0.0 110.797 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 44.59 24.05 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.069 -1.019 . . . . 0.0 110.473 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.2 t30 -158.52 17.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 110.727 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 1.8 p -106.4 -140.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -120.67 124.14 44.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.926 -1.109 . . . . 0.0 109.81 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 8.9 m -97.12 61.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.69 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.585 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.145 . . . . 0.0 110.237 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.251 0.548 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.7 m -144.56 110.59 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 110.807 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.536 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 26.5 m-85 -105.65 104.91 14.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.023 HG13 ' HB3' ' A' ' 42' ' ' PHE . 6.7 t -106.29 159.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.759 -1.213 . . . . 0.0 110.841 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 1.7 t0 -142.89 123.37 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.283 -0.885 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' N ' ' OG ' ' A' ' 12' ' ' SER . 1.8 tttt 38.3 66.68 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 110.094 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 15' ' ' SER . 2.1 m -133.31 -167.47 1.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 47' ' ' ILE . 39.4 mt-10 -143.29 103.67 4.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 77.4 t -105.59 127.61 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.093 -1.004 . . . . 0.0 110.878 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.9 OUTLIER -107.51 -139.08 0.37 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.483 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -66.47 61.6 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.5 m -107.07 164.55 12.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 110.141 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.596 HG23 ' HA ' ' A' ' 51' ' ' THR . 19.6 p -104.82 174.61 5.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 119.73 7.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -140.39 -36.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 54' ' ' GLY . . . -172.17 65.12 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.58 ' HB2' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -137.62 179.96 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -1.097 . . . . 0.0 110.24 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HD2' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -141.27 130.2 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.544 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.023 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.4 m-85 -109.79 162.41 14.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.8 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 9.4 t0 177.95 112.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 52.18 66.34 2.68 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.315 -2.314 . . . . 0.0 107.315 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 57' ' ' ILE . 3.8 t -145.24 117.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -1.101 . . . . 0.0 110.422 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 63' ' ' LYS . 10.6 m -98.85 90.91 4.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.674 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -110.51 167.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.448 -0.782 . . . . 0.0 109.957 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.736 HG23 ' N ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -122.77 -160.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.107 -0.995 . . . . 0.0 110.121 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.861 ' O ' HG22 ' A' ' 66' ' ' THR . 44.1 m -49.13 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 109.941 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.523 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 3.5 t -139.99 132.31 28.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.034 -1.041 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.596 ' HA ' HG23 ' A' ' 36' ' ' THR . 33.2 p -85.38 59.71 5.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 109.658 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 t -119.59 126.5 51.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 110.02 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -169.81 75.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -0.974 . . . . 0.0 110.723 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -133.5 -54.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.528 ' HB3' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -104.7 -171.32 1.9 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -1.088 . . . . 0.0 109.959 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 37.4 ptt180 -105.31 136.47 44.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.306 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.692 HG22 HG22 ' A' ' 45' ' ' VAL . 1.8 mt -109.59 157.54 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.71 156.92 43.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.718 . . . . 0.0 110.292 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 157.33 124.42 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.552 -1.308 . . . . 0.0 110.575 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.03 -7.89 22.26 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.594 1.313 . . . . 0.0 108.76 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.48 33.05 0.64 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.513 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 2.8 t -71.68 137.98 48.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -1.035 . . . . 0.0 110.165 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' THR . 1.6 mtpt -137.22 118.41 14.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.87 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 47' ' ' ILE . 2.5 tt -104.26 170.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.2 t -143.36 77.93 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.108 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 49' ' ' THR . 7.2 p 52.9 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 110.971 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 64' ' ' ILE . 74.0 m -124.21 -149.8 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 69' ' ' ILE . 43.4 mm -131.09 169.4 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.528 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -57.83 136.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 55' ' ' SER . 0.8 OUTLIER -147.24 90.28 1.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 111.028 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . -74.38 65.04 2.06 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' A' ' 89' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 3.5 mmtt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.367 0.604 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.559 HD11 ' SG ' ' A' ' 85' ' ' CYS . 7.8 tp -138.57 156.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 109.845 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.9 m -154.21 125.91 7.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.183 -0.948 . . . . 0.0 110.055 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 56.53 55.29 30.52 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 82' ' ' ILE . 88.4 m -133.14 140.46 47.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -1.092 . . . . 0.0 111.064 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -101.95 166.38 10.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.079 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CD1' ' O ' ' A' ' 86' ' ' THR . 1.9 m-85 -152.8 157.26 40.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.835 -1.165 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER 177.48 132.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.656 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . . . -41.79 136.7 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.434 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.365 0.602 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 5' ' ' THR . 8.1 t -96.46 57.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.477 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 11' ' ' LEU . 7.9 m120 -149.01 111.75 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 9.5 p -98.4 111.05 23.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 73.9 -0.71 3.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 109.902 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -110.94 -177.18 3.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 109.599 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -143.47 99.69 3.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.604 HD12 HG21 ' A' ' 27' ' ' VAL . 4.4 tp -90.36 25.81 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.643 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 t 54.65 93.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.123 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -37.99 -28.54 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.761 . . . . 0.0 111.318 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 12' ' ' SER . 9.1 p30 -83.48 11.41 7.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -99.68 -149.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 0.0 109.522 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -113.82 99.63 7.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.023 -1.048 . . . . 0.0 109.781 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.3 m -73.97 55.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 110.104 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.212 179.642 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.444 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.001 0.429 . . . . 0.0 110.271 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -149.45 107.41 3.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.064 -1.023 . . . . 0.0 110.386 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 10.3 m-85 -106.9 88.28 2.71 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.854 HG13 ' CB ' ' A' ' 42' ' ' PHE . 11.0 t -93.73 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 111.371 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 7.5 t0 -150.07 126.5 10.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.0 109.852 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER 41.66 56.6 3.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.006 -1.059 . . . . 0.0 110.181 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.665 ' OG ' HG12 ' A' ' 27' ' ' VAL . 15.4 m -122.37 176.95 5.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.92 . . . . 0.0 110.77 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.812 ' HB2' HG23 ' A' ' 46' ' ' THR . 21.8 mt-10 -144.06 100.39 3.55 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 108.789 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.58 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.0 m -106.55 152.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 32.9 t80 -134.57 85.93 2.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.02 43.78 13.21 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 50' ' ' SER . 1.9 m -104.69 166.23 10.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -1.083 . . . . 0.0 110.286 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -130.47 134.38 47.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HA ' HG21 ' A' ' 53' ' ' THR . 5.0 p -121.55 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 110.441 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -86.77 7.01 28.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.0 109.951 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.18 76.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 2.2 p -159.24 179.62 8.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.176 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.547 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -146.07 117.73 8.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 0.0 109.927 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.854 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.5 m-30 -98.94 150.52 21.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.036 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -145.83 71.79 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 109.589 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 88.33 73.68 1.28 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 HD12 ' A' ' 57' ' ' ILE . 3.1 t -145.55 138.85 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -1.159 . . . . 0.0 111.103 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.812 HG23 ' HB2' ' A' ' 31' ' ' GLU . 18.8 m -112.76 91.94 3.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.978 . . . . 0.0 109.112 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.751 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -112.3 170.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 14.6 t -118.18 -145.76 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.82 -1.175 . . . . 0.0 109.969 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.551 ' CA ' ' O ' ' A' ' 33' ' ' TYR . 39.9 m -64.81 80.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' THR . 3.0 p -137.59 149.98 47.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.299 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 67' ' ' CYS . 9.0 t -112.64 66.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 0.0 110.202 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.46 91.46 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 37' ' ' CYS . 62.4 p -123.5 141.32 52.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.139 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.68 -32.29 1.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB3' ' C ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -122.32 160.57 25.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 110.525 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 110.22 21.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.829 HD12 HG21 ' A' ' 45' ' ' VAL . 7.3 pt -106.95 159.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.074 -1.017 . . . . 0.0 112.424 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 5.5 t -146.12 -173.72 4.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 151.49 119.79 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.669 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.57 -7.5 21.33 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.699 1.368 . . . . 0.0 108.645 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.4 37.28 0.3 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.9 t -71.83 144.25 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.499 -1.001 . . . . 0.0 110.581 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' THR . 18.3 mtpt -144.41 117.93 9.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.622 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.68 ' HB ' HG22 ' A' ' 47' ' ' ILE . 3.7 tt -105.03 174.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.89 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -147.01 84.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.914 179.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' SER . 0.2 OUTLIER 60.07 135.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.765 ' O ' HG22 ' A' ' 51' ' ' THR . 42.3 t -167.15 167.93 13.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 69' ' ' ILE . 5.6 mt -99.88 179.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 110.027 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.552 ' H ' HG22 ' A' ' 68' ' ' ILE . 1.5 pt -45.51 171.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.113 -0.992 . . . . 0.0 110.039 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -133.32 -137.65 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 111.02 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.13 43.87 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.056 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.543 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 4.7 mmtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.504 HD12 HG13 ' A' ' 64' ' ' ILE . 2.1 tp -140.6 147.65 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.995 . . . . 0.0 110.542 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 m -145.27 111.78 5.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.278 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.99 57.07 3.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.503 ' SG ' HG13 ' A' ' 82' ' ' ILE . 69.8 m -138.85 153.9 48.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -105.4 157.75 17.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.489 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.5 m-85 -144.28 146.66 32.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.101 -0.999 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER 174.1 118.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.74 . . . . 0.0 109.408 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -33.93 125.35 0.45 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.8 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.1 t30 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.254 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.15 0.5 . . . . 0.0 109.864 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.485 ' CB ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 m -143.57 32.33 1.31 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -112.42 59.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 11.2 p -99.57 105.84 17.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.076 -1.015 . . . . 0.0 110.306 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 7' ' ' THR . 4.2 t-20 66.65 6.78 4.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -129.85 -165.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.023 -1.048 . . . . 0.0 110.395 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -142.99 104.47 4.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 16' ' ' LYS . 30.3 tp -91.38 21.21 4.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.324 -0.86 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER 71.5 0.77 3.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.472 -0.768 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.68 19.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.012 . . . . 0.0 109.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.6 t30 -157.4 13.71 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.996 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -101.15 -145.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.761 -1.212 . . . . 0.0 109.703 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.628 ' O ' HD21 ' A' ' 11' ' ' LEU . 1.8 tptt -104.0 131.7 50.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.01 . . . . 0.0 109.227 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' ' CB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.22 65.39 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 111.087 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.06 -1.025 . . . . 0.0 109.791 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.297 0.57 . . . . 0.0 110.978 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 9' ' ' SER . 54.7 m -154.73 110.74 3.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.672 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 28.6 m-85 -101.86 122.26 43.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.76 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.109 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.6 t -120.35 167.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 110.308 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.607 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.1 m-20 -146.95 113.81 6.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 47.43 68.6 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.872 -1.143 . . . . 0.0 110.037 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.721 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -133.86 -171.02 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.158 -0.964 . . . . 0.0 111.346 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.22 100.84 3.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 71.1 t -101.42 157.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 111.15 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.654 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.34 -140.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 49' ' ' THR . . . -71.24 58.78 1.11 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 50' ' ' SER . 0.8 OUTLIER -96.96 -144.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.394 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.791 HG21 HG23 ' A' ' 51' ' ' THR . 31.0 p -139.53 -158.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.956 -1.09 . . . . 0.0 110.99 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 36' ' ' THR . 36.1 t 178.7 53.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.94 48.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.74 88.14 2.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.557 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 67.3 p -169.95 174.13 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -1.109 . . . . 0.0 110.391 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -137.91 138.64 39.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.453 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.109 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.7 m-85 -118.29 168.79 10.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.911 -1.118 . . . . 0.0 110.398 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER 176.57 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 108.739 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.44 68.05 1.31 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.755 ' CG1' HG23 ' A' ' 47' ' ' ILE . 15.0 t -143.02 109.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.363 -1.08 . . . . 0.0 111.265 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' THR . 5.7 m -94.89 86.27 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.896 -1.128 . . . . 0.0 108.595 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.755 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -112.41 163.37 9.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.563 -0.711 . . . . 0.0 110.451 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.783 HG23 ' N ' ' A' ' 49' ' ' THR . 1.4 t -115.29 -152.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.04 -1.038 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.783 ' N ' HG23 ' A' ' 48' ' ' THR . 8.8 m -58.87 87.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.688 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 0.7 OUTLIER -138.59 -162.26 1.29 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.966 -1.084 . . . . 0.0 110.835 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.791 HG23 HG21 ' A' ' 36' ' ' THR . 0.4 OUTLIER -144.01 67.21 1.27 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.8 79.41 2.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.328 -0.858 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 28.9 p -121.57 175.11 6.38 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 110.684 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.45 -34.43 4.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.536 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -129.85 163.84 25.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -1.133 . . . . 0.0 110.386 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.7 ptm180 -96.02 136.75 36.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.739 HG22 HG22 ' A' ' 45' ' ' VAL . 2.2 mt -110.73 163.94 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -0.96 . . . . 0.0 111.312 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.2 OUTLIER -147.31 149.82 33.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 167.01 116.24 0.35 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.415 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.93 -5.92 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.651 1.343 . . . . 0.0 108.819 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.11 38.51 0.34 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.8 t -71.41 155.16 40.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -1.118 . . . . 0.0 110.711 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 83' ' ' SER . 0.1 OUTLIER -143.34 107.86 4.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.481 -0.762 . . . . 0.0 109.56 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 4.9 tt -104.49 168.59 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 0.0 109.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -150.74 97.93 2.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 0.0 110.628 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 2.2 p 55.63 108.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.336 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.76 -156.35 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 68' ' ' ILE . 24.1 mt -146.78 140.83 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.525 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -52.8 112.14 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 110.369 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' THR . 2.9 m -148.51 135.69 20.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.925 -1.109 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.71 77.44 0.64 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.28 0.562 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -122.58 157.34 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.849 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 11.3 t -151.76 101.83 2.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 81.59 57.85 2.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.88 150.51 34.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -1.136 . . . . 0.0 111.239 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.585 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 9.0 t -110.7 160.68 16.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.432 -0.793 . . . . 0.0 109.004 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.3 m-85 -131.18 154.22 48.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.804 -1.185 . . . . 0.0 110.839 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' ARG . 4.0 m -174.05 120.05 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.716 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.35 139.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.416 -0.802 . . . . 0.0 110.576 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.523 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.3 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.034 0.445 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.591 HG22 ' CB ' ' A' ' 17' ' ' CYS . 3.6 t -122.09 19.5 10.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.02 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.18 52.22 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.842 . . . . 0.0 109.934 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 7' ' ' THR . 11.0 t -98.67 92.51 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 109.786 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.8 OUTLIER 69.91 3.51 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.795 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.32 149.32 40.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.399 -0.813 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 27' ' ' VAL . 1.3 mt-30 -107.92 88.04 2.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 109.987 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.052 HD21 ' O ' ' A' ' 16' ' ' LYS . 3.3 tp -88.58 25.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 7.7 t 53.67 103.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.45 -23.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.3 t-20 -89.86 14.91 10.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 111.707 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 0.0 OUTLIER -113.56 -164.08 0.9 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.567 -1.333 . . . . 0.0 110.141 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 1.052 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -114.66 147.49 39.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.14 -0.975 . . . . 0.0 109.724 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' HB3' HD22 ' A' ' 11' ' ' LEU . 6.6 p -123.11 72.75 1.12 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.724 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.063 -1.023 . . . . 0.0 109.842 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.7 t30 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.121 0.486 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 87.0 m -153.33 114.39 4.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.903 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 27.9 m-85 -107.91 92.65 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.799 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.976 HG13 ' HB3' ' A' ' 42' ' ' PHE . 12.7 t -93.56 167.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.247 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.7 t0 -148.28 122.12 9.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 109.596 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 44.12 61.65 2.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 0.0 109.565 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.739 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -131.78 -174.88 3.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 111.222 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -145.17 104.46 3.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.706 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 11' ' ' LEU . 2.9 m -117.46 136.24 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.805 -1.184 . . . . 0.0 110.112 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.606 ' HB2' ' N ' ' A' ' 49' ' ' THR . 4.0 m-85 -97.87 -137.65 0.28 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 49' ' ' THR . . . -65.45 59.46 0.11 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.561 ' N ' ' O ' ' A' ' 33' ' ' TYR . 2.3 m -95.1 162.07 13.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -1.169 . . . . 0.0 110.043 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.443 HG21 HG23 ' A' ' 51' ' ' THR . 13.5 p -100.61 -169.38 1.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.401 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.886 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -168.51 140.25 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.767 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 1.8 t 178.55 43.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.27 41.0 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.789 ' OG ' HG22 ' A' ' 53' ' ' THR . 0.9 OUTLIER -131.12 171.87 12.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 109.955 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 2.2 tpt85 -146.46 129.71 16.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 109.948 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.976 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.8 m-85 -109.13 170.48 8.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.905 -1.122 . . . . 0.0 110.715 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -174.85 80.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.015 . . . . 0.0 110.176 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 83.71 66.72 1.49 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.059 HG21 HG22 ' A' ' 57' ' ' ILE . 2.3 t -146.97 136.71 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.808 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.5 m -107.77 93.2 4.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.763 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.93 171.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 110.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 49' ' ' THR . 1.6 t -118.69 -162.14 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.426 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 66' ' ' THR . 20.2 m -54.71 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' THR . 66.4 m -128.49 146.72 50.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 51' ' ' THR . 86.4 m -100.03 48.3 0.93 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.536 -0.728 . . . . 0.0 109.317 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 3.1 t -111.35 100.32 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.886 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -144.39 99.76 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.511 ' N ' ' HB ' ' A' ' 70' ' ' THR . . . -161.63 -48.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.561 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -101.57 -168.16 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.459 -1.024 . . . . 0.0 109.782 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.9 mtp85 -91.11 141.09 29.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.742 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.059 HG22 HG21 ' A' ' 45' ' ' VAL . 3.2 mm -113.1 127.27 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 110.155 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.418 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.3 152.96 40.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.245 -0.909 . . . . 0.0 110.012 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 118.0 0.42 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.7 -2.48 11.47 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.569 1.299 . . . . 0.0 109.704 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.85 30.76 0.18 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 7.2 t -73.02 152.89 41.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -1.068 . . . . 0.0 111.157 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.31 108.84 4.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.642 -0.661 . . . . 0.0 109.778 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.727 HG13 HD12 ' A' ' 82' ' ' ILE . 2.0 tt -99.02 176.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.062 -1.024 . . . . 0.0 110.123 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -151.77 75.21 1.14 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.906 -1.122 . . . . 0.0 110.953 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER 59.88 73.48 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 110.837 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' A' ' 64' ' ' ILE . 88.1 m -100.33 -178.26 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.465 ' O ' ' O ' ' A' ' 69' ' ' ILE . 1.1 tt -89.76 -178.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.658 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 5.1 pt -51.05 -174.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.511 ' HB ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -142.37 -148.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 110.701 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 70' ' ' THR . . . 113.24 34.92 1.7 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.487 2.035 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.374 0.607 . . . . 0.0 110.25 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.727 HD12 HG13 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -143.29 146.38 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 -179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.443 ' O ' ' SG ' ' A' ' 85' ' ' CYS . 1.7 t -157.11 136.99 12.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.85 -1.156 . . . . 0.0 111.283 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 52.37 61.98 6.17 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 87' ' ' PHE . 55.9 m -135.46 168.53 19.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.283 . . . . 0.0 111.07 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.64 123.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.627 -0.671 . . . . 0.0 109.201 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.726 ' CD1' HD13 ' A' ' 57' ' ' ILE . 10.8 m-85 -126.98 160.51 30.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.857 -1.152 . . . . 0.0 111.478 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 89' ' ' ALA . 7.0 p -166.58 129.03 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -34.48 142.41 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 110.892 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.561 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.4 t-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.099 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.271 0.558 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.753 ' O ' HG22 ' A' ' 5' ' ' THR . 20.7 m -126.32 60.64 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.126 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -133.98 65.76 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.394 -0.816 . . . . 0.0 110.003 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.51 HG23 ' N ' ' A' ' 8' ' ' ASN . 9.8 t -102.53 -139.23 0.35 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.31 -0.869 . . . . 0.0 110.419 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -41.73 -23.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.223 -0.923 . . . . 0.0 110.967 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -107.78 162.97 13.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.0 110.557 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.406 ' OE1' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.51 106.87 17.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.828 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 12' ' ' SER . 4.0 tp -88.57 32.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.6 t 67.3 2.8 2.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.53 -0.731 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 45.4 22.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.956 -1.09 . . . . 0.0 110.497 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' SER . 41.4 t30 -160.8 15.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.1 m -96.82 -136.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.091 -1.005 . . . . 0.0 109.168 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -115.0 123.76 49.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.871 -1.143 . . . . 0.0 109.87 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.03 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 0.0 110.529 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.856 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.89 . . . . 0.0 109.646 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.28 0.562 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 3.3 m -155.25 111.6 3.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.048 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CD1' ' NH2' ' A' ' 41' ' ' ARG . 3.7 t80 -111.09 101.72 10.23 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.078 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.061 HG13 ' HB3' ' A' ' 42' ' ' PHE . 11.4 t -104.27 164.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.537 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -145.63 122.73 11.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 109.713 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 44.12 64.96 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.013 . . . . 0.0 109.525 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.743 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -134.26 -169.8 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 111.613 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 21.1 tt0 -145.06 98.39 3.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.856 HG12 ' CB ' ' A' ' 18' ' ' GLU . 62.1 t -105.62 138.84 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.847 -1.158 . . . . 0.0 110.43 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' THR . 1.8 t80 -142.75 129.21 20.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.93 40.71 9.87 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.553 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 14.0 m -103.94 165.73 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -1.136 . . . . 0.0 110.247 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.88 HG21 HG22 ' A' ' 51' ' ' THR . 6.8 p -105.05 -170.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 110.015 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.945 ' HA ' HG21 ' A' ' 53' ' ' THR . 36.3 t -172.53 128.31 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.576 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.441 ' O ' HG22 ' A' ' 38' ' ' THR . 19.4 m -163.02 33.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 109.689 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 123.92 62.62 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.531 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 28.7 p -143.0 170.81 15.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.572 ' NH2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -139.48 127.47 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.067 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.061 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.7 m-85 -109.06 169.69 8.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 45' ' ' VAL . 5.7 t70 178.99 112.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 52.87 62.72 5.64 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.819 HG12 HG23 ' A' ' 47' ' ' ILE . 14.5 t -142.83 123.14 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -1.014 . . . . 0.0 110.772 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 41.8 m -101.47 98.6 8.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.096 -1.003 . . . . 0.0 109.354 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.819 HG23 HG12 ' A' ' 45' ' ' VAL . 1.3 pt -113.38 156.58 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.191 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -135.78 127.73 29.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.847 . . . . 0.0 109.805 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER 40.85 79.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.876 . . . . 0.0 110.013 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.2 t -138.98 148.91 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.071 -1.018 . . . . 0.0 110.773 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.88 HG22 HG21 ' A' ' 36' ' ' THR . 4.1 p -115.97 41.23 2.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 1.2 t -104.89 116.65 32.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 110.177 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.945 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -146.28 112.25 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 110.225 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 165.32 -31.31 0.23 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.7 p -113.09 163.07 15.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.044 -1.268 . . . . 0.0 110.707 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -91.78 120.22 32.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.0 109.591 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -99.71 156.73 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.078 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -147.11 142.49 27.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.695 -0.628 . . . . 0.0 109.897 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 163.59 114.14 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.383 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.59 -7.48 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 N-CA-C 108.427 -1.413 . . . . 0.0 108.427 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.93 26.91 1.61 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.4 t -72.03 147.27 47.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.406 -1.055 . . . . 0.0 110.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 115.24 9.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.539 HG13 HD12 ' A' ' 82' ' ' ILE . 7.5 tt -104.94 174.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.734 ' C ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.48 99.03 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.565 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.734 HG23 ' C ' ' A' ' 65' ' ' SER . 1.2 p 69.24 -68.17 0.2 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.664 -0.647 . . . . 0.0 110.719 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.581 ' C ' HG22 ' A' ' 68' ' ' ILE . 0.5 OUTLIER 65.63 -153.84 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.066 . . . . 0.0 110.526 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.581 HG22 ' C ' ' A' ' 67' ' ' CYS . 1.3 tt 172.54 95.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ILE . 5.1 mt 59.88 134.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.308 -0.87 . . . . 0.0 110.062 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -113.28 -71.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.979 -1.076 . . . . 0.0 111.105 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.419 ' H ' ' HA3' ' A' ' 54' ' ' GLY . . . 45.23 71.6 0.47 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 89' ' ' ALA . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 23.3 mmtt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.473 0.654 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.557 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.2 tp -128.92 151.65 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.85 . . . . 0.0 110.399 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 104.99 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.11 5.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.557 ' SG ' HD11 ' A' ' 82' ' ' ILE . 56.8 m -134.5 153.81 51.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -1.193 . . . . 0.0 110.464 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -109.4 163.48 13.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 86' ' ' THR . 3.2 m-85 -138.88 159.68 41.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.15 -0.969 . . . . 0.0 110.06 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -176.48 38.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 110.21 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 41.82 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.296 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 54' ' ' GLY . 1.5 t-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.961 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.254 0.55 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.872 ' CG2' HD22 ' A' ' 11' ' ' LEU . 13.2 t -144.63 35.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -99.67 57.95 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 1.8 t -98.34 95.61 7.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.904 . . . . 0.0 109.542 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 7' ' ' THR . 6.4 t-20 70.4 7.03 6.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.8 m -126.7 179.92 5.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 8.7 tt0 -134.47 95.6 3.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.949 . . . . 0.0 110.043 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.872 HD22 ' CG2' ' A' ' 5' ' ' THR . 12.5 tp -88.53 31.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.975 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 68.52 3.54 3.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 0.0 110.551 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.09 25.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.608 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' SER . 28.6 t30 -162.29 19.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.621 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' SER . 2.0 m -104.61 -144.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 14.6 mmtm -114.14 91.55 3.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.836 -1.165 . . . . 0.0 110.155 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 p -65.62 67.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -0.784 . . . . 0.0 110.642 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 14.0 mm-40 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.274 0.559 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.56 112.32 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 110.764 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 27.2 m-85 -101.8 96.46 7.08 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.107 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -100.6 163.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 111.115 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.591 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 3.8 t0 -141.44 119.01 11.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.532 -0.73 . . . . 0.0 109.379 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 28' ' ' ASP . 4.5 ttmm 39.98 70.45 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.21 -0.932 . . . . 0.0 109.926 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.768 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.0 m -131.76 -178.79 5.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.9 . . . . 0.0 110.886 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -144.97 97.53 3.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 1.9 m -104.2 153.15 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.966 -1.084 . . . . 0.0 110.576 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 10.2 t80 -139.48 138.33 36.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.169 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 38.26 40.04 0.83 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.476 ' CG2' ' N ' ' A' ' 36' ' ' THR . 2.4 m -94.66 167.61 11.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.149 -1.206 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.823 HG21 HG23 ' A' ' 51' ' ' THR . 10.9 p -105.39 -52.31 2.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.857 . . . . 0.0 110.157 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.1 OUTLIER 59.74 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.0 110.075 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.722 HG22 HG21 ' A' ' 53' ' ' THR . 8.0 t -173.51 64.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 117.42 32.76 1.42 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.614 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -133.77 -178.18 4.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -1.144 . . . . 0.0 110.039 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 26' ' ' TYR . 3.2 tpt180 -142.71 125.71 16.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 108.764 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.107 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.6 m-85 -103.96 162.09 13.43 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 3.5 t0 -170.09 103.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.539 -0.726 . . . . 0.0 109.144 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 61.39 67.69 2.0 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.742 ' CG1' HG23 ' A' ' 47' ' ' ILE . 4.6 t -145.58 127.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 110.835 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 31' ' ' GLU . 61.7 m -108.43 87.78 2.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 108.815 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.742 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.76 154.75 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.653 -0.654 . . . . 0.0 110.427 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.78 HG23 ' N ' ' A' ' 49' ' ' THR . 1.5 t -108.65 -150.26 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.78 ' N ' HG23 ' A' ' 48' ' ' THR . 87.9 m -45.1 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.134 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -139.71 135.95 33.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 111.307 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.823 HG23 HG21 ' A' ' 36' ' ' THR . 97.5 m -108.35 61.24 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 29.3 m -114.91 113.68 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 110.766 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.722 HG21 HG22 ' A' ' 38' ' ' THR . 34.7 p -131.91 -151.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.371 -0.83 . . . . 0.0 109.642 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 90' ' ' ASN . . . 76.55 -65.87 2.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -101.89 171.53 7.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.286 -1.126 . . . . 0.0 109.448 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.501 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -104.96 158.7 16.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.775 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.706 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -123.33 155.07 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.689 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.531 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.73 157.67 43.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.259 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 160.29 127.32 0.89 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.146 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.55 -5.5 17.17 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.673 1.354 . . . . 0.0 108.871 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.98 35.13 0.36 Allowed Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.514 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 10.1 t -71.76 147.45 47.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.757 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.71 120.02 10.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.01 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.519 HG21 ' HB ' ' A' ' 47' ' ' ILE . 3.8 tt -104.25 178.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.289 -0.882 . . . . 0.0 109.938 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 66' ' ' THR . 3.2 t -150.8 58.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.889 -1.132 . . . . 0.0 111.14 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 65' ' ' SER . 1.6 m 66.83 83.85 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 111.349 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.48 -149.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 109.371 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 68' ' ' ILE . 7.6 mm -120.85 158.21 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.91 -1.119 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 3.7 tt -52.35 144.77 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 110.229 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 70' ' ' THR . 3.4 t -148.66 107.68 3.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.481 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -92.69 62.08 2.33 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.905 ' HA3' ' HB2' ' A' ' 89' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.318 0.58 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.581 HD11 ' SG ' ' A' ' 85' ' ' CYS . 10.5 tp -127.95 142.65 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -142.87 125.28 15.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 63.65 62.64 5.11 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 82' ' ' ILE . 59.2 m -145.39 148.45 33.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 111.079 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.531 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 13.5 t -116.74 157.66 25.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.34 152.14 50.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.769 -1.207 . . . . 0.0 110.602 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.6 m -170.54 124.77 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.352 -0.842 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.905 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . . . -45.1 147.65 0.68 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 110.559 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 41' ' ' ARG . 1.1 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.051 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.262 0.553 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.798 ' CG2' HD22 ' A' ' 11' ' ' LEU . 5.1 t -122.31 56.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.13 93.28 5.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.331 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 9' ' ' SER . 10.1 t -134.66 -138.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.63 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 7' ' ' THR . 11.6 m-20 -39.47 -27.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.811 . . . . 0.0 110.606 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 4.7 m -108.49 -164.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.149 -0.97 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -140.75 127.56 20.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.798 HD22 ' CG2' ' A' ' 5' ' ' THR . 21.4 tp -88.27 24.02 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.7 t 61.03 11.25 3.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.49 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' SER . 10.7 t30 -161.04 15.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 111.03 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.2 m -98.79 -139.0 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.392 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 3.7 tptt -114.78 141.15 48.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.3 93.54 2.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 110.599 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.642 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 110.437 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.428 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.9 m120 . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.135 0.493 . . . . 0.0 109.985 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.846 ' O ' HG23 ' A' ' 27' ' ' VAL . 11.9 m -155.35 31.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.557 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' HB3' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -45.78 119.7 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 110.024 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.904 HG22 ' HB2' ' A' ' 42' ' ' PHE . 30.4 t -119.13 161.25 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 110.609 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -142.03 118.87 11.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 109.672 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.8 mmtp 43.26 68.12 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.511 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.7 m -133.47 -172.09 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 111.115 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.564 ' HB3' HG23 ' A' ' 46' ' ' THR . 11.2 tt0 -143.81 99.21 3.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.66 HG13 HD11 ' A' ' 47' ' ' ILE . 40.2 t -101.06 150.06 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.052 . . . . 0.0 110.575 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -143.16 116.19 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 43.33 51.44 6.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.528 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 2.4 m -107.08 156.5 18.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 35' ' ' THR . 19.4 p -91.04 -173.14 3.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.721 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.8 OUTLIER -157.87 124.28 4.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.362 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.422 ' OG1' ' C ' ' A' ' 37' ' ' CYS . 0.7 OUTLIER -163.98 55.87 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.981 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.439 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 96.79 96.21 1.87 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.564 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 14.1 p -177.98 173.38 1.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -1.152 . . . . 0.0 110.28 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CB ' ' ND2' ' A' ' 90' ' ' ASN . 6.3 tpt180 -146.97 131.81 18.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 109.649 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.904 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.9 m-85 -109.35 169.86 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.9 t70 178.33 116.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 109.136 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.75 65.37 2.45 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.859 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.0 t -145.33 138.06 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -1.09 . . . . 0.0 110.83 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 31' ' ' GLU . 81.5 m -116.61 94.68 4.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 109.228 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.707 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.3 pt -114.08 172.39 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.833 HG23 ' N ' ' A' ' 49' ' ' THR . 2.0 t -131.38 -146.52 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.378 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.833 ' N ' HG23 ' A' ' 48' ' ' THR . 6.6 m -54.91 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 11.3 p -139.61 158.29 44.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -0.921 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -118.04 45.31 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.854 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -95.72 103.49 15.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 110.13 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 37' ' ' CYS . 3.0 p -138.6 112.93 8.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 110.416 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 176.3 -54.89 0.11 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.543 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -102.63 -173.54 2.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.817 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 7.8 ttp180 -104.02 125.96 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.096 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.859 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.49 153.62 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.965 . . . . 0.0 110.308 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.57 160.64 41.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 154.09 122.56 0.86 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.22 -5.62 17.41 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.692 1.364 . . . . 0.0 109.036 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.53 34.12 0.33 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -72.26 154.9 40.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 110.206 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.54 113.19 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -96.68 172.26 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.058 -1.026 . . . . 0.0 109.161 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 11.0 t -149.04 67.81 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.898 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.9 m 64.01 98.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 111.06 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 64' ' ' ILE . 76.8 m -107.92 -144.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.413 -0.804 . . . . 0.0 109.246 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 97.0 mt -128.26 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.77 -1.206 . . . . 0.0 110.581 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 tp -151.17 158.39 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 55' ' ' SER . 0.2 OUTLIER -125.8 -154.22 0.61 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.431 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . 105.39 38.33 2.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.487 2.05 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.446 0.641 . . . . 0.0 110.564 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 82' ' ' ILE . 6.9 tp -127.41 156.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -154.39 116.79 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.02 . . . . 0.0 110.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.15 46.78 33.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.24 159.99 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.028 -1.277 . . . . 0.0 111.361 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.402 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -116.96 154.82 30.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 85' ' ' CYS . 9.0 m-85 -133.13 147.91 52.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.927 -1.108 . . . . 0.0 110.401 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' ALA . 29.1 t -173.39 124.25 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.97 141.68 0.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.548 ' ND2' ' CB ' ' A' ' 41' ' ' ARG . 4.4 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.084 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.342 0.591 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 5' ' ' THR . 10.5 t -141.59 53.49 1.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.885 . . . . 0.0 109.998 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 1.8 m120 -146.64 139.54 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 9' ' ' SER . 17.1 p -103.47 -135.49 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -42.71 -15.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.251 -0.905 . . . . 0.0 111.668 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.5 p -103.99 160.73 14.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.701 -1.249 . . . . 0.0 108.74 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HG2' ' N ' ' A' ' 11' ' ' LEU . 38.9 tt0 -107.13 155.13 20.2 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.024 -1.048 . . . . 0.0 111.899 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 31.9 tp -108.77 41.94 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.666 . . . . 0.0 109.292 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 18.4 t 58.57 12.78 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.792 . . . . 0.0 110.864 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 41.07 25.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.688 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' SER . 31.4 t30 -170.7 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.973 -1.079 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -103.67 -147.02 0.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.99 -1.068 . . . . 0.0 109.539 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.99 142.26 45.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.827 -1.171 . . . . 0.0 109.871 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.35 100.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.454 -0.779 . . . . 0.0 111.209 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.863 ' CB ' HG12 ' A' ' 32' ' ' VAL . 16.5 pm0 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.216 0.532 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' SER . 4.8 m -155.14 111.76 3.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -110.25 96.2 6.07 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.088 HG13 ' CB ' ' A' ' 42' ' ' PHE . 3.9 t -98.6 164.45 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 111.178 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 29' ' ' LYS . 41.5 m-20 -144.78 124.94 13.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.502 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 11.1 tttp 42.82 67.47 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.82 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.786 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.5 m -133.34 -174.07 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 111.239 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CB ' HG23 ' A' ' 46' ' ' THR . 3.1 tt0 -143.37 103.33 4.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.863 HG12 ' CB ' ' A' ' 18' ' ' GLU . 47.7 t -105.47 142.86 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.012 -1.055 . . . . 0.0 110.071 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t80 -140.09 102.93 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 51.89 53.36 30.36 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.538 HG21 ' CD1' ' A' ' 47' ' ' ILE . 55.2 m -114.23 154.79 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -1.168 . . . . 0.0 110.238 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.414 HG21 HG23 ' A' ' 51' ' ' THR . 22.8 p -86.22 140.28 30.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.18 43.42 2.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -77.85 3.81 13.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 166.26 97.12 0.11 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.518 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 38.2 p -177.6 167.65 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -1.196 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -138.52 123.0 18.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 179.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.088 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.46 170.5 7.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.825 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 11.7 t70 178.7 98.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 65.65 58.33 9.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.784 HG22 HG22 ' A' ' 57' ' ' ILE . 17.1 t -139.98 126.79 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.523 -0.986 . . . . 0.0 110.736 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.583 HG23 ' CB ' ' A' ' 31' ' ' GLU . 54.1 m -109.47 94.96 5.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 35' ' ' THR . 1.4 pt -113.28 175.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.756 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -132.51 -153.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.986 -1.071 . . . . 0.0 110.673 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.756 ' N ' HG23 ' A' ' 48' ' ' THR . 28.3 m -53.68 85.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' THR . 18.7 m -139.87 144.7 37.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 110.595 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 51' ' ' THR . 97.7 m -90.04 39.94 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -91.23 127.69 36.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.763 . . . . 0.0 110.632 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.518 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.91 130.55 0.11 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 148.82 -42.09 0.84 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -101.87 -168.59 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -1.14 . . . . 0.0 110.236 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.521 ' N ' ' OG ' ' A' ' 55' ' ' SER . 20.0 ttt180 -114.44 120.24 39.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.784 HG22 HG22 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.75 154.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.968 . . . . 0.0 110.341 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -146.52 160.41 42.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.347 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 156.26 127.34 1.01 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.337 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.07 -7.58 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.803 1.422 . . . . 0.0 108.503 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.06 38.33 0.46 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.503 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 3.6 t -71.64 127.55 32.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -1.054 . . . . 0.0 110.805 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.87 111.15 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.767 . . . . 0.0 109.268 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.467 ' HB ' HG22 ' A' ' 47' ' ' ILE . 4.6 tt -104.72 162.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 110.59 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.451 ' O ' ' OG1' ' A' ' 66' ' ' THR . 17.6 t -144.79 88.21 1.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.4 p 54.15 74.58 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 52' ' ' SER . 0.5 OUTLIER -148.03 149.36 31.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.051 -1.03 . . . . 0.0 110.617 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.61 ' C ' HG23 ' A' ' 69' ' ' ILE . 18.5 mm 59.59 158.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.878 . . . . 0.0 110.643 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.61 HG23 ' C ' ' A' ' 68' ' ' ILE . 1.3 pt -160.42 16.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.848 -0.533 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.505 ' C ' ' HA3' ' A' ' 54' ' ' GLY . 0.2 OUTLIER -155.09 -149.54 0.27 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 110.67 -179.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -65.99 -150.77 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.559 ' N ' ' HB2' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.382 0.61 . . . . 0.0 110.681 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.555 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -133.41 135.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 110.008 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -141.75 105.44 4.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 75.35 51.46 7.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.555 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 99.2 m -126.2 141.43 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -103.25 152.6 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.042 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' A' ' 88' ' ' SER . 3.7 m-85 -134.89 141.13 46.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.002 -1.061 . . . . 0.0 110.212 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' PHE . 1.5 m 178.29 135.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.109 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.05 148.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.382 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.476 ' N ' ' HA ' ' A' ' 55' ' ' SER . 27.9 p-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.318 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.438 ' HB3' ' ND2' ' A' ' 6' ' ' ASN . 17.2 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.822 0.344 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 5' ' ' THR . 6.5 t -142.04 41.55 1.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.782 -1.199 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 9.3 p30 -136.92 111.66 8.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 110.67 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 45.8 p -98.39 43.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.03 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER 165.27 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.711 -0.618 . . . . 0.0 109.579 -179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.403 ' HB3' ' H ' ' A' ' 25' ' ' CYS . 0.2 OUTLIER -108.21 -163.54 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.047 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -143.34 104.34 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.748 HD21 ' O ' ' A' ' 16' ' ' LYS . 8.8 tp -88.47 21.36 2.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 109.743 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 12.5 t 56.69 107.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.362 -0.836 . . . . 0.0 109.837 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.43 -22.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.28 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -82.81 6.61 17.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 110.377 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -106.16 -163.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.836 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.748 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -107.29 123.06 47.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 111.022 -178.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' A' ' 5' ' ' THR . 5.9 m -90.51 57.64 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.482 -0.761 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 1.4 tm-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.672 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 1.6 m -156.6 120.27 4.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -119.66 88.13 2.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.348 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 42' ' ' PHE . 4.3 t -94.08 170.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 111.023 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 1.4 m-20 -150.14 114.7 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 12' ' ' SER . 6.3 tttm 45.19 67.86 0.65 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 15' ' ' SER . 14.9 m -130.67 -164.39 1.42 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.006 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 20.4 tt0 -144.93 100.1 3.44 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.258 -0.902 . . . . 0.0 108.696 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.636 HG21 HD11 ' A' ' 11' ' ' LEU . 73.5 t -105.18 133.63 48.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.496 -0.753 . . . . 0.0 110.595 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -133.55 125.51 29.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 41.5 39.96 2.63 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.559 HG22 ' N ' ' A' ' 36' ' ' THR . 96.7 m -94.69 171.19 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -1.212 . . . . 0.0 110.04 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.559 ' N ' HG22 ' A' ' 35' ' ' THR . 29.8 p -99.06 -51.66 3.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.569 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 1.0 OUTLIER 57.6 42.56 23.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.556 ' N ' HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -97.35 71.87 2.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.325 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.23 65.13 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.865 ' OG ' HG22 ' A' ' 53' ' ' THR . 99.5 p -162.55 162.89 27.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 110.249 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -123.53 125.46 44.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.657 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.01 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.97 168.99 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.056 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD2' ' NE ' ' A' ' 41' ' ' ARG . 1.1 m-20 -175.4 98.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.071 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 64.3 68.35 1.69 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.063 HG21 HG22 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -145.25 150.14 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.193 . . . . 0.0 110.558 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 52.2 m -122.04 90.9 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.184 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.761 HG23 HG13 ' A' ' 45' ' ' VAL . 1.1 pt -114.07 167.69 6.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.704 HG23 ' N ' ' A' ' 49' ' ' THR . 3.1 t -125.27 -151.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.057 -1.027 . . . . 0.0 110.013 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.704 ' N ' HG23 ' A' ' 48' ' ' THR . 3.2 m -57.03 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.896 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 3.5 p -138.27 142.41 39.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.893 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 36' ' ' THR . 0.1 OUTLIER -92.77 50.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.87 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.78 142.69 35.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.17 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.865 HG22 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 175.96 134.33 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.894 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 140.87 -22.6 2.64 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.53 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 88.1 p -121.05 179.39 4.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.335 -1.097 . . . . 0.0 110.067 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 mtp85 -91.7 114.57 27.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 108.773 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.063 HG22 HG21 ' A' ' 45' ' ' VAL . 1.3 mm -98.03 130.35 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.909 -1.119 . . . . 0.0 110.859 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.643 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.97 164.08 33.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.946 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 154.38 116.12 0.58 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.217 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.36 -6.38 19.04 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.699 1.368 . . . . 0.0 109.132 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.44 26.79 0.77 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 11.1 t -72.42 144.44 48.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -1.113 . . . . 0.0 110.628 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 7.9 mmtt -136.09 106.07 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 109.303 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.621 ' HB ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -104.63 155.85 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.605 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -146.47 100.17 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.534 -0.728 . . . . 0.0 109.707 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 4.1 p 54.86 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.469 -0.769 . . . . 0.0 110.097 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.422 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.05 -150.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 110.292 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.2 tt -131.22 143.1 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 109.989 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.772 HD12 ' OG1' ' A' ' 53' ' ' THR . 1.1 tt -81.74 108.06 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 110.616 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.405 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.9 m -148.22 160.34 43.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.219 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 69.57 3.29 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.416 0.627 . . . . 0.0 110.327 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.734 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -118.99 158.37 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.69 ' N ' HD13 ' A' ' 82' ' ' ILE . 21.1 t -155.73 112.34 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.926 -1.109 . . . . 0.0 111.02 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 73.63 60.14 3.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.46 163.23 29.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -1.226 . . . . 0.0 110.014 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.12 110.2 5.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 109.663 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.557 ' HD2' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -141.88 164.87 29.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 111.032 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -169.58 71.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 58.29 144.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.825 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.809 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.296 0.569 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 5' ' ' THR . 14.9 t -145.11 64.05 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.659 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 6' ' ' ASN . 27.5 p30 -162.95 102.71 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 110.494 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 3.3 p -104.48 34.39 3.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.226 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' THR . 10.3 t30 174.89 -21.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.401 ' CB ' ' H ' ' A' ' 25' ' ' CYS . 2.0 p -107.16 -161.69 0.8 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -140.41 122.47 15.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.588 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD21 ' O ' ' A' ' 16' ' ' LYS . 11.3 tp -98.62 29.39 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER 70.92 -0.81 2.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 110.77 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.64 22.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.026 . . . . 0.0 109.665 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -156.11 9.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.975 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.9 m -105.18 -144.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 0.0 109.643 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' O ' HD21 ' A' ' 11' ' ' LEU . 15.2 tttm -118.09 137.02 53.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.114 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 27.9 p -117.05 60.68 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.23 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 mm-40 . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.427 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 3.8 m-20 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.25 0.548 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 57.8 m -150.01 116.49 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 t80 -96.63 98.12 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 109.137 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.039 HG13 ' HB3' ' A' ' 42' ' ' PHE . 5.4 t -94.36 165.41 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 110.535 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 11.4 t0 -141.07 121.3 13.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 37.32 69.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.427 -0.796 . . . . 0.0 110.32 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.574 ' OG ' HG12 ' A' ' 27' ' ' VAL . 5.6 m -130.34 -170.71 2.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.923 . . . . 0.0 111.187 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 46' ' ' THR . 25.8 mt-10 -143.54 101.59 3.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 47' ' ' ILE . 70.9 t -108.94 145.23 16.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.261 -0.9 . . . . 0.0 111.197 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -115.91 -140.5 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.559 ' HA3' HG23 ' A' ' 49' ' ' THR . . . -65.43 65.94 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.896 HG23 ' O ' ' A' ' 50' ' ' SER . 84.9 m -105.91 153.18 22.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.073 -1.251 . . . . 0.0 110.433 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.497 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER -115.45 117.92 31.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.433 -0.792 . . . . 0.0 109.896 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -82.63 155.34 24.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.759 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.448 ' CB ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -167.18 43.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -0.797 . . . . 0.0 109.607 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.87 75.2 1.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -156.14 177.97 10.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.163 . . . . 0.0 110.621 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 12.6 tpp85 -141.19 124.14 16.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.039 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -105.44 167.46 9.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.767 -1.208 . . . . 0.0 110.43 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -178.39 114.23 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.477 -0.764 . . . . 0.0 109.027 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.31 67.2 1.97 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.68 ' CG1' HG23 ' A' ' 47' ' ' ILE . 3.6 t -145.27 127.57 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -1.089 . . . . 0.0 110.572 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . 93.2 m -106.93 91.16 3.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.68 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.08 161.92 7.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.58 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.695 HG23 ' N ' ' A' ' 49' ' ' THR . 2.3 t -111.03 -153.92 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 110.555 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.695 ' N ' HG23 ' A' ' 48' ' ' THR . 17.2 m -61.35 77.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 109.918 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.896 ' O ' HG23 ' A' ' 35' ' ' THR . 1.3 p -139.74 172.56 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.085 -1.009 . . . . 0.0 110.686 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 36' ' ' THR . 0.6 OUTLIER -126.89 94.81 4.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.039 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -125.45 70.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.647 HG21 ' HA ' ' A' ' 37' ' ' CYS . 67.1 p -103.93 -172.45 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.466 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 91.88 -36.67 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -133.52 161.54 34.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -1.048 . . . . 0.0 109.583 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 ptp85 -93.58 151.02 19.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 58' ' ' SER . 3.5 mt -122.33 165.63 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.887 . . . . 0.0 110.834 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.551 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.09 147.15 30.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.809 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 163.03 110.56 0.25 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.06 -8.55 23.82 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 N-CA-C 108.461 -1.4 . . . . 0.0 108.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.84 29.43 1.27 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -72.05 147.69 46.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.48 -1.012 . . . . 0.0 110.195 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 104.08 4.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.758 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.452 ' HB ' HG22 ' A' ' 47' ' ' ILE . 4.6 tt -95.86 166.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.872 . . . . 0.0 109.963 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.511 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -146.72 97.79 2.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.548 ' CA ' ' HB2' ' A' ' 50' ' ' SER . 24.1 p 48.96 102.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 110.597 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.19 -142.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.783 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 68' ' ' ILE . 2.7 tt -154.48 134.51 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.448 HD12 ' CB ' ' A' ' 38' ' ' THR . 3.0 tt -54.35 114.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.5 t -148.23 135.19 20.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -70.72 64.94 0.85 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 6.8 mmpt? . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.357 0.598 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -127.2 159.69 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.04 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.828 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -151.95 102.91 2.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 69.07 52.97 20.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.545 ' H ' HD11 ' A' ' 82' ' ' ILE . 43.6 m -133.19 151.09 51.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -1.19 . . . . 0.0 110.492 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.569 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -105.33 164.24 12.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.023 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.1 m-85 -135.41 166.54 22.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 2.6 t 168.03 114.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 0.0 110.022 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -43.73 134.88 4.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' N ' ' HA ' ' A' ' 55' ' ' SER . 4.2 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.218 0.533 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 5' ' ' THR . 5.5 t -145.06 28.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -101.01 79.16 1.99 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 7' ' ' THR . 3.9 t -98.31 105.06 17.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.4 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 7' ' ' THR . 12.5 m120 60.6 13.1 4.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.663 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 1.5 t -128.63 -167.57 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.54 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -143.66 115.32 8.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.019 . . . . 0.0 110.555 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.926 HD21 ' O ' ' A' ' 16' ' ' LYS . 5.6 tp -110.23 20.38 17.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.95 . . . . 0.0 109.686 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 6.0 t 54.21 99.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -41.18 -26.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 110.723 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 12' ' ' SER . 11.4 m-20 -80.85 3.64 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -101.28 -159.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.831 -1.168 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.926 ' O ' HD21 ' A' ' 11' ' ' LEU . 5.1 mttp -116.2 134.0 55.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.455 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 26.9 p -99.58 78.06 2.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.193 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 18.3 mm-40 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.292 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.428 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.11 0.481 . . . . 0.0 110.401 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 10.2 m -143.79 108.76 4.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 110.437 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.512 ' O ' ' NH1' ' A' ' 41' ' ' ARG . 45.2 m-85 -103.36 96.28 6.65 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.988 HG13 ' CB ' ' A' ' 42' ' ' PHE . 5.0 t -103.32 167.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 111.312 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.3 t0 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.743 . . . . 0.0 109.667 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 48.08 67.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.007 . . . . 0.0 109.862 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.708 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.1 m -133.34 -173.32 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.266 -0.896 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 32.8 tt0 -139.75 101.28 4.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 11' ' ' LEU . 77.2 t -100.76 137.17 29.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.488 -0.758 . . . . 0.0 111.069 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.59 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -137.47 122.4 18.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 39.94 47.19 3.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 36' ' ' THR . 18.6 m -103.28 166.92 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -1.167 . . . . 0.0 110.433 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.935 HG21 HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -136.01 90.69 2.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.396 -0.815 . . . . 0.0 110.075 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 27.4 p -97.47 96.31 8.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.8 p -78.82 -28.68 44.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.125 -0.984 . . . . 0.0 109.606 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . -164.5 68.6 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.466 ' HB3' ' OG1' ' A' ' 53' ' ' THR . 57.6 p -135.81 174.8 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -1.124 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -136.39 123.85 22.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.912 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.988 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -101.4 168.76 9.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 110.717 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.9 t0 -173.68 109.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.38 69.71 0.96 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.795 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.1 t -145.15 131.9 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -1.127 . . . . 0.0 110.922 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.531 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 4.4 m -109.05 96.35 6.25 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.395 -0.816 . . . . 0.0 109.346 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.706 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.32 176.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.803 HG23 ' N ' ' A' ' 49' ' ' THR . 1.9 t -136.24 -147.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.803 ' N ' HG23 ' A' ' 48' ' ' THR . 3.7 m -60.26 80.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.321 -0.862 . . . . 0.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 48' ' ' THR . 1.4 m -139.34 142.97 37.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.263 -0.898 . . . . 0.0 110.507 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.935 HG22 HG21 ' A' ' 36' ' ' THR . 4.0 p -91.55 53.19 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.438 ' C ' HG22 ' A' ' 53' ' ' THR . 5.3 t -94.97 122.38 37.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.511 HG23 HG13 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -172.16 135.85 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 144.6 -28.56 1.91 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.501 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -130.36 178.56 6.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -1.05 . . . . 0.0 109.933 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -94.34 138.6 32.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.134 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.795 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.1 mt -115.79 155.5 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.547 ' H ' HG22 ' A' ' 86' ' ' THR . 1.1 m -147.28 145.3 29.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 112.57 0.26 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.106 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -7.04 20.21 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.697 1.367 . . . . 0.0 109.068 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.65 32.58 0.48 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.484 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -72.25 155.57 40.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -1.018 . . . . 0.0 110.102 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 105.31 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.545 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 tt -102.05 154.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.92 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.553 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -145.91 108.22 4.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.482 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 10.7 p 50.62 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 52' ' ' SER . 0.0 OUTLIER -127.59 -151.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.85 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -134.9 139.38 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 69' ' ' ILE . 7.8 tt -70.41 105.08 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.028 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.2 m -148.48 148.04 29.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.362 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.38 57.89 1.57 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.29 0.566 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.773 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -132.73 139.28 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.653 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -144.27 79.07 1.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 96.11 45.94 2.72 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -131.99 160.54 35.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.12 -1.224 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.585 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 9.8 t -117.07 157.49 25.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.7 m-85 -137.37 137.56 39.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.881 -1.137 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ARG . 12.2 t -171.11 136.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.53 139.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.374 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.501 ' N ' ' HA ' ' A' ' 55' ' ' SER . 13.0 p30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.199 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.337 0.589 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.654 ' CG2' HD22 ' A' ' 11' ' ' LEU . 7.2 t -130.83 30.94 4.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 109.797 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.95 70.06 8.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 103.84 15.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.979 . . . . 0.0 110.356 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 44.72 24.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 110.044 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.02 -162.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.883 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.493 ' CB ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -143.65 107.52 4.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.043 -1.036 . . . . 0.0 110.502 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.654 HD22 ' CG2' ' A' ' 5' ' ' THR . 18.4 tp -100.32 21.72 12.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.653 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 22.0 t 61.34 12.41 4.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.584 -0.697 . . . . 0.0 110.273 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.98 28.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 110.273 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.1 t30 -162.25 19.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 110.922 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -112.17 -149.16 0.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.05 -1.031 . . . . 0.0 109.43 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -108.81 127.86 54.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.955 -1.091 . . . . 0.0 110.056 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 29.3 p -106.43 69.11 0.78 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 110.354 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 18.5 tp10 . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.151 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.271 0.557 . . . . 0.0 109.77 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 11.1 m -155.26 117.44 4.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.0 110.862 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.551 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 3.6 m-85 -109.39 94.8 5.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.96 HG22 ' HB2' ' A' ' 42' ' ' PHE . 12.0 t -99.8 165.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.904 -1.123 . . . . 0.0 111.31 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 7.8 t0 -146.54 109.59 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.707 . . . . 0.0 109.332 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.96 69.59 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.979 -1.076 . . . . 0.0 109.742 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.551 ' OG ' HG12 ' A' ' 27' ' ' VAL . 9.7 m -131.83 -167.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.923 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -142.13 101.61 3.96 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.665 HG13 ' HB ' ' A' ' 35' ' ' THR . 80.9 t -102.06 125.84 56.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 110.856 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.591 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -132.84 123.0 25.25 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 41.97 42.52 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.665 ' HB ' HG13 ' A' ' 32' ' ' VAL . 52.1 m -104.24 162.14 13.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -1.067 . . . . 0.0 110.195 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.423 ' N ' HG22 ' A' ' 35' ' ' THR . 24.4 p -98.56 178.22 5.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.991 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.413 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -158.95 65.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.367 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -110.88 40.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.877 . . . . 0.0 110.314 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 118.46 91.19 1.42 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.515 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 10.8 p -172.17 178.55 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -1.203 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.551 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -146.67 122.44 10.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.881 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.96 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.3 m-85 -102.07 166.3 10.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.518 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.8 t70 -176.13 111.26 0.1 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.71 66.32 2.35 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.715 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.7 t -144.1 129.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -1.064 . . . . 0.0 110.957 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.403 HG23 ' CB ' ' A' ' 31' ' ' GLU . 45.8 m -110.37 90.89 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.247 -0.908 . . . . 0.0 109.122 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.671 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -111.4 164.86 6.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 109.86 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.725 HG23 ' N ' ' A' ' 49' ' ' THR . 1.5 t -122.41 -154.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 109.94 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.725 ' N ' HG23 ' A' ' 48' ' ' THR . 3.2 m -48.25 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' THR . 12.6 p -139.26 154.43 47.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.6 p -110.42 53.34 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -111.51 110.05 20.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 110.522 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -151.49 113.7 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.272 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 169.36 -42.94 0.21 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.226 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.549 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -110.0 177.04 4.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.237 . . . . 0.0 110.382 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -97.25 126.89 42.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.715 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.8 mt -104.75 158.42 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 110.844 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.545 ' CB ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -148.72 155.1 40.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 110.534 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.1 125.13 0.75 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.728 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -74.95 -5.61 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.01 39.33 0.24 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -71.88 151.48 43.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.463 -1.022 . . . . 0.0 110.536 -179.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -145.03 113.52 6.67 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.472 HG22 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -104.49 166.71 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.526 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -147.35 96.71 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 110.251 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 65' ' ' SER . 19.3 p 50.16 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.04 -146.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.933 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 tt -143.66 -177.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.1 pp -46.21 123.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.015 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 55' ' ' SER . 2.4 m -92.08 -134.53 0.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.502 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 89.86 24.66 29.4 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.331 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 9.6 mmtt . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.341 0.591 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.956 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.852 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.956 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -156.23 83.52 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.522 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 77.02 59.2 3.21 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.573 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.46 159.34 42.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -1.147 . . . . 0.0 110.716 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -106.86 154.64 20.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.607 -0.683 . . . . 0.0 110.07 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.5 m-85 -134.28 141.88 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 89' ' ' ALA . 21.4 t -177.7 121.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 110.367 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.13 139.63 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.52 -0.738 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.549 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.304 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.302 0.573 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -141.05 92.96 2.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 108.978 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 11' ' ' LEU . 2.4 t30 175.89 111.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 3.9 p -101.25 107.01 18.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.1 OUTLIER 69.4 8.33 6.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 110.667 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.2 -170.47 1.65 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.019 . . . . 0.0 110.359 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -141.83 99.71 3.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 109.268 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD13 HG21 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -92.63 38.02 1.01 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.13 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 18.2 t 58.47 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.678 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.59 22.64 2.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 110.461 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -157.4 19.35 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.131 -0.981 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 10.5 p -100.17 -162.74 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.914 -1.116 . . . . 0.0 109.348 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 19.8 tptt -108.25 112.33 24.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 29.6 p -97.31 86.33 3.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.512 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.485 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.111 -0.993 . . . . 0.0 109.425 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.111 0.481 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -155.09 111.75 3.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.435 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.489 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.2 m-85 -100.77 129.1 46.61 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.096 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -125.1 160.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.916 -1.115 . . . . 0.0 110.979 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -149.29 115.55 5.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 0.0 109.416 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 mttt 52.03 65.43 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 109.823 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.611 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.7 m -133.45 -170.49 2.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 111.122 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CB ' HG23 ' A' ' 46' ' ' THR . 2.6 tm-20 -143.26 99.36 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 16' ' ' LYS . 97.3 t -105.23 149.81 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.955 . . . . 0.0 111.689 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.582 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -127.35 -143.6 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 49' ' ' THR . . . -66.41 68.16 0.16 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.4 m -114.91 157.78 22.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -1.133 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.581 ' CG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -112.36 170.83 7.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 53' ' ' THR . 36.9 t -133.75 140.28 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.819 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.57 ' H ' ' HG1' ' A' ' 53' ' ' THR . 32.8 m -155.3 19.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.495 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 132.18 67.47 0.09 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -151.63 -178.81 6.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.124 -1.221 . . . . 0.0 110.247 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG3' ' HG3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.3 138.08 23.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.751 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.096 ' HB3' HG13 ' A' ' 27' ' ' VAL . 6.0 m-85 -110.1 161.62 15.36 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.537 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 45' ' ' VAL . 1.6 t70 -179.09 113.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 49.49 64.33 3.48 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.582 ' CG1' HG23 ' A' ' 47' ' ' ILE . 3.1 t -145.8 136.47 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -1.012 . . . . 0.0 110.426 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 31' ' ' GLU . 87.7 m -116.03 97.96 6.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.532 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.582 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.6 pt -114.93 174.39 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.401 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.72 HG23 ' N ' ' A' ' 49' ' ' THR . 1.0 OUTLIER -122.04 -160.09 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 110.537 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.72 ' N ' HG23 ' A' ' 48' ' ' THR . 8.7 m -61.62 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.882 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.496 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.892 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.581 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 10.5 p -95.83 57.46 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.444 ' C ' HG22 ' A' ' 53' ' ' THR . 0.4 OUTLIER -114.25 133.24 55.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.551 -0.718 . . . . 0.0 110.454 -179.496 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.588 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.4 75.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.855 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -132.22 -61.48 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.554 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 61.1 p -103.61 -159.62 0.73 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.489 -1.006 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -115.21 123.48 48.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.401 -0.812 . . . . 0.0 110.188 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 HG22 ' A' ' 45' ' ' VAL . 2.0 mt -98.98 163.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 109.959 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.71 151.36 37.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.701 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 159.55 115.28 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.03 -2.8 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.743 1.391 . . . . 0.0 108.657 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.25 28.59 0.63 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.51 153.7 41.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.444 -1.033 . . . . 0.0 110.711 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.35 111.03 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.797 . . . . 0.0 110.05 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.939 HG13 HD12 ' A' ' 82' ' ' ILE . 3.6 tt -103.88 167.65 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.971 . . . . 0.0 109.226 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -144.83 100.55 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.346 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 81.0 p 46.39 56.39 6.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.556 -0.715 . . . . 0.0 110.712 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.04 162.34 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 69' ' ' ILE . 79.4 mt -108.32 171.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 68' ' ' ILE . 1.7 mp -38.75 121.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 0.0 110.415 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 72' ' ' GLY . 89.6 m -130.32 61.1 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.992 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.554 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -65.78 74.43 0.11 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.556 0.693 . . . . 0.0 110.711 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.939 HD12 HG13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -147.92 129.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.599 -0.688 . . . . 0.0 109.347 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -142.53 116.24 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.943 . . . . 0.0 110.528 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.44 48.77 8.84 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.42 149.36 49.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 0.0 110.506 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -104.17 163.06 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.149 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 86' ' ' THR . 6.3 m-85 -132.62 144.49 50.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.491 ' C ' ' HB2' ' A' ' 55' ' ' SER . 2.0 t -176.08 116.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 109.75 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HA ' ' CB ' ' A' ' 55' ' ' SER . . . -37.76 155.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.496 -0.753 . . . . 0.0 110.882 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 55' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.877 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.358 0.599 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.727 HG22 HD22 ' A' ' 11' ' ' LEU . 3.0 t -133.42 7.08 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -69.69 73.14 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 110.494 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 50.1 p -98.29 99.32 10.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.0 109.499 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 7' ' ' THR . 9.5 m120 58.15 15.95 3.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.694 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER -130.89 172.84 11.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.472 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.16 114.26 24.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.727 HD22 HG22 ' A' ' 5' ' ' THR . 15.7 tp -102.45 28.39 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.769 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 21.8 t 64.22 6.25 2.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.731 -0.606 . . . . 0.0 110.914 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.0 25.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.06 -1.025 . . . . 0.0 109.44 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' SER . 37.5 t30 -163.47 17.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.416 -0.803 . . . . 0.0 110.491 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -104.29 -147.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.425 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 3.4 tmtm? -114.94 119.04 35.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.796 -1.19 . . . . 0.0 110.493 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.01 66.14 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.718 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.521 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.7 m-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.984 0.421 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 88.5 m -149.68 123.26 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 111.182 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 20.1 m-85 -115.58 96.65 5.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.02 HG13 ' HB3' ' A' ' 42' ' ' PHE . 12.2 t -94.32 163.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.912 . . . . 0.0 111.315 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.553 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.91 120.53 9.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.548 -0.72 . . . . 0.0 109.467 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 13.6 tptm 47.92 59.76 4.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.275 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.579 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.7 m -133.58 178.19 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.184 -0.947 . . . . 0.0 110.982 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.6 tt0 -143.61 109.58 5.28 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 47' ' ' ILE . 5.7 m -116.05 164.98 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.892 -1.13 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.57 ' HB3' ' CA ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -121.53 -139.17 0.33 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.471 ' HA3' HG23 ' A' ' 49' ' ' THR . . . -65.97 66.87 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 50' ' ' SER . 19.6 m -99.36 163.58 12.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.683 ' CG2' HG22 ' A' ' 51' ' ' THR . 6.7 p -106.88 -170.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.119 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.787 ' CA ' HG21 ' A' ' 53' ' ' THR . 0.9 OUTLIER -141.15 -87.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.912 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 m 46.13 37.14 3.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.362 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 102.03 109.49 3.28 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.601 ' CB ' HG22 ' A' ' 53' ' ' THR . 47.0 t 177.87 161.89 0.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.419 -1.047 . . . . 0.0 110.184 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.536 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -141.7 128.61 20.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.991 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.02 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.0 m-85 -110.67 167.11 10.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -177.73 112.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.098 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.79 70.49 0.84 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.717 ' CG1' HG23 ' A' ' 47' ' ' ILE . 7.4 t -145.52 127.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.413 -1.051 . . . . 0.0 111.126 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -106.92 91.13 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.238 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.717 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -114.35 170.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.375 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.646 HG23 ' N ' ' A' ' 49' ' ' THR . 5.3 t -118.46 -151.21 0.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.648 ' O ' HG22 ' A' ' 66' ' ' THR . 3.2 m -63.5 86.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.378 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 35' ' ' THR . 7.9 t -139.37 144.72 38.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 110.759 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.683 HG22 ' CG2' ' A' ' 36' ' ' THR . 43.9 p -96.72 61.4 1.88 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.28 111.26 23.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.787 HG21 ' CA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -142.66 162.75 34.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.883 . . . . 0.0 110.142 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 116.24 -56.9 0.51 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.508 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -101.86 -179.6 4.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -1.133 . . . . 0.0 111.213 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 6.1 ttp85 -109.69 128.05 54.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.5 mt -103.57 161.18 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 111.006 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.606 ' CB ' ' HG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -146.65 146.3 30.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.13 118.05 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.437 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.94 -6.98 20.41 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 N-CA-C 108.69 -1.312 . . . . 0.0 108.69 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.95 38.61 0.29 Allowed Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -71.85 159.4 34.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.446 -1.032 . . . . 0.0 110.139 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 62' ' ' CYS . 5.1 mmtm -143.11 109.51 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.757 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.507 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.6 tt -102.6 172.45 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.003 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.477 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.6 t -151.17 76.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.17 . . . . 0.0 110.78 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 49' ' ' THR . 4.1 p 55.24 113.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.456 ' N ' ' OG ' ' A' ' 50' ' ' SER . 30.0 m -139.36 -157.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 69' ' ' ILE . 1.9 mt -121.97 -149.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.166 -0.959 . . . . 0.0 109.898 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.52 ' H ' HG22 ' A' ' 68' ' ' ILE . 37.0 mt -61.3 144.72 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' GLY . 75.2 m -123.7 -13.76 7.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.948 -1.095 . . . . 0.0 110.938 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.482 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . -36.12 94.2 0.01 OUTLIER Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 70' ' ' THR . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.466 0.651 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -125.11 155.94 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.796 ' N ' HD13 ' A' ' 82' ' ' ILE . 43.6 t -146.8 114.75 6.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.385 -0.822 . . . . 0.0 110.407 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 70.47 48.79 34.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.68 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.79 148.22 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -1.045 . . . . 0.0 110.804 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.606 ' HG1' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -109.27 153.91 23.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.392 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 88' ' ' SER . 10.3 m-85 -127.13 160.6 30.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.575 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 171.03 127.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.798 . . . . 0.0 109.877 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -42.58 141.46 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.508 ' N ' ' HA ' ' A' ' 55' ' ' SER . 2.4 t30 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.044 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.36 0.6 . . . . 0.0 109.625 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -134.31 35.68 3.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -94.5 68.84 3.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.502 HG23 ' O ' ' A' ' 7' ' ' THR . 1.9 t -99.05 94.09 6.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.437 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 67.4 4.68 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.711 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -114.18 -168.5 1.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 99.74 3.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 4.5 tp -88.42 27.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.932 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 p 71.67 1.28 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.464 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.14 24.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.77 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 12' ' ' SER . 17.8 p30 -157.28 16.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.535 ' OG ' ' CD2' ' A' ' 11' ' ' LEU . 22.1 p -105.73 -138.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.29 98.43 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 15.4 p -82.76 50.01 1.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 110.402 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.955 -1.091 . . . . 0.0 110.456 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.002 0.429 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.62 123.47 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.932 -1.105 . . . . 0.0 111.365 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.461 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -109.77 93.86 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 1.03 HG13 ' HB3' ' A' ' 42' ' ' PHE . 4.5 t -93.67 167.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 110.643 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.2 OUTLIER -149.49 120.63 7.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.956 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 44.46 60.76 2.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 109.763 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.749 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -128.1 -169.19 2.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.69 104.57 4.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 47' ' ' ILE . 99.5 t -110.99 137.89 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 111.47 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -107.09 -139.68 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.563 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 49' ' ' THR . . . -68.16 61.68 0.39 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.2 m -111.43 156.84 21.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -1.143 . . . . 0.0 110.189 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.781 HG21 HG23 ' A' ' 51' ' ' THR . 0.7 OUTLIER -106.42 -173.18 2.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.654 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.8 OUTLIER -150.84 76.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.649 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 m -90.97 47.31 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.24 95.31 2.22 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.556 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 25.1 p -174.06 173.04 3.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.331 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HD3' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -135.81 133.78 38.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.221 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.03 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.7 m-85 -112.92 163.15 15.01 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.953 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 8.7 t70 -177.19 111.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.9 . . . . 0.0 109.122 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 50.63 66.67 2.29 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.817 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.6 t -144.42 127.99 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.084 . . . . 0.0 111.033 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 22.1 m -104.76 96.01 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.352 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 32' ' ' VAL . 1.1 pp -114.44 169.06 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.821 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -112.78 -150.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.821 ' N ' HG23 ' A' ' 48' ' ' THR . 34.8 m -73.41 94.37 2.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.195 -0.941 . . . . 0.0 110.016 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.505 ' HB3' ' CA ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -139.9 157.86 45.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 111.394 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.781 HG23 HG21 ' A' ' 36' ' ' THR . 27.5 m -104.09 50.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.592 -0.692 . . . . 0.0 109.372 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.525 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -102.7 102.81 13.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.344 -0.848 . . . . 0.0 110.594 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.654 HG21 ' HA ' ' A' ' 37' ' ' CYS . 82.1 p -141.19 113.94 8.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 166.14 -27.09 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.555 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 72.6 p -118.85 162.01 19.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -91.36 119.08 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.867 . . . . 0.0 108.997 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.817 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -99.64 152.29 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 0.0 111.65 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.63 140.73 26.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.814 -0.554 . . . . 0.0 109.906 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 171.21 120.23 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.114 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.09 -5.32 16.86 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.719 1.379 . . . . 0.0 108.899 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.61 33.88 0.32 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 1.7 t -72.02 160.1 33.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.98 -1.306 . . . . 0.0 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 17.5 mmtt -141.51 110.79 6.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.592 HG21 ' HB ' ' A' ' 47' ' ' ILE . 6.6 tt -99.45 171.53 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.016 -1.052 . . . . 0.0 109.314 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 2.2 t -152.94 87.83 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.505 ' CA ' ' HB3' ' A' ' 50' ' ' SER . 10.2 p 52.21 104.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 110.948 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 82.0 m -119.55 -152.73 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.49 -0.756 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.746 ' N ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -138.59 170.85 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.913 -1.117 . . . . 0.0 110.58 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.96 137.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 0.0 109.402 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 2.1 t -145.42 -166.5 2.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 111.039 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -172.63 30.8 0.11 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.184 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.588 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.315 0.579 . . . . 0.0 110.098 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 1.6 tp -132.46 151.35 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.457 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -140.82 118.76 11.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.168 -0.958 . . . . 0.0 110.679 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.04 46.13 37.77 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.561 ' HB3' ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -128.15 154.27 45.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.232 -1.158 . . . . 0.0 111.43 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.579 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.74 165.81 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 0.0 109.056 178.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -155.4 155.67 34.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.784 -1.197 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -175.76 41.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 111.145 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.555 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.8 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 110.843 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.164 0.507 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 6' ' ' ASN . . . -107.19 68.2 0.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 8.3 t 49.14 78.75 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -1.219 . . . . 0.0 110.206 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.1 OUTLIER 68.65 -75.06 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.89 . . . . 0.0 110.466 179.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 17' ' ' CYS . 5.8 t -145.46 13.59 1.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.026 -1.046 . . . . 0.0 110.453 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 2.3 m120 -97.05 96.41 8.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.264 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -113.77 20.18 16.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 22' ' ' LEU . 1.2 t-20 -177.33 -32.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.193 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -108.73 -151.29 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.967 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -143.36 110.19 5.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 110.439 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 27' ' ' VAL . 25.6 tp -94.15 36.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.625 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.8 OUTLIER 68.92 2.19 3.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.145 -0.972 . . . . 0.0 110.737 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 46.56 23.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.941 -1.1 . . . . 0.0 109.639 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -159.91 12.12 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.189 -0.945 . . . . 0.0 111.465 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' SER . 4.3 m -98.65 -144.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.788 -1.195 . . . . 0.0 109.537 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' A' ' 18' ' ' GLU . 1.4 tptt -107.41 89.97 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 29.7 p -65.55 64.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.347 -0.845 . . . . 0.0 110.746 -179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 16' ' ' LYS . 33.2 mm-40 -100.21 25.07 7.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.031 -1.043 . . . . 0.0 110.115 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.512 ' C ' ' HG1' ' A' ' 5' ' ' THR . 0.0 OUTLIER -171.33 133.01 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.259 -0.901 . . . . 0.0 110.242 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.71 -163.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 110.143 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.415 ' HB ' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -147.7 162.73 38.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.934 . . . . 0.0 110.223 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -95.29 -83.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 0.0 110.235 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 22' ' ' LEU . 9.2 m -165.03 24.55 0.06 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.109 -0.994 . . . . 0.0 110.775 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 38' ' ' THR . 36.4 m-80 -157.49 76.45 0.82 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.943 -1.098 . . . . 0.0 110.655 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.442 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -155.79 128.02 7.65 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.065 -1.022 . . . . 0.0 110.823 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -136.23 91.95 2.73 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.102 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -94.4 164.39 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.303 -0.873 . . . . 0.0 110.776 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.625 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.8 t0 -137.42 117.04 12.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' C ' ' O ' ' A' ' 28' ' ' ASP . 6.7 tttt 40.29 71.3 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.064 -1.023 . . . . 0.0 110.189 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.831 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -131.51 -175.01 3.57 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.11 -0.994 . . . . 0.0 110.982 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.9 OUTLIER -144.13 100.8 3.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.612 -0.68 . . . . 0.0 109.996 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 10.4 m -110.22 151.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.637 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.547 ' O ' ' CA ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -125.85 94.45 4.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.099 -1.0 . . . . 0.0 110.348 -179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.688 ' O ' HG23 ' A' ' 49' ' ' THR . . . 60.97 46.11 95.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 50' ' ' SER . 6.2 m -102.45 146.43 28.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -1.092 . . . . 0.0 110.369 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.483 ' O ' HG21 ' A' ' 53' ' ' THR . 2.7 t -90.32 159.7 16.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.431 -0.793 . . . . 0.0 110.39 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 38' ' ' THR . 1.2 m -113.87 -79.79 0.59 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.858 . . . . 0.0 110.253 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.488 ' CB ' ' O ' ' A' ' 37' ' ' CYS . 2.1 m 68.25 -68.39 0.17 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.124 -0.985 . . . . 0.0 110.405 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' O ' ' C ' ' A' ' 53' ' ' THR . . . -155.61 104.34 0.25 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.584 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -178.34 179.56 0.78 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.275 -1.132 . . . . 0.0 109.924 -179.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.46 127.56 13.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 110.104 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.102 ' HB3' HG13 ' A' ' 27' ' ' VAL . 4.6 m-85 -109.17 172.85 6.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.139 -0.976 . . . . 0.0 110.398 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 58' ' ' SER . 0.9 OUTLIER 177.21 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.235 -0.916 . . . . 0.0 109.821 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 66.07 66.48 2.39 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.976 HG21 HG22 ' A' ' 57' ' ' ILE . 2.4 t -146.28 148.83 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.313 -1.11 . . . . 0.0 110.564 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 46' ' ' THR . 13.3 m -122.25 89.7 3.17 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.447 -0.783 . . . . 0.0 109.312 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.71 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.65 168.92 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 0.0 110.48 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.476 ' O ' ' N ' ' A' ' 50' ' ' SER . 5.4 t -115.89 -164.88 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.199 -0.938 . . . . 0.0 109.948 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 34' ' ' GLY . 2.0 m -49.63 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 0.0 109.918 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 35' ' ' THR . 6.2 p -132.21 137.46 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.052 -1.03 . . . . 0.0 111.253 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 51' ' ' THR . 26.3 m -87.86 40.13 0.92 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.587 -0.696 . . . . 0.0 109.268 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 68' ' ' ILE . 0.4 OUTLIER -102.17 103.01 13.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.491 -0.755 . . . . 0.0 110.149 -179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.584 ' HA ' ' HB2' ' A' ' 40' ' ' SER . 6.0 p -146.28 95.56 2.63 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.563 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -156.0 -53.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.567 ' CB ' ' N ' ' A' ' 89' ' ' ALA . 2.6 p -105.73 -162.62 0.88 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.303 -1.116 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 11.4 mtp180 -95.84 137.62 34.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.519 -0.738 . . . . 0.0 109.917 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.976 HG22 HG21 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -118.3 128.57 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.993 . . . . 0.0 110.186 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.692 ' HA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.68 157.4 43.96 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.19 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.48 125.6 0.81 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.2 -4.97 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.635 1.334 . . . . 0.0 109.4 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.07 33.63 0.2 Allowed Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 8.3 t -72.89 146.25 46.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.353 -1.087 . . . . 0.0 110.646 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.87 111.28 9.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.446 -0.784 . . . . 0.0 109.381 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.929 HG13 HD12 ' A' ' 82' ' ' ILE . 5.4 tt -104.39 171.46 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 110.611 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.457 ' O ' ' SG ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -142.97 96.35 2.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.32 -0.863 . . . . 0.0 110.046 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 67' ' ' CYS . 16.7 p 54.64 -93.8 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.691 -0.631 . . . . 0.0 110.597 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.552 ' N ' ' OG1' ' A' ' 66' ' ' THR . 3.9 m 70.3 -167.5 0.16 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.044 -1.035 . . . . 0.0 109.994 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.47 ' O ' ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -130.59 -169.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.0 110.457 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 70' ' ' THR . 5.4 mt -42.47 167.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.333 -0.854 . . . . 0.0 110.703 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -137.61 -139.67 0.15 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.233 -0.917 . . . . 0.0 110.867 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 108.87 44.41 1.12 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.536 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . 62.71 18.02 58.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 70' ' ' THR . 9.7 m -116.71 150.53 45.85 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.682 -0.893 . . . . 0.0 110.504 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.545 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.6 Cg_endo -72.79 -47.8 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.988 1.52 . . . . 0.0 110.159 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.767 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . 60.78 173.94 0.05 OUTLIER Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 110.237 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.767 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 47.4 Cg_endo -74.34 53.31 3.0 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.967 1.509 . . . . 0.0 110.342 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -117.12 22.2 12.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.304 -0.872 . . . . 0.0 110.257 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.31 -22.9 2.0 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.115 -0.991 . . . . 0.0 109.066 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.07 -8.56 58.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.698 -0.626 . . . . 0.0 109.918 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.483 ' HB3' ' O ' ' A' ' 77' ' ' SER . 8.2 t -71.02 149.06 46.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 110.252 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -111.9 103.34 11.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.944 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.929 HD12 HG13 ' A' ' 64' ' ' ILE . 1.1 tt -120.66 124.18 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 110.106 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.73 123.53 23.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.201 -0.937 . . . . 0.0 110.312 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 71.9 60.8 4.05 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.484 ' SG ' HG13 ' A' ' 82' ' ' ILE . 56.3 m -138.79 146.12 40.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.3 -1.118 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 111.25 13.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 109.607 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.543 ' CB ' ' O ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -142.69 160.13 40.91 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.184 -0.948 . . . . 0.0 110.58 -179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -176.02 94.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 110.187 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' N ' ' CB ' ' A' ' 55' ' ' SER . . . 50.89 172.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 110.326 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.54 ' HA ' ' CD ' ' A' ' 56' ' ' ARG . 28.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.217 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.234 0.54 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -111.25 101.58 1.34 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 64.45 -69.11 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -1.096 . . . . 0.0 110.505 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' GLY . 0.6 OUTLIER -133.76 -75.42 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 110.467 -179.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 5' ' ' THR . 5.5 t -127.96 53.34 1.79 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.009 -1.057 . . . . 0.0 109.577 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.65 70.45 1.44 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 111.001 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.495 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 4.4 t -98.97 21.82 11.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.086 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.958 ' HB3' HG22 ' A' ' 23' ' ' THR . 2.7 m-20 168.49 -17.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.652 -0.655 . . . . 0.0 110.808 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 23' ' ' THR . 3.2 m -108.02 -160.44 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 0.0 110.068 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -140.14 117.34 11.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.121 -0.987 . . . . 0.0 110.713 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.837 HD21 ' O ' ' A' ' 16' ' ' LYS . 1.8 tp -111.24 19.93 17.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 17.1 t 53.34 104.82 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.901 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.71 -24.36 0.06 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.173 -0.954 . . . . 0.0 110.429 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.2 m-20 -87.46 2.54 50.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.0 111.361 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.742 ' HG ' ' HG ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -101.12 -162.98 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.619 -1.301 . . . . 0.0 110.547 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.837 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -111.55 162.75 14.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.353 -0.842 . . . . 0.0 110.364 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 28.6 p -128.92 71.4 1.42 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.811 . . . . 0.0 110.69 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.585 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -105.32 53.99 0.71 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.027 -1.046 . . . . 0.0 110.516 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.606 ' HD3' HG11 ' A' ' 32' ' ' VAL . 13.9 ptmt -169.97 -175.49 2.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.404 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.473 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.3 OUTLIER -98.36 -31.93 11.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.335 -0.853 . . . . 0.0 110.363 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 20' ' ' SER . 24.6 m 60.21 139.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 110.219 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.903 ' O ' HG23 ' A' ' 23' ' ' THR . 8.2 mp -95.52 -83.61 0.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.049 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.958 HG22 ' HB3' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -171.39 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.314 -0.866 . . . . 0.0 110.259 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.476 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -157.32 67.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 110.118 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -153.84 113.9 3.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.802 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HB2' ' HD3' ' A' ' 41' ' ' ARG . 37.7 m-85 -108.98 110.62 21.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.017 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -114.64 164.33 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.816 -1.177 . . . . 0.0 111.041 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 14.3 t70 -149.29 110.3 4.35 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.462 -0.774 . . . . 0.0 109.865 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.8 OUTLIER 54.95 63.45 2.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.127 -0.983 . . . . 0.0 110.061 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 15' ' ' SER . 4.9 m -133.88 -167.81 2.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.284 -0.885 . . . . 0.0 111.324 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 10.3 tt0 -143.28 104.03 4.21 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.606 HG11 ' HD3' ' A' ' 19' ' ' LYS . 53.1 t -103.94 142.19 18.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 110.97 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.585 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -114.25 -152.6 0.51 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.503 -0.748 . . . . 0.0 109.364 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 49' ' ' THR . . . -66.69 67.55 0.18 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 50' ' ' SER . 2.9 m -110.2 159.56 17.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.256 -1.144 . . . . 0.0 110.801 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 35' ' ' THR . 1.3 p -89.2 -168.81 2.28 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.484 -0.76 . . . . 0.0 110.385 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.926 ' HA ' HG21 ' A' ' 53' ' ' THR . 30.6 t -174.33 102.65 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.242 -0.911 . . . . 0.0 110.331 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.1 m -118.42 1.33 11.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.235 -0.916 . . . . 0.0 110.136 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . 151.16 77.33 0.02 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 53' ' ' THR . 11.7 t -149.93 170.63 18.36 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.165 -1.197 . . . . 0.0 110.515 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.54 ' HD3' ' HB2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -132.99 133.07 42.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 109.625 179.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.017 ' HB3' HG13 ' A' ' 27' ' ' VAL . 2.8 m-85 -111.4 160.79 16.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.261 -0.899 . . . . 0.0 110.455 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 8.5 t0 -171.74 116.13 0.38 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 0.0 109.186 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.68 67.34 1.58 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.63 ' CG1' HG23 ' A' ' 47' ' ' ILE . 2.7 t -144.86 126.7 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.442 -1.034 . . . . 0.0 110.537 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 25.3 m -106.86 96.28 6.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.288 -0.883 . . . . 0.0 109.194 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.63 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pt -113.72 160.74 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 110.493 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.594 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -106.01 -162.31 0.85 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 110.115 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.594 ' N ' HG23 ' A' ' 48' ' ' THR . 55.1 m -64.16 91.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 0.0 110.137 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 35' ' ' THR . 13.7 p -139.24 164.5 29.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.16 -0.963 . . . . 0.0 110.684 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.1 p -108.68 72.17 0.81 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.426 -0.796 . . . . 0.0 109.83 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.5 t -124.16 105.8 9.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.31 -0.869 . . . . 0.0 110.14 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.926 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -151.07 117.84 5.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.352 -0.843 . . . . 0.0 110.215 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 168.51 -30.74 0.17 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.467 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -122.8 167.6 13.3 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.556 -0.967 . . . . 0.0 109.555 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 9.9 ttm180 -91.56 136.4 33.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.767 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.622 ' CD1' ' CZ ' ' A' ' 87' ' ' PHE . 3.3 mt -114.66 163.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.051 -1.031 . . . . 0.0 111.4 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.575 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -148.3 145.84 28.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.764 -0.585 . . . . 0.0 110.052 178.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 165.74 109.67 0.22 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.42 -1.371 . . . . 0.0 110.494 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.01 -4.77 15.79 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.758 1.399 . . . . 0.0 108.748 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.98 30.08 0.6 Allowed Glycine 0 N--CA 1.485 1.927 0 N-CA-C 108.245 -1.942 . . . . 0.0 108.245 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.464 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.3 t -72.07 157.85 37.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -1.063 . . . . 0.0 110.608 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HG2' ' C ' ' A' ' 62' ' ' CYS . 2.7 mmtp -144.5 110.98 5.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.659 -0.65 . . . . 0.0 109.653 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.559 HG21 ' HB ' ' A' ' 47' ' ' ILE . 6.9 tt -101.1 170.52 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 120.905 -1.122 . . . . 0.0 109.812 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' O ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.74 91.1 1.52 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.902 -1.124 . . . . 0.0 111.387 -179.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.522 ' O ' ' O ' ' A' ' 65' ' ' SER . 13.3 p 46.08 109.81 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.654 0.74 . . . . 0.0 111.576 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 66.8 m -140.24 145.4 37.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.396 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.421 ' H ' HG23 ' A' ' 68' ' ' ILE . 1.3 pt -55.36 -179.28 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.24 -0.913 . . . . 0.0 109.9 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.0 mt -54.79 153.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.736 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.568 HG23 ' CG1' ' A' ' 73' ' ' VAL . 5.7 m -98.33 -122.16 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.202 -0.936 . . . . 0.0 110.916 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 95.29 35.59 5.69 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.93 65.02 0.99 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.717 HG22 ' CD2' ' A' ' 87' ' ' PHE . 5.2 m -88.58 168.36 16.25 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.175 -1.191 . . . . 0.0 109.879 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 45.8 Cg_endo -73.41 168.98 23.38 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 123.718 1.378 . . . . 0.0 111.107 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.623 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -77.6 -46.79 2.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.411 -0.805 . . . . 0.0 111.483 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 41.8 Cg_endo -69.41 -25.45 30.2 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.375 1.197 . . . . 0.0 110.975 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 76' ' ' PRO . 1.4 m 42.5 62.58 1.67 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.097 -1.002 . . . . 0.0 110.709 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.18 -21.13 4.65 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.069 -1.019 . . . . 0.0 108.375 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.6 -71.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.535 0.683 . . . . 0.0 110.111 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 2.7 t -64.99 155.28 35.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.487 -0.758 . . . . 0.0 110.63 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.04 109.12 20.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.44 -0.787 . . . . 0.0 109.639 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.719 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -125.83 158.52 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 110.161 -179.301 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.719 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -147.41 96.58 2.72 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 0.0 110.883 -179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.1 55.14 4.92 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.559 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.02 158.2 42.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -1.167 . . . . 0.0 110.881 -179.658 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.582 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -111.06 161.04 16.3 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.717 ' CD2' HG22 ' A' ' 73' ' ' VAL . 7.5 m-85 -146.43 162.22 38.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.729 -1.232 . . . . 0.0 111.276 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 1.2 t 169.19 116.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -37.62 138.01 0.39 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.375 -0.828 . . . . 0.0 110.813 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.467 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.853 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.25 0.548 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -131.34 120.78 2.97 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 2' ' ' GLY . 0.7 OUTLIER 62.74 -72.18 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.319 -1.106 . . . . 0.0 110.07 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 2' ' ' GLY . 8.1 t -155.55 -62.87 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.826 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.561 HG21 ' H ' ' A' ' 18' ' ' GLU . 7.3 t -134.08 50.78 2.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.394 -0.816 . . . . 0.0 109.791 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 9' ' ' SER . 6.6 m120 -140.64 106.68 5.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 110.97 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.3 p -98.62 28.55 4.16 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.953 0.882 . . . . 0.0 108.64 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER 176.71 -26.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.297 0.57 . . . . 0.0 109.596 -179.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.514 ' O ' ' HB3' ' A' ' 6' ' ' ASN . 19.3 m -107.74 -165.69 1.07 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 109.277 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -144.73 115.94 7.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.786 -1.196 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 1.7 tp -91.63 140.71 29.46 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.188 -0.945 . . . . 0.0 109.096 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.539 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -54.07 139.09 35.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.004 -1.06 . . . . 0.0 109.978 -179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.27 -12.48 9.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.342 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -115.61 17.4 16.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.977 . . . . 0.0 110.702 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 30' ' ' SER . 8.2 p -94.28 -147.15 0.26 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' CB ' ' HA ' ' A' ' 31' ' ' GLU . 4.0 tttt -121.41 120.4 34.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.0 110.18 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.6 t -56.21 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.342 -0.849 . . . . 0.0 110.329 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.851 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.44 -145.24 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.252 -0.905 . . . . 0.0 110.484 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' ' CB ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -149.17 149.5 31.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.505 -179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 1.4 m 68.3 113.24 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.292 -0.88 . . . . 0.0 110.978 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.736 ' C ' HD23 ' A' ' 22' ' ' LEU . 24.4 m -166.16 137.24 3.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.546 -0.721 . . . . 0.0 109.369 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.801 HD23 ' N ' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -168.68 64.99 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 0.0 111.017 -179.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.631 HG21 ' C ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -167.98 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 0.0 110.343 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' H ' HG23 ' A' ' 23' ' ' THR . 68.7 m-80 -155.21 106.66 2.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.971 -1.081 . . . . 0.0 109.93 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 12.9 m -141.97 109.26 5.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 110.31 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 6.6 t80 -100.8 103.86 15.09 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.537 -0.727 . . . . 0.0 109.157 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.928 HG13 ' HB3' ' A' ' 42' ' ' PHE . 8.0 t -101.69 164.62 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 0.0 111.022 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.4 OUTLIER -142.47 119.29 11.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.421 -0.799 . . . . 0.0 109.452 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 26.2 tttt 42.78 67.75 0.58 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 109.835 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.724 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.1 m -132.96 -168.04 2.01 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' CB ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -144.8 96.91 2.94 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.13 -0.982 . . . . 0.0 109.784 179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.851 HG12 ' CB ' ' A' ' 18' ' ' GLU . 61.3 t -102.33 138.55 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.131 -0.981 . . . . 0.0 110.086 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 49' ' ' THR . 4.6 t80 -135.92 114.81 12.13 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.348 -0.845 . . . . 0.0 110.085 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.44 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 42.26 48.58 5.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.457 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 22.5 m -104.9 163.92 12.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -1.134 . . . . 0.0 109.771 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.3 p -99.79 174.63 6.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.848 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.966 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -157.5 143.35 17.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.722 . . . . 0.0 109.872 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -166.62 37.64 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.223 -0.923 . . . . 0.0 109.941 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.13 62.03 0.38 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 9.2 t -142.91 176.17 9.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -1.139 . . . . 0.0 110.084 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -145.75 124.16 12.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -0.933 . . . . 0.0 110.158 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.928 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -99.65 172.69 7.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.235 -0.916 . . . . 0.0 110.139 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' SER . 7.8 t70 179.0 95.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.263 -0.898 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 68.7 67.66 1.89 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.084 HG21 HG22 ' A' ' 57' ' ' ILE . 1.1 t -145.88 159.42 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 110.603 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 27.4 m -130.33 88.26 2.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.543 -0.723 . . . . 0.0 109.617 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.786 HG23 HG13 ' A' ' 45' ' ' VAL . 1.1 pp -111.08 165.59 6.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.466 -0.771 . . . . 0.0 109.519 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.753 HG23 ' N ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -129.88 -157.03 0.79 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.085 . . . . 0.0 110.788 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.753 ' N ' HG23 ' A' ' 48' ' ' THR . 5.6 m -46.45 86.43 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.63 -0.669 . . . . 0.0 110.858 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' THR . 9.3 m -140.5 -167.05 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.068 -1.02 . . . . 0.0 110.446 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 67' ' ' CYS . 0.3 OUTLIER -150.03 72.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.376 -0.828 . . . . 0.0 109.84 179.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' A' ' 67' ' ' CYS . 8.4 t -131.79 112.47 12.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.567 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.966 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -151.65 121.75 7.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 168.48 -25.98 0.12 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.463 ' HA ' ' C ' ' A' ' 89' ' ' ALA . 26.0 p -122.7 -170.15 2.04 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.313 -1.11 . . . . 0.0 109.918 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 28.1 mtp180 -94.87 115.94 28.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 0.0 109.843 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.084 HG22 HG21 ' A' ' 45' ' ' VAL . 1.2 mm -98.98 122.52 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.979 -1.076 . . . . 0.0 109.965 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.477 ' CA ' HG23 ' A' ' 45' ' ' VAL . 44.9 m -145.78 168.3 21.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.15 -0.969 . . . . 0.0 110.46 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 151.02 123.05 1.08 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.5 -5.68 17.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.691 1.363 . . . . 0.0 109.416 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.25 23.72 0.87 Allowed Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.239 -1.944 . . . . 0.0 108.239 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.46 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 5.1 t -73.17 143.44 47.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.499 -1.001 . . . . 0.0 110.648 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.62 113.22 7.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.574 -0.704 . . . . 0.0 109.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.589 ' HB ' HG22 ' A' ' 47' ' ' ILE . 3.0 tt -104.04 168.13 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.0 110.257 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 15.2 t -152.26 89.88 1.47 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 49' ' ' THR . 2.2 p 56.71 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.815 ' O ' HG23 ' A' ' 51' ' ' THR . 83.5 m -146.5 -159.09 0.97 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.0 155.72 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.36 -0.838 . . . . 0.0 109.929 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.546 ' O ' HD12 ' A' ' 69' ' ' ILE . 1.8 pp -92.51 121.85 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.497 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.428 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.7 m -148.41 150.77 34.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.866 . . . . 0.0 110.13 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.39 51.32 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 135.44 90.55 0.32 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.513 ' HB ' ' HD2' ' A' ' 74' ' ' PRO . 21.2 m -86.83 165.6 31.34 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.266 -1.138 . . . . 0.0 110.144 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 43.4 Cg_endo -71.12 178.49 5.35 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.85 1.447 . . . . 0.0 110.759 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -81.48 -50.56 0.91 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.37 -0.831 . . . . 0.0 111.397 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.738 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 45.9 Cg_endo -72.9 -38.21 3.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.568 1.299 . . . . 0.0 110.953 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.445 ' O ' ' C ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER 61.45 41.42 12.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 0.0 110.063 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -42.64 -28.1 0.21 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.356 -0.84 . . . . 0.0 108.972 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -80.91 -68.11 0.72 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.546 0.688 . . . . 0.0 109.39 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 2.2 t -63.97 159.92 18.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.783 . . . . 0.0 110.021 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 65' ' ' SER . 3.6 mptp? -105.29 90.44 3.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.804 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.854 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.97 154.76 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.261 -0.899 . . . . 0.0 109.979 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.854 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.6 OUTLIER -148.05 89.77 1.77 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.207 -0.933 . . . . 0.0 110.781 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 97.19 61.67 0.93 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.655 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.3 OUTLIER -138.39 171.95 13.62 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.12 -1.224 . . . . 0.0 110.563 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.11 119.06 10.62 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.472 -0.767 . . . . 0.0 109.554 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.609 ' CE2' ' HB3' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -147.4 149.6 33.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.821 -1.174 . . . . 0.0 111.614 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 34.5 p -163.72 73.08 0.29 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.735 -0.603 . . . . 0.0 109.688 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 59.75 162.89 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.321 -0.862 . . . . 0.0 109.937 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.351 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.74 ' N ' HG22 ' A' ' 7' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.337 0.589 . . . . 0.0 110.296 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.92 -107.85 1.0 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 14.5 t -71.82 -14.64 62.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -1.195 . . . . 0.0 109.868 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 3' ' ' SER . 1.6 p 169.71 -51.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 0.0 109.865 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.472 ' O ' HG21 ' A' ' 21' ' ' THR . 9.9 t -145.81 49.02 1.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.195 -0.941 . . . . 0.0 109.858 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.57 ' OD1' HG21 ' A' ' 21' ' ' THR . 2.8 m120 -138.85 117.83 12.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.113 -0.992 . . . . 0.0 110.914 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.74 HG22 ' N ' ' A' ' 1' ' ' ASP . 40.6 p -102.17 106.16 16.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.366 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.4 OUTLIER 74.01 -1.47 3.06 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.378 -0.826 . . . . 0.0 110.023 -179.016 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -109.62 177.43 4.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.0 109.673 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -131.06 112.32 12.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.146 -0.971 . . . . 0.0 110.169 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.51 ' HG ' ' OG ' ' A' ' 15' ' ' SER . 7.3 tp -88.63 54.57 3.08 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.098 -1.001 . . . . 0.0 110.053 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.54 ' HB2' ' CA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 63.06 8.17 3.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 0.0 110.961 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' A' ' 14' ' ' ASN . . . 54.05 16.98 1.26 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 12' ' ' SER . 0.6 OUTLIER 174.75 30.86 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.98 -1.075 . . . . 0.0 110.918 179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.571 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -92.44 -146.24 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.019 -1.05 . . . . 0.0 109.564 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.571 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.1 OUTLIER -104.69 103.83 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.967 -1.083 . . . . 0.0 109.521 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.64 59.78 3.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 0.0 110.538 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.594 ' HG2' ' CD2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -85.84 54.85 3.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.976 . . . . 0.0 110.061 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 9.8 mtmm 54.5 -170.09 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.292 -0.88 . . . . 0.0 110.213 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 35' ' ' THR . 0.2 OUTLIER 63.79 83.89 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.369 -0.832 . . . . 0.0 110.322 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.57 HG21 ' OD1' ' A' ' 6' ' ' ASN . 6.0 m -162.92 152.52 15.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 0.0 109.785 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.586 HD22 HG23 ' A' ' 38' ' ' THR . 1.2 tp -117.63 -121.11 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.057 -1.027 . . . . 0.0 110.309 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 8' ' ' ASN . 4.2 t -151.93 37.95 0.58 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.84 -1.163 . . . . 0.0 110.215 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -155.91 52.36 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 110.493 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 37' ' ' CYS . 8.0 p -152.09 116.51 5.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.061 -1.024 . . . . 0.0 110.455 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.539 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 93.0 m-85 -100.69 100.19 10.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.348 -0.845 . . . . 0.0 109.554 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.055 HG13 ' HB3' ' A' ' 42' ' ' PHE . 5.6 t -94.37 166.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.074 -1.017 . . . . 0.0 110.247 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.54 ' CA ' ' HB2' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.79 124.84 12.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.218 -0.926 . . . . 0.0 110.1 -179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER 42.77 63.26 1.5 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.149 -0.97 . . . . 0.0 109.586 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.848 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.1 m -130.9 -179.12 5.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.313 -0.867 . . . . 0.0 111.114 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.5 mt-10 -145.3 103.77 3.87 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.571 -0.705 . . . . 0.0 109.216 179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.518 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.9 m -112.4 130.86 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.594 ' CD2' ' HG2' ' A' ' 18' ' ' GLU . 2.7 t80 -118.27 94.63 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.434 -0.791 . . . . 0.0 109.902 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 20' ' ' SER . . . 74.96 33.18 55.65 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 1.092 HG23 ' O ' ' A' ' 50' ' ' SER . 19.2 m -108.66 147.23 32.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -1.189 . . . . 0.0 110.208 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 51' ' ' THR . 8.1 t -97.94 150.8 20.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.341 -0.849 . . . . 0.0 110.22 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 19.8 p -135.44 58.2 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 110.138 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 HD22 ' A' ' 22' ' ' LEU . 29.6 m -66.21 -108.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.811 -1.18 . . . . 0.0 109.726 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.97 66.37 3.6 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 7.8 t -144.05 168.16 20.66 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -1.18 . . . . 0.0 110.758 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 3.9 tpt180 -138.85 124.53 19.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.448 -0.782 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.055 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.48 177.53 4.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 0.0 110.565 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 10.0 t0 173.39 108.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 56.45 67.34 2.27 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 47' ' ' ILE . 16.5 t -145.76 125.13 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.433 -1.039 . . . . 0.0 111.419 -177.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -103.44 96.1 6.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.889 . . . . 0.0 108.659 178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.907 ' CD1' HG21 ' A' ' 35' ' ' THR . 1.1 pt -111.14 167.15 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 0.0 110.698 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.96 112.47 10.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.239 -0.913 . . . . 0.0 110.577 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.513 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER 38.08 72.3 0.13 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.433 -0.792 . . . . 0.0 111.288 179.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 1.092 ' O ' HG23 ' A' ' 35' ' ' THR . 44.3 t -140.13 139.96 35.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 110.786 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.486 ' HA ' HG22 ' A' ' 36' ' ' THR . 29.8 p -103.85 50.97 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 109.918 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.441 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 0.6 OUTLIER -89.86 54.7 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.817 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 40' ' ' SER . 10.1 p -84.21 173.46 11.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 110.152 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 94.21 -18.57 56.6 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.529 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 1.2 p -124.63 154.67 40.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -1.19 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 37.1 ttm180 -91.97 114.41 26.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.636 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.683 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.8 OUTLIER -101.2 146.55 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.012 -1.055 . . . . 0.0 111.301 -179.142 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 m -147.31 152.35 38.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.653 -0.655 . . . . 0.0 109.716 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 166.03 124.4 0.71 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.24 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -73.2 -5.65 17.53 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.74 1.389 . . . . 0.0 108.761 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.93 32.12 0.46 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.534 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 1.9 t -72.51 139.09 47.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.527 -0.984 . . . . 0.0 110.658 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -132.18 110.55 10.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.464 -0.772 . . . . 0.0 109.854 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 5.9 tt -100.35 172.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.175 -0.953 . . . . 0.0 109.967 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.49 ' HB2' ' HB3' ' A' ' 81' ' ' LYS . 16.0 m -151.93 94.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.017 -1.052 . . . . 0.0 110.962 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 0.7 OUTLIER 45.59 105.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 179.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 17.1 t -133.53 163.84 28.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.77 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.537 HG22 ' N ' ' A' ' 69' ' ' ILE . 2.9 mp -80.52 167.62 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.251 -0.906 . . . . 0.0 110.897 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.537 ' N ' HG22 ' A' ' 68' ' ' ILE . 10.0 mt -84.63 120.97 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.421 -0.799 . . . . 0.0 109.395 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -148.54 139.16 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.071 -1.018 . . . . 0.0 110.617 -179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.454 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -82.28 58.12 4.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 134.15 89.23 0.34 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.735 HG23 ' HD2' ' A' ' 74' ' ' PRO . 3.3 p -86.48 148.41 46.63 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.252 -1.146 . . . . 0.0 109.525 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.735 ' HD2' HG23 ' A' ' 73' ' ' VAL . 42.5 Cg_endo -68.71 175.72 6.85 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.841 1.443 . . . . 0.0 111.017 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.877 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -75.5 -56.17 1.91 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.4 -0.812 . . . . 0.0 111.077 -179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 42.4 Cg_endo -70.06 -26.47 26.15 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.804 1.423 . . . . 0.0 110.888 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.457 ' HA ' ' HG2' ' A' ' 74' ' ' PRO . 0.9 OUTLIER 47.29 43.95 15.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.05 -1.031 . . . . 0.0 110.579 179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -44.42 -25.93 0.3 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.121 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 77' ' ' SER . . . -79.35 -76.42 0.21 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.535 -0.728 . . . . 0.0 109.67 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 99.1 m -63.95 176.75 0.89 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 0.0 110.316 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -115.67 107.85 15.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.305 -0.872 . . . . 0.0 109.948 179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.895 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -128.69 156.38 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.303 -0.873 . . . . 0.0 110.38 -179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.895 ' N ' HD13 ' A' ' 82' ' ' ILE . 36.4 t -147.59 87.69 1.65 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.28 -0.888 . . . . 0.0 110.533 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 62' ' ' CYS . . . 90.95 60.15 1.35 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.578 ' N ' HD11 ' A' ' 82' ' ' ILE . 49.9 m -142.55 156.39 45.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -1.193 . . . . 0.0 111.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -112.5 157.9 20.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.537 -0.727 . . . . 0.0 109.044 178.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' ARG . 1.9 m-85 -144.89 161.69 38.68 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.868 -1.145 . . . . 0.0 110.66 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.475 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER 176.47 56.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.85 . . . . 0.0 110.294 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.529 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 42.56 -166.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 109.825 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 40' ' ' SER . 1.5 p-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.992 -1.067 . . . . 0.0 110.27 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.739 ' HA ' HG22 ' A' ' 7' ' ' THR . 11.2 t70 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.233 0.539 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.78 -108.55 2.96 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 7.6 p -94.99 86.38 4.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -1.11 . . . . 0.0 110.217 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.5 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.8 OUTLIER 73.0 -72.17 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.475 -0.766 . . . . 0.0 110.698 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 5' ' ' THR . 14.6 t -137.06 47.05 2.14 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.963 -1.086 . . . . 0.0 110.795 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -138.41 90.98 2.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.531 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.739 HG22 ' HA ' ' A' ' 1' ' ' ASP . 14.5 p -98.44 41.27 1.14 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.7 OUTLIER 168.31 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.369 0.604 . . . . 0.0 109.665 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.547 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 34.3 m -108.19 -163.71 0.91 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.365 -0.835 . . . . 0.0 110.583 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -135.55 120.67 18.85 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.446 -0.784 . . . . 0.0 109.702 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 16' ' ' LYS . 8.0 tp -88.15 21.67 2.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 0.0 110.138 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 10.6 t 64.64 5.88 2.96 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.642 -0.661 . . . . 0.0 111.118 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.13 21.05 0.46 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.991 -1.068 . . . . 0.0 110.072 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -154.0 14.05 0.46 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 110.469 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.491 ' HB2' ' HG ' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -112.46 -156.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.598 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -108.09 148.27 30.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.018 . . . . 0.0 110.055 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' HB3' HD22 ' A' ' 11' ' ' LEU . 7.2 p -123.05 68.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.216 -0.927 . . . . 0.0 110.504 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.32 67.44 3.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.969 . . . . 0.0 110.322 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.499 ' CG ' ' OG1' ' A' ' 5' ' ' THR . 0.0 OUTLIER -179.48 -169.82 0.15 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.295 -0.878 . . . . 0.0 110.219 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -170.77 96.52 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.258 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.852 HG23 ' H ' ' A' ' 23' ' ' THR . 4.9 t -168.87 -175.61 2.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 0.0 110.368 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tp -92.19 33.36 1.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 0.0 109.1 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.852 ' H ' HG23 ' A' ' 21' ' ' THR . 2.0 m -53.28 115.7 2.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.635 -0.666 . . . . 0.0 110.23 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.545 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 5.5 m-20 -84.29 103.24 13.31 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.575 -0.703 . . . . 0.0 110.405 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' N ' ' OG ' ' A' ' 9' ' ' SER . 1.0 OUTLIER -157.9 122.61 4.31 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 110.955 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.542 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -87.3 102.32 14.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.151 -0.968 . . . . 0.0 108.757 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.021 HG22 ' HB2' ' A' ' 42' ' ' PHE . 18.8 t -100.85 163.84 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.922 -1.111 . . . . 0.0 111.515 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 37.6 t0 -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' N ' ' OG ' ' A' ' 12' ' ' SER . 12.8 tttt 43.27 68.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.885 -1.134 . . . . 0.0 109.989 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.569 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.5 m -133.74 -171.05 2.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.061 . . . . 0.0 111.655 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -144.33 103.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.449 HG11 ' NZ ' ' A' ' 19' ' ' LYS . 90.7 t -106.13 151.09 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.937 -1.102 . . . . 0.0 110.968 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.536 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 2.3 t80 -140.37 76.65 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 109.898 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 19' ' ' LYS . . . 65.98 61.35 5.59 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -111.41 149.26 31.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -1.144 . . . . 0.0 109.978 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 37' ' ' CYS . 18.2 p -67.38 -68.49 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 110.313 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.587 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.6 OUTLIER 51.42 42.42 29.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.099 -1.001 . . . . 0.0 109.988 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -85.15 36.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.255 -0.903 . . . . 0.0 110.726 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.502 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 152.08 54.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.578 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.57 -176.24 5.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.299 -1.118 . . . . 0.0 109.849 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -131.68 134.24 45.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.726 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.021 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.5 m-85 -111.97 150.85 29.97 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.894 -1.129 . . . . 0.0 110.416 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 14.4 t0 -166.15 119.75 1.12 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.491 -0.756 . . . . 0.0 109.105 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.42 68.89 1.03 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.711 ' CG1' HG23 ' A' ' 47' ' ' ILE . 2.3 t -145.85 135.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -1.165 . . . . 0.0 111.036 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.401 HG23 ' CB ' ' A' ' 31' ' ' GLU . 65.5 m -115.43 90.61 3.38 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.711 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.34 172.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.456 -0.777 . . . . 0.0 110.495 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.577 HG23 ' N ' ' A' ' 49' ' ' THR . 5.1 t -129.14 -155.21 0.69 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.247 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.577 ' N ' HG23 ' A' ' 48' ' ' THR . 1.3 m -58.62 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 48' ' ' THR . 8.6 t -139.13 -175.6 4.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.467 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 67' ' ' CYS . 3.6 t -133.78 61.61 1.67 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.891 . . . . 0.0 110.292 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 t -112.07 100.28 8.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 110.01 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.587 HG22 ' HA ' ' A' ' 37' ' ' CYS . 3.5 p -131.21 -164.2 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.297 -0.877 . . . . 0.0 110.03 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.54 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . 94.1 -68.26 1.43 Allowed Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.447 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.579 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -101.66 -169.58 1.7 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.155 -1.203 . . . . 0.0 111.722 -178.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 3.7 ppt_? -107.6 139.59 41.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.735 -0.603 . . . . 0.0 110.131 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.683 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.7 mt -107.75 160.66 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 120.996 -1.065 . . . . 0.0 110.531 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.442 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -146.65 148.54 32.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.369 -0.832 . . . . 0.0 110.334 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 171.11 124.0 0.73 Allowed Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.393 -1.385 . . . . 0.0 110.597 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -76.35 -1.26 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.746 1.393 . . . . 0.0 108.905 178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -173.21 38.15 0.14 Allowed Glycine 0 N--CA 1.486 1.99 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.41 155.57 39.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.442 -1.034 . . . . 0.0 110.683 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.63 111.05 5.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.629 -0.67 . . . . 0.0 109.786 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -101.71 165.14 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.939 . . . . 0.0 109.406 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.506 ' HB3' ' CB ' ' A' ' 81' ' ' LYS . 2.0 t -152.16 86.35 1.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.008 -1.058 . . . . 0.0 110.664 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.2 p 55.02 114.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.543 -0.723 . . . . 0.0 110.3 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.575 ' O ' HD13 ' A' ' 68' ' ' ILE . 60.5 m -143.23 -143.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 110.532 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 67' ' ' CYS . 10.0 mm -132.32 165.59 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.327 -0.858 . . . . 0.0 109.744 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 40.6 mt -45.85 151.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.099 -1.0 . . . . 0.0 109.863 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.424 ' CB ' ' O ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -123.84 -144.78 0.33 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.151 -0.968 . . . . 0.0 110.74 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 55' ' ' SER . . . 115.22 57.84 0.35 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.433 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . 63.92 15.53 58.24 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.506 HG22 ' C ' ' A' ' 71' ' ' GLY . 3.7 m -128.28 83.93 64.7 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.724 -0.869 . . . . 0.0 110.349 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -84.62 8.56 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.983 1.517 . . . . 0.0 110.317 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -72.03 -49.83 9.75 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.364 -0.835 . . . . 0.0 111.163 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 46.0 Cg_endo -73.99 4.18 4.44 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.736 1.388 . . . . 0.0 111.308 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.8 m -122.06 13.26 10.49 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.883 -1.135 . . . . 0.0 110.269 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.17 -22.78 1.84 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.078 -1.014 . . . . 0.0 108.965 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' ' HE3' ' A' ' 81' ' ' LYS . . . -87.69 7.19 31.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.623 -0.673 . . . . 0.0 110.012 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 18.3 t -81.23 150.05 28.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 111.118 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -103.83 94.52 5.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.426 -0.796 . . . . 0.0 109.413 179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.88 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.19 151.8 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.25 -0.906 . . . . 0.0 110.541 -179.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.88 ' N ' HD13 ' A' ' 82' ' ' ILE . 15.6 m -147.44 103.98 3.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 110.234 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 83.84 48.19 5.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.704 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.48 159.6 38.88 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.173 -1.193 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.494 ' C ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -120.08 163.09 18.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.539 -0.726 . . . . 0.0 109.453 179.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 86' ' ' THR . 4.0 m-85 -134.61 161.73 34.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.085 -1.01 . . . . 0.0 109.973 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 55' ' ' SER . 0.3 OUTLIER 175.09 124.51 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 110.45 -179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.509 ' HA ' ' HB2' ' A' ' 55' ' ' SER . . . -42.01 146.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.341 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 1.6 t30 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.077 -0.963 . . . . 0.0 109.887 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.411 0.624 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.73 -142.4 8.46 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -49.46 -26.94 3.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -1.166 . . . . 0.0 109.737 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 17' ' ' CYS . 1.9 p 173.16 -51.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.57 -0.706 . . . . 0.0 109.91 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.569 ' CG2' HD22 ' A' ' 11' ' ' LEU . 13.3 t -146.23 19.33 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 11' ' ' LEU . 4.8 m120 -89.48 57.52 4.0 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.393 -0.817 . . . . 0.0 110.519 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 75.2 p -98.63 105.47 17.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.382 -0.824 . . . . 0.0 109.438 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' THR . 14.2 m-20 67.09 6.04 4.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.442 -0.786 . . . . 0.0 109.86 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.43 178.7 6.52 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.348 -0.845 . . . . 0.0 109.185 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 10.8 tt0 -131.32 112.29 12.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.969 -1.082 . . . . 0.0 110.566 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.569 HD22 ' CG2' ' A' ' 5' ' ' THR . 5.3 tp -100.7 29.89 4.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 109.827 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 9.1 t 65.3 6.34 3.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.596 -0.69 . . . . 0.0 110.797 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 44.59 24.05 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.069 -1.019 . . . . 0.0 110.473 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' SER . 64.2 t30 -158.52 17.62 0.21 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.078 -1.014 . . . . 0.0 110.727 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.526 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 1.8 p -106.4 -140.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.058 -1.026 . . . . 0.0 109.782 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.526 ' N ' ' OG ' ' A' ' 15' ' ' SER . 0.6 OUTLIER -120.67 124.14 44.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.926 -1.109 . . . . 0.0 109.81 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' HB2' ' HB2' ' A' ' 4' ' ' CYS . 8.9 m -97.12 61.22 1.74 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.69 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.585 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.67 39.75 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.869 -1.145 . . . . 0.0 110.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER 174.35 143.03 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 109.904 179.675 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 p -72.09 178.59 3.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.178 -0.952 . . . . 0.0 110.517 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 ' SG ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -138.11 -161.88 1.23 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 110.317 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' O ' ' HB ' ' A' ' 23' ' ' THR . 9.9 tp -130.25 -70.78 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 109.894 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 1.1 t 171.79 36.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.411 -0.806 . . . . 0.0 109.804 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.99 52.77 0.56 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -0.924 . . . . 0.0 110.216 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.7 m -144.56 110.59 5.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.136 -0.977 . . . . 0.0 110.807 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.536 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 26.5 m-85 -105.65 104.91 14.73 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.023 HG13 ' HB3' ' A' ' 42' ' ' PHE . 6.7 t -106.29 159.26 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.759 -1.213 . . . . 0.0 110.841 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.526 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 1.7 t0 -142.89 123.37 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.283 -0.885 . . . . 0.0 110.223 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' N ' ' OG ' ' A' ' 12' ' ' SER . 1.8 tttt 38.3 66.68 0.47 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.436 -0.79 . . . . 0.0 110.094 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 15' ' ' SER . 2.1 m -133.31 -167.47 1.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 111.197 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 47' ' ' ILE . 39.4 mt-10 -143.29 103.67 4.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' N ' ' HB2' ' A' ' 16' ' ' LYS . 77.4 t -105.59 127.61 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.093 -1.004 . . . . 0.0 110.878 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.596 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.9 OUTLIER -107.51 -139.08 0.37 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.483 ' C ' ' HA ' ' A' ' 49' ' ' THR . . . -66.47 61.6 0.17 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.5 m -107.07 164.55 12.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -1.157 . . . . 0.0 110.141 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.596 HG23 ' HA ' ' A' ' 51' ' ' THR . 19.6 p -104.82 174.61 5.8 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.0 110.326 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -148.75 119.73 7.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.201 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.7 m -140.39 -36.93 0.47 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.288 -0.882 . . . . 0.0 110.14 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 54' ' ' GLY . . . -172.17 65.12 0.14 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.58 ' HB2' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -137.62 179.96 6.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -1.097 . . . . 0.0 110.24 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.559 ' HD2' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -141.27 130.2 23.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.457 -0.777 . . . . 0.0 109.544 179.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.023 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.4 m-85 -109.79 162.41 14.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -0.977 . . . . 0.0 110.8 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 9.4 t0 177.95 112.87 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.498 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 52.18 66.34 2.68 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 107.315 -2.314 . . . . 0.0 107.315 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.692 HG22 HG22 ' A' ' 57' ' ' ILE . 3.8 t -145.24 117.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -1.101 . . . . 0.0 110.422 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 63' ' ' LYS . 10.6 m -98.85 90.91 4.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 109.679 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.674 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -110.51 167.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.448 -0.782 . . . . 0.0 109.957 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.736 HG23 ' N ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -122.77 -160.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.107 -0.995 . . . . 0.0 110.121 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.861 ' O ' HG22 ' A' ' 66' ' ' THR . 44.1 m -49.13 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.278 -0.889 . . . . 0.0 109.941 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.523 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 3.5 t -139.99 132.31 28.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.034 -1.041 . . . . 0.0 111.562 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.596 ' HA ' HG23 ' A' ' 36' ' ' THR . 33.2 p -85.38 59.71 5.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.554 -0.716 . . . . 0.0 109.658 179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 t -119.59 126.5 51.35 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.331 -0.856 . . . . 0.0 110.02 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -169.81 75.37 0.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -0.974 . . . . 0.0 110.723 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.58 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -133.5 -54.57 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.528 ' HB3' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -104.7 -171.32 1.9 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.351 -1.088 . . . . 0.0 109.959 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 37.4 ptt180 -105.31 136.47 44.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.167 -0.958 . . . . 0.0 110.306 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.692 HG22 HG22 ' A' ' 45' ' ' VAL . 1.8 mt -109.59 157.54 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.091 -1.006 . . . . 0.0 110.602 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.71 156.92 43.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.552 -0.718 . . . . 0.0 110.292 179.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 157.33 124.42 0.8 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.552 -1.308 . . . . 0.0 110.575 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -70.03 -7.89 22.26 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.594 1.313 . . . . 0.0 108.76 178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.48 33.05 0.64 Allowed Glycine 0 N--CA 1.486 2.017 0 N-CA-C 108.029 -2.028 . . . . 0.0 108.029 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.513 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 2.8 t -71.68 137.98 48.25 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.44 -1.035 . . . . 0.0 110.165 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' THR . 1.6 mtpt -137.22 118.41 14.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.378 -0.826 . . . . 0.0 109.87 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 47' ' ' ILE . 2.5 tt -104.26 170.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.278 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.486 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 1.2 t -143.36 77.93 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 110.108 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 49' ' ' THR . 7.2 p 52.9 104.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.569 -0.707 . . . . 0.0 110.971 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 64' ' ' ILE . 74.0 m -124.21 -149.8 0.43 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.415 -0.803 . . . . 0.0 109.808 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.528 HG22 ' N ' ' A' ' 69' ' ' ILE . 43.4 mm -131.09 169.4 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.162 -0.961 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.528 ' N ' HG22 ' A' ' 68' ' ' ILE . 0.4 OUTLIER -57.83 136.6 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -0.884 . . . . 0.0 110.132 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.954 ' OG1' HG22 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -147.24 90.28 1.87 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 0.0 111.028 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . -74.38 65.04 2.06 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.656 ' HA3' ' HB2' ' A' ' 89' ' ' ALA . . . 68.51 52.25 26.97 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.954 HG22 ' OG1' ' A' ' 70' ' ' THR . 3.3 m -95.71 166.64 14.14 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.673 -0.898 . . . . 0.0 110.415 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 40.6 Cg_endo -70.34 146.88 57.86 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.912 1.48 . . . . 0.0 110.613 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.711 ' HB1' ' HB2' ' A' ' 78' ' ' ALA . . . 41.47 71.37 1.33 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.499 -0.75 . . . . 0.0 110.092 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.4 ' O ' ' HB3' ' A' ' 77' ' ' SER . 43.1 Cg_endo -69.18 136.66 35.13 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.133 1.596 . . . . 0.0 109.506 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.52 ' CB ' ' SG ' ' A' ' 80' ' ' CYS . 0.1 OUTLIER 61.62 14.61 6.15 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.979 -1.076 . . . . 0.0 108.93 -179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.711 ' HB2' ' HB1' ' A' ' 75' ' ' ALA . . . -53.78 -19.13 3.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.493 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . -93.01 -61.37 1.59 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.751 -0.593 . . . . 0.0 110.076 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.52 ' SG ' ' CB ' ' A' ' 77' ' ' SER . 30.5 p -63.84 -155.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.765 . . . . 0.0 110.056 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 79' ' ' ALA . 3.5 mmtt -120.52 133.43 55.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 110.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.559 HD11 ' SG ' ' A' ' 85' ' ' CYS . 7.8 tp -138.57 156.74 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 109.845 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.9 m -154.21 125.91 7.61 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.183 -0.948 . . . . 0.0 110.055 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 56.53 55.29 30.52 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' HD11 ' A' ' 82' ' ' ILE . 88.4 m -133.14 140.46 47.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -1.092 . . . . 0.0 111.064 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.561 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -101.95 166.38 10.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.447 -0.783 . . . . 0.0 109.079 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CD1' ' O ' ' A' ' 86' ' ' THR . 1.9 m-85 -152.8 157.26 40.52 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.835 -1.165 . . . . 0.0 110.401 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.3 OUTLIER 177.48 132.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.517 -0.739 . . . . 0.0 109.405 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.656 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . . . -41.79 136.7 1.9 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.193 -0.942 . . . . 0.0 110.311 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.434 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.841 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.231 0.539 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 3' ' ' SER . . . -141.25 106.44 0.47 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER 70.7 -56.34 0.61 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -1.15 . . . . 0.0 110.552 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.94 -158.4 0.88 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.065 -1.022 . . . . 0.0 110.633 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.799 HG23 ' O ' ' A' ' 5' ' ' THR . 8.1 t -96.46 57.69 1.67 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.35 -0.844 . . . . 0.0 110.477 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.408 ' ND2' ' HB2' ' A' ' 11' ' ' LEU . 7.9 m120 -149.01 111.75 4.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.058 -1.026 . . . . 0.0 110.782 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 23' ' ' THR . 9.5 p -98.4 111.05 23.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 109.234 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER 73.9 -0.71 3.28 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.476 -0.765 . . . . 0.0 109.902 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -110.94 -177.18 3.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 109.599 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -143.47 99.69 3.47 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.947 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.604 HD12 HG21 ' A' ' 27' ' ' VAL . 4.4 tp -90.36 25.81 2.13 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.239 -0.913 . . . . 0.0 109.473 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.643 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 t 54.65 93.77 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.123 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -37.99 -28.54 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.482 -0.761 . . . . 0.0 111.318 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.482 ' N ' ' O ' ' A' ' 12' ' ' SER . 9.1 p30 -83.48 11.41 7.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.003 -1.061 . . . . 0.0 110.772 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -99.68 -149.5 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.901 -1.124 . . . . 0.0 109.522 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.4 OUTLIER -113.82 99.63 7.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.023 -1.048 . . . . 0.0 109.781 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 82.3 m -73.97 55.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 110.104 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -123.21 80.15 1.74 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.468 -0.77 . . . . 0.0 109.212 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -171.92 -145.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.766 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.439 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -106.77 -150.0 0.44 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.355 -0.841 . . . . 0.0 110.19 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.521 HG21 ' OG1' ' A' ' 7' ' ' THR . 2.6 m -165.01 151.05 10.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.863 HD13 HG22 ' A' ' 38' ' ' THR . 0.1 OUTLIER -158.59 22.97 0.23 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 110.575 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 7' ' ' THR . 15.4 p 48.95 38.34 12.17 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.246 -0.909 . . . . 0.0 111.09 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.444 ' C ' ' SG ' ' A' ' 25' ' ' CYS . 0.6 OUTLIER -157.73 53.28 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.019 -1.051 . . . . 0.0 110.271 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -149.45 107.41 3.71 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.064 -1.023 . . . . 0.0 110.386 -179.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 10.3 m-85 -106.9 88.28 2.71 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.854 HG13 ' CB ' ' A' ' 42' ' ' PHE . 11.0 t -93.73 170.03 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.178 -0.951 . . . . 0.0 111.371 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.643 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 7.5 t0 -150.07 126.5 10.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.565 -0.709 . . . . 0.0 109.852 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.473 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.7 OUTLIER 41.66 56.6 3.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.006 -1.059 . . . . 0.0 110.181 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.665 ' OG ' HG12 ' A' ' 27' ' ' VAL . 15.4 m -122.37 176.95 5.6 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.92 . . . . 0.0 110.77 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.812 ' HB2' HG23 ' A' ' 46' ' ' THR . 21.8 mt-10 -144.06 100.39 3.55 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 108.789 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.58 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.0 m -106.55 152.23 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.486 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 32.9 t80 -134.57 85.93 2.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 0.0 110.456 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 19' ' ' LYS . . . 78.02 43.78 13.21 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 50' ' ' SER . 1.9 m -104.69 166.23 10.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.359 -1.083 . . . . 0.0 110.286 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.459 ' N ' ' CG2' ' A' ' 35' ' ' THR . 0.0 OUTLIER -130.47 134.38 47.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' HA ' HG21 ' A' ' 53' ' ' THR . 5.0 p -121.55 84.87 2.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 110.441 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.863 HG22 HD13 ' A' ' 22' ' ' LEU . 18.4 p -86.77 7.01 28.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.417 -0.802 . . . . 0.0 109.951 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.18 76.28 0.02 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 2.2 p -159.24 179.62 8.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -1.175 . . . . 0.0 110.176 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.547 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -146.07 117.73 8.09 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.393 -0.817 . . . . 0.0 109.927 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.854 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.5 m-30 -98.94 150.52 21.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.036 . . . . 0.0 109.624 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.518 ' OD1' ' NH2' ' A' ' 41' ' ' ARG . 0.2 OUTLIER -145.83 71.79 1.28 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.065 -1.022 . . . . 0.0 109.589 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 88.33 73.68 1.28 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.829 HG21 HD12 ' A' ' 57' ' ' ILE . 3.1 t -145.55 138.85 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.23 -1.159 . . . . 0.0 111.103 -178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.812 HG23 ' HB2' ' A' ' 31' ' ' GLU . 18.8 m -112.76 91.94 3.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.978 . . . . 0.0 109.112 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.751 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -112.3 170.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -178.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.558 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 14.6 t -118.18 -145.76 0.38 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.82 -1.175 . . . . 0.0 109.969 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.551 ' CA ' ' O ' ' A' ' 33' ' ' TYR . 39.9 m -64.81 80.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.118 -0.989 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' THR . 3.0 p -137.59 149.98 47.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 0.0 110.299 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 67' ' ' CYS . 9.0 t -112.64 66.73 0.65 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 0.0 110.202 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.46 91.46 4.25 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.878 . . . . 0.0 109.762 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 ' HA ' ' A' ' 37' ' ' CYS . 62.4 p -123.5 141.32 52.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 0.0 110.139 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.68 -32.29 1.84 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.959 -1.257 . . . . 0.0 109.959 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HB3' ' C ' ' A' ' 88' ' ' SER . 0.3 OUTLIER -122.32 160.57 25.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -1.176 . . . . 0.0 110.525 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 110.22 21.53 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.829 HD12 HG21 ' A' ' 45' ' ' VAL . 7.3 pt -106.95 159.62 6.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.074 -1.017 . . . . 0.0 112.424 -177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 5.5 t -146.12 -173.72 4.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 151.49 119.79 0.87 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.271 -1.442 . . . . 0.0 110.669 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.57 -7.5 21.33 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.699 1.368 . . . . 0.0 108.645 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.4 37.28 0.3 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.505 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.9 t -71.83 144.25 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.499 -1.001 . . . . 0.0 110.581 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' THR . 18.3 mtpt -144.41 117.93 9.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.286 -0.884 . . . . 0.0 110.622 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.68 ' HB ' HG22 ' A' ' 47' ' ' ILE . 3.7 tt -105.03 174.5 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.89 . . . . 0.0 110.279 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -147.01 84.15 1.59 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.277 -0.889 . . . . 0.0 109.914 179.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 65' ' ' SER . 0.2 OUTLIER 60.07 135.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.281 -0.887 . . . . 0.0 110.164 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.765 ' O ' HG22 ' A' ' 51' ' ' THR . 42.3 t -167.15 167.93 13.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.76 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 69' ' ' ILE . 5.6 mt -99.88 179.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 0.0 110.027 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.552 ' H ' HG22 ' A' ' 68' ' ' ILE . 1.5 pt -45.51 171.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.113 -0.992 . . . . 0.0 110.039 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.433 ' OG1' ' N ' ' A' ' 53' ' ' THR . 0.2 OUTLIER -133.32 -137.65 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 111.02 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.13 43.87 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 98.8 67.07 0.87 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.727 HG23 ' HD2' ' A' ' 74' ' ' PRO . 5.4 p -89.85 147.71 38.11 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.459 -1.024 . . . . 0.0 111.14 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.727 ' HD2' HG23 ' A' ' 73' ' ' VAL . 44.0 Cg_endo -71.18 145.44 49.09 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 124.037 1.546 . . . . 0.0 110.908 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.842 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -50.04 -56.18 19.41 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.301 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.842 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 42.0 Cg_endo -70.25 70.32 1.85 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.831 1.437 . . . . 0.0 110.117 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 82' ' ' ILE . 1.2 m -59.25 73.52 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.561 -0.712 . . . . 0.0 110.774 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 76' ' ' PRO . . . -57.47 -17.64 14.41 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.165 -0.959 . . . . 0.0 108.625 178.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.98 -78.84 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.419 0.628 . . . . 0.0 110.192 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 67.8 m -74.54 -172.24 1.45 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.86 . . . . 0.0 110.399 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.543 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 4.7 mmtp -114.73 113.83 24.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 0.0 109.386 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.533 HG22 ' HB2' ' A' ' 77' ' ' SER . 2.1 tp -140.6 147.65 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.109 -0.995 . . . . 0.0 110.542 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 27.4 m -145.27 111.78 5.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 110.278 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.99 57.07 3.83 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.503 ' SG ' HG13 ' A' ' 82' ' ' ILE . 69.8 m -138.85 153.9 48.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.2 -1.177 . . . . 0.0 110.484 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -105.4 157.75 17.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.795 . . . . 0.0 109.489 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' A' ' 57' ' ' ILE . 35.5 m-85 -144.28 146.66 32.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.101 -0.999 . . . . 0.0 110.582 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 89' ' ' ALA . 0.1 OUTLIER 174.1 118.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.515 -0.74 . . . . 0.0 109.408 -179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -33.93 125.35 0.45 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 110.8 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.444 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.1 t30 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.254 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 t0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.247 0.546 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.65 -125.76 1.16 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.07 -33.51 67.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.198 . . . . 0.0 109.407 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 p 176.96 -42.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.537 -0.727 . . . . 0.0 109.864 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.485 ' CB ' ' SG ' ' A' ' 17' ' ' CYS . 17.6 m -143.57 32.33 1.31 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.232 -0.918 . . . . 0.0 110.175 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -112.42 59.17 0.64 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 11.2 p -99.57 105.84 17.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.076 -1.015 . . . . 0.0 110.306 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 7' ' ' THR . 4.2 t-20 66.65 6.78 4.69 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.456 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -129.85 -165.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.023 -1.048 . . . . 0.0 110.395 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -142.99 104.47 4.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.024 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 16' ' ' LYS . 30.3 tp -91.38 21.21 4.64 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.324 -0.86 . . . . 0.0 109.893 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER 71.5 0.77 3.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.472 -0.768 . . . . 0.0 110.792 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.68 19.4 0.89 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.012 . . . . 0.0 109.986 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.6 t30 -157.4 13.71 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.958 . . . . 0.0 110.996 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.4 m -101.15 -145.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.761 -1.212 . . . . 0.0 109.703 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.628 ' O ' HD21 ' A' ' 11' ' ' LEU . 1.8 tptt -104.0 131.7 50.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.083 -1.01 . . . . 0.0 109.227 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' ' CB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.22 65.39 1.24 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.01 -1.056 . . . . 0.0 111.087 -178.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.582 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -98.05 147.78 24.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.06 -1.025 . . . . 0.0 109.791 179.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 57.69 158.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.048 -1.032 . . . . 0.0 110.006 -179.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.57 122.38 45.48 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.079 -1.013 . . . . 0.0 110.377 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.452 ' CG2' ' SG ' ' A' ' 37' ' ' CYS . 3.4 m -93.55 152.96 18.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 110.008 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.05 54.94 1.47 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.368 -0.832 . . . . 0.0 109.378 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.47 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 0.2 OUTLIER -161.04 -158.36 0.58 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.337 -0.852 . . . . 0.0 110.701 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.455 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -95.75 115.11 26.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.609 -0.682 . . . . 0.0 110.978 -179.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.513 ' N ' ' OG ' ' A' ' 9' ' ' SER . 54.7 m -154.73 110.74 3.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.84 . . . . 0.0 109.672 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 28.6 m-85 -101.86 122.26 43.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.398 -0.814 . . . . 0.0 109.76 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.109 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.6 t -120.35 167.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.949 . . . . 0.0 110.308 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.607 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 1.1 m-20 -146.95 113.81 6.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 109.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 tttt 47.43 68.6 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.872 -1.143 . . . . 0.0 110.037 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.721 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.6 m -133.86 -171.02 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.158 -0.964 . . . . 0.0 111.346 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.22 100.84 3.62 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 16' ' ' LYS . 71.1 t -101.42 157.44 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.112 -0.992 . . . . 0.0 111.15 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.654 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -134.34 -140.43 0.18 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.336 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.558 ' O ' HG23 ' A' ' 49' ' ' THR . . . -71.24 58.78 1.11 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.832 -1.707 . . . . 0.0 108.832 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 50' ' ' SER . 0.8 OUTLIER -96.96 -144.0 0.29 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -1.101 . . . . 0.0 110.394 -179.382 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.791 HG21 HG23 ' A' ' 51' ' ' THR . 31.0 p -139.53 -158.05 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.956 -1.09 . . . . 0.0 110.99 -179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 36' ' ' THR . 36.1 t 178.7 53.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.548 -0.72 . . . . 0.0 109.378 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.94 48.06 1.01 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.898 . . . . 0.0 110.009 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.74 88.14 2.04 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.557 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 67.3 p -169.95 174.13 5.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -1.109 . . . . 0.0 110.391 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.546 ' O ' ' HA ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -137.91 138.64 39.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.839 . . . . 0.0 109.453 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.109 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.7 m-85 -118.29 168.79 10.28 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.911 -1.118 . . . . 0.0 110.398 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.682 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.2 OUTLIER 176.57 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.116 -0.99 . . . . 0.0 108.739 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 47.44 68.05 1.31 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 107.172 -2.371 . . . . 0.0 107.172 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.755 ' CG1' HG23 ' A' ' 47' ' ' ILE . 15.0 t -143.02 109.37 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.363 -1.08 . . . . 0.0 111.265 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 46' ' ' THR . 5.7 m -94.89 86.27 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.896 -1.128 . . . . 0.0 108.595 177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.755 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -112.41 163.37 9.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.563 -0.711 . . . . 0.0 110.451 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.783 HG23 ' N ' ' A' ' 49' ' ' THR . 1.4 t -115.29 -152.52 0.5 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.04 -1.038 . . . . 0.0 110.28 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.783 ' N ' HG23 ' A' ' 48' ' ' THR . 8.8 m -58.87 87.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.046 -1.034 . . . . 0.0 109.688 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 0.7 OUTLIER -138.59 -162.26 1.29 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.966 -1.084 . . . . 0.0 110.835 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.791 HG23 HG21 ' A' ' 36' ' ' THR . 0.4 OUTLIER -144.01 67.21 1.27 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.534 -0.729 . . . . 0.0 109.755 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.8 79.41 2.95 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.328 -0.858 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 28.9 p -121.57 175.11 6.38 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.237 -0.915 . . . . 0.0 110.684 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.45 -34.43 4.17 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.536 ' CB ' ' HA2' ' A' ' 72' ' ' GLY . 0.4 OUTLIER -129.85 163.84 25.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -1.133 . . . . 0.0 110.386 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.7 ptm180 -96.02 136.75 36.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.334 -0.854 . . . . 0.0 109.517 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.739 HG22 HG22 ' A' ' 45' ' ' VAL . 2.2 mt -110.73 163.94 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.164 -0.96 . . . . 0.0 111.312 -178.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.585 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.2 OUTLIER -147.31 149.82 33.57 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.682 -0.636 . . . . 0.0 109.899 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 167.01 116.24 0.35 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.415 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -70.93 -5.92 18.01 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.651 1.343 . . . . 0.0 108.819 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -163.11 38.51 0.34 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.465 ' O ' ' HB ' ' A' ' 46' ' ' THR . 3.8 t -71.41 155.16 40.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -1.118 . . . . 0.0 110.711 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 83' ' ' SER . 0.1 OUTLIER -143.34 107.86 4.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.481 -0.762 . . . . 0.0 109.56 179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.539 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 4.9 tt -104.49 168.59 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 0.0 109.968 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -150.74 97.93 2.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.072 -1.017 . . . . 0.0 110.628 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 2.2 p 55.63 108.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.336 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.76 -156.35 0.73 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.383 -0.823 . . . . 0.0 109.771 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 68' ' ' ILE . 24.1 mt -146.78 140.83 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.525 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 69' ' ' ILE . 1.0 OUTLIER -52.8 112.14 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.513 -0.742 . . . . 0.0 110.369 -179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 53' ' ' THR . 2.9 m -148.51 135.69 20.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.925 -1.109 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -71.71 77.44 0.64 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' A' ' 55' ' ' SER . . . 109.94 115.21 3.68 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.597 HG13 ' HD2' ' A' ' 74' ' ' PRO . 69.3 t -89.54 143.3 30.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.258 -1.142 . . . . 0.0 110.047 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.597 ' HD2' HG13 ' A' ' 73' ' ' VAL . 43.3 Cg_endo -69.88 139.31 39.51 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.035 1.545 . . . . 0.0 110.893 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.623 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . -57.53 -45.24 99.88 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.512 -0.742 . . . . 0.0 111.277 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 75' ' ' ALA . 43.1 Cg_endo -70.86 -49.59 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.244 1.128 . . . . 0.0 110.24 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.423 ' OG ' HG22 ' A' ' 82' ' ' ILE . 1.0 OUTLIER 64.02 35.01 10.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 110.936 179.184 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.82 -23.96 0.87 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.033 -1.042 . . . . 0.0 108.905 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.87 -73.77 0.45 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.557 -0.714 . . . . 0.0 110.102 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.0 t -66.63 168.19 9.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.473 -0.767 . . . . 0.0 110.385 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -113.58 103.89 11.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.125 -0.984 . . . . 0.0 110.816 -179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -122.58 157.34 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.412 -0.805 . . . . 0.0 109.849 179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 63' ' ' LYS . 11.3 t -151.76 101.83 2.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.172 -0.955 . . . . 0.0 110.143 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 81.59 57.85 2.66 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.559 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.88 150.51 34.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -1.136 . . . . 0.0 111.239 -179.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.585 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 9.0 t -110.7 160.68 16.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.432 -0.793 . . . . 0.0 109.004 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.491 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.3 m-85 -131.18 154.22 48.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.804 -1.185 . . . . 0.0 110.839 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 56' ' ' ARG . 4.0 m -174.05 120.05 0.27 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.464 -0.772 . . . . 0.0 109.716 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.35 139.35 0.76 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.416 -0.802 . . . . 0.0 110.576 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.523 ' N ' ' HA ' ' A' ' 55' ' ' SER . 7.3 t30 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.137 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.147 0.499 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.4 -129.31 6.26 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 t -45.11 -25.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.87 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 178.15 -62.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.282 -0.886 . . . . 0.0 110.177 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.591 HG22 ' CB ' ' A' ' 17' ' ' CYS . 3.6 t -122.09 19.5 10.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.067 -1.02 . . . . 0.0 109.789 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -83.18 52.22 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.352 -0.842 . . . . 0.0 109.934 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 7' ' ' THR . 11.0 t -98.67 92.51 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.523 -0.736 . . . . 0.0 109.786 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.8 OUTLIER 69.91 3.51 4.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.167 -0.958 . . . . 0.0 109.795 -179.112 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.32 149.32 40.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.399 -0.813 . . . . 0.0 109.717 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 27' ' ' VAL . 1.3 mt-30 -107.92 88.04 2.64 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 109.987 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.052 HD21 ' O ' ' A' ' 16' ' ' LYS . 3.3 tp -88.58 25.14 1.78 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.221 -0.925 . . . . 0.0 109.525 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 7.7 t 53.67 103.32 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -42.45 -23.52 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 110.5 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 12' ' ' SER . 1.3 t-20 -89.86 14.91 10.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 111.707 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 0.0 OUTLIER -113.56 -164.08 0.9 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.567 -1.333 . . . . 0.0 110.141 179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 1.052 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.2 OUTLIER -114.66 147.49 39.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.14 -0.975 . . . . 0.0 109.724 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' HB3' HD22 ' A' ' 11' ' ' LEU . 6.6 p -123.11 72.75 1.12 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.365 -0.834 . . . . 0.0 110.724 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -84.56 138.22 32.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.063 -1.023 . . . . 0.0 109.842 179.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 70.73 -172.9 0.17 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.187 -0.946 . . . . 0.0 110.011 -179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -93.03 176.5 6.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.184 -0.948 . . . . 0.0 110.391 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.4 m -152.36 149.91 29.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.112 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.442 ' HA ' HD12 ' A' ' 22' ' ' LEU . 9.2 tp -71.11 -139.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 0.0 110.496 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.501 ' HB ' ' HB3' ' A' ' 8' ' ' ASN . 70.6 p -136.05 39.88 2.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.197 -0.939 . . . . 0.0 110.537 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.461 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 38.7 t30 -149.52 63.31 1.01 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.136 -0.977 . . . . 0.0 110.417 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 87.0 m -153.33 114.39 4.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.903 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 27.9 m-85 -107.91 92.65 4.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.396 -0.815 . . . . 0.0 109.799 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.976 HG13 ' HB3' ' A' ' 42' ' ' PHE . 12.7 t -93.56 167.73 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 O-C-N 120.947 -1.096 . . . . 0.0 110.247 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 44' ' ' GLY . 1.7 t0 -148.28 122.12 9.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.329 -0.857 . . . . 0.0 109.596 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 44.12 61.65 2.27 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 0.0 109.565 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.739 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -131.78 -174.88 3.54 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.276 -0.89 . . . . 0.0 111.222 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -145.17 104.46 3.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.706 179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 11' ' ' LEU . 2.9 m -117.46 136.24 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.805 -1.184 . . . . 0.0 110.112 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.606 ' HB2' ' N ' ' A' ' 49' ' ' THR . 4.0 m-85 -97.87 -137.65 0.28 Allowed 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 49' ' ' THR . . . -65.45 59.46 0.11 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.561 ' N ' ' O ' ' A' ' 33' ' ' TYR . 2.3 m -95.1 162.07 13.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -1.169 . . . . 0.0 110.043 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.443 HG21 HG23 ' A' ' 51' ' ' THR . 13.5 p -100.61 -169.38 1.71 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.922 . . . . 0.0 110.401 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.886 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -168.51 140.25 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.767 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 37' ' ' CYS . 1.8 t 178.55 43.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.138 -0.976 . . . . 0.0 110.543 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.27 41.0 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.789 ' OG ' HG22 ' A' ' 53' ' ' THR . 0.9 OUTLIER -131.12 171.87 12.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -1.168 . . . . 0.0 109.955 179.894 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 2.2 tpt85 -146.46 129.71 16.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 0.0 109.948 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.976 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.8 m-85 -109.13 170.48 8.03 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.905 -1.122 . . . . 0.0 110.715 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -174.85 80.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.076 -1.015 . . . . 0.0 110.176 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 28' ' ' ASP . . . 83.71 66.72 1.49 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.059 HG21 HG22 ' A' ' 57' ' ' ILE . 2.3 t -146.97 136.71 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -1.214 . . . . 0.0 110.808 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.5 m -107.77 93.2 4.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.763 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -113.93 171.99 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 110.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 49' ' ' THR . 1.6 t -118.69 -162.14 0.88 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 0.0 110.426 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.651 ' O ' HG23 ' A' ' 66' ' ' THR . 20.2 m -54.71 87.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.514 ' O ' HG23 ' A' ' 35' ' ' THR . 66.4 m -128.49 146.72 50.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.175 -0.953 . . . . 0.0 110.763 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.604 HG22 ' O ' ' A' ' 51' ' ' THR . 86.4 m -100.03 48.3 0.93 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.536 -0.728 . . . . 0.0 109.317 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 3.1 t -111.35 100.32 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.57 -0.706 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.886 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.0 OUTLIER -144.39 99.76 3.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 110.242 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.511 ' N ' ' HB ' ' A' ' 70' ' ' THR . . . -161.63 -48.15 0.02 OUTLIER Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.561 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -101.57 -168.16 1.51 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.459 -1.024 . . . . 0.0 109.782 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 1.9 mtp85 -91.11 141.09 29.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.966 . . . . 0.0 109.742 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.059 HG22 HG21 ' A' ' 45' ' ' VAL . 3.2 mm -113.1 127.27 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.037 -1.039 . . . . 0.0 110.155 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.418 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.3 152.96 40.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.245 -0.909 . . . . 0.0 110.012 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 118.0 0.42 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.028 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.7 -2.48 11.47 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.569 1.299 . . . . 0.0 109.704 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.85 30.76 0.18 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 7.2 t -73.02 152.89 41.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -1.068 . . . . 0.0 111.157 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.31 108.84 4.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.642 -0.661 . . . . 0.0 109.778 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.727 HG13 HD12 ' A' ' 82' ' ' ILE . 2.0 tt -99.02 176.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.062 -1.024 . . . . 0.0 110.123 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -151.77 75.21 1.14 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.906 -1.122 . . . . 0.0 110.953 -179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER 59.88 73.48 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.334 -0.854 . . . . 0.0 110.837 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' A' ' 64' ' ' ILE . 88.1 m -100.33 -178.26 3.76 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.179 -0.951 . . . . 0.0 110.235 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.735 HG22 ' OG ' ' A' ' 77' ' ' SER . 1.1 tt -89.76 -178.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.906 . . . . 0.0 110.658 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.489 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 5.1 pt -51.05 -174.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.431 -0.793 . . . . 0.0 110.435 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.511 ' HB ' ' N ' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -142.37 -148.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 110.701 -179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' H ' HG22 ' A' ' 70' ' ' THR . . . 113.24 34.92 1.7 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . 79.04 34.43 33.55 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.466 -1.854 . . . . 0.0 108.466 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.579 ' HB ' ' CG ' ' A' ' 76' ' ' PRO . 20.1 m -118.39 96.65 50.08 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.482 -1.011 . . . . 0.0 110.697 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.454 ' O ' ' C ' ' A' ' 75' ' ' ALA . 50.6 Cg_endo -79.5 -52.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.962 1.506 . . . . 0.0 111.052 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.871 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -38.12 -53.17 2.94 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.461 -0.774 . . . . 0.0 110.774 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.871 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 47.6 Cg_endo -74.89 162.05 38.0 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.79 1.416 . . . . 0.0 110.225 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.735 ' OG ' HG22 ' A' ' 68' ' ' ILE . 0.1 OUTLIER 74.82 -6.43 1.94 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.585 -0.697 . . . . 0.0 110.458 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.85 -7.62 36.18 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.863 -1.148 . . . . 0.0 108.988 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.74 -33.92 40.38 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.603 -0.686 . . . . 0.0 109.965 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' ' O ' ' A' ' 77' ' ' SER . 16.9 p -73.81 -161.63 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.426 -0.796 . . . . 0.0 109.602 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.454 ' CE ' ' O ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -116.4 130.41 56.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.165 -0.959 . . . . 0.0 110.25 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.727 HD12 HG13 ' A' ' 64' ' ' ILE . 0.9 OUTLIER -143.29 146.38 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.537 -0.727 . . . . 0.0 109.604 -179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.443 ' O ' ' SG ' ' A' ' 85' ' ' CYS . 1.7 t -157.11 136.99 12.46 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.85 -1.156 . . . . 0.0 111.283 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 52.37 61.98 6.17 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 87' ' ' PHE . 55.9 m -135.46 168.53 19.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.018 -1.283 . . . . 0.0 111.07 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.64 123.91 15.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.627 -0.671 . . . . 0.0 109.201 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.726 ' CD1' HD13 ' A' ' 57' ' ' ILE . 10.8 m-85 -126.98 160.51 30.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.857 -1.152 . . . . 0.0 111.478 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 89' ' ' ALA . 7.0 p -166.58 129.03 1.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.495 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -34.48 142.41 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.482 -0.761 . . . . 0.0 110.892 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.561 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.4 t-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.099 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.5 p30 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.119 0.485 . . . . 0.0 110.103 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -154.04 138.17 6.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.8 t 45.89 -92.83 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.281 -1.129 . . . . 0.0 110.149 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 8.1 t -128.6 -60.18 1.12 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.013 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.753 ' O ' HG22 ' A' ' 5' ' ' THR . 20.7 m -126.32 60.64 1.31 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.146 -0.971 . . . . 0.0 110.126 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -133.98 65.76 1.57 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.394 -0.816 . . . . 0.0 110.003 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.634 HG21 HD22 ' A' ' 22' ' ' LEU . 9.8 t -102.53 -139.23 0.35 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.31 -0.869 . . . . 0.0 110.419 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.51 ' N ' HG23 ' A' ' 7' ' ' THR . 0.2 OUTLIER -41.73 -23.47 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.223 -0.923 . . . . 0.0 110.967 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -107.78 162.97 13.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.0 110.557 -179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.406 ' OE1' ' CE2' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -107.51 106.87 17.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.354 -0.841 . . . . 0.0 109.828 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 12' ' ' SER . 4.0 tp -88.57 32.83 0.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 110.257 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.6 t 67.3 2.8 2.98 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.53 -0.731 . . . . 0.0 110.862 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 45.4 22.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.956 -1.09 . . . . 0.0 110.497 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 12' ' ' SER . 41.4 t30 -160.8 15.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.109 -0.994 . . . . 0.0 110.815 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.1 m -96.82 -136.23 0.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.091 -1.005 . . . . 0.0 109.168 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -115.0 123.76 49.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.871 -1.143 . . . . 0.0 109.87 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 t -56.03 98.27 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.372 -0.83 . . . . 0.0 110.529 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.856 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.26 -154.73 0.15 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.275 -0.89 . . . . 0.0 109.646 179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' ' CB ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -148.21 150.76 34.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.027 -1.046 . . . . 0.0 110.845 -179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 19' ' ' LYS . 3.0 t 68.94 95.4 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.389 -0.82 . . . . 0.0 110.827 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' N ' ' A' ' 22' ' ' LEU . 26.0 m -151.0 -93.7 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.309 -0.869 . . . . 0.0 109.617 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.634 HD22 HG21 ' A' ' 7' ' ' THR . 0.7 OUTLIER 53.17 37.43 25.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 110.243 179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.801 HG21 ' HA ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -144.23 -151.53 0.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.102 -0.999 . . . . 0.0 110.698 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -93.34 110.26 21.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.401 -0.812 . . . . 0.0 110.809 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 9' ' ' SER . 3.3 m -155.25 111.6 3.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.0 110.048 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.572 ' CD1' ' NH2' ' A' ' 41' ' ' ARG . 3.7 t80 -111.09 101.72 10.23 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.544 -0.723 . . . . 0.0 109.078 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.061 HG13 ' HB3' ' A' ' 42' ' ' PHE . 11.4 t -104.27 164.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.054 -1.029 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.537 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.5 OUTLIER -145.63 122.73 11.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.412 -0.805 . . . . 0.0 109.713 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.8 OUTLIER 44.12 64.96 1.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.078 -1.013 . . . . 0.0 109.525 -179.624 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.743 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -134.26 -169.8 2.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 111.613 -178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 21.1 tt0 -145.06 98.39 3.16 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.856 HG12 ' CB ' ' A' ' 18' ' ' GLU . 62.1 t -105.62 138.84 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.847 -1.158 . . . . 0.0 110.43 -179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' THR . 1.8 t80 -142.75 129.21 20.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.289 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 45.93 40.71 9.87 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.553 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 14.0 m -103.94 165.73 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.269 -1.136 . . . . 0.0 110.247 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.88 HG21 HG22 ' A' ' 51' ' ' THR . 6.8 p -105.05 -170.2 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -0.826 . . . . 0.0 110.015 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.945 ' HA ' HG21 ' A' ' 53' ' ' THR . 36.3 t -172.53 128.31 0.53 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 110.576 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.801 ' HA ' HG21 ' A' ' 23' ' ' THR . 19.4 m -163.02 33.24 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 109.689 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 123.92 62.62 0.19 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.531 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 28.7 p -143.0 170.81 15.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.572 ' NH2' ' CD1' ' A' ' 26' ' ' TYR . 0.1 OUTLIER -139.48 127.47 22.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 0.0 110.067 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.061 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.7 m-85 -109.06 169.69 8.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.683 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 45' ' ' VAL . 5.7 t70 178.99 112.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.389 -0.819 . . . . 0.0 109.08 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 52.87 62.72 5.64 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.819 HG12 HG23 ' A' ' 47' ' ' ILE . 14.5 t -142.83 123.14 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.477 -1.014 . . . . 0.0 110.772 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 41.8 m -101.47 98.6 8.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.096 -1.003 . . . . 0.0 109.354 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.819 HG23 HG12 ' A' ' 45' ' ' VAL . 1.3 pt -113.38 156.58 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 110.191 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' C ' ' A' ' 49' ' ' THR . 0.6 OUTLIER -135.78 127.73 29.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.344 -0.847 . . . . 0.0 109.805 -179.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER 40.85 79.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.298 -0.876 . . . . 0.0 110.013 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 29.2 t -138.98 148.91 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.071 -1.018 . . . . 0.0 110.773 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.88 HG22 HG21 ' A' ' 36' ' ' THR . 4.1 p -115.97 41.23 2.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.436 -0.79 . . . . 0.0 109.527 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 67' ' ' CYS . 1.2 t -104.89 116.65 32.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.374 -0.829 . . . . 0.0 110.177 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.945 HG21 ' HA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -146.28 112.25 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.334 -0.854 . . . . 0.0 110.225 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 165.32 -31.31 0.23 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.7 p -113.09 163.07 15.18 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.044 -1.268 . . . . 0.0 110.707 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -91.78 120.22 32.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.349 -0.845 . . . . 0.0 109.591 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.742 HG22 HG22 ' A' ' 45' ' ' VAL . 1.3 mt -99.71 156.73 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.208 -0.997 . . . . 0.0 111.078 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -147.11 142.49 27.43 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.695 -0.628 . . . . 0.0 109.897 179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 163.59 114.14 0.3 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.383 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.59 -7.48 21.3 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 N-CA-C 108.427 -1.413 . . . . 0.0 108.427 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -146.93 26.91 1.61 Allowed Glycine 0 N--CA 1.485 1.91 0 N-CA-C 108.252 -1.939 . . . . 0.0 108.252 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 46' ' ' THR . 1.4 t -72.03 147.27 47.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.406 -1.055 . . . . 0.0 110.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 115.24 9.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.335 -0.853 . . . . 0.0 109.739 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.539 HG13 HD12 ' A' ' 82' ' ' ILE . 7.5 tt -104.94 174.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.319 -0.863 . . . . 0.0 110.19 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.734 ' C ' HG23 ' A' ' 66' ' ' THR . 0.1 OUTLIER -152.48 99.03 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.565 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.734 HG23 ' C ' ' A' ' 65' ' ' SER . 1.2 p 69.24 -68.17 0.2 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.664 -0.647 . . . . 0.0 110.719 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.581 ' C ' HG22 ' A' ' 68' ' ' ILE . 0.5 OUTLIER 65.63 -153.84 0.26 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.994 -1.066 . . . . 0.0 110.526 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.581 HG22 ' C ' ' A' ' 67' ' ' CYS . 1.3 tt 172.54 95.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.268 -0.895 . . . . 0.0 110.214 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 68' ' ' ILE . 5.1 mt 59.88 134.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.308 -0.87 . . . . 0.0 110.062 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.495 ' HA ' ' CG1' ' A' ' 73' ' ' VAL . 0.2 OUTLIER -113.28 -71.81 0.73 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.979 -1.076 . . . . 0.0 111.105 -179.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.419 ' H ' ' HA3' ' A' ' 54' ' ' GLY . . . 45.23 71.6 0.47 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 89' ' ' ALA . . . 46.63 83.56 0.02 OUTLIER Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.495 ' CG1' ' HA ' ' A' ' 70' ' ' THR . 24.0 m -84.99 163.07 47.5 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.103 -1.234 . . . . 0.0 110.39 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -79.51 150.09 21.73 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 124.157 1.609 . . . . 0.0 110.65 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.006 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -46.79 -60.01 4.41 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.181 -0.95 . . . . 0.0 109.755 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.006 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 49.9 Cg_endo -73.13 83.98 1.38 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.028 1.541 . . . . 0.0 110.027 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ALA . 8.0 p -43.81 -50.7 7.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.461 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . . . 44.74 25.95 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.056 -1.027 . . . . 0.0 108.839 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -160.43 -69.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.533 -0.73 . . . . 0.0 109.826 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 2.4 t -73.05 165.29 25.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.468 -0.77 . . . . 0.0 109.574 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 23.3 mmtt -99.2 94.51 6.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.557 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.2 tp -128.92 151.65 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.85 . . . . 0.0 110.399 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.61 104.99 3.25 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.91 50.11 5.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.557 ' SG ' HD11 ' A' ' 82' ' ' ILE . 56.8 m -134.5 153.81 51.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.173 -1.193 . . . . 0.0 110.464 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.578 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -109.4 163.48 13.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 86' ' ' THR . 3.2 m-85 -138.88 159.68 41.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.15 -0.969 . . . . 0.0 110.06 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -176.48 38.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.232 -0.918 . . . . 0.0 110.21 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 55' ' ' SER . . . 41.82 -169.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.601 -0.687 . . . . 0.0 110.296 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 54' ' ' GLY . 1.5 t-20 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.961 -179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 34.8 p-10 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.243 0.544 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 3' ' ' SER . . . -166.85 111.47 0.45 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.546 ' HB2' ' CB ' ' A' ' 6' ' ' ASN . 69.3 m 43.25 65.55 0.95 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.311 -1.111 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 61.85 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.463 -0.773 . . . . 0.0 110.306 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.872 ' CG2' HD22 ' A' ' 11' ' ' LEU . 13.2 t -144.63 35.6 1.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.023 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 1.1 t-20 -99.67 57.95 1.03 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 0.0 110.533 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 1.8 t -98.34 95.61 7.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.254 -0.904 . . . . 0.0 109.542 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 7' ' ' THR . 6.4 t-20 70.4 7.03 6.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.233 -0.917 . . . . 0.0 109.666 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.522 ' CB ' ' CG2' ' A' ' 21' ' ' THR . 4.8 m -126.7 179.92 5.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.331 -0.855 . . . . 0.0 110.009 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 26' ' ' TYR . 8.7 tt0 -134.47 95.6 3.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.181 -0.949 . . . . 0.0 110.043 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.872 HD22 ' CG2' ' A' ' 5' ' ' THR . 12.5 tp -88.53 31.11 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.318 -0.864 . . . . 0.0 109.975 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 68.52 3.54 3.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.147 -0.97 . . . . 0.0 110.551 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.09 25.5 0.11 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.608 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' SER . 28.6 t30 -162.29 19.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 110.621 -179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' SER . 2.0 m -104.61 -144.87 0.37 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.012 -1.055 . . . . 0.0 109.665 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 14.6 mmtm -114.14 91.55 3.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.836 -1.165 . . . . 0.0 110.155 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.1 p -65.62 67.79 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -0.784 . . . . 0.0 110.642 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 14.0 mm-40 -88.4 54.55 3.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.167 -0.958 . . . . 0.0 110.157 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 45.77 81.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.24 -0.913 . . . . 0.0 109.905 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 1.6 m -151.59 -62.57 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 110.448 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.522 ' CG2' ' CB ' ' A' ' 9' ' ' SER . 80.5 m -46.74 166.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.858 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.493 ' N ' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -145.6 -74.95 0.22 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.639 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.427 ' HA ' ' OG ' ' A' ' 9' ' ' SER . 5.0 t -154.2 13.5 0.44 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.157 -0.964 . . . . 0.0 110.933 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.36 65.17 0.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.826 -1.171 . . . . 0.0 110.481 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 m -153.56 112.32 3.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.087 -1.008 . . . . 0.0 110.764 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.525 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 27.2 m-85 -101.8 96.46 7.08 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.107 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -100.6 163.67 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 111.115 -178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.591 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 3.8 t0 -141.44 119.01 11.6 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.532 -0.73 . . . . 0.0 109.379 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 28' ' ' ASP . 4.5 ttmm 39.98 70.45 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.21 -0.932 . . . . 0.0 109.926 -179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.768 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.0 m -131.76 -178.79 5.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.261 -0.9 . . . . 0.0 110.886 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.582 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.3 OUTLIER -144.97 97.53 3.03 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.457 -0.777 . . . . 0.0 109.172 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 47' ' ' ILE . 1.9 m -104.2 153.15 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.966 -1.084 . . . . 0.0 110.576 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.556 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 10.2 t80 -139.48 138.33 36.31 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.469 -0.77 . . . . 0.0 109.169 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 38.26 40.04 0.83 Allowed Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 20' ' ' SER . 2.4 m -94.66 167.61 11.36 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.149 -1.206 . . . . 0.0 110.244 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.823 HG21 HG23 ' A' ' 51' ' ' THR . 10.9 p -105.39 -52.31 2.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.857 . . . . 0.0 110.157 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.577 ' HA ' HG22 ' A' ' 53' ' ' THR . 0.1 OUTLIER 59.74 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.0 110.075 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.722 HG22 HG21 ' A' ' 53' ' ' THR . 8.0 t -173.51 64.14 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.0 110.475 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' CA ' ' A' ' 54' ' ' GLY . . . 117.42 32.76 1.42 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.614 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.1 OUTLIER -133.77 -178.18 4.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -1.144 . . . . 0.0 110.039 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HD2' ' O ' ' A' ' 26' ' ' TYR . 3.2 tpt180 -142.71 125.71 16.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.347 -0.846 . . . . 0.0 108.764 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.107 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.6 m-85 -103.96 162.09 13.43 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 110.637 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 28' ' ' ASP . 3.5 t0 -170.09 103.07 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.539 -0.726 . . . . 0.0 109.144 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 61.39 67.69 2.0 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.393 -1.883 . . . . 0.0 108.393 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.742 ' CG1' HG23 ' A' ' 47' ' ' ILE . 4.6 t -145.58 127.79 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.236 . . . . 0.0 110.835 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 31' ' ' GLU . 61.7 m -108.43 87.78 2.57 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.198 -0.939 . . . . 0.0 108.815 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.742 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.76 154.75 11.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.653 -0.654 . . . . 0.0 110.427 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.78 HG23 ' N ' ' A' ' 49' ' ' THR . 1.5 t -108.65 -150.26 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.78 ' N ' HG23 ' A' ' 48' ' ' THR . 87.9 m -45.1 88.23 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.474 -0.766 . . . . 0.0 110.134 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' THR . 0.4 OUTLIER -139.71 135.95 33.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.935 -1.103 . . . . 0.0 111.307 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.823 HG23 HG21 ' A' ' 36' ' ' THR . 97.5 m -108.35 61.24 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 29.3 m -114.91 113.68 24.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 110.766 -179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.722 HG21 HG22 ' A' ' 38' ' ' THR . 34.7 p -131.91 -151.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.371 -0.83 . . . . 0.0 109.642 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 90' ' ' ASN . . . 76.55 -65.87 2.75 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 70' ' ' THR . 0.4 OUTLIER -101.89 171.53 7.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.286 -1.126 . . . . 0.0 109.448 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.501 ' HB2' ' HG3' ' A' ' 41' ' ' ARG . 0.6 OUTLIER -104.96 158.7 16.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 110.775 -179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.706 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -123.33 155.07 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.689 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.531 ' CB ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.73 157.67 43.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.39 -0.819 . . . . 0.0 110.259 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 160.29 127.32 0.89 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.146 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.55 -5.5 17.17 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.673 1.354 . . . . 0.0 108.871 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -161.98 35.13 0.36 Allowed Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.514 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 10.1 t -71.76 147.45 47.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.397 -1.061 . . . . 0.0 110.757 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.71 120.02 10.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.282 -0.886 . . . . 0.0 110.01 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.519 HG21 ' HB ' ' A' ' 47' ' ' ILE . 3.8 tt -104.25 178.51 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.289 -0.882 . . . . 0.0 109.938 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 66' ' ' THR . 3.2 t -150.8 58.35 0.92 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.889 -1.132 . . . . 0.0 111.14 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 65' ' ' SER . 1.6 m 66.83 83.85 0.16 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.148 -0.97 . . . . 0.0 111.349 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.48 -149.41 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.156 -0.965 . . . . 0.0 109.371 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 68' ' ' ILE . 7.6 mm -120.85 158.21 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.91 -1.119 . . . . 0.0 110.524 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 52' ' ' SER . 3.7 tt -52.35 144.77 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.383 -0.823 . . . . 0.0 110.229 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 70' ' ' THR . 3.4 t -148.66 107.68 3.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.227 -0.921 . . . . 0.0 111.079 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.545 ' N ' HG22 ' A' ' 73' ' ' VAL . . . -92.69 62.08 2.33 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 178.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.905 ' HA3' ' HB2' ' A' ' 89' ' ' ALA . . . 81.47 34.97 24.24 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 107.381 -2.287 . . . . 0.0 107.381 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 71' ' ' GLY . 4.1 m -132.99 163.14 53.23 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.941 -0.741 . . . . 0.0 110.587 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.527 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 52.3 Cg_endo -80.18 -42.69 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.73 1.384 . . . . 0.0 109.519 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 74' ' ' PRO . . . 61.04 153.48 0.1 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.521 -0.737 . . . . 0.0 110.254 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.52 59.1 3.95 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.178 1.62 . . . . 0.0 110.955 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.97 11.45 13.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.162 -0.961 . . . . 0.0 110.013 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.18 -23.87 0.98 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.361 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.91 -3.57 48.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 110.105 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.8 t -76.6 -178.44 4.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.027 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 105.15 8.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.241 -0.912 . . . . 0.0 110.331 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.581 HD11 ' SG ' ' A' ' 85' ' ' CYS . 10.5 tp -127.95 142.65 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.094 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.9 t -142.87 125.28 15.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.284 -0.885 . . . . 0.0 110.366 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 63.65 62.64 5.11 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 82' ' ' ILE . 59.2 m -145.39 148.45 33.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -1.183 . . . . 0.0 111.079 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.531 ' CG2' ' CB ' ' A' ' 58' ' ' SER . 13.5 t -116.74 157.66 25.13 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.34 152.14 50.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.769 -1.207 . . . . 0.0 110.602 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 56' ' ' ARG . 1.6 m -170.54 124.77 0.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.352 -0.842 . . . . 0.0 110.153 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.905 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . . . -45.1 147.65 0.68 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 0.0 110.559 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.505 ' OD1' ' HB3' ' A' ' 41' ' ' ARG . 1.1 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.051 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 1' ' ' ASP . 63.6 t0 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.207 0.527 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 3' ' ' SER . . . -161.62 -158.81 9.67 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 2' ' ' GLY . 28.0 t -41.87 -53.27 3.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.373 -1.075 . . . . 0.0 110.458 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.61 -79.53 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 0.0 110.288 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.798 ' CG2' HD22 ' A' ' 11' ' ' LEU . 5.1 t -122.31 56.59 1.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.234 -0.916 . . . . 0.0 110.046 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.13 93.28 5.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 110.331 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.755 HG21 ' O ' ' A' ' 21' ' ' THR . 10.1 t -134.66 -138.86 0.17 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.465 -0.772 . . . . 0.0 109.63 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' N ' HG23 ' A' ' 7' ' ' THR . 11.6 m-20 -39.47 -27.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.811 . . . . 0.0 110.606 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.489 ' CB ' ' HB2' ' A' ' 25' ' ' CYS . 4.7 m -108.49 -164.35 0.95 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.149 -0.97 . . . . 0.0 110.599 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -140.75 127.56 20.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.551 -0.718 . . . . 0.0 109.774 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.798 HD22 ' CG2' ' A' ' 5' ' ' THR . 21.4 tp -88.27 24.02 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.203 -0.936 . . . . 0.0 110.167 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 8.7 t 61.03 11.25 3.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.196 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.49 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' SER . 10.7 t30 -161.04 15.09 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 111.03 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 30' ' ' SER . 1.2 m -98.79 -139.0 0.31 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.865 -1.147 . . . . 0.0 109.392 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 3.7 tptt -114.78 141.15 48.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.038 -1.039 . . . . 0.0 109.507 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.3 93.54 2.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 110.599 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.642 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.19 -145.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.429 -0.794 . . . . 0.0 110.437 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -76.66 -161.53 0.2 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 110.087 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.83 171.4 9.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.901 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.755 ' O ' HG21 ' A' ' 7' ' ' THR . 17.7 m -138.09 142.54 40.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.888 . . . . 0.0 110.15 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.464 HD22 ' HA ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -136.59 28.64 2.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.207 -0.933 . . . . 0.0 110.412 -179.811 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 38' ' ' THR . 0.2 OUTLIER -156.87 -149.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.2 -0.937 . . . . 0.0 110.317 -179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.428 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 1.9 m120 -87.44 122.85 31.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.266 -0.896 . . . . 0.0 109.985 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.846 ' O ' HG23 ' A' ' 27' ' ' VAL . 11.9 m -155.35 31.74 0.38 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.213 -0.93 . . . . 0.0 110.557 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.497 ' CD1' ' HB3' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -45.78 119.7 2.32 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.503 -0.748 . . . . 0.0 110.024 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.904 HG22 ' HB2' ' A' ' 42' ' ' PHE . 30.4 t -119.13 161.25 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.995 -1.065 . . . . 0.0 110.609 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -142.03 118.87 11.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.383 -0.823 . . . . 0.0 109.672 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' ASP . 2.8 mmtp 43.26 68.12 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 109.718 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.511 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.7 m -133.47 -172.09 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 111.115 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.564 ' HB3' HG23 ' A' ' 46' ' ' THR . 11.2 tt0 -143.81 99.21 3.37 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.66 HG13 HD11 ' A' ' 47' ' ' ILE . 40.2 t -101.06 150.06 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.016 -1.052 . . . . 0.0 110.575 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.476 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -143.16 116.19 8.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 43.33 51.44 6.38 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.528 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 2.4 m -107.08 156.5 18.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.092 -1.24 . . . . 0.0 110.1 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 35' ' ' THR . 19.4 p -91.04 -173.14 3.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.721 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.8 OUTLIER -157.87 124.28 4.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 110.362 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.503 ' HA ' HG21 ' A' ' 23' ' ' THR . 0.7 OUTLIER -163.98 55.87 0.16 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.981 179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.439 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 96.79 96.21 1.87 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.564 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 14.1 p -177.98 173.38 1.52 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -1.152 . . . . 0.0 110.28 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.548 ' CB ' ' ND2' ' A' ' 90' ' ' ASN . 6.3 tpt180 -146.97 131.81 18.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 109.649 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.904 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.9 m-85 -109.35 169.86 8.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.054 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.9 t70 178.33 116.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.429 -0.794 . . . . 0.0 109.136 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 47.75 65.37 2.45 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.859 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.0 t -145.33 138.06 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -1.09 . . . . 0.0 110.83 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 31' ' ' GLU . 81.5 m -116.61 94.68 4.71 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.352 -0.842 . . . . 0.0 109.228 178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.707 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.3 pt -114.08 172.39 3.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.413 -0.805 . . . . 0.0 110.379 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.833 HG23 ' N ' ' A' ' 49' ' ' THR . 2.0 t -131.38 -146.52 0.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.08 -1.013 . . . . 0.0 110.378 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.833 ' N ' HG23 ' A' ' 48' ' ' THR . 6.6 m -54.91 84.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 110.594 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 48' ' ' THR . 11.3 p -139.61 158.29 44.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.226 -0.921 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -118.04 45.31 2.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.854 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 t -95.72 103.49 15.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 110.13 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 37' ' ' CYS . 3.0 p -138.6 112.93 8.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 110.416 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 39' ' ' GLY . . . 176.3 -54.89 0.11 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.543 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -102.63 -173.54 2.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.817 -179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 7.8 ttp180 -104.02 125.96 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 110.096 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.859 HG22 ' CG2' ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.49 153.62 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.155 -0.965 . . . . 0.0 110.308 -179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.57 160.64 41.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 110.647 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 154.09 122.56 0.86 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.695 -1.241 . . . . 0.0 110.143 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -71.22 -5.62 17.41 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.692 1.364 . . . . 0.0 109.036 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.53 34.12 0.33 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 108.806 -1.718 . . . . 0.0 108.806 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -72.26 154.9 40.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 0.0 110.206 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.54 113.19 6.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 0.0 110.364 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.508 HG22 ' HA ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -96.68 172.26 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.058 -1.026 . . . . 0.0 109.161 179.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 11.0 t -149.04 67.81 1.04 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.904 -1.123 . . . . 0.0 110.898 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.9 m 64.01 98.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 111.06 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 64' ' ' ILE . 76.8 m -107.92 -144.89 0.39 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.413 -0.804 . . . . 0.0 109.246 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 77' ' ' SER . 97.0 mt -128.26 -64.24 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.77 -1.206 . . . . 0.0 110.581 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 8.1 tp -151.17 158.39 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.074 -1.016 . . . . 0.0 110.227 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 55' ' ' SER . 0.2 OUTLIER -125.8 -154.22 0.61 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.231 -0.918 . . . . 0.0 110.431 179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' C ' ' A' ' 54' ' ' GLY . . . 105.39 38.33 2.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' H ' ' CB ' ' A' ' 55' ' ' SER . . . 76.55 33.36 47.92 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.441 ' HB ' ' CG ' ' A' ' 76' ' ' PRO . 6.3 m -129.0 91.66 41.98 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.481 -1.011 . . . . 0.0 111.052 -178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -81.32 -29.55 1.89 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.909 1.479 . . . . 0.0 109.797 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.869 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -49.49 -55.41 22.57 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.505 -0.747 . . . . 0.0 110.727 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.869 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 44.0 Cg_endo -70.51 156.83 60.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.777 1.409 . . . . 0.0 110.389 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.7 OUTLIER 69.26 4.76 4.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.155 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.84 -21.38 2.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.002 . . . . 0.0 109.136 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.72 -8.95 59.82 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.549 -0.719 . . . . 0.0 109.669 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.4 ' C ' ' HD2' ' A' ' 81' ' ' LYS . 19.0 t -71.61 170.32 13.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.364 -0.835 . . . . 0.0 109.788 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -114.68 111.44 21.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 0.0 110.564 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.455 HD12 ' HA ' ' A' ' 82' ' ' ILE . 6.9 tp -127.41 156.17 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.482 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.1 t -154.39 116.79 4.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.069 -1.02 . . . . 0.0 110.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.15 46.78 33.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.508 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -129.24 159.99 34.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.028 -1.277 . . . . 0.0 111.361 -179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.402 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -116.96 154.82 30.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.175 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 85' ' ' CYS . 9.0 m-85 -133.13 147.91 52.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.927 -1.108 . . . . 0.0 110.401 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 89' ' ' ALA . 29.1 t -173.39 124.25 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 109.932 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.97 141.68 0.83 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 0.0 110.507 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.548 ' ND2' ' CB ' ' A' ' 41' ' ' ARG . 4.4 t30 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.084 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.239 0.542 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.97 -109.47 0.82 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.1 t -59.95 -62.75 1.64 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.2 t -147.02 -61.18 0.29 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.27 -0.894 . . . . 0.0 110.117 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 5' ' ' THR . 10.5 t -141.59 53.49 1.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.885 . . . . 0.0 109.998 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.437 ' CG ' ' HB2' ' A' ' 11' ' ' LEU . 1.8 m120 -146.64 139.54 25.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.942 . . . . 0.0 110.864 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.547 ' O ' ' N ' ' A' ' 9' ' ' SER . 17.1 p -103.47 -135.49 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.675 -0.641 . . . . 0.0 109.493 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.762 ' CB ' HG22 ' A' ' 23' ' ' THR . 9.6 t-20 -42.71 -15.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.251 -0.905 . . . . 0.0 111.668 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 7' ' ' THR . 25.5 p -103.99 160.73 14.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.701 -1.249 . . . . 0.0 108.74 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' HG2' ' N ' ' A' ' 11' ' ' LEU . 38.9 tt0 -107.13 155.13 20.2 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.024 -1.048 . . . . 0.0 111.899 -177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 11' ' ' LEU . 31.9 tp -108.77 41.94 1.5 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.635 -0.666 . . . . 0.0 109.292 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 18.4 t 58.57 12.78 2.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.434 -0.792 . . . . 0.0 110.864 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 41.07 25.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.18 -0.95 . . . . 0.0 110.688 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 12' ' ' SER . 31.4 t30 -170.7 25.15 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.973 -1.079 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.566 ' OG ' ' N ' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -103.67 -147.02 0.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.99 -1.068 . . . . 0.0 109.539 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.99 142.26 45.89 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.827 -1.171 . . . . 0.0 109.871 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.35 100.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.454 -0.779 . . . . 0.0 111.209 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.863 ' CB ' HG12 ' A' ' 32' ' ' VAL . 16.5 pm0 -83.22 -141.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.762 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -151.07 145.2 25.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.053 -1.029 . . . . 0.0 110.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 58.56 105.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -0.815 . . . . 0.0 110.522 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.7 m -137.4 143.86 42.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.376 -0.827 . . . . 0.0 109.951 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD22 ' HA ' ' A' ' 38' ' ' THR . 0.4 OUTLIER -84.13 -140.71 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.972 . . . . 0.0 110.39 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.762 HG22 ' CB ' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -129.62 27.08 5.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.178 -0.951 . . . . 0.0 110.448 -179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -143.99 75.89 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.113 -0.992 . . . . 0.0 110.056 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' SER . 4.8 m -155.14 111.76 3.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.926 . . . . 0.0 110.622 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 0.1 OUTLIER -110.25 96.2 6.07 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.088 HG13 ' CB ' ' A' ' 42' ' ' PHE . 3.9 t -98.6 164.45 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.415 -0.803 . . . . 0.0 111.178 -178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 29' ' ' LYS . 41.5 m-20 -144.78 124.94 13.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.503 -0.748 . . . . 0.0 109.502 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 11.1 tttp 42.82 67.47 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.217 -0.927 . . . . 0.0 109.82 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.786 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.5 m -133.34 -174.07 3.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 111.239 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.583 ' CB ' HG23 ' A' ' 46' ' ' THR . 3.1 tt0 -143.37 103.33 4.1 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.863 HG12 ' CB ' ' A' ' 18' ' ' GLU . 47.7 t -105.47 142.86 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.012 -1.055 . . . . 0.0 110.071 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.506 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t80 -140.09 102.93 4.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.37 -0.831 . . . . 0.0 109.952 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 51.89 53.36 30.36 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.538 HG21 ' CD1' ' A' ' 47' ' ' ILE . 55.2 m -114.23 154.79 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -1.168 . . . . 0.0 110.238 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.414 HG21 HG23 ' A' ' 51' ' ' THR . 22.8 p -86.22 140.28 30.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 110.338 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.18 43.42 2.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.332 -0.855 . . . . 0.0 110.303 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.632 ' HA ' HD22 ' A' ' 22' ' ' LEU . 17.9 p -77.85 3.81 13.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 166.26 97.12 0.11 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.518 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 38.2 p -177.6 167.65 2.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.167 -1.196 . . . . 0.0 110.541 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -138.52 123.0 18.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 179.06 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.088 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.46 170.5 7.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.22 -0.925 . . . . 0.0 110.825 -178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 11.7 t70 178.7 98.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 65.65 58.33 9.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 107.633 -2.187 . . . . 0.0 107.633 -178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.784 HG22 HG22 ' A' ' 57' ' ' ILE . 17.1 t -139.98 126.79 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.523 -0.986 . . . . 0.0 110.736 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.583 HG23 ' CB ' ' A' ' 31' ' ' GLU . 54.1 m -109.47 94.96 5.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.509 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.538 ' CD1' HG21 ' A' ' 35' ' ' THR . 1.4 pt -113.28 175.18 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.756 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -132.51 -153.03 0.52 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.986 -1.071 . . . . 0.0 110.673 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.756 ' N ' HG23 ' A' ' 48' ' ' THR . 28.3 m -53.68 85.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.345 -0.847 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' THR . 18.7 m -139.87 144.7 37.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -0.977 . . . . 0.0 110.595 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 51' ' ' THR . 97.7 m -90.04 39.94 0.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.386 -0.821 . . . . 0.0 109.382 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' ILE . 0.8 OUTLIER -91.23 127.69 36.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.763 . . . . 0.0 110.632 -179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.518 ' CA ' ' HB3' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.91 130.55 0.11 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.127 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 148.82 -42.09 0.84 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.642 -1.783 . . . . 0.0 108.642 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.559 ' HB2' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -101.87 -168.59 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -1.14 . . . . 0.0 110.236 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.521 ' N ' ' OG ' ' A' ' 55' ' ' SER . 20.0 ttt180 -114.44 120.24 39.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.17 -0.956 . . . . 0.0 110.37 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.784 HG22 HG22 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -100.75 154.05 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.152 -0.968 . . . . 0.0 110.341 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.442 ' O ' ' OG1' ' A' ' 86' ' ' THR . 0.1 OUTLIER -146.52 160.41 42.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.387 -0.821 . . . . 0.0 110.347 179.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 156.26 127.34 1.01 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.337 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.07 -7.58 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.803 1.422 . . . . 0.0 108.503 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -160.06 38.33 0.46 Allowed Glycine 0 N--CA 1.484 1.867 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.503 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 3.6 t -71.64 127.55 32.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.407 -1.054 . . . . 0.0 110.805 -179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.87 111.15 15.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.472 -0.767 . . . . 0.0 109.268 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.467 ' HB ' HG22 ' A' ' 47' ' ' ILE . 4.6 tt -104.72 162.33 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.147 -0.971 . . . . 0.0 110.59 -179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 80' ' ' CYS . 17.6 t -144.79 88.21 1.89 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 109.734 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 65' ' ' SER . 3.4 p 54.15 74.58 0.32 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.263 -0.898 . . . . 0.0 110.049 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 0.5 OUTLIER -148.03 149.36 31.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.051 -1.03 . . . . 0.0 110.617 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.61 ' C ' HG23 ' A' ' 69' ' ' ILE . 18.5 mm 59.59 158.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.878 . . . . 0.0 110.643 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.61 HG23 ' C ' ' A' ' 68' ' ' ILE . 1.3 pt -160.42 16.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.848 -0.533 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.85 ' HB ' HG21 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -155.09 -149.54 0.27 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.006 -1.059 . . . . 0.0 110.67 -179.332 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' O ' HG22 ' A' ' 73' ' ' VAL . . . -65.99 -150.77 0.11 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.559 ' N ' ' HB2' ' A' ' 55' ' ' SER . . . -67.59 61.53 0.3 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.85 HG21 ' HB ' ' A' ' 70' ' ' THR . 8.0 m -121.36 115.36 31.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.443 -1.034 . . . . 0.0 110.826 -179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' A' ' 75' ' ' ALA . 44.1 Cg_endo -71.93 72.29 2.65 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.827 1.435 . . . . 0.0 109.552 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.872 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . -45.84 175.62 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.434 -0.791 . . . . 0.0 110.623 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.872 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 43.6 Cg_endo -69.83 63.39 1.83 Allowed 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.034 1.544 . . . . 0.0 110.337 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.458 ' HB2' ' SG ' ' A' ' 67' ' ' CYS . 17.0 m -132.08 31.09 4.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.305 -0.872 . . . . 0.0 110.353 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.76 -15.35 11.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.952 . . . . 0.0 109.228 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -89.19 -10.9 45.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.523 -0.736 . . . . 0.0 110.314 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 65' ' ' SER . 15.7 p -63.83 -158.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.182 -0.949 . . . . 0.0 110.132 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -139.18 121.69 16.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.001 -1.062 . . . . 0.0 110.681 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.555 ' CG1' ' HB2' ' A' ' 85' ' ' CYS . 0.0 OUTLIER -133.41 135.3 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.384 -0.823 . . . . 0.0 110.008 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -141.75 105.44 4.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.882 . . . . 0.0 110.204 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 75.35 51.46 7.4 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.555 ' HB2' ' CG1' ' A' ' 82' ' ' ILE . 99.2 m -126.2 141.43 51.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -103.25 152.6 21.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.377 -0.827 . . . . 0.0 109.042 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.428 ' O ' ' OG ' ' A' ' 88' ' ' SER . 3.7 m-85 -134.89 141.13 46.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.002 -1.061 . . . . 0.0 110.212 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 87' ' ' PHE . 1.5 m 178.29 135.08 0.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 110.109 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -41.05 148.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 0.0 110.382 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.476 ' N ' ' HA ' ' A' ' 55' ' ' SER . 27.9 p-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.318 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.43 -175.58 47.23 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 1.9 m -43.79 113.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.144 . . . . 0.0 110.077 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 3' ' ' SER . 17.2 t 63.15 -120.11 0.56 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 0.0 110.278 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 5' ' ' THR . 6.5 t -142.04 41.55 1.66 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.782 -1.199 . . . . 0.0 109.942 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 6' ' ' ASN . 9.3 p30 -136.92 111.66 8.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.283 -0.886 . . . . 0.0 110.67 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 45.8 p -98.39 43.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.03 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER 165.27 -22.76 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.711 -0.618 . . . . 0.0 109.579 -179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.54 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.2 OUTLIER -108.21 -163.54 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.462 -0.774 . . . . 0.0 110.047 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -143.34 104.34 4.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 110.328 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.748 HD21 ' O ' ' A' ' 16' ' ' LYS . 8.8 tp -88.47 21.36 2.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.27 -0.894 . . . . 0.0 109.743 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 29' ' ' LYS . 12.5 t 56.69 107.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.362 -0.836 . . . . 0.0 109.837 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -47.43 -22.95 0.51 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 0.0 110.28 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -82.81 6.61 17.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 110.377 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -106.16 -163.6 0.94 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 110.836 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.748 ' O ' HD21 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -107.29 123.06 47.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.052 -1.03 . . . . 0.0 111.022 -178.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' HB3' ' HB ' ' A' ' 5' ' ' THR . 5.9 m -90.51 57.64 3.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.482 -0.761 . . . . 0.0 110.12 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 1.4 tm-20 -87.94 46.0 1.34 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.672 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' C ' ' OG ' ' A' ' 20' ' ' SER . 2.6 mptt 58.36 109.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.141 -0.975 . . . . 0.0 110.255 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.489 ' HB3' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -173.83 -66.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.118 -0.989 . . . . 0.0 110.534 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.54 HG21 ' HB2' ' A' ' 9' ' ' SER . 69.5 m -42.28 138.67 1.64 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.324 -0.86 . . . . 0.0 110.74 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.436 ' C ' ' OG1' ' A' ' 23' ' ' THR . 0.1 OUTLIER -111.09 -51.02 2.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.807 179.557 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' C ' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -164.12 -61.38 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -0.853 . . . . 0.0 110.231 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -90.84 91.03 8.18 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.338 -0.851 . . . . 0.0 110.011 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 1.6 m -156.6 120.27 4.29 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 110.565 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 0.8 OUTLIER -119.66 88.13 2.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.348 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.01 HG13 ' HB3' ' A' ' 42' ' ' PHE . 4.3 t -94.08 170.41 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 111.023 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 1.4 m-20 -150.14 114.7 5.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.549 -0.719 . . . . 0.0 109.889 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 12' ' ' SER . 6.3 tttm 45.19 67.86 0.65 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.0 110.473 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 15' ' ' SER . 14.9 m -130.67 -164.39 1.42 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.09 -1.006 . . . . 0.0 110.301 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 20.4 tt0 -144.93 100.1 3.44 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.258 -0.902 . . . . 0.0 108.696 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.636 HG21 HD11 ' A' ' 11' ' ' LEU . 73.5 t -105.18 133.63 48.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.496 -0.753 . . . . 0.0 110.595 -178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.579 ' HB3' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -133.55 125.51 29.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 41.5 39.96 2.63 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.559 HG22 ' N ' ' A' ' 36' ' ' THR . 96.7 m -94.69 171.19 8.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.139 -1.212 . . . . 0.0 110.04 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.559 ' N ' HG22 ' A' ' 35' ' ' THR . 29.8 p -99.06 -51.66 3.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 0.0 110.569 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.556 ' HA ' ' CG2' ' A' ' 53' ' ' THR . 1.0 OUTLIER 57.6 42.56 23.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.137 -0.977 . . . . 0.0 110.019 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.556 ' N ' HG21 ' A' ' 53' ' ' THR . 0.2 OUTLIER -97.35 71.87 2.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.325 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.23 65.13 0.74 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.865 ' OG ' HG22 ' A' ' 53' ' ' THR . 99.5 p -162.55 162.89 27.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 110.249 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -123.53 125.46 44.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.882 . . . . 0.0 109.657 179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.01 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.2 m-85 -104.97 168.99 8.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 110.056 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD2' ' NE ' ' A' ' 41' ' ' ARG . 1.1 m-20 -175.4 98.21 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.247 -0.908 . . . . 0.0 110.071 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 64.3 68.35 1.69 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.063 HG21 HG22 ' A' ' 57' ' ' ILE . 0.9 OUTLIER -145.25 150.14 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -1.193 . . . . 0.0 110.558 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 52.2 m -122.04 90.9 3.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.452 -0.78 . . . . 0.0 109.184 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.761 HG23 HG13 ' A' ' 45' ' ' VAL . 1.1 pt -114.07 167.69 6.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.704 HG23 ' N ' ' A' ' 49' ' ' THR . 3.1 t -125.27 -151.83 0.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.057 -1.027 . . . . 0.0 110.013 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.704 ' N ' HG23 ' A' ' 48' ' ' THR . 3.2 m -57.03 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.153 -0.967 . . . . 0.0 109.896 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 66' ' ' THR . 3.5 p -138.27 142.41 39.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.272 -0.893 . . . . 0.0 110.493 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 36' ' ' THR . 0.1 OUTLIER -92.77 50.78 1.62 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.413 -0.804 . . . . 0.0 109.87 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.855 ' O ' HG23 ' A' ' 53' ' ' THR . 0.2 OUTLIER -105.78 142.69 35.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.17 -179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.865 HG22 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER 175.96 134.33 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.497 -0.752 . . . . 0.0 109.894 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 140.87 -22.6 2.64 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.53 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 88.1 p -121.05 179.39 4.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.335 -1.097 . . . . 0.0 110.067 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.555 ' O ' ' HB3' ' A' ' 87' ' ' PHE . 3.3 mtp85 -91.7 114.57 27.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 108.773 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.063 HG22 HG21 ' A' ' 45' ' ' VAL . 1.3 mm -98.03 130.35 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.909 -1.119 . . . . 0.0 110.859 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.643 ' CA ' HG23 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -145.97 164.08 33.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.946 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 154.38 116.12 0.58 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.689 -1.244 . . . . 0.0 110.217 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.36 -6.38 19.04 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.699 1.368 . . . . 0.0 109.132 178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.44 26.79 0.77 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 11.1 t -72.42 144.44 48.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -1.113 . . . . 0.0 110.628 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 83' ' ' SER . 7.9 mmtt -136.09 106.07 6.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.448 -0.782 . . . . 0.0 109.303 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.621 ' HB ' HG22 ' A' ' 47' ' ' ILE . 0.5 OUTLIER -104.63 155.85 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.605 -179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -146.47 100.17 3.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.534 -0.728 . . . . 0.0 109.707 179.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 4.1 p 54.86 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.469 -0.769 . . . . 0.0 110.097 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.422 ' HB3' ' OG ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.05 -150.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 110.292 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.2 tt -131.22 143.1 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.315 -0.866 . . . . 0.0 109.989 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.772 HD12 ' OG1' ' A' ' 53' ' ' THR . 1.1 tt -81.74 108.06 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 110.616 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.405 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 4.9 m -148.22 160.34 43.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -0.963 . . . . 0.0 110.219 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.79 69.57 3.29 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . 115.02 98.42 2.2 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.799 HG23 ' CE1' ' A' ' 87' ' ' PHE . 31.6 m -86.28 164.38 38.54 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.177 -1.19 . . . . 0.0 110.238 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HG2' ' HA ' ' A' ' 77' ' ' SER . 46.3 Cg_endo -71.49 163.02 40.42 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 124.019 1.536 . . . . 0.0 110.793 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.834 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -78.96 -53.44 1.13 Allowed Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.305 -0.872 . . . . 0.0 110.963 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.834 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 47.8 Cg_endo -73.79 -25.98 13.96 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.755 1.397 . . . . 0.0 110.897 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 78' ' ' ALA . 0.4 OUTLIER 68.27 -60.28 0.42 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.112 -0.993 . . . . 0.0 110.513 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.515 ' N ' ' OG ' ' A' ' 77' ' ' SER . . . 44.01 26.79 0.16 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -160.14 -62.03 0.06 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.527 -0.733 . . . . 0.0 109.482 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.444 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 16.4 t -74.04 166.43 23.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.688 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.8 OUTLIER -104.01 82.79 2.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.119 -0.988 . . . . 0.0 110.327 -179.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.734 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -118.99 158.37 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.391 -0.818 . . . . 0.0 109.724 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.69 ' N ' HD13 ' A' ' 82' ' ' ILE . 21.1 t -155.73 112.34 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.926 -1.109 . . . . 0.0 111.02 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 73.63 60.14 3.82 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.46 163.23 29.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.116 -1.226 . . . . 0.0 110.014 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.12 110.2 5.92 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.385 -0.822 . . . . 0.0 109.663 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.799 ' CE1' HG23 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -141.88 164.87 29.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.135 -0.978 . . . . 0.0 111.032 -179.313 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -169.58 71.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.403 -0.811 . . . . 0.0 110.334 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 88' ' ' SER . . . 58.29 144.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.379 -0.825 . . . . 0.0 110.79 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' HA ' ' A' ' 55' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.809 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.273 0.558 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -175.1 99.96 0.14 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.441 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER 65.4 -63.94 0.19 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -1.166 . . . . 0.0 110.191 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER -148.75 -77.81 0.15 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.162 -0.962 . . . . 0.0 110.127 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 5' ' ' THR . 14.9 t -145.11 64.05 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.659 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 6' ' ' ASN . 27.5 p30 -162.95 102.71 1.0 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 110.494 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 3.3 p -104.48 34.39 3.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 109.226 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' THR . 10.3 t30 174.89 -21.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.313 0.578 . . . . 0.0 110.061 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 22' ' ' LEU . 2.0 p -107.16 -161.69 0.8 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.182 -0.949 . . . . 0.0 110.305 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -140.41 122.47 15.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.588 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.542 HD13 HD11 ' A' ' 22' ' ' LEU . 11.3 tp -98.62 29.39 3.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.525 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.6 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.0 OUTLIER 70.92 -0.81 2.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 110.77 -179.697 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 47.64 22.13 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.059 -1.026 . . . . 0.0 109.665 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -156.11 9.69 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.975 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 30' ' ' SER . 19.9 m -105.18 -144.73 0.37 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.937 -1.102 . . . . 0.0 109.643 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' O ' HD21 ' A' ' 11' ' ' LEU . 15.2 tttm -118.09 137.02 53.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.131 -0.981 . . . . 0.0 110.114 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.502 ' HB2' ' CG2' ' A' ' 5' ' ' THR . 27.9 p -117.05 60.68 0.74 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 110.23 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 33' ' ' TYR . 2.8 mm-40 -92.2 36.21 0.99 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.2 -0.938 . . . . 0.0 110.373 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.597 ' HE2' HD12 ' A' ' 22' ' ' LEU . 1.4 ptmt -127.99 -142.86 0.27 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.1 -1.0 . . . . 0.0 110.257 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.467 ' N ' ' HG3' ' A' ' 19' ' ' LYS . 1.4 t -115.11 -66.23 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.38 -0.825 . . . . 0.0 110.415 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -142.25 161.9 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.302 -0.873 . . . . 0.0 110.29 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.944 HD23 ' HB2' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -109.68 -17.78 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.4 -0.812 . . . . 0.0 109.699 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 22' ' ' LEU . 85.3 m 58.31 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.382 -0.824 . . . . 0.0 110.346 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 22' ' ' LEU . 3.8 m-20 -139.3 85.39 2.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.113 -0.992 . . . . 0.0 110.23 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.944 ' HB2' HD23 ' A' ' 22' ' ' LEU . 57.8 m -150.01 116.49 5.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' HB3' ' CZ ' ' A' ' 41' ' ' ARG . 4.6 t80 -96.63 98.12 9.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.1 -1.0 . . . . 0.0 109.137 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.039 HG13 ' HB3' ' A' ' 42' ' ' PHE . 5.4 t -94.36 165.41 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.922 . . . . 0.0 110.535 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.6 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 11.4 t0 -141.07 121.3 13.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 109.827 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 37.32 69.58 0.22 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.427 -0.796 . . . . 0.0 110.32 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.574 ' OG ' HG12 ' A' ' 27' ' ' VAL . 5.6 m -130.34 -170.71 2.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -0.923 . . . . 0.0 111.187 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 46' ' ' THR . 25.8 mt-10 -143.54 101.59 3.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 47' ' ' ILE . 70.9 t -108.94 145.23 16.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.261 -0.9 . . . . 0.0 111.197 -178.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.638 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.6 OUTLIER -115.91 -140.5 0.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.5 -0.75 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.559 ' HA3' HG23 ' A' ' 49' ' ' THR . . . -65.43 65.94 0.1 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.896 HG23 ' O ' ' A' ' 50' ' ' SER . 84.9 m -105.91 153.18 22.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.073 -1.251 . . . . 0.0 110.433 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.497 ' CG2' ' HB ' ' A' ' 51' ' ' THR . 0.6 OUTLIER -115.45 117.92 31.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.433 -0.792 . . . . 0.0 109.896 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.647 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.0 OUTLIER -82.63 155.34 24.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 110.759 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.448 ' CB ' HD12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -167.18 43.32 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -0.797 . . . . 0.0 109.607 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.87 75.2 1.13 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.485 ' HB2' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -156.14 177.97 10.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.163 . . . . 0.0 110.621 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.558 ' CZ ' ' HB3' ' A' ' 26' ' ' TYR . 12.6 tpp85 -141.19 124.14 16.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.428 -0.795 . . . . 0.0 109.896 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.039 ' HB3' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -105.44 167.46 9.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.767 -1.208 . . . . 0.0 110.43 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -178.39 114.23 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.477 -0.764 . . . . 0.0 109.027 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.31 67.2 1.97 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.68 ' CG1' HG23 ' A' ' 47' ' ' ILE . 3.6 t -145.27 127.57 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -1.089 . . . . 0.0 110.572 -178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' A' ' 31' ' ' GLU . 93.2 m -106.93 91.16 3.55 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.68 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -109.08 161.92 7.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.58 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.695 HG23 ' N ' ' A' ' 49' ' ' THR . 2.3 t -111.03 -153.92 0.53 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 0.0 110.555 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.695 ' N ' HG23 ' A' ' 48' ' ' THR . 17.2 m -61.35 77.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.392 -0.818 . . . . 0.0 109.918 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.896 ' O ' HG23 ' A' ' 35' ' ' THR . 1.3 p -139.74 172.56 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.085 -1.009 . . . . 0.0 110.686 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.497 ' HB ' ' CG2' ' A' ' 36' ' ' THR . 0.6 OUTLIER -126.89 94.81 4.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.316 -0.865 . . . . 0.0 110.039 179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.1 t -125.45 70.97 1.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.163 -0.961 . . . . 0.0 110.203 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.647 HG21 ' HA ' ' A' ' 37' ' ' CYS . 67.1 p -103.93 -172.45 2.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 0.0 110.265 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.466 ' HA3' ' HA2' ' A' ' 71' ' ' GLY . . . 91.88 -36.67 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.493 ' HB2' ' HA2' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -133.52 161.54 34.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -1.048 . . . . 0.0 109.583 179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 4.0 ptp85 -93.58 151.02 19.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.028 -1.045 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.551 HG22 ' N ' ' A' ' 58' ' ' SER . 3.5 mt -122.33 165.63 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.887 . . . . 0.0 110.834 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.551 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -147.09 147.15 30.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.809 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 62' ' ' CYS . . . 163.03 110.56 0.25 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.348 -1.406 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.06 -8.55 23.82 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 N-CA-C 108.461 -1.4 . . . . 0.0 108.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -148.84 29.43 1.27 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.903 -2.079 . . . . 0.0 107.903 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.5 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . 0.6 OUTLIER -72.05 147.69 46.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.48 -1.012 . . . . 0.0 110.195 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.32 104.08 4.89 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.431 -0.793 . . . . 0.0 109.758 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.452 ' HB ' HG22 ' A' ' 47' ' ' ILE . 4.6 tt -95.86 166.2 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.872 . . . . 0.0 109.963 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.511 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -146.72 97.79 2.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.117 -0.989 . . . . 0.0 110.427 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.548 ' CA ' ' HB2' ' A' ' 50' ' ' SER . 24.1 p 48.96 102.44 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.535 -0.728 . . . . 0.0 110.597 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.19 -142.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.783 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 68' ' ' ILE . 2.7 tt -154.48 134.51 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 0.0 110.301 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.448 HD12 ' CB ' ' A' ' 38' ' ' THR . 3.0 tt -54.35 114.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.182 -0.949 . . . . 0.0 110.274 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.5 t -148.23 135.19 20.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.354 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HA3' ' A' ' 54' ' ' GLY . . . -70.72 64.94 0.85 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 55' ' ' SER . . . 126.84 117.39 2.1 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.579 HG13 ' HD2' ' A' ' 74' ' ' PRO . 60.5 t -96.55 146.15 30.8 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -1.095 . . . . 0.0 110.059 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.579 ' HD2' HG13 ' A' ' 73' ' ' VAL . 42.8 Cg_endo -69.72 153.82 68.66 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.865 1.456 . . . . 0.0 110.858 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -66.72 -49.94 47.36 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.455 -0.778 . . . . 0.0 110.729 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 44.4 Cg_endo -74.05 -50.15 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.735 1.387 . . . . 0.0 110.561 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.0 t 67.17 30.54 7.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.214 -0.929 . . . . 0.0 110.405 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' SER . . . -43.84 -26.81 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.35 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 77' ' ' SER . . . -81.35 -74.17 0.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.588 -0.695 . . . . 0.0 109.812 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.6 t -63.14 163.72 9.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.419 -0.801 . . . . 0.0 109.982 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 6.8 mmpt? -104.17 107.9 19.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 110.31 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -127.2 159.69 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 110.04 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.828 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.7 OUTLIER -151.95 102.91 2.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.373 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 69.07 52.97 20.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.545 ' H ' HD11 ' A' ' 82' ' ' ILE . 43.6 m -133.19 151.09 51.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -1.19 . . . . 0.0 110.492 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.569 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -105.33 164.24 12.01 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 110.023 179.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.569 ' CD1' ' O ' ' A' ' 86' ' ' THR . 7.1 m-85 -135.41 166.54 22.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.201 -0.937 . . . . 0.0 110.503 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 2.6 t 168.03 114.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 0.0 110.022 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -43.73 134.88 4.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.264 -0.898 . . . . 0.0 110.148 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' N ' ' HA ' ' A' ' 55' ' ' SER . 4.2 t30 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.106 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.281 0.562 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.79 -86.43 0.06 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.434 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 88.0 p -78.48 -17.24 56.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -1.138 . . . . 0.0 110.178 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 174.59 -79.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 110.448 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 5' ' ' THR . 5.5 t -145.06 28.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.066 -1.021 . . . . 0.0 109.947 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -101.01 79.16 1.99 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 110.272 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 7' ' ' THR . 3.9 t -98.31 105.06 17.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.293 -0.88 . . . . 0.0 109.4 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.923 ' CB ' HG23 ' A' ' 23' ' ' THR . 12.5 m120 60.6 13.1 4.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.663 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.54 ' OG ' ' N ' ' A' ' 10' ' ' GLN . 1.5 t -128.63 -167.57 1.79 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -0.848 . . . . 0.0 109.909 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.54 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -143.66 115.32 8.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.019 . . . . 0.0 110.555 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.926 HD21 ' O ' ' A' ' 16' ' ' LYS . 5.6 tp -110.23 20.38 17.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.95 . . . . 0.0 109.686 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 6.0 t 54.21 99.08 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.201 -0.937 . . . . 0.0 109.175 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -41.18 -26.06 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 110.723 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 12' ' ' SER . 11.4 m-20 -80.85 3.64 21.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 110.808 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -101.28 -159.63 0.75 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.831 -1.168 . . . . 0.0 110.227 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.926 ' O ' HD21 ' A' ' 11' ' ' LEU . 5.1 mttp -116.2 134.0 55.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 110.455 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 26.9 p -99.58 78.06 2.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.193 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HB2' ' HA ' ' A' ' 33' ' ' TYR . 18.3 mm-40 -101.01 50.25 0.87 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 110.292 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.01 94.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' THR . 0.1 OUTLIER -179.61 63.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.947 . . . . 0.0 110.124 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 9' ' ' SER . 84.5 m -146.72 139.14 24.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 110.219 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.601 HD22 HG22 ' A' ' 38' ' ' THR . 1.1 tp -134.31 40.99 2.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.892 . . . . 0.0 109.944 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.923 HG23 ' CB ' ' A' ' 8' ' ' ASN . 35.9 m 59.61 25.15 14.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.408 -0.808 . . . . 0.0 110.369 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.428 ' HB3' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -157.42 52.06 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.401 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 10.2 m -143.79 108.76 4.96 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.144 -0.973 . . . . 0.0 110.437 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.512 ' O ' ' NH1' ' A' ' 41' ' ' ARG . 45.2 m-85 -103.36 96.28 6.65 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.988 HG13 ' CB ' ' A' ' 42' ' ' PHE . 5.0 t -103.32 167.81 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.047 -1.033 . . . . 0.0 111.312 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 5.3 t0 -149.09 115.2 5.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.743 . . . . 0.0 109.667 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 48.08 67.86 0.77 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.088 -1.007 . . . . 0.0 109.862 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.708 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.1 m -133.34 -173.32 3.18 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.266 -0.896 . . . . 0.0 110.951 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' A' ' 46' ' ' THR . 32.8 tt0 -139.75 101.28 4.16 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.53 HG21 HD11 ' A' ' 11' ' ' LEU . 77.2 t -100.76 137.17 29.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.488 -0.758 . . . . 0.0 111.069 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.59 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.2 OUTLIER -137.47 122.4 18.93 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 33' ' ' TYR . . . 39.94 47.19 3.27 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.511 HG22 ' N ' ' A' ' 36' ' ' THR . 18.6 m -103.28 166.92 10.14 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.216 -1.167 . . . . 0.0 110.433 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.935 HG21 HG22 ' A' ' 51' ' ' THR . 0.5 OUTLIER -136.01 90.69 2.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.396 -0.815 . . . . 0.0 110.075 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 37' ' ' CYS . 27.4 p -97.47 96.31 8.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.112 -0.992 . . . . 0.0 110.565 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.601 HG22 HD22 ' A' ' 22' ' ' LEU . 82.8 p -78.82 -28.68 44.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.125 -0.984 . . . . 0.0 109.606 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 24' ' ' ASN . . . -164.5 68.6 0.21 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.466 ' HB3' ' OG1' ' A' ' 53' ' ' THR . 57.6 p -135.81 174.8 10.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -1.124 . . . . 0.0 110.314 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.512 ' NH1' ' O ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -136.39 123.85 22.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.241 -0.912 . . . . 0.0 109.912 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.988 ' CB ' HG13 ' A' ' 27' ' ' VAL . 3.3 m-85 -101.4 168.76 9.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 110.717 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 45' ' ' VAL . 2.9 t0 -173.68 109.65 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.38 69.71 0.96 Allowed Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.795 ' CG2' HG22 ' A' ' 57' ' ' ILE . 3.1 t -145.15 131.9 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.283 -1.127 . . . . 0.0 110.922 -178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.531 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . 4.4 m -109.05 96.35 6.25 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.395 -0.816 . . . . 0.0 109.346 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.706 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -114.32 176.04 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.279 -0.888 . . . . 0.0 110.309 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.803 HG23 ' N ' ' A' ' 49' ' ' THR . 1.9 t -136.24 -147.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.151 -0.968 . . . . 0.0 110.449 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.803 ' N ' HG23 ' A' ' 48' ' ' THR . 3.7 m -60.26 80.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.321 -0.862 . . . . 0.0 110.092 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 48' ' ' THR . 1.4 m -139.34 142.97 37.61 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.263 -0.898 . . . . 0.0 110.507 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.935 HG22 HG21 ' A' ' 36' ' ' THR . 4.0 p -91.55 53.19 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 109.862 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.438 ' C ' HG22 ' A' ' 53' ' ' THR . 5.3 t -94.97 122.38 37.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 110.126 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.511 HG23 HG13 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -172.16 135.85 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 144.6 -28.56 1.91 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.501 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -130.36 178.56 6.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.414 -1.05 . . . . 0.0 109.933 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 0.9 OUTLIER -94.34 138.6 32.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 0.0 110.134 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.795 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.1 mt -115.79 155.5 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 0.0 110.726 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.547 ' H ' HG22 ' A' ' 86' ' ' THR . 1.1 m -147.28 145.3 29.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 0.0 110.379 179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.468 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 167.54 112.57 0.26 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.106 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.15 -7.04 20.21 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.697 1.367 . . . . 0.0 109.068 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -158.65 32.58 0.48 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.484 ' O ' ' HB ' ' A' ' 46' ' ' THR . 0.6 OUTLIER -72.25 155.57 40.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.47 -1.018 . . . . 0.0 110.102 -179.348 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -141.42 105.31 4.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.46 -0.775 . . . . 0.0 109.418 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.545 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.3 tt -102.05 154.87 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.92 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.553 ' CB ' ' HB2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER -145.91 108.22 4.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 110.482 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 10.7 p 50.62 105.16 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.553 -0.717 . . . . 0.0 110.581 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.434 ' CB ' ' HB2' ' A' ' 52' ' ' SER . 0.0 OUTLIER -127.59 -151.87 0.5 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 0.0 109.85 179.696 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.3 tp -134.9 139.38 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.159 -0.963 . . . . 0.0 110.522 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.621 HG23 ' O ' ' A' ' 69' ' ' ILE . 7.8 tt -70.41 105.08 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.028 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.42 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 8.2 m -148.48 148.04 29.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 110.362 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.38 57.89 1.57 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 55' ' ' SER . . . 138.25 113.16 1.14 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.553 ' HB ' ' CG ' ' A' ' 87' ' ' PHE . 5.3 t -96.84 145.2 29.17 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 110.099 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.541 ' HD2' ' CG1' ' A' ' 73' ' ' VAL . 43.4 Cg_endo -71.91 137.61 29.77 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.963 1.507 . . . . 0.0 110.63 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -62.43 -52.37 66.4 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.405 -0.81 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 42.6 Cg_endo -69.97 -32.84 16.94 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.628 1.33 . . . . 0.0 110.364 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 78' ' ' ALA . 0.9 OUTLIER 66.11 -59.33 0.32 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.893 . . . . 0.0 111.002 179.378 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' N ' ' OG ' ' A' ' 77' ' ' SER . . . 47.26 24.96 0.49 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.972 -1.08 . . . . 0.0 108.513 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.84 -57.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 51.5 t -84.38 168.19 15.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.645 -0.66 . . . . 0.0 109.547 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -99.85 115.88 30.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.012 -1.055 . . . . 0.0 110.258 -179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.773 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -132.73 139.28 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.319 -0.863 . . . . 0.0 110.258 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.653 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.5 OUTLIER -144.27 79.07 1.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 0.0 110.973 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 96.11 45.94 2.72 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.434 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -131.99 160.54 35.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.12 -1.224 . . . . 0.0 110.765 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.585 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 9.8 t -117.07 157.49 25.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.262 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.585 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.7 m-85 -137.37 137.56 39.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.881 -1.137 . . . . 0.0 110.914 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 56' ' ' ARG . 12.2 t -171.11 136.23 1.06 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.53 139.23 0.82 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.29 -0.881 . . . . 0.0 110.374 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.501 ' N ' ' HA ' ' A' ' 55' ' ' SER . 13.0 p30 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.199 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 31.4 t70 . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.233 0.539 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 4' ' ' CYS . . . -123.51 131.43 8.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 4' ' ' CYS . 1.0 OUTLIER 49.88 -89.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.346 -1.091 . . . . 0.0 110.014 -179.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.531 ' N ' ' O ' ' A' ' 2' ' ' GLY . 9.0 t -130.62 -68.37 0.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.654 ' CG2' HD22 ' A' ' 11' ' ' LEU . 7.2 t -130.83 30.94 4.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.293 -0.879 . . . . 0.0 109.797 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.95 70.06 8.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 0.0 110.258 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 103.84 15.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -0.979 . . . . 0.0 110.356 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.504 ' HB3' ' CB ' ' A' ' 23' ' ' THR . 2.0 t-20 44.72 24.7 0.11 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -0.966 . . . . 0.0 110.044 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.02 -162.59 1.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.883 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.493 ' CB ' ' HA ' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -143.65 107.52 4.68 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.043 -1.036 . . . . 0.0 110.502 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.654 HD22 ' CG2' ' A' ' 5' ' ' THR . 18.4 tp -100.32 21.72 12.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.308 -0.87 . . . . 0.0 109.653 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 28' ' ' ASP . 22.0 t 61.34 12.41 4.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.584 -0.697 . . . . 0.0 110.273 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 40.98 28.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.0 110.273 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 21.1 t30 -162.25 19.27 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.164 -0.96 . . . . 0.0 110.922 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 30' ' ' SER . 0.9 OUTLIER -112.17 -149.16 0.44 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.05 -1.031 . . . . 0.0 109.43 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -108.81 127.86 54.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.955 -1.091 . . . . 0.0 110.056 179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 29.3 p -106.43 69.11 0.78 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.331 -0.856 . . . . 0.0 110.354 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 33' ' ' TYR . 18.5 tp10 -84.62 55.4 3.4 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.133 -0.979 . . . . 0.0 110.151 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 45.29 74.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 110.038 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.474 ' OG ' ' N ' ' A' ' 35' ' ' THR . 0.6 OUTLIER -160.84 66.96 0.31 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.293 -0.879 . . . . 0.0 110.264 -179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.15 155.26 32.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.276 -0.89 . . . . 0.0 110.253 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.65 -77.28 0.56 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.231 -0.918 . . . . 0.0 110.235 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.504 ' CB ' ' HB3' ' A' ' 8' ' ' ASN . 0.6 OUTLIER -172.13 29.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.301 -0.874 . . . . 0.0 110.265 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.403 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -155.32 67.48 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.77 179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 11.1 m -155.26 117.44 4.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.0 110.862 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.551 ' O ' ' CD ' ' A' ' 41' ' ' ARG . 3.6 m-85 -109.39 94.8 5.22 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.96 HG22 ' HB2' ' A' ' 42' ' ' PHE . 12.0 t -99.8 165.95 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.904 -1.123 . . . . 0.0 111.31 -178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.533 ' HA ' ' OG ' ' A' ' 12' ' ' SER . 7.8 t0 -146.54 109.59 4.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.568 -0.707 . . . . 0.0 109.332 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.96 69.59 0.59 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.979 -1.076 . . . . 0.0 109.742 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.551 ' OG ' HG12 ' A' ' 27' ' ' VAL . 9.7 m -131.83 -167.25 1.84 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.208 -0.932 . . . . 0.0 110.923 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -142.13 101.61 3.96 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.665 HG13 ' HB ' ' A' ' 35' ' ' THR . 80.9 t -102.06 125.84 56.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 110.856 -178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.591 ' CB ' ' HA ' ' A' ' 48' ' ' THR . 0.8 OUTLIER -132.84 123.0 25.25 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.5 ' O ' ' HA ' ' A' ' 49' ' ' THR . . . 41.97 42.52 4.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.665 ' HB ' HG13 ' A' ' 32' ' ' VAL . 52.1 m -104.24 162.14 13.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -1.067 . . . . 0.0 110.195 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.423 ' N ' HG22 ' A' ' 35' ' ' THR . 24.4 p -98.56 178.22 5.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.93 . . . . 0.0 109.991 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.413 ' HA ' HG21 ' A' ' 53' ' ' THR . 0.1 OUTLIER -158.95 65.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.367 179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -110.88 40.88 1.92 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.877 . . . . 0.0 110.314 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.436 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 118.46 91.19 1.42 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.515 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 10.8 p -172.17 178.55 2.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.155 -1.203 . . . . 0.0 110.391 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.551 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.2 OUTLIER -146.67 122.44 10.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.881 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.96 ' HB2' HG22 ' A' ' 27' ' ' VAL . 3.3 m-85 -102.07 166.3 10.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.281 -0.887 . . . . 0.0 110.518 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 10.8 t70 -176.13 111.26 0.1 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 49.71 66.32 2.35 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.715 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.7 t -144.1 129.65 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.391 -1.064 . . . . 0.0 110.957 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.403 HG23 ' CB ' ' A' ' 31' ' ' GLU . 45.8 m -110.37 90.89 3.45 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.247 -0.908 . . . . 0.0 109.122 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.671 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.1 pt -111.4 164.86 6.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.342 -0.849 . . . . 0.0 109.86 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.725 HG23 ' N ' ' A' ' 49' ' ' THR . 1.5 t -122.41 -154.09 0.58 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.167 -0.958 . . . . 0.0 109.94 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.725 ' N ' HG23 ' A' ' 48' ' ' THR . 3.2 m -48.25 91.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.265 -0.897 . . . . 0.0 109.802 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 48' ' ' THR . 12.6 p -139.26 154.43 47.97 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 111.081 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.6 p -110.42 53.34 0.7 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.64 -0.662 . . . . 0.0 109.452 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -111.51 110.05 20.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.441 -0.787 . . . . 0.0 110.522 -179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER -151.49 113.7 4.54 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.272 179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.502 ' HA3' ' N ' ' A' ' 71' ' ' GLY . . . 169.36 -42.94 0.21 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.226 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.549 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -110.0 177.04 4.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.097 -1.237 . . . . 0.0 110.382 -179.612 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -97.25 126.89 42.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.715 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.8 mt -104.75 158.42 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 110.844 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.545 ' CB ' ' OG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -148.72 155.1 40.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.411 -0.806 . . . . 0.0 110.534 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 166.1 125.13 0.75 Allowed Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.392 -1.385 . . . . 0.0 110.728 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -74.95 -5.61 17.03 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 N-CA-C 108.271 -1.473 . . . . 0.0 108.271 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.01 39.33 0.24 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.267 -1.933 . . . . 0.0 108.267 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -71.88 151.48 43.34 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.463 -1.022 . . . . 0.0 110.536 -179.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -145.03 113.52 6.67 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.626 -0.671 . . . . 0.0 109.576 178.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.472 HG22 ' HA ' ' A' ' 47' ' ' ILE . 4.5 tt -104.49 166.71 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.179 -0.951 . . . . 0.0 110.526 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -147.35 96.71 2.75 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.375 -0.828 . . . . 0.0 110.251 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 65' ' ' SER . 19.3 p 50.16 103.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.53 -0.731 . . . . 0.0 110.006 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.04 -146.84 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 110.933 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 tt -143.66 -177.75 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 110.269 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.1 pp -46.21 123.88 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -0.993 . . . . 0.0 110.015 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.542 HG22 ' HB3' ' A' ' 55' ' ' SER . 2.4 m -92.08 -134.53 0.14 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.502 ' N ' ' HA3' ' A' ' 54' ' ' GLY . . . 89.86 24.66 29.4 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 115.0 68.13 0.45 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.511 ' CG1' ' HA ' ' A' ' 70' ' ' THR . 24.5 m -86.35 164.22 39.03 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.323 -1.104 . . . . 0.0 110.573 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 73' ' ' VAL . 43.0 Cg_endo -68.3 129.41 19.14 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.149 1.605 . . . . 0.0 110.353 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.019 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -44.17 -58.61 4.68 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.164 -0.96 . . . . 0.0 109.494 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.019 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 51.6 Cg_endo -77.16 92.25 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.903 1.475 . . . . 0.0 109.58 178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.473 ' OG ' ' HB3' ' A' ' 80' ' ' CYS . 0.2 OUTLIER -79.81 55.92 2.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.797 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.25 -24.92 1.32 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.015 -1.053 . . . . 0.0 108.977 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.431 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . -81.36 -76.49 0.24 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.592 0.711 . . . . 0.0 109.688 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.504 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 3.3 t -63.11 168.9 3.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.757 -0.589 . . . . 0.0 109.501 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.504 ' N ' ' SG ' ' A' ' 80' ' ' CYS . 9.6 mmtt -98.9 112.1 24.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.007 . . . . 0.0 110.228 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.956 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -123.29 160.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.456 -0.777 . . . . 0.0 109.852 -179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.956 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.9 OUTLIER -156.23 83.52 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.245 -0.909 . . . . 0.0 110.522 -179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 77.02 59.2 3.21 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.573 ' SG ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.46 159.34 42.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.249 -1.147 . . . . 0.0 110.716 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.574 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -106.86 154.64 20.74 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.607 -0.683 . . . . 0.0 110.07 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 86' ' ' THR . 22.5 m-85 -134.28 141.88 47.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -0.818 . . . . 0.0 109.743 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 89' ' ' ALA . 21.4 t -177.7 121.55 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.087 -1.008 . . . . 0.0 110.367 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -40.13 139.63 0.68 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.52 -0.738 . . . . 0.0 110.337 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.549 ' N ' ' HA ' ' A' ' 55' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.304 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.988 0.423 . . . . 0.0 110.026 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.34 -136.57 4.02 Favored Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.617 -1.278 . . . . 0.0 110.128 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 55.8 m -63.79 -22.47 66.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.346 -1.091 . . . . 0.0 110.192 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 3' ' ' SER . 1.8 p 173.71 -47.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.408 -0.808 . . . . 0.0 109.626 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.744 ' O ' HG22 ' A' ' 5' ' ' THR . 0.9 OUTLIER -141.05 92.96 2.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.468 -0.77 . . . . 0.0 108.978 179.316 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' HA ' HG22 ' A' ' 21' ' ' THR . 2.4 t30 175.89 111.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -0.957 . . . . 0.0 109.904 -179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.503 ' O ' ' CB ' ' A' ' 8' ' ' ASN . 3.9 p -101.25 107.01 18.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 7' ' ' THR . 0.1 OUTLIER 69.4 8.33 6.72 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.364 -0.835 . . . . 0.0 110.667 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -111.2 -170.47 1.65 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.069 -1.019 . . . . 0.0 110.359 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -141.83 99.71 3.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.837 . . . . 0.0 109.268 179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD13 HG21 ' A' ' 27' ' ' VAL . 0.4 OUTLIER -92.63 38.02 1.01 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.305 -0.872 . . . . 0.0 110.13 -179.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 15' ' ' SER . 18.2 t 58.47 152.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.156 -0.965 . . . . 0.0 109.678 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.59 22.64 2.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 0.0 110.461 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -157.4 19.35 0.28 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.131 -0.981 . . . . 0.0 111.084 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.555 ' HB3' ' HB3' ' A' ' 12' ' ' SER . 10.5 p -100.17 -162.74 0.97 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.914 -1.116 . . . . 0.0 109.348 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HB2' ' HG2' ' A' ' 31' ' ' GLU . 19.8 tptt -108.25 112.33 24.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.128 -0.983 . . . . 0.0 109.476 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 5' ' ' THR . 29.6 p -97.31 86.33 3.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.512 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -107.56 127.04 53.27 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.111 -0.993 . . . . 0.0 109.425 179.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.531 ' HD2' ' HA2' ' A' ' 34' ' ' GLY . 7.8 tttt 69.92 119.15 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.236 -0.915 . . . . 0.0 110.089 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.1 145.81 35.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 110.359 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.489 HG22 ' HA ' ' A' ' 6' ' ' ASN . 12.2 t -90.86 -146.96 0.2 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.404 -0.81 . . . . 0.0 110.067 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.456 ' N ' HG23 ' A' ' 21' ' ' THR . 1.1 mp -111.4 -81.72 0.58 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.613 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.1 t -179.76 33.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.158 -0.964 . . . . 0.0 110.18 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -157.12 60.87 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 110.534 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.6 m -155.09 111.75 3.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.078 -1.014 . . . . 0.0 110.435 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.489 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.2 m-85 -100.77 129.1 46.61 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.096 HG13 ' HB3' ' A' ' 42' ' ' PHE . 3.4 t -125.1 160.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.916 -1.115 . . . . 0.0 110.979 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -149.29 115.55 5.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.585 -0.697 . . . . 0.0 109.416 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.6 mttt 52.03 65.43 1.5 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.044 -1.035 . . . . 0.0 109.823 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.611 ' OG ' HG12 ' A' ' 27' ' ' VAL . 2.7 m -133.45 -170.49 2.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.144 -0.972 . . . . 0.0 111.122 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.538 ' CB ' HG23 ' A' ' 46' ' ' THR . 2.6 tm-20 -143.26 99.36 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 16' ' ' LYS . 97.3 t -105.23 149.81 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.173 -0.955 . . . . 0.0 111.689 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.582 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -127.35 -143.6 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.078 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' O ' HG23 ' A' ' 49' ' ' THR . . . -66.41 68.16 0.16 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.4 m -114.91 157.78 22.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.273 -1.133 . . . . 0.0 109.858 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.581 ' CG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -112.36 170.83 7.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.191 -0.943 . . . . 0.0 110.46 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.451 ' O ' HD13 ' A' ' 22' ' ' LEU . 36.9 t -133.75 140.28 46.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.389 -0.819 . . . . 0.0 110.315 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.57 ' H ' ' HG1' ' A' ' 53' ' ' THR . 32.8 m -155.3 19.67 0.42 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.055 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.495 ' O ' ' HA2' ' A' ' 54' ' ' GLY . . . 132.18 67.47 0.09 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.588 ' CB ' ' HA ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -151.63 -178.81 6.92 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.124 -1.221 . . . . 0.0 110.247 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' HG3' ' HG3' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -147.3 138.08 23.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.751 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.096 ' HB3' HG13 ' A' ' 27' ' ' VAL . 6.0 m-85 -110.1 161.62 15.36 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.537 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 45' ' ' VAL . 1.6 t70 -179.09 113.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 49.49 64.33 3.48 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.697 -2.161 . . . . 0.0 107.697 -178.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.582 ' CG1' HG23 ' A' ' 47' ' ' ILE . 3.1 t -145.8 136.47 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.479 -1.012 . . . . 0.0 110.426 -178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 31' ' ' GLU . 87.7 m -116.03 97.96 6.37 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.532 178.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.582 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.6 pt -114.93 174.39 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.306 -0.871 . . . . 0.0 110.401 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.72 HG23 ' N ' ' A' ' 49' ' ' THR . 1.0 OUTLIER -122.04 -160.09 0.85 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 110.537 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.72 ' N ' HG23 ' A' ' 48' ' ' THR . 8.7 m -61.62 93.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.423 -0.798 . . . . 0.0 109.882 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.496 ' CB ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -139.36 154.61 47.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.144 -0.972 . . . . 0.0 110.892 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.581 ' HA ' ' CG2' ' A' ' 36' ' ' THR . 10.5 p -95.83 57.46 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.094 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.444 ' C ' HG22 ' A' ' 53' ' ' THR . 0.4 OUTLIER -114.25 133.24 55.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.551 -0.718 . . . . 0.0 110.454 -179.496 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.588 ' HA ' ' CB ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -178.4 75.66 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.287 -0.883 . . . . 0.0 109.855 179.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' HB2' ' A' ' 40' ' ' SER . . . -132.22 -61.48 0.08 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.554 ' N ' ' HA2' ' A' ' 71' ' ' GLY . 61.1 p -103.61 -159.62 0.73 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.489 -1.006 . . . . 0.0 110.758 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.495 ' HG3' ' HG3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -115.21 123.48 48.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.401 -0.812 . . . . 0.0 110.188 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.581 HG22 HG22 ' A' ' 45' ' ' VAL . 2.0 mt -98.98 163.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 109.959 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.71 151.36 37.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.445 -0.784 . . . . 0.0 109.701 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 159.55 115.28 0.4 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.03 -2.8 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.743 1.391 . . . . 0.0 108.657 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.25 28.59 0.63 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 1.4 t -72.51 153.7 41.21 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.444 -1.033 . . . . 0.0 110.711 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.35 111.03 6.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.797 . . . . 0.0 110.05 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.939 HG13 HD12 ' A' ' 82' ' ' ILE . 3.6 tt -103.88 167.65 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.971 . . . . 0.0 109.226 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.489 ' O ' ' OG1' ' A' ' 66' ' ' THR . 0.2 OUTLIER -144.83 100.55 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.346 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' ' CB ' ' A' ' 50' ' ' SER . 81.0 p 46.39 56.39 6.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.556 -0.715 . . . . 0.0 110.712 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.04 162.34 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 0.0 110.202 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 69' ' ' ILE . 79.4 mt -108.32 171.54 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.31 -0.869 . . . . 0.0 109.199 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.569 ' N ' HG22 ' A' ' 68' ' ' ILE . 1.7 mp -38.75 121.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 0.0 110.415 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.657 ' HA ' HG23 ' A' ' 73' ' ' VAL . 89.6 m -130.32 61.1 1.6 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.0 110.992 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.607 ' N ' HG22 ' A' ' 73' ' ' VAL . . . -65.78 74.43 0.11 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 55' ' ' SER . . . 61.72 26.17 66.51 Favored Glycine 0 N--CA 1.483 1.827 0 N-CA-C 106.865 -2.494 . . . . 0.0 106.865 -177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 70' ' ' THR . 2.9 m -132.73 82.31 56.42 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.971 -0.723 . . . . 0.0 110.652 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 77' ' ' SER . 53.6 Cg_endo -77.83 -23.83 9.11 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.97 1.511 . . . . 0.0 110.727 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.809 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -42.61 -52.87 10.24 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.206 -0.934 . . . . 0.0 111.017 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.809 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 44.8 Cg_endo -71.58 -10.97 27.6 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.656 1.345 . . . . 0.0 110.448 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 74' ' ' PRO . 23.0 p -112.57 13.93 20.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.9 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.31 -14.68 12.35 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.276 -0.89 . . . . 0.0 109.35 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.89 -19.14 30.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.742 . . . . 0.0 109.981 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 81' ' ' LYS . 3.3 t -82.64 167.86 17.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.515 ' N ' ' SG ' ' A' ' 80' ' ' CYS . 0.0 OUTLIER -105.6 137.81 42.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.711 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.939 HD12 HG13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -147.92 129.84 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.599 -0.688 . . . . 0.0 109.347 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.0 t -142.53 116.24 9.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.943 . . . . 0.0 110.528 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 76.44 48.77 8.84 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.42 149.36 49.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -1.116 . . . . 0.0 110.506 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -104.17 163.06 12.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 109.149 179.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 86' ' ' THR . 6.3 m-85 -132.62 144.49 50.39 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.06 -1.025 . . . . 0.0 110.304 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.491 ' C ' ' HB2' ' A' ' 55' ' ' SER . 2.0 t -176.08 116.57 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 109.75 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HA ' ' CB ' ' A' ' 55' ' ' SER . . . -37.76 155.65 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.496 -0.753 . . . . 0.0 110.882 -179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 55' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.877 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.818 ' HB3' HG22 ' A' ' 7' ' ' THR . 9.4 p-10 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.098 0.475 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.66 -71.15 0.09 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.08 -39.56 90.38 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.29 -1.123 . . . . 0.0 110.609 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -176.27 -70.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.311 -0.868 . . . . 0.0 109.627 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.727 HG22 HD22 ' A' ' 11' ' ' LEU . 3.0 t -133.42 7.08 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 0.0 109.593 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -69.69 73.14 0.38 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.397 -0.814 . . . . 0.0 110.494 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.818 HG22 ' HB3' ' A' ' 1' ' ' ASP . 50.1 p -98.29 99.32 10.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.172 -0.955 . . . . 0.0 109.499 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 7' ' ' THR . 9.5 m120 58.15 15.95 3.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.866 . . . . 0.0 109.694 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.468 ' OG ' ' O ' ' A' ' 22' ' ' LEU . 0.4 OUTLIER -130.89 172.84 11.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.428 -0.795 . . . . 0.0 109.472 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -116.16 114.26 24.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.727 HD22 HG22 ' A' ' 5' ' ' THR . 15.7 tp -102.45 28.39 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.769 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 28' ' ' ASP . 21.8 t 64.22 6.25 2.88 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.731 -0.606 . . . . 0.0 110.914 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.0 25.17 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.06 -1.025 . . . . 0.0 109.44 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 12' ' ' SER . 37.5 t30 -163.47 17.63 0.07 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.416 -0.803 . . . . 0.0 110.491 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -104.29 -147.65 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.425 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 3.4 tmtm? -114.94 119.04 35.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.796 -1.19 . . . . 0.0 110.493 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.01 66.14 4.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.718 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' CD ' ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -84.13 157.6 21.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 0.0 110.242 -179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp 48.15 -94.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.32 -0.863 . . . . 0.0 110.332 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.437 ' N ' ' O ' ' A' ' 18' ' ' GLU . 17.3 p -168.86 173.86 6.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.038 -1.039 . . . . 0.0 110.561 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.441 ' N ' ' OG1' ' A' ' 5' ' ' THR . 2.7 m -136.48 153.54 51.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.464 -0.772 . . . . 0.0 109.963 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 23' ' ' THR . 0.4 OUTLIER -89.08 -140.35 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.566 ' H ' HD23 ' A' ' 22' ' ' LEU . 7.3 p -131.42 48.23 2.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.233 -0.917 . . . . 0.0 109.774 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.43 ' O ' ' SG ' ' A' ' 25' ' ' CYS . 6.7 m-20 -157.6 46.47 0.38 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.379 -0.826 . . . . 0.0 110.134 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 24' ' ' ASN . 88.5 m -149.68 123.26 9.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.063 -1.023 . . . . 0.0 111.182 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.57 ' CD1' ' N ' ' A' ' 26' ' ' TYR . 20.1 m-85 -115.58 96.65 5.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.02 HG13 ' HB3' ' A' ' 42' ' ' PHE . 12.2 t -94.32 163.92 2.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.242 -0.912 . . . . 0.0 111.315 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.553 ' HA ' ' CB ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -145.91 120.53 9.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.548 -0.72 . . . . 0.0 109.467 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 12' ' ' SER . 13.6 tptm 47.92 59.76 4.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.001 -1.062 . . . . 0.0 110.275 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.579 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.7 m -133.58 178.19 7.12 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.184 -0.947 . . . . 0.0 110.982 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 4.6 tt0 -143.61 109.58 5.28 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 47' ' ' ILE . 5.7 m -116.05 164.98 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.892 -1.13 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.57 ' HB3' ' CA ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -121.53 -139.17 0.33 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.471 ' HA3' HG23 ' A' ' 49' ' ' THR . . . -65.97 66.87 0.13 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 50' ' ' SER . 19.6 m -99.36 163.58 12.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 110.279 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.683 ' CG2' HG22 ' A' ' 51' ' ' THR . 6.7 p -106.88 -170.45 1.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.119 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.787 ' CA ' HG21 ' A' ' 53' ' ' THR . 0.9 OUTLIER -141.15 -87.91 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.242 -0.912 . . . . 0.0 110.277 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.5 m 46.13 37.14 3.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.362 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . 102.03 109.49 3.28 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.601 ' CB ' HG22 ' A' ' 53' ' ' THR . 47.0 t 177.87 161.89 0.57 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.419 -1.047 . . . . 0.0 110.184 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.536 ' CD ' ' O ' ' A' ' 26' ' ' TYR . 0.5 OUTLIER -141.7 128.61 20.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.991 179.402 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.02 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.0 m-85 -110.67 167.11 10.47 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 110.131 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -177.73 112.11 0.08 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.442 -0.786 . . . . 0.0 109.098 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 59' ' ' GLY . . . 50.79 70.49 0.84 Allowed Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.526 -2.23 . . . . 0.0 107.526 -178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.717 ' CG1' HG23 ' A' ' 47' ' ' ILE . 7.4 t -145.52 127.59 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.413 -1.051 . . . . 0.0 111.126 -178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 86.3 m -106.92 91.13 3.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.92 . . . . 0.0 109.238 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.717 HG23 ' CG1' ' A' ' 45' ' ' VAL . 1.2 pp -114.35 170.8 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.457 -0.777 . . . . 0.0 110.375 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.646 HG23 ' N ' ' A' ' 49' ' ' THR . 5.3 t -118.46 -151.21 0.48 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.119 -0.988 . . . . 0.0 110.241 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.648 ' O ' HG22 ' A' ' 66' ' ' THR . 3.2 m -63.5 86.95 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.91 . . . . 0.0 110.378 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 35' ' ' THR . 7.9 t -139.37 144.72 38.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.121 -0.987 . . . . 0.0 110.759 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.683 HG22 ' CG2' ' A' ' 36' ' ' THR . 43.9 p -96.72 61.4 1.88 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.452 -0.78 . . . . 0.0 110.148 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.28 111.26 23.43 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.267 -0.896 . . . . 0.0 109.764 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.787 HG21 ' CA ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -142.66 162.75 34.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.288 -0.883 . . . . 0.0 110.142 -179.64 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 39' ' ' GLY . . . 116.24 -56.9 0.51 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.508 ' HA ' ' N ' ' A' ' 90' ' ' ASN . 0.6 OUTLIER -101.86 -179.6 4.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -1.133 . . . . 0.0 111.213 -179.157 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 41' ' ' ARG . 6.1 ttp85 -109.69 128.05 54.99 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.604 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.5 mt -103.57 161.18 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 111.006 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.606 ' CB ' ' HG1' ' A' ' 86' ' ' THR . 0.0 OUTLIER -146.65 146.3 30.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.441 -0.787 . . . . 0.0 110.164 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.484 ' O ' ' O ' ' A' ' 44' ' ' GLY . . . 169.13 118.05 0.43 Allowed Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.437 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.94 -6.98 20.41 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 N-CA-C 108.69 -1.312 . . . . 0.0 108.69 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -164.95 38.61 0.29 Allowed Glycine 0 N--CA 1.484 1.85 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 0.7 OUTLIER -71.85 159.4 34.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.446 -1.032 . . . . 0.0 110.139 -179.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 62' ' ' CYS . 5.1 mmtm -143.11 109.51 5.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.757 . . . . 0.0 110.298 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.507 ' CG2' ' HB ' ' A' ' 47' ' ' ILE . 2.6 tt -102.6 172.45 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -0.972 . . . . 0.0 109.003 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.477 ' O ' ' OG1' ' A' ' 66' ' ' THR . 2.6 t -151.17 76.86 1.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.827 -1.17 . . . . 0.0 110.78 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 49' ' ' THR . 4.1 p 55.24 113.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 80' ' ' CYS . 30.0 m -139.36 -157.45 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 69' ' ' ILE . 1.9 mt -121.97 -149.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.166 -0.959 . . . . 0.0 109.898 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.52 ' H ' HG22 ' A' ' 68' ' ' ILE . 37.0 mt -61.3 144.72 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.525 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.655 ' C ' HG22 ' A' ' 73' ' ' VAL . 75.2 m -123.7 -13.76 7.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.948 -1.095 . . . . 0.0 110.938 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 1.002 ' O ' HG13 ' A' ' 73' ' ' VAL . . . -36.12 94.2 0.01 OUTLIER Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 70' ' ' THR . . . 40.05 28.71 0.17 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.002 HG13 ' O ' ' A' ' 71' ' ' GLY . 17.9 m -127.61 75.21 77.85 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 0.0 111.232 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HA ' ' OG ' ' A' ' 77' ' ' SER . 49.3 Cg_endo -78.21 -20.46 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.881 1.464 . . . . 0.0 110.149 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.67 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . . . -62.48 -50.03 80.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.0 111.139 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 75' ' ' ALA . 43.2 Cg_endo -70.02 -2.93 11.18 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.399 1.21 . . . . 0.0 110.704 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' A' ' 80' ' ' CYS . 2.3 p -116.84 10.46 14.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.967 . . . . 0.0 110.102 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.84 1.82 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.924 -1.11 . . . . 0.0 109.199 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.49 -9.1 59.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.556 -0.715 . . . . 0.0 109.835 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 77' ' ' SER . 6.8 t -72.06 149.44 44.86 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.412 -0.805 . . . . 0.0 109.997 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -104.79 103.68 13.33 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.225 -0.922 . . . . 0.0 109.938 180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.796 HD13 ' N ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -125.11 155.94 33.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.796 ' N ' HD13 ' A' ' 82' ' ' ILE . 43.6 t -146.8 114.75 6.52 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.385 -0.822 . . . . 0.0 110.407 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 70.47 48.79 34.83 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.68 ' HB2' HD11 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -132.79 148.22 52.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.424 -1.045 . . . . 0.0 110.804 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.606 ' HG1' ' CB ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -109.27 153.91 23.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.392 179.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' O ' ' CB ' ' A' ' 88' ' ' SER . 10.3 m-85 -127.13 160.6 30.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 110.575 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER 171.03 127.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.424 -0.798 . . . . 0.0 109.877 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 88' ' ' SER . . . -42.58 141.46 1.02 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 0.0 110.346 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.508 ' N ' ' HA ' ' A' ' 55' ' ' SER . 2.4 t30 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.995 -1.003 . . . . 0.0 110.044 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' CG ' ' HA ' ' A' ' 7' ' ' THR . 10.7 t70 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.238 0.542 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.55 -104.07 2.74 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.5 t -76.37 -58.81 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.302 -1.117 . . . . 0.0 109.848 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 17' ' ' CYS . 3.7 m -142.14 -49.53 0.37 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -0.86 . . . . 0.0 109.625 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.606 ' OG1' HG22 ' A' ' 21' ' ' THR . 15.3 t -134.31 35.68 3.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 1' ' ' ASP . 2.2 t-20 -94.5 68.84 3.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.096 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 22' ' ' LEU . 1.9 t -99.05 94.09 6.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 0.0 110.437 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' OG1' ' A' ' 23' ' ' THR . 0.5 OUTLIER 67.4 4.68 3.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 110.711 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -114.18 -168.5 1.37 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 110.08 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.36 99.74 3.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.877 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' OG ' ' A' ' 15' ' ' SER . 4.5 tp -88.42 27.59 1.23 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.912 . . . . 0.0 109.932 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 1.1 p 71.67 1.28 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 0.0 110.464 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 12' ' ' SER . . . 44.14 24.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.076 -1.015 . . . . 0.0 109.77 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 12' ' ' SER . 17.8 p30 -157.28 16.69 0.27 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.416 -0.802 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.535 ' OG ' ' CD2' ' A' ' 11' ' ' LEU . 22.1 p -105.73 -138.48 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.177 -0.952 . . . . 0.0 109.769 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -112.29 98.43 7.3 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.119 -0.988 . . . . 0.0 109.347 179.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 15.4 p -82.76 50.01 1.6 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.396 -0.815 . . . . 0.0 110.402 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -90.1 141.2 28.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.955 -1.091 . . . . 0.0 110.456 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' CD ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER 68.87 -156.9 0.17 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 0.0 110.345 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -123.32 -168.1 1.71 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 0.0 110.22 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.696 HG23 ' N ' ' A' ' 22' ' ' LEU . 6.6 t -166.6 -145.24 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.386 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.696 ' N ' HG23 ' A' ' 21' ' ' THR . 0.4 OUTLIER -114.37 -142.85 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.153 -0.967 . . . . 0.0 110.672 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 8' ' ' ASN . 0.2 OUTLIER -137.73 44.26 2.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 110.341 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.441 ' OD1' ' O ' ' A' ' 23' ' ' THR . 2.7 m120 -158.24 69.44 0.51 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 110.05 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -155.62 123.47 5.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.932 -1.105 . . . . 0.0 111.365 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.461 ' O ' ' HD3' ' A' ' 41' ' ' ARG . 1.0 OUTLIER -109.77 93.86 4.72 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 1.03 HG13 ' HB3' ' A' ' 42' ' ' PHE . 4.5 t -93.67 167.13 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 0.0 110.643 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 12' ' ' SER . 0.2 OUTLIER -149.49 120.63 7.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.35 -0.844 . . . . 0.0 109.956 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER 44.46 60.76 2.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.06 -1.025 . . . . 0.0 109.763 -179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.749 ' OG ' HG12 ' A' ' 27' ' ' VAL . 1.4 m -128.1 -169.19 2.02 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.135 -0.978 . . . . 0.0 111.345 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.576 ' HA ' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -144.69 104.57 4.04 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.684 HG13 HD11 ' A' ' 47' ' ' ILE . 99.5 t -110.99 137.89 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 111.47 -178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.601 ' HB2' ' HA ' ' A' ' 48' ' ' THR . 0.3 OUTLIER -107.09 -139.68 0.37 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.509 -0.745 . . . . 0.0 109.563 179.352 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 49' ' ' THR . . . -68.16 61.68 0.39 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' TYR . 1.2 m -111.43 156.84 21.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -1.143 . . . . 0.0 110.189 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.781 HG21 HG23 ' A' ' 51' ' ' THR . 0.7 OUTLIER -106.42 -173.18 2.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.516 -0.74 . . . . 0.0 109.915 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.674 ' O ' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -150.84 76.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.0 110.649 -179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.422 ' HA ' HD22 ' A' ' 22' ' ' LEU . 1.9 m -90.97 47.31 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.0 109.987 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.24 95.31 2.22 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.556 ' HB3' ' CA ' ' A' ' 53' ' ' THR . 25.1 p -174.06 173.04 3.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.331 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.538 ' HD3' ' N ' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -135.81 133.78 38.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 110.221 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.03 ' HB3' HG13 ' A' ' 27' ' ' VAL . 5.7 m-85 -112.92 163.15 15.01 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.432 -0.793 . . . . 0.0 109.953 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 42' ' ' PHE . 8.7 t70 -177.19 111.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.259 -0.9 . . . . 0.0 109.122 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 59' ' ' GLY . . . 50.63 66.67 2.29 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.817 ' CG2' HG22 ' A' ' 57' ' ' ILE . 2.6 t -144.42 127.99 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.358 -1.084 . . . . 0.0 111.033 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 62' ' ' CYS . 22.1 m -104.76 96.01 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.352 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.684 HD11 HG13 ' A' ' 32' ' ' VAL . 1.1 pp -114.44 169.06 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.302 -0.874 . . . . 0.0 110.58 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.821 HG23 ' N ' ' A' ' 49' ' ' THR . 1.3 t -112.78 -150.21 0.46 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.039 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.821 ' N ' HG23 ' A' ' 48' ' ' THR . 34.8 m -73.41 94.37 2.07 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.195 -0.941 . . . . 0.0 110.016 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.505 ' HB3' ' CA ' ' A' ' 66' ' ' THR . 0.3 OUTLIER -139.9 157.86 45.02 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.052 -1.03 . . . . 0.0 111.394 -179.454 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.781 HG23 HG21 ' A' ' 36' ' ' THR . 27.5 m -104.09 50.57 0.79 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.592 -0.692 . . . . 0.0 109.372 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.525 ' CB ' ' HB2' ' A' ' 67' ' ' CYS . 0.1 OUTLIER -102.7 102.81 13.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.344 -0.848 . . . . 0.0 110.594 -179.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.654 HG21 ' HA ' ' A' ' 37' ' ' CYS . 82.1 p -141.19 113.94 8.35 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 70' ' ' THR . . . 166.14 -27.09 0.17 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.555 ' HA ' ' CA ' ' A' ' 89' ' ' ALA . 72.6 p -118.85 162.01 19.19 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -1.102 . . . . 0.0 110.41 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 3.6 ttt180 -91.36 119.08 31.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.867 . . . . 0.0 108.997 179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.817 HG22 ' CG2' ' A' ' 45' ' ' VAL . 1.0 OUTLIER -99.64 152.29 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.041 -1.037 . . . . 0.0 111.65 -178.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.63 140.73 26.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.814 -0.554 . . . . 0.0 109.906 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' GLY . . . 171.21 120.23 0.54 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.114 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -72.09 -5.32 16.86 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.719 1.379 . . . . 0.0 108.899 178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -162.61 33.88 0.32 Allowed Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 63' ' ' LYS . 1.7 t -72.02 160.1 33.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.98 -1.306 . . . . 0.0 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 82' ' ' ILE . 17.5 mmtt -141.51 110.79 6.33 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.439 -0.788 . . . . 0.0 110.265 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.592 HG21 ' HB ' ' A' ' 47' ' ' ILE . 6.6 tt -99.45 171.53 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.016 -1.052 . . . . 0.0 109.314 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . 2.2 t -152.94 87.83 1.3 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.904 -1.122 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.505 ' CA ' ' HB3' ' A' ' 50' ' ' SER . 10.2 p 52.21 104.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.467 -0.771 . . . . 0.0 110.948 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.525 ' HB2' ' CB ' ' A' ' 52' ' ' SER . 82.0 m -119.55 -152.73 0.51 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.49 -0.756 . . . . 0.0 109.223 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.746 ' N ' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -138.59 170.85 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.913 -1.117 . . . . 0.0 110.58 -179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -53.96 137.38 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 0.0 109.402 179.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.712 ' OG1' HG13 ' A' ' 73' ' ' VAL . 2.1 t -145.42 -166.5 2.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 111.039 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -172.63 30.8 0.11 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 128.2 78.79 0.24 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.712 HG13 ' OG1' ' A' ' 70' ' ' THR . 14.2 m -94.22 124.28 56.31 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.231 -1.158 . . . . 0.0 110.564 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.62 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 49.1 Cg_endo -74.74 152.35 42.03 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 124.022 1.538 . . . . 0.0 110.44 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.888 ' HB1' ' HD2' ' A' ' 76' ' ' PRO . . . 64.32 179.02 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 110.224 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.888 ' HD2' ' HB1' ' A' ' 75' ' ' ALA . 46.0 Cg_endo -73.85 63.52 4.9 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.934 1.491 . . . . 0.0 110.623 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 1.0 OUTLIER 71.42 -49.7 0.68 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.166 -0.959 . . . . 0.0 111.223 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 50.77 24.01 1.59 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.774 -1.204 . . . . 0.0 108.073 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -157.16 -60.03 0.09 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 66' ' ' THR . 7.8 t -83.44 179.04 7.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.638 -0.664 . . . . 0.0 109.571 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -102.33 104.12 14.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.958 -1.089 . . . . 0.0 110.098 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' LYS . 1.6 tp -132.46 151.35 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.135 -0.978 . . . . 0.0 110.457 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -140.82 118.76 11.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.168 -0.958 . . . . 0.0 110.679 -179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 62' ' ' CYS . . . 72.04 46.13 37.77 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.561 ' HB3' ' CE2' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -128.15 154.27 45.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.232 -1.158 . . . . 0.0 111.43 -179.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.579 ' C ' ' CG ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.74 165.81 12.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.476 -0.765 . . . . 0.0 109.056 178.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.579 ' CG ' ' C ' ' A' ' 86' ' ' THR . 0.1 OUTLIER -155.4 155.67 34.0 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.784 -1.197 . . . . 0.0 110.131 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -175.76 41.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.019 -1.051 . . . . 0.0 111.145 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.555 ' CA ' ' HA ' ' A' ' 55' ' ' SER . . . 55.8 155.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.439 -0.788 . . . . 0.0 110.843 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 41' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.548 179.586 . . . . . . . . 2 2 . 1 stop_ save_